Citrus Sinensis ID: 010146
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.905 | 0.597 | 0.528 | 1e-159 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.976 | 0.594 | 0.478 | 1e-142 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.963 | 0.611 | 0.489 | 1e-136 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.990 | 0.614 | 0.467 | 1e-135 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.994 | 0.608 | 0.470 | 1e-133 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.970 | 0.592 | 0.463 | 1e-132 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.976 | 0.589 | 0.456 | 1e-131 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.972 | 0.596 | 0.470 | 1e-131 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.955 | 0.581 | 0.456 | 1e-121 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.970 | 0.588 | 0.436 | 1e-115 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 274/518 (52%), Positives = 350/518 (67%), Gaps = 50/518 (9%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G+N VTGL RF++SW++ DDP+ NY ++DP GVPQ +K S + FR GPWNGL
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
+TG P L+PNP+Y +EYV E EV+Y + L SVLT M +NP G QR TW++ Q W
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
++ ++D CD Y LCG+Y CN+N + A C CL+GFV K+P W D S+GC+RR
Sbjct: 282 FYL---SAMMDSCDQYTLCGSYGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRR 337
Query: 181 TQLDCEHG-DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
+LDC G DGFLK +KLPDT S DKN+ + CK++C +NC+C+AY+ D+R GG
Sbjct: 338 VKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGK 397
Query: 240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVIL 299
GC+LWF DLID++ +E GQDLY+R+A+SE++ +R R
Sbjct: 398 GCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSS----------------- 440
Query: 300 IGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLG 359
R +E++ELP D +T+++AT FS NKLG
Sbjct: 441 ----------------------------RKQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472
Query: 360 EGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419
+GGFGPVY+G L GQE+AVKRLS++S QGVEEFKNE+ LIAKLQHRNLV++LG C +
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532
Query: 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479
ERMLIYEY PNKSL+ FIFD R + LDW KR +II+GIARG+LYLH+DSRLRIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592
Query: 480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
ASNVLLD+DMN KISDFG+AR G D+TEANT RVVGT
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 257/537 (47%), Positives = 350/537 (65%), Gaps = 32/537 (5%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG + TG RF+ SWKS DDP+ ++ ++++ G P+ +R+GPWNG+
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIR 226
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G P++QP F + +++ EV Y F + KS V + + I+ G QR TW+E Q W
Sbjct: 227 FSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN 286
Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
F P DQCD Y CG Y C+ N+ S C C++GF P++P W L D SDGC+
Sbjct: 287 QFWYAP-----KDQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCV 340
Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
R+T L C GDGF++ + +KLPDT+ + VD+ I + C++ C ++C+CTA+AN D+RG G
Sbjct: 341 RKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSG 400
Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVV--IIIICALLATG 296
SGC+ W +L D++ ++GGQDLY+R+A ++L++ KR + K++ I + LL
Sbjct: 401 SGCVTWTGELFDIRNYAKGGQDLYVRLAATDLED----KRNRSAKIIGSSIGVSVLLLLS 456
Query: 297 VILIGGFMYMRKKKR---------------RDQ-GNTVGSSELDYIDRGNRKENMELPMF 340
I+ F++ RK+KR RD N V S +I R N +++ELP+
Sbjct: 457 FIIF--FLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLM 514
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
++ +A AT+NFS NKLG+GGFG VY+G L +GQE+AVKRLSK+S QG +EFKNEV LI
Sbjct: 515 EFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLI 574
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
A+LQH NLVRLL CC E+MLIYEYL N SL+ +FD +R L+W R II GIAR
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GLLYLHQDSR RIIHRDLKASN+LLD M PKISDFGMAR FG D+TEANT +VVGT
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 256/523 (48%), Positives = 352/523 (67%), Gaps = 25/523 (4%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNG 58
MKLG N T ++ +SSWK+ DP+ ++ +D RG+PQ + RK S +R G WNG
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221
Query: 59 LHWTGTPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQ 117
L +TG P + + N ++ +++ S+ EV Y + + +++ +V+N G+ R +Q Q
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWT-PRHRIVSRLVLNNTGKLHRFIQSKQNQ 280
Query: 118 KWAPFVPFSGLILDQCDNYALCGAYAICNMNS-NSARCECLEGFVPKSPSEWDLLDTSDG 176
++ + D+CD Y++CGAYA+C +NS N+ C CL+GF PKS +W++ + G
Sbjct: 281 ----WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYG 336
Query: 177 CIRRTQLDCEHGDGFLKRESVKLPDTSFSRVD--KNISILACKELCSKNCSCTAYANADV 234
C+ +CE D F+K +KLPDTS+S D +++ CK CS NCSCTAYAN D+
Sbjct: 337 CVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDI 396
Query: 235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLA 294
R GG GCLLWF DL+DM+ S GQD+YIRM F + + + ++ V +++ +
Sbjct: 397 REGGKGCLLWFGDLVDMREYSSFGQDVYIRMG------FAKIEFKGREVVGMVVGSVVAI 450
Query: 295 TGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSW 354
V+++ + +K +R +G +G +E+++LP+FD TI+ ATD+FS+
Sbjct: 451 AVVLVVVFACFRKKIMKRYRGEN--------FRKGIEEEDLDLPIFDRKTISIATDDFSY 502
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
N LG GGFGPVY+G L +GQEIAVKRLS +SGQGVEEFKNEV LIAKLQHRNLVRLLGC
Sbjct: 503 VNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGC 562
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
C +E MLIYEY+PNKSL+ FIFD R+ LDW KR II G+ARG+LYLHQDSRLRII
Sbjct: 563 CIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRII 622
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
HRDLKA NVLLDNDMNPKISDFG+A++FG DQ+E++T+RVVGT
Sbjct: 623 HRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 484 bits (1245), Expect = e-135, Method: Compositional matrix adjust.
Identities = 248/531 (46%), Positives = 339/531 (63%), Gaps = 19/531 (3%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
M+LG GL R ++SWKS DP + I ++ RG PQ + KG +R G W G
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
W+G P++ ++ +V+NE+EV + + + +SV+T ++N G R TW+ + ++W
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274
Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNM-NSNSARCECLEGFVPKSPSEWDLLDTSDGC 177
F VP +QCDNYA CG C+ +S + C CL GF PK P W L D+S GC
Sbjct: 275 DFWSVP-----KEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGC 329
Query: 178 IRRTQLD-CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANA--DV 234
++ + C DGF+K + +K+PDTS + VD NI++ CK+ C KNCSC AYA+A +
Sbjct: 330 TKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHES 389
Query: 235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLA 294
+ G GCL W ++D + GQD YIR+ EL + R K++V++I+I + A
Sbjct: 390 KRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAA 449
Query: 295 TGVILIGGFMYMRKKKR----RDQGNTVGSSELDYID----RGNRKENMELPMFDWNTIA 346
++ + F +R++++ R D+ + ++ N ELP+FD NTI
Sbjct: 450 VMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIV 509
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 406
AT+NFS +NKLG GGFGPVY+G+L EIAVKRLS++SGQG+EEFKNEV LI+KLQHR
Sbjct: 510 AATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHR 569
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
NLVR+LGCC +E+ML+YEYLPNKSL+ FIF + LDW KR +I+ GIARG+LYLH
Sbjct: 570 NLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLH 629
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
QDSRLRIIHRDLKASN+LLD++M PKISDFGMAR FG +Q E T RVVGT
Sbjct: 630 QDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 476 bits (1224), Expect = e-133, Method: Compositional matrix adjust.
Identities = 251/534 (47%), Positives = 339/534 (63%), Gaps = 20/534 (3%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G +G+ R M+SW+S DP N Y ++ RG PQ + KG + +R G W G
Sbjct: 158 MKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
W+G P++ ++ +V+N +EV + ++ +SV T MV+N G QR W + +KW
Sbjct: 218 WSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQRFRWNGRDKKW- 276
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSA-RCECLEGFVPKSPSEWDLLDTSDGCIR 179
+ F D+CD Y CG C+ S C CL G+ PK+P +W L D SDGC R
Sbjct: 277 --IGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTR 334
Query: 180 -RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANA--DVRG 236
+ C +GF K + VK+P+TS VD NI++ C++ C KNCSC AYA+A + +
Sbjct: 335 IKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQD 394
Query: 237 GGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATG 296
G GCL W +++D + GQD Y+R+ SEL + KK++V+I+I +
Sbjct: 395 GAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVM 454
Query: 297 VILIGGFMYMRKKKRRDQGN-------TVGSSELDYIDR------GNRKENMELPMFDWN 343
++LI Y+RK+++R Q N + S D D ++ + ELP+F+ +
Sbjct: 455 LLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELS 514
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
TIA AT+NF+++NKLG GGFGPVY+G+L G EIAVKRLSKSSGQG+EEFKNEV LI+KL
Sbjct: 515 TIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKL 574
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
QHRNLVR+LGCC +E+ML+YEYLPNKSL+ FIF + LDW KR II GI RG+L
Sbjct: 575 QHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGIL 634
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLHQDSRLRIIHRDLKASNVLLDN+M PKI+DFG+AR FG +Q E +T+RVVGT
Sbjct: 635 YLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 250/539 (46%), Positives = 343/539 (63%), Gaps = 37/539 (6%)
Query: 1 MKLGV-NLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGL 59
MK+G N G R + SWK+ DDP+ ++ ++ G P+ I +R+GPW G
Sbjct: 165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224
Query: 60 HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
++ P ++P + N +V Y + + K+++ +++ ++ G QRLTWME Q W
Sbjct: 225 RFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSW 284
Query: 120 AP--FVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGC 177
+ P D CDNY CG Y C+ N+ S C C++GF P + + L D S GC
Sbjct: 285 KQLWYSP-----KDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGC 337
Query: 178 IRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
+R+T+L C+ DGF++ + ++LPDT+ + VDK I + C+E C K C+CTA+AN D+R G
Sbjct: 338 VRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNG 397
Query: 238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGV 297
GSGC++W L D++ ++GGQDLY+R+A +L++ KR K KK II + + +
Sbjct: 398 GSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED----KRIKSKK----IIGSSIGVSI 449
Query: 298 ILIGGFM----YMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELP 338
+L+ F+ + RK+KR R Q N + + Y + N+ + +ELP
Sbjct: 450 LLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELP 509
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL 398
+ +W +A AT+NFS NKLG+GGFG VY+GML +G+EIAVKRLSK S QG +EF NEV
Sbjct: 510 LMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVR 569
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
LIAKLQH NLVRLLGCC + E+MLIYEYL N SL+ +FD TR+ L+W KR II GI
Sbjct: 570 LIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGI 629
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
ARGLLYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGT
Sbjct: 630 ARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 245/537 (45%), Positives = 351/537 (65%), Gaps = 32/537 (5%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG NL TGL RF++SW+S+DDP+ N+ Y+++ + +P+ + + R+GPWNG+
Sbjct: 169 MKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIR 228
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G P+ Q + ++ N EV Y F + +S + + + +G QRLTW + W
Sbjct: 229 FSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWN 288
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
F +S + QCD Y +CG YA C++N+ S C C++GF P++ +WD + GCIRR
Sbjct: 289 RF--WSSPVDPQCDTYIMCGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRR 345
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
TQL C GDGF + + +KLP+T+ + VD++I + CK+ C +C+CTA+ANAD+R GGSG
Sbjct: 346 TQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSG 404
Query: 241 CLLWFHDLIDMKVLSEG---GQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGV 297
C++W L D++ + GQDLY+R+A +++ KR K++ + + ++ +
Sbjct: 405 CVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK----KRNASGKIISLTVG--VSVLL 458
Query: 298 ILIGGFMYMRKKKR------------RDQG----NTVGSSELDYIDRGNRK-ENMELPMF 340
+LI ++ RK+KR R+Q V SS+ ++ G K E +ELP+
Sbjct: 459 LLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREF--SGEYKFEELELPLI 516
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
+ T+ AT+NFS NKLG+GGFG VY+G L +G+EIAVKRLSK+S QG +EF NEV LI
Sbjct: 517 EMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLI 576
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
A+LQH NLV++LGCC DE+MLIYEYL N SL+ ++F TR L+W++R I G+AR
Sbjct: 577 ARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVAR 636
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GLLYLHQDSR RIIHRDLK SN+LLD +M PKISDFGMAR F D+TEANT +VVGT
Sbjct: 637 GLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 253/538 (47%), Positives = 346/538 (64%), Gaps = 35/538 (6%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG + TG R + SWK+ DDP+ + +++ P+ I +R+GPWNG+
Sbjct: 161 MKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMR 220
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++ P + + +++ EV Y + + K+++ + + +N G QRLTW E TQ W
Sbjct: 221 FSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWK 280
Query: 121 P--FVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
+ P D CDNY +CG + C+ NS C C++GF P + WDL D S GC+
Sbjct: 281 QLWYSP-----KDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCM 334
Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
R+T+L C+ DGF + + +KLPDT+ + VD+ I + CKE C ++C+CTA+ANAD+R GG
Sbjct: 335 RKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGG 394
Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVI 298
SGC++W +++DM+ ++GGQDLY+R+A +EL++ KR K +K II + + ++
Sbjct: 395 SGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRIKNEK----IIGSSIGVSIL 446
Query: 299 LIGGFM----YMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPM 339
L+ F+ + RK+KR R Q N V S Y + + E +ELP+
Sbjct: 447 LLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPL 506
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLL 399
+ +A AT+NFS NKLG+GGFG VY+G L +G+EIAVKRLSK S QG +EF NEV L
Sbjct: 507 LELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRL 566
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
IAKLQH NLVRLLGCC + E+MLIYEYL N SL+ +FD TR+ L+W KR II GIA
Sbjct: 567 IAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIA 626
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
RGLLYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGT
Sbjct: 627 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 253/554 (45%), Positives = 327/554 (59%), Gaps = 60/554 (10%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKI-KFRAGPWNGL 59
M++ VN TG SW+S DP+ NY VDP G P+ V +G+K K+R+G WN
Sbjct: 164 MRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSA 223
Query: 60 HWTGTP--QLQPNPVYTFEYVSNENE---VFYRFNLIKSSVLTMMVINPQGEPQRLTWME 114
+TG P L N +Y F+ S +E V++ + SVL + G + L W E
Sbjct: 224 IFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNE 283
Query: 115 QTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTS 174
+KW F +CD Y CG + IC+M ++ C C+ G+ S W S
Sbjct: 284 TLKKWTKFQSEPD---SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----S 335
Query: 175 DGCIRRTQLDCEHG-----DGFLKRESVKLPDTSFSRVDKN-ISILACKELCSKNCSCTA 228
GC RRT L CE D FL +SVKLPD F + N + C+E C +NCSC A
Sbjct: 336 RGCRRRTPLKCERNISVGEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNA 393
Query: 229 YANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIII 288
Y+ GG GC++W DL+D++ GG L+IR+A SE+ +TK I +
Sbjct: 394 YSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENRKTK--------IAV 441
Query: 289 ICALLATGVILIGGFMYM--RKKKRRD-----------------------QGNTVGSSEL 323
I A+L GVILIG F + R K+++D + + S +
Sbjct: 442 IVAVLV-GVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSV 500
Query: 324 DYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLS 383
D + G ELP+F N IA AT++F +N+LG GGFGPVY+G+L +G+EIAVKRLS
Sbjct: 501 DIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLS 560
Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
SGQGV+EFKNE++LIAKLQHRNLVRLLGCC +E+ML+YEY+PNKSL+ F+FD T+
Sbjct: 561 GKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQ 620
Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
+DW R IIEGIARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFGMAR FG
Sbjct: 621 ALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFG 680
Query: 504 VDQTEANTDRVVGT 517
+Q EANT RVVGT
Sbjct: 681 GNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 235/538 (43%), Positives = 326/538 (60%), Gaps = 36/538 (6%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG + GL RF++SWKS+ DP+ +++++++ G+P+ +R+GPW+GL
Sbjct: 168 MKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFLEVYRSGPWDGLR 227
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G ++Q + + N EV Y F + + + + IN G + W Q+W
Sbjct: 228 FSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWN 287
Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
F +P D CD Y +CG YA C+M S S C C++GF P SP +W D + C
Sbjct: 288 MFWFMP-----KDTCDLYGICGPYAYCDM-STSPTCNCIKGFQPLSPQDWASGDVTGRCR 341
Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
R+TQL C D F + ++K+P T+ + VDK I + C+E C +C+CTAYAN+D+R GG
Sbjct: 342 RKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYANSDIRNGG 400
Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVI 298
SGC++W + D++ + GQDL++R+A +E ER R K +II I +L I
Sbjct: 401 SGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFG--ERRTIRGKIIGLIIGISLMLVLSFI 458
Query: 299 LIGGFMYMRKKKRRDQGNTVGSSELDYIDR--------------GNRKENMELPMFD--- 341
+ + + +KK++R + ++ + Y DR G R E +
Sbjct: 459 I---YCFWKKKQKRARAT---AAPIGYRDRIQELIITNGVVMSSGRRLLGEEEDLELPLT 512
Query: 342 -WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
+ T+ AT+NFS N LG GGFG VY+G L +GQEIAVKRLS+ S QG EFKNEV LI
Sbjct: 513 EFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLI 572
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIA 459
A+LQH NLVRLL CC DE++LIYEYL N SL+ +F+ T++ L+W R II GIA
Sbjct: 573 ARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIA 632
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
RGLLYLHQDSR +IIHRDLKASNVLLD +M PKISDFGMAR F D+TEANT +VVGT
Sbjct: 633 RGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETEANTRKVVGT 690
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.992 | 0.617 | 0.599 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.972 | 0.619 | 0.584 | 1e-173 | |
| 302143143 | 910 | unnamed protein product [Vitis vinifera] | 0.982 | 0.558 | 0.558 | 1e-172 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.982 | 0.316 | 0.563 | 1e-172 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.982 | 0.621 | 0.557 | 1e-171 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.986 | 0.613 | 0.561 | 1e-171 | |
| 302143131 | 1901 | unnamed protein product [Vitis vinifera] | 0.984 | 0.267 | 0.554 | 1e-170 | |
| 302143132 | 2646 | unnamed protein product [Vitis vinifera] | 0.992 | 0.193 | 0.552 | 1e-170 | |
| 224115106 | 755 | predicted protein [Populus trichocarpa] | 0.988 | 0.676 | 0.586 | 1e-170 | |
| 224122974 | 729 | predicted protein [Populus trichocarpa] | 0.982 | 0.696 | 0.582 | 1e-170 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/517 (59%), Positives = 388/517 (75%), Gaps = 4/517 (0%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G N+VTGL R++SSWKS++DPAQ + + +DPRG Q + +G KI +R G WNG
Sbjct: 160 MKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYR 219
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
WTGTPQL+PN +YT+ ++S E++Y+F+LI SSV + +V+N G QR TW+ +T WA
Sbjct: 220 WTGTPQLEPNMLYTYGFISTATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSWA 279
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
F S ++LDQCD+YALCGAY CN+N C CLEGF+PKSP +W + + SDGC+RR
Sbjct: 280 RF---SAVLLDQCDDYALCGAYGSCNVNKQPV-CACLEGFIPKSPKDWSIQEWSDGCVRR 335
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T+LDC+ GD FL+ VKLPD S VD + + CK+LC KNCSC AYAN+D+RGGGSG
Sbjct: 336 TKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSG 395
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
CLLWF +LID + L+ GGQDLYIR+A SEL N E+ + KK++ II+ + GV+++
Sbjct: 396 CLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSSDKKQLGIIVGTIITIVGVLVL 455
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
+Y R+KK + Q N S +Y D RKE+MELP FD +TIA+ATDNFS +NKLGE
Sbjct: 456 AFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGE 515
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
GGFG VY+G L EGQE+AVKRLSK+SGQG+ EFKNEV+LIAKLQHRNLV+LLGCC DE
Sbjct: 516 GGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDE 575
Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
R+LIYEY+PNKSL+ FIFD DW I+ GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 576 RILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKA 635
Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+NVLLDN MNPKISDFG+AR FG DQTEANT+++VGT
Sbjct: 636 ANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGT 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-173, Method: Compositional matrix adjust.
Identities = 302/517 (58%), Positives = 375/517 (72%), Gaps = 14/517 (2%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG NLVTGL F+SSWK ++PA + +D +G PQ + RK ++I +R G WNG +
Sbjct: 157 MKLGSNLVTGLNSFLSSWKGKENPAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQY 216
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
+TG P+L+P+P+YTFE+V N NEV+++F L SSV + + + P G Q TW QT W
Sbjct: 217 FTGFPELKPDPIYTFEFVFNRNEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDW- 275
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
F+ ++D+C+NYALCGA A C+ NS S C+CL+GF+ KSP+EW+ + + GCIRR
Sbjct: 276 --YVFATAVVDRCENYALCGANARCDSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRR 332
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T LDC DGF VKLPDTS S D + S++ C+ LC +NCSC AYAN D RG GSG
Sbjct: 333 TPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSG 392
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
CL WF DLID + L+EGGQD+YIR+A S+ KR+KK +I +L + ++++
Sbjct: 393 CLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILIL 452
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
G +R++K R GN + DR ++E MELPM D TI ATDNFS KLGE
Sbjct: 453 GIVFCIRRRKHRKNGN--------FEDR--KEEEMELPMLDLTTIEHATDNFSSSKKLGE 502
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
GGFG VY+G L EGQEIAVKRLSKSSGQG+ EFKNEVLLIAKLQHRNLV+LLGCC DE
Sbjct: 503 GGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDE 562
Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
+MLIYEY+PN+SL+ FIFD TR KFLDWSKR II+GIARGLLYLHQDSRLRIIHRD+KA
Sbjct: 563 KMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKA 622
Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
SN+LLDN++NPKISDFG+AR FG DQTEANT RVVGT
Sbjct: 623 SNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGT 659
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143143|emb|CBI20438.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 289/517 (55%), Positives = 385/517 (74%), Gaps = 9/517 (1%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G N VTGL R++SSWKS DDP++ ++ Y +DP G PQ R GS + FR+GPWNG+
Sbjct: 141 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 200
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
+ G P+L+PNPV+ + +V NE E+++ + L+ SSVL+ +V+NP G QRL W+ +T+ W
Sbjct: 201 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 260
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ S D CD+YALCGAY+ CN++ S RC C++GFVPK P +WD +D S+GC+R+
Sbjct: 261 VY---STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRK 316
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T LDC+ GDGF+K VKLPDT S ++++++ C LC +NCSC+AY N+D++GGGSG
Sbjct: 317 TSLDCQKGDGFVKCSGVKLPDTRNSWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSG 376
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
CLLWF DLID+K +E GQD YIRMA SELD + +R+ V + I ++ +++
Sbjct: 377 CLLWFGDLIDVKEFTENGQDFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVT 436
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
+Y+ KK+ + +G T ++E + R+E++ELP+FD +TI +AT NFS NKLGE
Sbjct: 437 ---LYLLKKRLKRKGTTELNNE--GAETNERQEDLELPLFDLDTILNATHNFSRNNKLGE 491
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
GGFGPVY+GML +G+EIAVKRLSK S QG++EFKNEV+ I+KLQHRNLV+LLGCC +E
Sbjct: 492 GGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEE 551
Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
+MLIYEY+PNKSL FIFD ++ LDW KR II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 552 KMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKA 611
Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
NVLLDN+MNP+ISDFGMAR+FG ++T+A T RVVGT
Sbjct: 612 DNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGT 648
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 293/520 (56%), Positives = 390/520 (75%), Gaps = 12/520 (2%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG N VTGL R++S+WKSADDP++ ++ Y +DPRG PQ + RKGS + FR+GPWNG+
Sbjct: 948 MKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILRKGSAVTFRSGPWNGVR 1007
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G P+L PN +YT+E+V NE E+++R+ L+ SSV++ +V+NP G QR+ W+++T W
Sbjct: 1008 FSGFPELGPNSIYTYEFVFNEKEMYFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTNGW- 1066
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ +S D CD+YALCG Y ICN+N S +CEC+EGFVPK ++WD+ D S+GC+R
Sbjct: 1067 --ILYSSAPKDDCDSYALCGVYGICNIN-RSPKCECMEGFVPKFQNDWDMADWSNGCVRS 1123
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T LDC++G+GF+K VKLPDT S ++++ ++ C +C NCSCTAY N D+R GGSG
Sbjct: 1124 TPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSCTAYTNLDIRDGGSG 1183
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNF-ERTKRRKKKKVVIIIICALLATGVIL 299
CLLWF DLID++ +E GQ++Y+RMA SEL E K KK II+ ++ + +IL
Sbjct: 1184 CLLWFGDLIDIREFNENGQEIYVRMAASELGGSKESGSNLKGKKRKWIIVGSVSSVVIIL 1243
Query: 300 IGGFM--YMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNK 357
+ F+ Y+ K KR+ + T+G Y KE+ +L +FD+ T++ AT++FS+ NK
Sbjct: 1244 VSLFLTLYLLKTKRQRKKGTMG-----YNLEVGHKEDSKLQLFDFATVSKATNHFSFDNK 1298
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
LGEGGFG VY+G+L EGQEIAVKRLSK SGQG++E KNEV+ IAKLQHRNLVRLLGCC
Sbjct: 1299 LGEGGFGLVYKGILQEGQEIAVKRLSKDSGQGLDELKNEVIYIAKLQHRNLVRLLGCCIH 1358
Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
+E+MLIYEY+ NKSL+ FIFD T++ LDW+KR II GIARGLLYLHQDSRLRIIHRD
Sbjct: 1359 GEEKMLIYEYMSNKSLDSFIFDKTQSMELDWNKRFLIINGIARGLLYLHQDSRLRIIHRD 1418
Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LKA N+LLD +M PKISDFGMAR+FG ++TEANT RVVGT
Sbjct: 1419 LKAGNILLDEEMAPKISDFGMARSFGGNETEANTKRVVGT 1458
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 288/517 (55%), Positives = 382/517 (73%), Gaps = 9/517 (1%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G N VTGL R++SSWKS DDP++ ++ Y +DP G PQ R GS + FR+GPWNG+
Sbjct: 159 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 218
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
+ G P+L+PNPV+ + +V NE E+++ + L+ SSVL+ +V+NP G QRL W+ +T+ W
Sbjct: 219 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 278
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ S D CD+YALCGAY+ CN++ S RC C++GFVPK P +WD +D S+GC+R+
Sbjct: 279 VY---STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRK 334
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T LDC+ GDGF K VKLPDT S ++++++ C LC +NCSC+AY N+D++GGGSG
Sbjct: 335 TSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSG 394
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
CLLWF DLID+K +E GQD YIRMA SELD + +R+ V + I ++ +++
Sbjct: 395 CLLWFGDLIDIKEFTENGQDFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVT 454
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
+Y+ KK+ + +G T ++E + R+E++ELP+F +TI +AT NFS NKLGE
Sbjct: 455 ---LYLLKKRLKRKGTTELNNE--GAETNERQEDLELPLFXLDTILNATHNFSRNNKLGE 509
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
GGFGPVY+GML +G+EIAVKRLSK S QG++EFKNEV+ I+KLQHRNLV+LLGCC +E
Sbjct: 510 GGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEE 569
Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
+MLIYEY+PNKSL FIFD ++ LDW KR II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 570 KMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKA 629
Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
NVLLDN+MNP+ISDFGMAR+FG ++T A T RVVGT
Sbjct: 630 DNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 293/522 (56%), Positives = 390/522 (74%), Gaps = 12/522 (2%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G++ VTGL R+++SWKS DP+ Y ++DP G+PQ +GS +FR+GPWNGL
Sbjct: 165 MKYGISFVTGLNRYLTSWKSPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLR 224
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G L+PNP+YTFE+V N+ E++Y++ + SSVL+ MV++P G QR TW+++TQ W
Sbjct: 225 FSGMINLKPNPIYTFEFVFNQEEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWT 284
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
++ + +D CD +ALCGA+ +CN+N NS C+CL+ F PKS EW D S GC+R+
Sbjct: 285 LYLTAN---MDNCDRFALCGAHGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRK 340
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
LDC +G+GF+K +K+PDT S +K I++ C+E+C KNCSCTAYAN DVR GGSG
Sbjct: 341 APLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSG 400
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIII-CALLATGVIL 299
C+LWF DLID++ +E GQD+YIR+A S +D + K R KK+V II+I +L+A ++
Sbjct: 401 CVLWFGDLIDIRQYNENGQDIYIRIAASVID--KPVKSRGKKRVRIIVIPVSLVAFSLLA 458
Query: 300 IGGFM-YMRKKKRRD---QGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWK 355
+ F+ ++RK K++ +GN V + E D + +R E++ELP+FD T+ DAT+ FS
Sbjct: 459 LCLFLRFLRKNKQQQLTREGNVVTNPEQDRT-KESRNEDLELPLFDLATLTDATNCFSIN 517
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
NKLG+GGFGPVY+G+L +GQEIAVKRLSK S QG+ EF+NEV+ IAKLQHRNLV+LLGCC
Sbjct: 518 NKLGQGGFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCC 577
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ERMLIYEY+PNKSL+ FIFD R LDW+KR II GIARGLLYLHQDSRLRIIH
Sbjct: 578 IELEERMLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIH 637
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
RDLKASN+LLD +MNPKISDFGMAR+FG D+T ANT R+VGT
Sbjct: 638 RDLKASNILLDYEMNPKISDFGMARSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143131|emb|CBI20426.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-170, Method: Compositional matrix adjust.
Identities = 298/537 (55%), Positives = 391/537 (72%), Gaps = 28/537 (5%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G NL+TGL +++SWKS DDP+ ++ +DPRG PQ ++GS + FR+GPWNGL
Sbjct: 1220 MKYGKNLITGLDSYLTSWKSTDDPSTGDFTNRLDPRGFPQMFLKEGSVVTFRSGPWNGLR 1279
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G P L+PN +YTF +V N+ E++Y + LI SSV+T MV++P G Q TW+++ Q W
Sbjct: 1280 FSGMPNLKPNSIYTFHFVLNQKEIYYTYELINSSVVTRMVLSPNGVLQDYTWIDRRQGWL 1339
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
++ +D CD YALCGAY C++N NS C CL+GFVPK P++W++ D S GC+RR
Sbjct: 1340 LYLTAQ---MDNCDRYALCGAYGSCDIN-NSPACGCLKGFVPKHPNDWNVADWSGGCVRR 1395
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T+L+C++GDGFLK VKLPDT S + +++ CK C KNC+CTAYAN+D+R GGSG
Sbjct: 1396 TRLNCQNGDGFLKYPGVKLPDTQDSWFNMTMNLKECKMKCLKNCNCTAYANSDIRNGGSG 1455
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
C+LWF +LID++ +E GQDLY+RMA SEL+ +E + +KK+V II+ + G+IL+
Sbjct: 1456 CVLWFGNLIDIREYNENGQDLYVRMAASELEEYESSD---QKKLVKIIVIPIGLAGLILL 1512
Query: 301 GGFMYMR-------------KKKRRDQGNTVGS-------SELDYIDRGNRKENMELPMF 340
F+ + + Q NT S E D+ + + KE++ELP+F
Sbjct: 1513 VIFVILHVLKRKRLKKKAPLGEGNSSQINTFCSLITMGHNPERDHTNE-SEKEDLELPLF 1571
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
D++TIA+ATDNFS NKLG+GGFGPVY+GML GQEIAVKRLSK+S QG++EFKNEVL I
Sbjct: 1572 DFDTIAEATDNFSRSNKLGQGGFGPVYKGMLRGGQEIAVKRLSKNSRQGLDEFKNEVLCI 1631
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
AKLQHRNLV+LLG C +E+MLIYEY+PNKSL FIFD T++ LDW KR II+GIAR
Sbjct: 1632 AKLQHRNLVKLLGYCIQYEEKMLIYEYMPNKSLNSFIFDQTQSMLLDWPKRFHIIKGIAR 1691
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GLLYLHQDSRLRIIHRDLKASN+LLD +MNPKISDFGMAR+F ++TEANT RVVGT
Sbjct: 1692 GLLYLHQDSRLRIIHRDLKASNILLDQEMNPKISDFGMARSFEENETEANTTRVVGT 1748
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143132|emb|CBI20427.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-170, Method: Compositional matrix adjust.
Identities = 291/527 (55%), Positives = 390/527 (74%), Gaps = 14/527 (2%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG N VTGL R++S+WKSADDP++ ++ Y +DPRG PQ + RKGS + FR+GPWNG+
Sbjct: 1975 MKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILRKGSAVTFRSGPWNGVR 2034
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++G P+L PN +YT+E+V NE E+++R+ L+ SSV++ +V+NP G QR+ W+++T W
Sbjct: 2035 FSGFPELGPNSIYTYEFVFNEKEMYFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTNGW- 2093
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ +S D CD+YALCG Y ICN+N S +CEC+EGFVPK ++WD+ D S+GC+R
Sbjct: 2094 --ILYSSAPKDDCDSYALCGVYGICNIN-RSPKCECMEGFVPKFQNDWDMADWSNGCVRS 2150
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T LDC++G+GF+K VKLPDT S ++++ ++ C +C NCSCTAY N D+R GGSG
Sbjct: 2151 TPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSCTAYTNLDIRDGGSG 2210
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNF-ERTKRRKKKKVVIIIICALLATGVIL 299
CLLWF DLID++ +E GQ++Y+RMA SEL E K KK II+ ++ + +IL
Sbjct: 2211 CLLWFGDLIDIREFNENGQEIYVRMAASELGGSKESGSNLKGKKRKWIIVGSVSSVVIIL 2270
Query: 300 IGGFM---YMRKKKRRDQGNTVGSSE------LDYIDRGNRKENMELPMFDWNTIADATD 350
+ F+ ++ K++R +GN + Y KE+ +L +FD+ T++ AT+
Sbjct: 2271 VSLFLTLYLLKTKRQRKKGNNPYYMHHYVFRTMGYNLEVGHKEDSKLQLFDFATVSKATN 2330
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
+FS+ NKLGEGGFG VY+G+L EGQEIAVKRLSK SGQG++E KNEV+ IAKLQHRNLVR
Sbjct: 2331 HFSFDNKLGEGGFGLVYKGILQEGQEIAVKRLSKDSGQGLDELKNEVIYIAKLQHRNLVR 2390
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
LLGCC +E+MLIYEY+ NKSL+ FIFD T++ LDW+KR II GIARGLLYLHQDSR
Sbjct: 2391 LLGCCIHGEEKMLIYEYMSNKSLDSFIFDKTQSMELDWNKRFLIINGIARGLLYLHQDSR 2450
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LRIIHRDLKA N+LLD +M PKISDFGMAR+FG ++TEANT RVVGT
Sbjct: 2451 LRIIHRDLKAGNILLDEEMAPKISDFGMARSFGGNETEANTKRVVGT 2497
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1560), Expect = e-170, Method: Compositional matrix adjust.
Identities = 304/518 (58%), Positives = 376/518 (72%), Gaps = 7/518 (1%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G NLVTGL R++SSWKSADDPA+ ++ + +DPRG Q + +G I +R G WNG
Sbjct: 117 MKWGKNLVTGLDRYISSWKSADDPARGDFTFRLDPRGYNQMLLMRGLTILYRTGIWNGFR 176
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
W G P+ N VY ++VS E +Y F+L+ SSV + +VINP PQRLTW+ QT W
Sbjct: 177 WGGVPETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLWG 236
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ S + +DQCD Y LCGA IC+ NSN A C CLE F+P++P W+ D S GC+RR
Sbjct: 237 SY---SVVQIDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVRR 292
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
TQL C++GDGFL+ VKLPD S S V+ ++S++ C+ +C NCSC AY N+D+R G SG
Sbjct: 293 TQLGCKNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGASG 352
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
C LWF DL D K L GGQDLYIRMA SEL +E+ K+K+ III + A ++++
Sbjct: 353 CYLWFDDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGTLISAVVLLVL 412
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYI-DRGNRKENMELPMFDWNTIADATDNFSWKNKLG 359
G +YMR++++ QG S +D + D RK++MELP FD+ TI +ATD FS+ NKLG
Sbjct: 413 GFMLYMRRRRKTRQGKK--SIRIDNLKDESGRKDDMELPAFDFITIKNATDYFSYNNKLG 470
Query: 360 EGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419
EGGFG VY+G LT+GQEIAVKRLSK+SGQG++EFKNEV+LIAKLQHRNLV+LLGCC D
Sbjct: 471 EGGFGSVYKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEGD 530
Query: 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479
ERMLIYEY+PNKSL+ FIFD LDW II GIARGLLYLHQDSRLRIIHRDLK
Sbjct: 531 ERMLIYEYMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDLK 590
Query: 480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
ASNVLLDN MNPKISDFGMAR FG DQ EANT+R+VGT
Sbjct: 591 ASNVLLDNSMNPKISDFGMARIFGGDQIEANTNRIVGT 628
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122974|ref|XP_002330410.1| predicted protein [Populus trichocarpa] gi|222871795|gb|EEF08926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 301/517 (58%), Positives = 374/517 (72%), Gaps = 9/517 (1%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G NLVTGL R++S WKS+DDPA+ ++ + +DPRG Q + +G I FR G WNG
Sbjct: 70 MKWGKNLVTGLDRYISPWKSSDDPARGDFAFRLDPRGYNQMLLMRGLTILFRTGTWNGFR 129
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
W G P N VY ++VS NE +YRF+L+ SS+ + +VI+P G PQRLTW+ QT W
Sbjct: 130 WGGVPDTVSNTVYREQFVSTPNESYYRFDLLNSSIPSRLVISPAGIPQRLTWIPQTNLWG 189
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+ S + +DQCD Y LCG IC++N + A C CLE FVPK+P W+ D GC+RR
Sbjct: 190 SY---SVVQIDQCDTYTLCGVNGICSIN-DQAVCSCLESFVPKTPDRWNSQDWFGGCVRR 245
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
TQL C +GDGFLK VKLPD S S V+ ++S+ C ++C NCSC AY+N+D+RGGGSG
Sbjct: 246 TQLGCNNGDGFLKHTGVKLPDMSDSWVNTSMSLNECGDMCLSNCSCVAYSNSDIRGGGSG 305
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
C LWF +L D K L +GG+DLYIRMA SEL + RRK +++++ I+ + + V+++
Sbjct: 306 CYLWFSELKDTKQLPQGGEDLYIRMAASEL---RISSRRKLRRIIVGIL--IPSVVVLVL 360
Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
G +YMR+K R Q T +Y D +RK+ MELP FD+ TI +ATD FS+ KLGE
Sbjct: 361 GLILYMRRKNPRRQAFTPSIRIENYKDESDRKDGMELPAFDFTTIENATDCFSFNKKLGE 420
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
GGFG VY+G L++GQEIAVKRLSK SGQG+ EFKNEV+LIAKLQHRNLV+LLGCC +E
Sbjct: 421 GGFGSVYKGTLSDGQEIAVKRLSKDSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGNE 480
Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
RMLIYEY+PNKSL+ FIFD T T LDW R II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 481 RMLIYEYMPNKSLDNFIFDQTNTNILDWQTRLNIIGGIARGLLYLHQDSRLRIIHRDLKA 540
Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
SNVLLD+ MNPKISDFGMAR FG DQ EANT R+VGT
Sbjct: 541 SNVLLDDSMNPKISDFGMARTFGGDQIEANTSRIVGT 577
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.524 | 0.346 | 0.507 | 1.9e-151 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.982 | 0.597 | 0.473 | 1.3e-130 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.961 | 0.609 | 0.501 | 1.3e-130 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.984 | 0.603 | 0.469 | 1.3e-125 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.982 | 0.599 | 0.459 | 5.1e-122 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.972 | 0.592 | 0.442 | 4.9e-108 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.974 | 0.598 | 0.416 | 1.2e-104 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.955 | 0.582 | 0.425 | 3.9e-99 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.974 | 0.607 | 0.414 | 2.8e-98 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.940 | 0.597 | 0.407 | 7.4e-98 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 1.9e-151, Sum P(2) = 1.9e-151
Identities = 140/276 (50%), Positives = 191/276 (69%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MK G+N VTGL RF++SW++ DDP+ NY ++DP GVPQ +K S + FR GPWNGL
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
+TG P L+PNP+Y +EYV E EV+Y + L SVLT M +NP G QR TW++ Q W
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
++ ++D CD Y LCG+Y CN+N + A C CL+GFV K+P W D S+GC+RR
Sbjct: 282 FYL---SAMMDSCDQYTLCGSYGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRR 337
Query: 181 TQLDCEHG-DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
+LDC G DGFLK +KLPDT S DKN+ + CK++C +NC+C+AY+ D+R GG
Sbjct: 338 VKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGK 397
Query: 240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFER 275
GC+LWF DLID++ +E GQDLY+R+A+SE++ +R
Sbjct: 398 GCILWFGDLIDIREYNENGQDLYVRLASSEIETLQR 433
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 253/534 (47%), Positives = 352/534 (65%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQA-VFRKGSKIKFRAGPWNGL 59
MKLG + TG RF+ SWKS DDP+ ++ ++++ G P+ ++ + S++ +R+GPWNG+
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRM-YRSGPWNGI 225
Query: 60 HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
++G P++QP F + +++ EV Y F + KS V + + I+ G QR TW+E Q W
Sbjct: 226 RFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNW 285
Query: 120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIR 179
F ++ DQCD Y CG Y C+ N++ C C++GF P++P W L D SDGC+R
Sbjct: 286 NQFW-YAPK--DQCDEYKECGVYGYCDSNTSPV-CNCIKGFKPRNPQVWGLRDGSDGCVR 341
Query: 180 RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
+T L C GDGF++ + +KLPDT+ + VD+ I + C++ C ++C+CTA+AN D+RG GS
Sbjct: 342 KTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGS 401
Query: 240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVIL 299
GC+ W +L D++ ++GGQDLY+R+A ++L++ +R LL + +I
Sbjct: 402 GCVTWTGELFDIRNYAKGGQDLYVRLAATDLED-KRNRSAKIIGSSIGVSVLLLLSFIIF 460
Query: 300 IGGFMYMRKKKR---------------RDQ-GNTVGSSELDYIDRGNRKENMELPMFDWN 343
F++ RK+KR RD N V S +I R N +++ELP+ ++
Sbjct: 461 ---FLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFE 517
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
+A AT+NFS NKLG+GGFG VY+G L +GQE+AVKRLSK+S QG +EFKNEV LIA+L
Sbjct: 518 EVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARL 577
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
QH NLVRLL CC E+MLIYEYL N SL+ +FD +R L+W R II GIARGLL
Sbjct: 578 QHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLL 637
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLHQDSR RIIHRDLKASN+LLD M PKISDFGMAR FG D+TEANT +VVGT
Sbjct: 638 YLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGT 691
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 263/524 (50%), Positives = 353/524 (67%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNG 58
MKLG N T ++ +SSWK+ DP+ ++ +D RG+PQ + RK S +R G WNG
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221
Query: 59 LHWTGTPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQ 117
L +TG P + + N ++ +++ S+ EV Y + + +++ +V+N G+ R +Q Q
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP-RHRIVSRLVLNNTGKLHRFIQSKQNQ 280
Query: 118 KWAPFVPFSGLILDQCDNYALCGAYAICNMNS-NSARCECLEGFVPKSPSEWDLLDTSDG 176
W + + D+CD Y++CGAYA+C +NS N+ C CL+GF PKS +W++ + G
Sbjct: 281 -W---ILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYG 336
Query: 177 CIRRTQLDCEHGDGFLKRESVKLPDTSFSRVD-KN-ISILACKELCSKNCSCTAYANADV 234
C+ +CE D F+K +KLPDTS+S D KN +++ CK CS NCSCTAYAN D+
Sbjct: 337 CVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDI 396
Query: 235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLA 294
R GG GCLLWF DL+DM+ S GQD+YIRM ++++ R +++A
Sbjct: 397 REGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVG-------SVVA 449
Query: 295 TGVILIGGFMYMRKK-KRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFS 353
V+L+ F RKK +R +G +G +E+++LP+FD TI+ ATD+FS
Sbjct: 450 IAVVLVVVFACFRKKIMKRYRGEN--------FRKGIEEEDLDLPIFDRKTISIATDDFS 501
Query: 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
+ N LG GGFGPVY+G L +GQEIAVKRLS +SGQGVEEFKNEV LIAKLQHRNLVRLLG
Sbjct: 502 YVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLG 561
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
CC +E MLIYEY+PNKSL+ FIFD R+ LDW KR II G+ARG+LYLHQDSRLRI
Sbjct: 562 CCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRI 621
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IHRDLKA NVLLDNDMNPKISDFG+A++FG DQ+E++T+RVVGT
Sbjct: 622 IHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGT 665
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
Identities = 250/532 (46%), Positives = 338/532 (63%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
MKLG + TG R + SWK+ DDP+ + +++ P+ I +R+GPWNG+
Sbjct: 161 MKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMR 220
Query: 61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
++ P + + +++ EV Y + + K+++ + + +N G QRLTW E TQ W
Sbjct: 221 FSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWK 280
Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
+S D CDNY +CG + C+ NS C C++GF P + WDL D S GC+R+
Sbjct: 281 QLW-YSPK--DLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRK 336
Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
T+L C+ DGF + + +KLPDT+ + VD+ I + CKE C ++C+CTA+ANAD+R GGSG
Sbjct: 337 TRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSG 396
Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVILI 300
C++W +++DM+ ++GGQDLY+R+A +EL++ +R LL + VI
Sbjct: 397 CVIWTREILDMRNYAKGGQDLYVRLAAAELED-KRIKNEKIIGSSIGVSILLLLSFVIF- 454
Query: 301 GGFMYMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPMFDWNTI 345
+ RK+KR R Q N V S Y + + E +ELP+ + +
Sbjct: 455 --HFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEAL 512
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
A AT+NFS NKLG+GGFG VY+G L +G+EIAVKRLSK S QG +EF NEV LIAKLQH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
NLVRLLGCC + E+MLIYEYL N SL+ +FD TR+ L+W KR II GIARGLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
HQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGT
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1200 (427.5 bits), Expect = 5.1e-122, P = 5.1e-122
Identities = 245/533 (45%), Positives = 335/533 (62%)
Query: 1 MKLGV-NLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGL 59
MK+G N G R + SWK+ DDP+ ++ ++ G P+ I +R+GPW G
Sbjct: 165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224
Query: 60 HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
++ P ++P + N +V Y + + K+++ +++ ++ G QRLTWME Q W
Sbjct: 225 RFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSW 284
Query: 120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIR 179
+S D CDNY CG Y C+ N+ S C C++GF P + + L D S GC+R
Sbjct: 285 KQLW-YSPK--DLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGCVR 339
Query: 180 RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
+T+L C+ DGF++ + ++LPDT+ + VDK I + C+E C K C+CTA+AN D+R GGS
Sbjct: 340 KTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGS 399
Query: 240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVIL 299
GC++W L D++ ++GGQDLY+R+A +L++ +R LL + +I
Sbjct: 400 GCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED-KRIKSKKIIGSSIGVSILLLLSFIIF 458
Query: 300 IGGFMYMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPMFDWNT 344
+ RK+KR R Q N + + Y + N+ + +ELP+ +W
Sbjct: 459 ---HFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKA 515
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+A AT+NFS NKLG+GGFG VY+GML +G+EIAVKRLSK S QG +EF NEV LIAKLQ
Sbjct: 516 LAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQ 575
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H NLVRLLGCC + E+MLIYEYL N SL+ +FD TR+ L+W KR II GIARGLLY
Sbjct: 576 HINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLY 635
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGT
Sbjct: 636 LHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGT 688
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 241/545 (44%), Positives = 315/545 (57%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKI-KFRAGPWNGL 59
M++ VN TG SW+S DP+ NY VDP G P+ V +G+K K+R+G WN
Sbjct: 164 MRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSA 223
Query: 60 HWTGTPQLQ--PNPVYTFEYVSNENE---VFYRFNLIKSSVLTMMVINPQGEPQRLTWME 114
+TG P + N +Y F+ S +E V++ + SVL + G + L W E
Sbjct: 224 IFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNE 283
Query: 115 QTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTS 174
+KW F +CD Y CG + IC+M ++ C C+ G+ S W S
Sbjct: 284 TLKKWTKFQSEPD---SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----S 335
Query: 175 DGCIRRTQLDCEHG-----DGFLKRESVKLPDTSFSRVDKN-ISILACKELCSKNCSCTA 228
GC RRT L CE D FL +SVKLPD F + N + C+E C +NCSC A
Sbjct: 336 RGCRRRTPLKCERNISVGEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNA 393
Query: 229 YANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXX 288
Y+ GG GC++W DL+D++ GG L+IR+A SE+ +T
Sbjct: 394 YSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGV 449
Query: 289 XC----ALLATGVI----LIGGF--------MYMRKKKRRDQGNTVGSSELDYIDRGNRK 332
ALL + G + + + + + + S +D + G
Sbjct: 450 ILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAV 509
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE 392
ELP+F N IA AT++F +N+LG GGFGPVY+G+L +G+EIAVKRLS SGQGV+E
Sbjct: 510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
FKNE++LIAKLQHRNLVRLLGCC +E+ML+YEY+PNKSL+ F+FD T+ +DW R
Sbjct: 570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
IIEGIARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFGMAR FG +Q EANT
Sbjct: 630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689
Query: 513 RVVGT 517
RVVGT
Sbjct: 690 RVVGT 694
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 226/542 (41%), Positives = 319/542 (58%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
M++ VN G R WKS DP+ Y +DP G + V +G K K+R+GPWN
Sbjct: 162 MRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAI 221
Query: 61 WTGTPQLQ--PNPVYTFEYVS---NENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQ 115
+TG P + N +Y F+ S + V++ + SS I P G ++ W +
Sbjct: 222 FTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKD 281
Query: 116 TQKW--APFVPFSGLILDQCDNYALCGAYAICNMNS--NSARCECLEGFVPKSPSEWDLL 171
+ W + P + +C+ Y CG Y++C+ + +S +C C++GF P +W+
Sbjct: 282 IRNWNLLQWKPST-----ECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNR 336
Query: 172 DTSDGCIRRTQLDCEHG------DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCS 225
D S GC RR L+C DGF + +K+PD F V + + CK++C+++CS
Sbjct: 337 DFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPD--FGSVVLHNNSETCKDVCARDCS 394
Query: 226 CTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXX 285
C AYA G GC++W DLIDM+ GG + IR+A S+L +
Sbjct: 395 CKAYALVV----GIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGGKENSTLWIIVFS 450
Query: 286 XXXXCALLATGVILIGGFMYMRKK---KRRD-------QGNTVGSSELDYIDRGNRKENM 335
LL + ++ F K K++D + SS + + G++ +
Sbjct: 451 VIGAF-LLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLV-GDQVDTP 508
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN 395
+LP+F ++++A AT +F+ +NKLG+GGFG VY+G +EG+EIAVKRLS S QG+EEFKN
Sbjct: 509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
E+LLIAKLQHRNLVRLLGCC +E+ML+YEY+PNKSL++F+FD ++ LDW KR ++I
Sbjct: 569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
GIARGLLYLH+DSRL+IIHRDLKASN+LLD +MNPKISDFGMAR F Q ANT RVV
Sbjct: 629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688
Query: 516 GT 517
GT
Sbjct: 689 GT 690
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 3.9e-99, P = 3.9e-99
Identities = 224/526 (42%), Positives = 303/526 (57%)
Query: 12 KRFMSSWKSADDPAQDNYIYEVDPRGVPQA-VFRKGSKIKFRAGPWNGLHWTGTPQLQPN 70
+ +SW S DP+ Y +DP QA +++ G+ +R+G WNG+++ G P
Sbjct: 182 RMLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPW---R 238
Query: 71 PVYTFEYVSNENEV---FYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSG 127
P+Y + + V +Y + +S L V+ P G + +Q W V +
Sbjct: 239 PLYRSGFTPAIDPVLGNYYTYTATNTS-LQRFVVLPNGTDICYMVRKSSQDWE-LVWYQP 296
Query: 128 LILDQCDNYALCGAYAICNMNSNS-ARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCE 186
++C+ YA CG A C + + A+C CL+GF PK +W+ + S GCIR L CE
Sbjct: 297 S--NECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCE 354
Query: 187 ---HGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLL 243
GDGFL ++K PD S+ V C+ +C NCSC AY V +GCL
Sbjct: 355 TNQSGDGFLPMGNIKWPDFSYW-VSTVGDEPGCRTVCLNNCSCGAY----VYTATTGCLA 409
Query: 244 WFHDLIDMKVLSEGGQDLYIRMATSELDN----FERTXXXXXXXXXXXXXCALL--ATGV 297
W ++LIDM L G L +++ SEL ++ C LL G
Sbjct: 410 WGNELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGR 469
Query: 298 IL---IGGFMYMRKKKRRDQGNTVG---SSELDYIDRGNRKENMELPMFDWNTIADATDN 351
+ + G R + Q N+ S + + D ++ EL ++ + I AT N
Sbjct: 470 NIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGKSHELKVYSLDRIRTATSN 529
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
FS NKLGEGGFGPVY G L G+E+AVKRL ++SGQG+EEFKNEV+LIAKLQHRNLVRL
Sbjct: 530 FSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRL 589
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
LGCC R+E++L+YEY+PNKSL+ F+F+ + + LDW KR IIEGIARGLLYLH+DSRL
Sbjct: 590 LGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRL 649
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
R++HRDLKASN+LLD DM PKISDFGMAR FG DQ + NT+RVVGT
Sbjct: 650 RVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGT 695
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 221/533 (41%), Positives = 308/533 (57%)
Query: 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
M L + TG + SWKS DP+ Y + P P+ V K + +R+GPWNG +
Sbjct: 158 MSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQY 217
Query: 61 WTGTPQLQPNPVYTFEY-VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
+ G P + + FE +S++N + +++L +++ +G + W Q+W
Sbjct: 218 FIGLPNMDYR-INLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEW 276
Query: 120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSAR-CECLEGFVPKSPSEWDLLDTSDGCI 178
++ +CD YA CG +A C N S C C+ GF P+S +EW+ + + GC+
Sbjct: 277 KTWLKVPST---KCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCV 333
Query: 179 RRTQLDCEH---------GDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAY 229
R+ L CE DGF++ + +K+P R N C E C KNCSCTAY
Sbjct: 334 RKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNP-QRSGANEQ--DCPESCLKNCSCTAY 390
Query: 230 ANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXX 289
+ D RG GCLLW +L+DM+ S G YIR+A SE +RT
Sbjct: 391 S-FD-RG--IGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFK--KRTNRSIVITVTLLVG 444
Query: 290 CALLATGVIL-IGGFMYMRKKKRRDQGNTVGSSELDYIDRG----NRKENMELPMFDWNT 344
L A V+L + R+K R + L D G N+ + ELP+F++
Sbjct: 445 AFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQV 504
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+A AT+NFS NKLG+GGFG VY+G L EG +IAVKRLS++SGQGVEEF NEV++I+KLQ
Sbjct: 505 LAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQ 564
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
HRNLVRLLG C +ERML+YE++P L+ ++FD + + LDW R II+GI RGL+Y
Sbjct: 565 HRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMY 624
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH+DSRL+IIHRDLKASN+LLD ++NPKISDFG+AR F ++ E +T RVVGT
Sbjct: 625 LHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGT 677
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 212/520 (40%), Positives = 301/520 (57%)
Query: 12 KRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNP 71
KR +SSWK+ DP+ ++ E+ + PQ +GS+ +R GPW + +TG P++ +
Sbjct: 167 KRVLSSWKNPTDPSPGEFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSH 226
Query: 72 VYTFEY----VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSG 127
V F+ + + Y ++S L+ + G ++ W W +
Sbjct: 227 VSKFDISQDVAAGTGSLTYSLER-RNSNLSYTTLTSAGS-LKIIW-NNGSGWVTDLEAP- 282
Query: 128 LILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCE- 186
+ CD Y CG + +C + SN +CECL+GFVPKS EW+ + + GC+RRT L C+
Sbjct: 283 --VSSCDVYNTCGPFGLC-IRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDV 339
Query: 187 ---------HGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
+GD F +VK PD F I+ C++ C NCSCTA++ +
Sbjct: 340 NSSATAQANNGDIFDIVANVKPPD--FYEYLSLINEEDCQQRCLGNCSCTAFSYIEQ--- 394
Query: 238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGV 297
GCL+W +L+D+ GG+ L IR+A+SEL R +
Sbjct: 395 -IGCLVWNRELVDVMQFVAGGETLSIRLASSELAGSNRVKIIVASIVSISVFM------I 447
Query: 298 ILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNK 357
++ + Y R K +++ N + R K ++ FD TI T+NFS +NK
Sbjct: 448 LVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQ-DVNFFDMQTILTITNNFSMENK 506
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
LG+GGFGPVY+G L +G+EIA+KRLS +SGQG+EEF NE++LI+KLQHRNLVRLLGCC
Sbjct: 507 LGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIE 566
Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
+E++LIYE++ NKSL FIFD T+ LDW KR +II+GIA GLLYLH+DS LR++HRD
Sbjct: 567 GEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRD 626
Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+K SN+LLD +MNPKISDFG+AR F Q +ANT RVVGT
Sbjct: 627 MKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGT 666
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 517 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-34 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 7e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 9e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.003 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 62/151 (41%), Positives = 83/151 (54%), Gaps = 10/151 (6%)
Query: 357 KLGEGGFGPVYRGMLT-----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
KLGEG FG VY+G L + E+AVK L + S Q +EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
LLG CT + M++ EY+P L ++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
IHRDL A N L+ ++ KISDFG++R
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRD 152
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 59/158 (37%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 408
KLGEG FG VY+G L + E+AVK L + +S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V+LLG CT + ++ EY+ L ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
IHRDL A N L+ ++ KISDFG++R D
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 58/163 (35%), Positives = 87/163 (53%), Gaps = 10/163 (6%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
LGEGGFG VY G+++A+K + K S +EE E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ L+ EY SL+ + + L + +I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 476 RDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRVVGT 517
RDLK N+LLD+D K++DFG+++ D++ T +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 56/156 (35%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 356 NKLGEGGFGPVYRGMLTEGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
KLGEG FG VY+G L E+AVK L + S + ++F E ++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLY 464
LLG CT + L+ EY+ L ++ F L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L + +HRDL A N L+ D+ KISDFG++R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 3e-36
Identities = 56/151 (37%), Positives = 80/151 (52%), Gaps = 11/151 (7%)
Query: 357 KLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVR 410
KLGEG FG VY+G L ++AVK L + + + EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
LLG CT + ++ EY+P L F+ + L Q+ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
+HRDL A N L+ ++ KISDFG++R
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 58/164 (35%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
KLG G FG VY+ G+ +AVK L K S + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+D L+ EY L ++ +R L + +I I RGL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IHRDLK N+LLD + KI+DFG+A+ + T VGT
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLLG 413
KLGEG FG VY + G+ +A+K + K + E E+ ++ KL+H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
D+ L+ EY L + + L + + I L YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+HRDLK N+LLD D + K++DFG+AR + VGT
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-33
Identities = 41/116 (35%), Positives = 69/116 (59%), Gaps = 8/116 (6%)
Query: 51 FRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRL 110
+R+GPWNG+ ++G P++Q Y + + N EV+Y + + +S+ + + ++ +G +R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 111 TWMEQTQKWAPF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKS 164
TW+ +Q W F P DQCD Y CG Y C++N S +C C++GFVPK+
Sbjct: 61 TWIPNSQDWNLFWSAP-----KDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 61/179 (34%), Positives = 93/179 (51%), Gaps = 27/179 (15%)
Query: 353 SWK--NKLGEGGFGPVYRGMLTE-GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRN 407
W LG G FG VY + + G+ +AVK LS S + +E + E+ +++ LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 408 LVRLLGCCTLRDERML-IY-EYLPNKSLEQFI--F-----DVTRTKFLDWSKRCQIIEGI 458
+VR G ++ L I+ EY+ SL + F V R +++ QI+EG+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR----KYTR--QILEGL 114
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
A YLH I+HRD+K +N+L+D+D K++DFG A+ G +T T V GT
Sbjct: 115 A----YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-27
Identities = 37/67 (55%), Positives = 51/67 (76%), Gaps = 1/67 (1%)
Query: 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLW 244
C GDGFL+ ++KLPDT+ + VD++I + C++ C NCSCTAYA AD+R GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 245 FHDLIDM 251
+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 15/172 (8%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 407
N+ + +G G FG VY+G+ L G +A+K++S + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYL 465
+V+ +G D +I EY N SL Q I KF + + + + +GL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H+ +IHRD+KA+N+L D K++DFG+A ++ + VVGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK----NEVLLIAKLQ 404
+ KLGEG +G VY+ G+ +A+K RL E E+ L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKR--CQIIEGIARG 461
H N+V+LL + L++EY + L++++ D + K Q++ G+A
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA-- 112
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
Y H RI+HRDLK N+L++ D K++DFG+ARAFG+ T VV
Sbjct: 113 --YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 15/155 (9%)
Query: 356 NKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
+LGEG FG V G+++AVK L+ S Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 410 RLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLH 466
+ G C R LI EYLP+ SL ++ R + ++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
R IHRDL A N+L++++ KISDFG+A+
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 12/152 (7%)
Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
F K+G+GGFG VY+ G+E+A+K + S + E+ NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI---IEGIARGLLYLHQ 467
G +DE ++ E+ SL+ + T QI + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL----TESQIAYVCKELLKGLEYLHS 116
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
IIHRD+KA+N+LL +D K+ DFG++
Sbjct: 117 ---NGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 59/163 (36%), Positives = 82/163 (50%), Gaps = 23/163 (14%)
Query: 358 LGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
LGEG FG VY+G LT +A+K L ++ + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQIIEG 457
LLG CT +++EYL + L +F+ D T LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YL S +HRDL A N L+ + KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 51/172 (29%), Positives = 90/172 (52%), Gaps = 25/172 (14%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEF----KNEVLLIAKLQHRNLVR 410
++GEG +G VY+ G+ +A+K++ E F E+ L+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 411 LLGCCTLRDER--MLIYEYLPN--KSL---EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
L T + + +++EY+ + L + F ++ K Q++EG+
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY----MKQLLEGLQ---- 114
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
YLH + I+HRD+K SN+L++ND K++DFG+AR + + T+RV+
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 9e-24
Identities = 41/89 (46%), Positives = 52/89 (58%), Gaps = 8/89 (8%)
Query: 181 TQLDCEHG---DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
T L+C DGFLK VKLPD + + IS+ C+E C NCSCTAYA + G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASA--ITAISLEECREACLSNCSCTAYAYNN---G 55
Query: 238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMA 266
GCLLW L +++ LS GG LY+R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 356 NKLGEGGFGPVYRGMLTE--GQEI--AVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
+LG G FG V +G+ G+E+ AVK L + G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFD---VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
L+G C + ML+ E P L +++ + + + + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+HRDL A NVLL N KISDFGM+RA G
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 23/180 (12%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
D + + K+GEG G VY+ G+E+A+K++ + Q E NE+L++ +
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCK 73
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL----EQFIFDVTRTKFLDWSKRCQI---IEG 457
H N+V + DE ++ EY+ SL Q + QI
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE---------PQIAYVCRE 124
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ +GL YLH +IHRD+K+ N+LL D + K++DFG A ++++ N+ VVGT
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 53/165 (32%), Positives = 89/165 (53%), Gaps = 20/165 (12%)
Query: 358 LGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG VY+G+ EG+ +A+K L + + + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT----KFLDWSKRCQIIEGIARGLLYLHQ 467
LG C L + LI + +P L ++ + L+W + IA+G+ YL +
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
R++HRDL A NVL+ + KI+DFG+A+ VD+ E + +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG G FG V+ G ++AVK L K E F E ++ KL+H LV+L C+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+ ++ EY+ SL F+ + + +D + QI EG+A YL
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA--AQIAEGMA----YLE---SR 122
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
IHRDL A N+L+ ++ KI+DFG+AR D+ A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.4 bits (246), Expect = 1e-22
Identities = 54/157 (34%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQH-R 406
++ KLGEG FG VY + +A+K L+K S + VE F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+V+L L+ EY+ SLE + + R L S+ I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 467 QDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAF 502
IIHRD+K N+LLD + K+ DFG+A+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 56/175 (32%), Positives = 80/175 (45%), Gaps = 25/175 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-Q 404
D+F + +GEG F V +E A+K L K + V+ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 405 HRNLVRLLGCCTLRDERML--IYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEG 457
H +++L T +DE L + EY PN L Q+I D T+F
Sbjct: 61 HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAE 110
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
I L YLH IIHRDLK N+LLD DM+ KI+DFG A+ + + +
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 51/148 (34%), Positives = 83/148 (56%), Gaps = 10/148 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G G FG V RG L + +A+K L + SS + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
G T M+I EY+ N SL++F+ KF + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL-RENDGKF-TVGQLVGMLRGIASGMKYL---SEMN 126
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMAR 500
+HRDL A N+L+++++ K+SDFG++R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 4/149 (2%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
F+ + KLG G FG V+ G+ +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
C++ + +I E + SL F+ + L + + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL A N+L+ D+ K++DFG+AR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRG---MLTEGQE---IAVKRLSKSSGQGVEE-FKNEVLLIAK 402
D K +LGEG FG V+ G L + +AVK L +++ + F+ E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----------IFDVTRTKFLDWSKR 451
QH N+V+ G CT D ++++EY+ + L +F + L S+
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
QI IA G++YL + +HRDL N L+ D+ KI DFGM+R
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 58/165 (35%), Positives = 95/165 (57%), Gaps = 20/165 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRL 411
LG G FG VY+G+ + EG+ + A+K L++++G EF +E L++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LG C L L+ + +P+ L ++ + + L+W + IA+G++YL +
Sbjct: 75 LGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
R++HRDL A NVL+ + + KI+DFG+AR D+ E N D
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 2e-20
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 21/177 (11%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKF-----LDWSKRCQIIEGIAR 460
+++ + + ++ EY L Q I F LDW Q+
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CL 114
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L YLH SR +I+HRD+K N+ L ++ K+ DFG+++ A T VVGT
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 55/153 (35%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQ----EIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRL 411
KLG+G FG V RG + +AVK L +++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
G L M++ E P SL + FL S C IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK--- 116
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
R IHRDL A N+LL +D KI DFG+ RA
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 50/155 (32%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+ TD + K+KLG G +G VY G+ + +AVK L K VEEF E ++ +++H
Sbjct: 4 ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
NLV+LLG CT +I E++ +L ++ + R + ++ + I+ + YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ + IHRDL A N L+ + K++DFG++R
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 60/154 (38%), Positives = 83/154 (53%), Gaps = 19/154 (12%)
Query: 358 LGEGGFGPV--YRGMLTE---GQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRL 411
LGEG FG V Y G+ +AVK L + GQ +K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
GCC+ + + LI EY+P SL ++ + + L +++ QI EG+A YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ--QICEGMA----YLHS 125
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
IHRDL A NVLLDND KI DFG+A+A
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
+G+G FG V G GQ++AVK L K + F E ++ L+H NLV+LLG
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII--EGIARGLLYLHQDSRLR 472
+ ++ EY+ SL ++ R + Q+ + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEYLEEK---N 122
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARA 501
+HRDL A NVL+ D+ K+SDFG+A+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 52/151 (34%), Positives = 89/151 (58%), Gaps = 7/151 (4%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
K+GEG +G VY+G GQ +A+K++ +S +GV E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
LI+E+L + L++++ + + +++D + I +G+L+ H R+
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
+HRDLK N+L+DN K++DFG+ARAFG+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 5/157 (3%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
KLG G FG V+ G+ +AVK L K ++F E ++ KL+H L++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
CTL + ++ E + SL +++ L + + +A G+ YL + I
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
HRDL A NVL+ + K++DFG+AR D EA
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 14/169 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
F KLGEG +G VY+ + E GQ +A+K + + ++E E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARGLLYLHQD 468
G + ++ EY S + D+ K L + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ IHRD+KA N+LL+ + K++DFG++ + NT V+GT
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLLG 413
K+GEG +G VY+ G+ +A+K++ E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+ + L++E++ + L + I D R + L S + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+HRDLK N+L++ + K++DFG+AR+FG T VV
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV 160
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 50/152 (32%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG VY G+ L +G AVK +S ++ + V++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 412 LGCCTLRDERMLIY-EYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
LG ++ + I+ E +P SL + + + + R QI+ G+ YLH
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+HRD+K +N+L+D + K++DFGMA+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 5e-19
Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG+G FG V + G+ A+K L K + VE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 414 CCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
+ E L + EY P L ++ F R +F ++ +I+ + YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YA--AEIVLALE----YLH 110
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L II+RDLK N+LLD D + K++DFG+A+ + + NT GT
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 55/149 (36%), Positives = 79/149 (53%), Gaps = 16/149 (10%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG G FG V+ G ++A+K L K E F E L+ +LQH LVRL T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 417 LRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ +I EY+ N SL F+ +T K +D + QI EG+A ++ R
Sbjct: 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA--AQIAEGMA----FIE---RK 121
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL+A+N+L+ + KI+DFG+AR
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 29/167 (17%)
Query: 352 FSW-KNKL-GEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQG-------VEEFKNEVL 398
F W K +L G+G +G VY + +T G+ +AVK++ + +G+ V+ ++E+
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQ 453
+ L H N+V+ LG T + + EY+P S+ + F+ +F Q
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----EQ 116
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
++EG+A YLH I+HRDLKA N+L+D D KISDFG+++
Sbjct: 117 VLEGLA----YLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 57/158 (36%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG G FG V+ G ++AVK L K V+ F E L+ LQH LVRL T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+ +I EY+ SL F+ V K +D+S + IA G+ Y+ R
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---RK 122
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
IHRDL+A+NVL+ + KI+DFG+AR ++ A
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 55/160 (34%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 358 LGEGGFGPVYRGML-------TEGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 409
LG G FG VY G + +AVK L K ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDWSKRCQIIEGIARGLLYL 465
+LLG C L + + +I E + L ++ D +F L + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 466 HQDSRLRIIHRDLKASNVLL-----DNDMNPKISDFGMAR 500
Q + IHRDL A N L+ D D KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 53/163 (32%), Positives = 87/163 (53%), Gaps = 32/163 (19%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
K+GEG +G VY+ G+ +A+K++ ++ +GV E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------------QIIEGIARG 461
++ L++E+L D+ K++D S Q+++GIA
Sbjct: 66 VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA-- 113
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
Y H R++HRDLK N+L+D + K++DFG+ARAFGV
Sbjct: 114 --YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 51/167 (30%), Positives = 74/167 (44%), Gaps = 17/167 (10%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQEIAVK---RLSKSSGQGVEEFKNEVLLI 400
D+ + LG G FG VY RG + E+ V S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIE 456
+K H+N+VRL+G R R ++ E + L+ F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMAR 500
+A+G YL ++ IHRD+ A N LL KI+DFGMAR
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
++G G FG V+ G E +++A+K + + E+F E ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLLYLHQDSRLRII 474
R L++E++ + L ++ R + +S+ + + G+ YL + +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
HRDL A N L+ + K+SDFGM R DQ ++T
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 358 LGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LG+G FG V Y + G+ +AVK+L S+ + + +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 413 GCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
G C R L+ EYLP SL ++ + LD K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
R +HRDL N+L++++ KI DFG+ + D+
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 51/147 (34%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLLGCC 415
K+G+G FG VY+G+L E+AVK + + +F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKF--LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+ ++ E +P SL F+ R K L K Q+ A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL A N L+ + KISDFGM+R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 53/164 (32%), Positives = 92/164 (56%), Gaps = 22/164 (13%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNL 408
NF KLGEG + VY+G T G+ +A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRTKFLDWSKRCQIIEGIAR 460
VRL ++ ML++EY+ +K L++++ D K + Q+++GIA
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTY----QLLKGIA- 114
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
+ H++ R++HRDLK N+L++ K++DFG+ARAFG+
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 48/150 (32%), Positives = 89/150 (59%), Gaps = 14/150 (9%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G G FG V+RG+L G++ +A+K L + + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEGIARGLLYLHQDSR 470
G T M+I EY+ N +L++++ R ++S + ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +HRDL A N+L+++++ K+SDFG++R
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 24/160 (15%)
Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----------EVLLIAKL 403
KLGEG + VY+ E G+ +A+K++ + E K E+ L+ +L
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
+H N++ LL + L++E++ LE+ I D + ++ RGL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD-KSIVLTPADIKSYMLM-TLRGLE 116
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
YLH I+HRDLK +N+L+ +D K++DFG+AR+FG
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 25/155 (16%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
NK+G G FG VY + L G+ +AVK R+ + + ++E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 413 GCCTLRDERMLIY-EYLPNKSLEQF-----IFD--VTRTKFLDWSKRCQIIEGIARGLLY 464
G + E++ I+ EY +LE+ I D V R L Q++EG+A Y
Sbjct: 66 GV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL------QLLEGLA----Y 114
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
LH I+HRD+K +N+ LD++ K+ DFG A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 26/156 (16%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKR-----LSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+G FG VY + G+E+AVK+ S + + V + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLY 464
GC + + EY+P S++ + VTR K+ QI+EG+ Y
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTR-----QILEGVE----Y 119
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
LH + I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 51/158 (32%), Positives = 89/158 (56%), Gaps = 10/158 (6%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK-NEVLLIAKLQHR 406
NF K+GEG +G VY+ G+ +A+K RL + +GV E+ L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+V+LL ++ L++E+L ++ L++F+ D + + + + +GL + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
R++HRDLK N+L++ + K++DFG+ARAFGV
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 357 KLGEGGFGPVYRGML------TEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 409
+LGE FG VY+G L + Q +A+K L K+ G EEFK+E ++ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQIIE 456
LLG T +I+ Y + L +F+ D T L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ +L S ++H+DL NVL+ + +N KISD G+ R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 358 LGEGGFGPVYRGML----TEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LGEG FG V G L ++AVK +L + +EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 412 LGCC-TLRDER-----MLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGL 462
+G C + M+I ++ + L F+ + L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
YL S IHRDL A N +L DM ++DFG+++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
LG G FG V+ G ++A+K + + + ++F E ++ KL H NLV+L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
+ ++ EY+ N L ++ R L + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 478 LKASNVLLDNDMNPKISDFGMAR 500
L A N L+ D K+SDFG+AR
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 31/168 (18%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQG---------VEEFKNEVLLIAKLQHRN 407
+G G FG VY GM + G+ +AVK++ S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGL 462
+V+ LG D + EY+P S+ + F+ T + + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
YLH IIHRD+K +N+L+DN KISDFG+++ + EAN
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK-----KLEAN 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 35/176 (19%)
Query: 357 KLGEGGFGPVYRGML-TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
LG+G G VY+ G+ A+K++ + ++ E+ + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 415 ----CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC-----QIIEGIAR----G 461
+ ++ EY+ SL + K+ ++ IAR G
Sbjct: 68 FYKEGEIS----IVLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQILKG 111
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L YLH IIHRD+K SN+L+++ KI+DFG+++ ++ T + VGT
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 48/151 (31%), Positives = 84/151 (55%), Gaps = 9/151 (5%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
K+GEG +G V++ E EI A+KR+ +GV E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+ L++EY ++ L+++ FD +D + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
+HRDLK N+L++ + K++DFG+ARAFG+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 355 KNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
K +LGEG FG V+ +L E + +AVK L ++S ++F+ E L+ LQH+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI-FDVTRTKFLDWSK-----------RCQIIE 456
VR G CT ++++EY+ + L +F+ K L + I
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 46/170 (27%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNL 408
F+ +G+G FG VY+ + Q +A+K L ++ + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 409 VRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+ G L+ ++ +I EY S D+ + LD + I+ + GL YLH+
Sbjct: 62 TKYYGS-FLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ IHRD+KA+N+LL + + K++DFG++ ++ NT VGT
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QH 405
D T F +GEG +G VY+ + ++ ++ EE K E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 406 RNLVRLLGC------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ------ 453
N+ G D+ L+ E S + D+ + KR +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
I+ RGL YLH++ ++IHRD+K N+LL + K+ DFG++ +D T +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172
Query: 514 VVGT 517
+GT
Sbjct: 173 FIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/159 (29%), Positives = 87/159 (54%), Gaps = 16/159 (10%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSG-QGVEEFK-NEVLLIAKLQ---HRNLV 409
++GEG +G VY+ L G+ +A+K++ +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 410 RLLGCC-TLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
RLL C R +R L++E++ ++ L ++ + + + ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDF 122
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
LH RI+HRDLK N+L+ +D KI+DFG+AR +
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 51/175 (29%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
++ D ++ K+G+G G VY + + GQE+A+K+++ E NE+L++ +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
+H N+V L + DE ++ EYL SL DV +D + + + L
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH + ++IHRD+K+ N+LL D + K++DFG +Q++ +T +VGT
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 53/172 (30%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 355 KNKLGEGGFGPVY-----------------RGMLTEGQEIAVKRLSKSSGQGV-EEFKNE 396
KLGEG FG V+ +AVK L + E+F E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRTKFLDW 448
V ++++L N+ RLLG CT+ +I EY+ N L QF+ +K L +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 449 SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
S + IA G+ YL L +HRDL N L+ + KI+DFGM+R
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 25/167 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 406
D + K+GEG +G VY+ E IA+K++ + +GV E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD----WSKRCQIIEG----I 458
N+VRL L++EYL D+ K +D ++K ++I+ I
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGV 504
RG+ Y H R++HRDLK N+L+D N K++DFG+ARAFG+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
|
Length = 294 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 52/165 (31%), Positives = 91/165 (55%), Gaps = 20/165 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG VY+G+ + EG+++ A+K L + +S + +E +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LG C L LI + +P L ++ + + L+W + IA+G+ YL +
Sbjct: 75 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
R++HRDL A NVL+ + KI+DFG+A+ G D+ E + +
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 39/168 (23%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
KLGEG FG VY+ + G+ +A+K++ ++ G + + E+ ++ KL+H N+V L+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI 73
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF---------DVT------RTKFLDWSKRC---QI 454
+ E ++ D++ K + +C Q+
Sbjct: 74 D---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+EGI YLH++ I+HRD+KA+N+L+DN KI+DFG+AR +
Sbjct: 125 LEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 350 DNFSWKNKLGEGGFGPVY----RGMLTEGQE-------------IAVKRLSKSSGQGVE- 391
++K KLGEG FG V+ GM + +AVK L + + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRT 443
+F E+ ++++L+ N++RLL C D +I EY+ N L QF+ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +S + IA G+ YL S L +HRDL N L+ + KI+DFGM+R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 53/155 (34%), Positives = 88/155 (56%), Gaps = 20/155 (12%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLS------KSSGQGVEEFKNEVLLIAKLQHRNLV 409
LG+G +G VY G+ +GQ IAVK++ ++ + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 410 RLLGCCTLRDERMLIY-EYLPNKSLEQFI--FD-VTRTKFLDWSKRCQIIEGIARGLLYL 465
+ LG C L D + I+ E++P S+ + F + F ++K QI++G+A YL
Sbjct: 66 QYLGTC-LDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK--QILDGVA----YL 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
H + ++HRD+K +NV+L + K+ DFG AR
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 55/154 (35%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
+GEG FG V +G T GQ++AVK + + F E ++ KL H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
L + ++ E + +L F+ TR + L + Q +A G+ YL +++H
Sbjct: 69 LHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 476 RDLKASNVLLDNDMNPKISDFGMARA--FGVDQT 507
RDL A N+L+ D K+SDFG+AR GVD +
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 52/175 (29%), Positives = 94/175 (53%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
+I D ++ K+G+G G V+ + + GQE+A+K+++ E NE+L++ +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L++ N+V L + DE ++ EYL SL DV +D ++ + + L
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH + ++IHRD+K+ NVLL D + K++DFG +Q++ +T +VGT
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 355 KNKLGEGGFGPV----------YRGMLTEGQE-----IAVKRL-SKSSGQGVEEFKNEVL 398
K KLGEG FG V + G + +AVK L + + +F E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKF--------LDWS 449
++++L++ N++RLLG C D +I EY+ N L QF+ + F + +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ IA G+ YL + L +HRDL N L+ N KI+DFGM+R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
++ KLG G FG V+ G ++AVK L K E F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LV+L + + ++ EY+ SL F+ D + L + +A G+ Y+
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
R+ IHRDL+++N+L+ + + KI+DFG+AR
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 351 NFSWKNKLGEGGFGPVYRG----MLTEGQEI--AVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
N K +LGEG FG V+ + E +I AVK L +S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----------FDVTRTKFLDWSKRCQI 454
H ++V+ G C D ++++EY+ + L +F+ + R L S+ I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+++ ++G G +G VY+ E+ A+K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLY 464
V G RD+ ++ EY SL Q I+ VTR + I + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSE-----LQIAYVCRETLKGLAY 116
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
LH+ IHRD+K +N+LL D + K++DFG++
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
LG+G +G VY Q IA+K + + + V+ E+ L + L+HRN+V+ LG +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII----EGIARGLLYLHQDSRLR 472
+ E +P SL + R+K+ Q I + I GL YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLS----ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 473 IIHRDLKASNVLLDNDMNP-KISDFGMAR 500
I+HRD+K NVL++ KISDFG ++
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 29/177 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM---LTEGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAK 402
+N + +G+G FG V++ L + +AVK L + +S +F+ E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----------------- 445
H N+V+LLG C + L++EY+ L +F+ +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 446 --LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L +++ I + +A G+ YL S + +HRDL N L+ +M KI+DFG++R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 17/152 (11%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G+G FG VY G L ++GQ+I AVK L++ + + VE+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
G C L E +++ Y+ + L FI T + + I G +A+G+ YL
Sbjct: 63 GIC-LPSEGSPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYLASK 117
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +HRDL A N +LD K++DFG+AR
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 358 LGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVR 410
LG G FG V+ +G+ EG E + VK L K+ + ++ EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLY 464
LLG C + +I EY L+QF+ + + L ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L S R +HRDL A N L+ + K+S +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 33/171 (19%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSG---QGVEEFKNEVLLIAK 402
D + N++ EG +G VYR G+ +A+K+L + G + E +LL K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60
Query: 403 LQHRNLVRL----LGCCTLRDERMLIYEYLPN--KSLEQFIFDVTRTKFLDWSKRC---Q 453
LQH N+V + +G + D+ ++ EY+ + KSL + + FL +C Q
Sbjct: 61 LQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQ 114
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
++ G+A +LH + I+HRDLK SN+LL+N KI DFG+AR +G
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
++ D ++ K+G+G G VY + + GQE+A+K+++ E NE+L++ +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
++ N+V L + DE ++ EYL SL DV +D + + + L
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH + ++IHRD+K+ N+LL D + K++DFG +Q++ +T +VGT
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 57/171 (33%), Positives = 91/171 (53%), Gaps = 14/171 (8%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRL---SKSSGQGVEEFKNEVLLIAKLQHR 406
F N++GEG +G VYR T EI A+K++ ++ G + + E+ L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 407 NLVRLLGCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
N+V L + D L+ EY + L + ++ F + +C ++ + RGL Y
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-FSESQVKC-LMLQLLRGLQY 123
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
LH++ IIHRDLK SN+LL + KI+DFG+AR +G+ T +VV
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 52/165 (31%), Positives = 91/165 (55%), Gaps = 20/165 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG VY+G+ + +G+ + A+K L + +S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LG C L L+ + +P L ++ + + L+W + IA+G+ YL +
Sbjct: 75 LGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
+R++HRDL A NVL+ + + KI+DFG+AR +D+TE + D
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 9/170 (5%)
Query: 351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
+F NK+G+G FG V++ + + + A+K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
++R + + ++ EY N L + + + R + L + + I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/164 (32%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 357 KLGEGGFGPVYRGML-----TEGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
+LGE FG +Y+G L Q +A+K L ++ Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIF--------------DVTRTKFLDWSKRCQIIE 456
LLG T +++EYL L +F+ D T LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YL S +H+DL A N+L+ ++ KISD G++R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG+G FG V+ G +A+K L K E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
+ ++ EY+ SL F+ K+L + + IA G+ Y+ R+ +HR
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 477 DLKASNVLLDNDMNPKISDFGMAR 500
DL+A+N+L+ ++ K++DFG+AR
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
++ D ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
++ N+V L + DE ++ EYL SL DV +D + + + L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH + ++IHRD+K+ N+LL D + K++DFG +Q++ + +VGT
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 16/149 (10%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG G FG V+ + ++AVK + K VE F E ++ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ +I E++ SL F+ K +D+S + IA G+ ++ Q +
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN-- 122
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL+A+N+L+ + KI+DFG+AR
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 49/147 (33%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLGCCT 416
LG+G FG V++G L + +AVK + Q ++ +F +E ++ + H N+V+L+G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE---GIARGLLYLHQDSRLRI 473
R ++ E +P F+ K D K Q+++ A G+ YL +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL A N L+ + KISDFGM+R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 22/154 (14%)
Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G G FG V RG L +A+K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
G T M+I E++ N +L+ F+ F V + ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--------VGMLRGIAAGMKYL- 122
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
S + +HRDL A N+L+++++ K+SDFG++R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHRNLVRLL 412
+G+G FG V + ++G+ + K + + E + +EV ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 413 GCCTLRD-ERMLIY-EYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYLH--Q 467
R + + I EY L Q I + K+++ +I+ + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
D ++HRDLK +N+ LD + N K+ DFG+A+ G D + A T VGT
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 55/159 (34%), Positives = 88/159 (55%), Gaps = 17/159 (10%)
Query: 358 LGEGGFGPVY------RGMLTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVR 410
LGEG FG V G T G+++AVK L +S G + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 411 LLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQ 467
G CT LI E+LP+ SL++++ R K ++ ++ + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
SR + +HRDL A NVL++++ KI DFG+ +A D+
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 20/152 (13%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG V++G+ + EG I A+K + SG Q +E + +L + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LG C L+ + P SL + + + L+W + IA+G+ YL +
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
R++HR+L A N+LL +D +I+DFG+A
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G G VY + L +++A+KR L K V+E + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDWSKRCQIIEGIARGLLYLHQD 468
+ DE L+ YL SL D+ ++ + LD + +++ + +GL YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGT 517
+ IHRD+KA N+LL D + KI+DFG++ + G D+T VGT
Sbjct: 122 GQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
+LG G FG V G ++A+K + + S +EF E ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
+ ++ EY+ N L ++ + + S+ ++ + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 477 DLKASNVLLDNDMNPKISDFGMAR 500
DL A N L+D+ K+SDFG++R
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 28/182 (15%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSSGQG-VEEF 393
P+ +WN I +++ +GEG FG V + + + + A+KR+ + + + +F
Sbjct: 2 PVLEWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54
Query: 394 KNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVT 441
E+ ++ KL H N++ LLG C R L EY P+ +L F+ F +
Sbjct: 55 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 442 RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
+ L + +ARG+ YL Q + IHRDL A N+L+ + KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 500 RA 501
R
Sbjct: 172 RG 173
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 26/174 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTEGQE----IAVKRLS-KSSGQGVEEFKNEVLLI 400
D LGEG FG V R G+ + +AVK L ++ + + + +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
+ +H+N++ LLG CT +I EY +L +F+ FD+T+ + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +ARG+ YL +SR R IHRDL A NVL+ D KI+DFG+AR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 17/166 (10%)
Query: 357 KLGEGGFGPVYR-GMLTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
++GEG G V++ G+ +A+K+ L + G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 414 CCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
L+ EY+P+ L + + D R + + +++G+A Y+H
Sbjct: 67 V-FPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRMLLKGVA----YMHA-- 117
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
I+HRDLK +N+L+ D KI+DFG+AR F ++ + +V
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 52/148 (35%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVRLL 412
+LG+G FG VY E E+ A+K++ K EE N EV + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
DE ++EY+ +L Q + D F + R II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH---KHG 119
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMAR 500
HRDLK N+L+ KI+DFG+AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 19/158 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEI---AVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LGEG FG V G L + I AVK +++ + +E+F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 413 GCCTLRDER------MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGL 462
G C E ++I ++ + L F+ +R ++L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
YL S IHRDL A N +L+ +MN ++DFG+++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G G FG V G L G+ +A+K L + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
G T M++ EY+ N SL+ F+ F V + ++ GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--------VGMLRGIASGMKYL- 122
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
S + +HRDL A N+L+++++ K+SDFG++R D A T R
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 29/163 (17%)
Query: 358 LGEGGFGPVYRGML------TEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVR 410
LG+G FG VY G+ +A+K +++++ EF NE ++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 411 LLGCCTLRDERMLIYEYL-------------PNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
LLG + +++ E + P + T KF+ + E
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA-----AE- 127
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YL + +HRDL A N ++ D+ KI DFGM R
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 358 LGEGGFGPVYRGML------TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRNLV 409
LGEG FG V + E +AVK L ++ + + + +E+ ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG------------ 457
LLG CT ++ EY + +L F+ R S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 458 --IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ +L + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
D + F+ ++G+G FG VY+G+ +E+ A+K + + +E+ + E+ ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
+ R G + +I EYL S D+ + L+ + I+ I +GL Y
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDY 116
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH + R IHRD+KA+NVLL + K++DFG+A Q + NT VGT
Sbjct: 117 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 52/149 (34%), Positives = 80/149 (53%), Gaps = 14/149 (9%)
Query: 357 KLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRL 411
++G G FG VY R + T + +A+K++S S Q E++++ EV + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 412 LGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
GC LR+ L+ EY + + I +V + K L + I G +GL YLH R
Sbjct: 81 KGC-YLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMA 499
IHRD+KA N+LL K++DFG A
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
+LG G FG V+ G ++A+K +++ + E+F E ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLLYLHQDSRLRII 474
+ ++ E++ N L ++ R + SK + + + G+ YL ++S I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 475 HRDLKASNVLLDNDMNPKISDFGMAR 500
HRDL A N L+ + K+SDFGM R
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 355 KNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
K +LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQII 455
V+ G C D ++++EY+ + L +F+ L S+ I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
DNF K+GEG G V + G+++AVK++ Q E NEV+++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V + + DE ++ E+L +L VT T+ ++ + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLAVLKALSFLHAQ 134
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFG 497
+IHRD+K+ ++LL +D K+SDFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRL 411
+GEG +G V + G+ +A+K+ +S E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
+ L++EY+ LE + W Q+++ IA Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW----QLLQAIA----YCH 117
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
IIHRD+K N+L+ K+ DFG ARA TD V
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 347 DATDNFSWK--NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
D N W+ +LG+G FG VY+ E G A K + S + +E++ E+ ++A
Sbjct: 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
H +V+LLG + ++ E+ P +++ + ++ R L + I + L
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQ 124
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
YLH ++IIHRDLKA NVLL D + K++DFG++
Sbjct: 125 YLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 12/150 (8%)
Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+KLGEG + VY+G LT+ +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
L++EYL +K L+Q++ D + + K + + RGL Y H R
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCH---RR 123
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARA 501
+++HRDLK N+L++ K++DFG+ARA
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 13/164 (7%)
Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
KLGEG + V++G LTE +A+K RL G + EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
L++EYL +K L+Q++ D + K + I RGL Y H R
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCH---RR 123
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+++HRDLK N+L++ K++DFG+ARA V T+ ++ VV
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV 166
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 41/154 (26%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+ D + +LG+G FG VY+ G A K + S + +E+F E+ ++++ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
N+V L ++ ++ E+ +L+ + ++ R L + + + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
H ++IHRDLKA N+LL D + K++DFG++
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 47/155 (30%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
+LG G FG V +G M + ++A+K L + + V +E E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
G C + ML+ E L +F+ + + S +++ ++ G+ YL +
Sbjct: 62 GVCE-AEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
+HRDL A NVLL N KISDFG+++A G D +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 49/184 (26%), Positives = 95/184 (51%), Gaps = 29/184 (15%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFK----NEVLLIAKL 403
D F ++GEG +G VY R T G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEK--EGFPITAIREIKILRQL 63
Query: 404 QHRNLVRLLGCCTLRDERM----------LIYEYLPNKSLEQFIFDVTRTKFLDWSKR-- 451
HRN+V L T + + + L++EY+ + + + + + +S+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHI 118
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
++ + GL Y H+ + L HRD+K SN+LL+N K++DFG+AR + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 512 DRVV 515
++V+
Sbjct: 176 NKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 16/152 (10%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+G FG VY + G+E+A K++ S + + V + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 412 LGCCTLRDERML--IYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
GC R E+ L EY+P S+ +Q T+ + QI+EG++ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHSN 125
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 47/144 (32%), Positives = 78/144 (54%), Gaps = 6/144 (4%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
KLG+G FG V+ G ++A+K L K E F E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
+ ++ E++ SL F+ + K+L + + IA G+ Y+ R+ IHR
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 477 DLKASNVLLDNDMNPKISDFGMAR 500
DL+A+N+L+ +++ KI+DFG+AR
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 22/164 (13%)
Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLS----KSSGQG--VEEFKNEVLLIAKLQHRNLV 409
LG G F Y R + T G +AVK+++ SS Q VE + E+ L+A+L H +++
Sbjct: 8 LGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 410 RLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQI--IEGIARGLLYLH 466
R+LG T D ++ E++ S+ + +K+ + + I E + RGL YLH
Sbjct: 67 RMLG-ATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 467 QDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEA 509
++ +IIHRD+K +N+L+D+ +I+DFG A T A
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 7e-13
Identities = 51/174 (29%), Positives = 92/174 (52%), Gaps = 13/174 (7%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
D + F+ K+G+G FG V++G+ Q++ A+K + + +E+ + E+ ++++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 405 HRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
+ + G L+D ++ +I EYL S D+ LD ++ I+ I +GL
Sbjct: 61 SPYVTKYYGS-YLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 115
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH + + IHRD+KA+NVLL K++DFG+A + T+ + VGT
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 351 NFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
+F KLG+G +G VY+ L++ Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 408 LVR-----LLGC--CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-----DWSKRCQII 455
++ L G C + EY P L + I + + L W Q+
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL- 112
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
RGL LH+ +I+HRDLK++N+LL + KI D G+++ + + A T +
Sbjct: 113 ---LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QI 162
Query: 516 GT 517
GT
Sbjct: 163 GT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 33/160 (20%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLLG 413
+G G +G V T+ G+++A+K+LS+ Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 414 CCTLRDERMLIYEYLPNKSLEQF--IFDVT-----------RTKFLDWSKRCQIIEGIAR 460
T P SLE F ++ VT + + L ++ I R
Sbjct: 82 VFT------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
GL Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQ 404
NF + K+G+G F VY+ + L +G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-----DWSKRCQIIEGIA 459
H N+++ L +E ++ E L + I + K L W Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L ++H RI+HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 43/184 (23%)
Query: 354 WKNKLGEGGFGPVYRGMLTEGQE-----------------IAVKRL-SKSSGQGVEEFKN 395
+K KLGEG FG V+ + Q+ +AVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-------- 447
EV ++++L+ N++RLLG C D +I EY+ N L QF+ + D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDA 125
Query: 448 -----------WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496
+S + IA G+ YL S L +HRDL N L+ ++ KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 497 GMAR 500
GM+R
Sbjct: 183 GMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
D + F+ ++G+G FG V++G+ Q++ A+K + + +E+ + E+ ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
+ + G + +I EYL S D+ R D + +++ I +GL Y
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDY 116
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH + + IHRD+KA+NVLL + K++DFG+A Q + NT VGT
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM---LTEGQ---EIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
+N S+ LG G FG V L++ ++AVK L + E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
L H N+V LLG CT+ ++I EY L F+ R FL +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKG 153
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +L + IHRDL A NVLL + KI DFG+AR
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 46/169 (27%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
++F ++G G +G VY+ + G+ A+K + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V G RD+ + E+ SL Q I+ VT L S+ + +GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ +HRD+K +N+LL ++ + K++DFG++ + T A +GT
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 32/160 (20%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+G FG VY + G+E+AVK++ S + + V + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 412 LGCCTLRD--ERML--IYEYLPNKSLEQ-------FIFDVTRTKFLDWSKRCQIIEGIAR 460
GC LRD ER L E++P S++ +VTR +++ QI+EG+
Sbjct: 70 YGC--LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----YTR--QILEGV-- 119
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
YLH + I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 120 --SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 31/171 (18%)
Query: 358 LGEGGFGPVYRGMLTEGQ------EIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVR 410
LGEG FG V + + +AVK L +++ + + +E L+ ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------------FDVTRTKFLDWSKRCQIIE-- 456
L G C+ +LI EY SL F+ D R + + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 457 -------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I+RG+ YL + ++++HRDL A NVL+ KISDFG++R
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 51/185 (27%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 407
+G G +G V + G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFDVTRT---------KFLDWSKRCQ 453
++ LL + L S E F + ++ T + L Q
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQ 106
Query: 454 -IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-- 510
+ I RGL YLH +IHRDLK SN+L++++ + KI DFG+AR D+ E
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 511 TDRVV 515
T+ VV
Sbjct: 164 TEYVV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 407
F+ ++G G FG VY E+ A+K++S S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+ GC L+ EY + + + +V + K L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAITHGALQGLAYLHS 143
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
+ +IHRD+KA N+LL K++DFG A
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 39/186 (20%)
Query: 357 KLGEGGFGPVYRGMLTE---GQEIAVKRL--SKSSGQGVEEFK-NEVLLIAKLQHRNLVR 410
+G G +G VY+ G+E A+K+ K G+ + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 411 LLGCCTLRDERMLIY------EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR---- 460
L+ L +Y E+ L Q I KF +KR I + +
Sbjct: 67 LVEVF-LEHADKSVYLLFDYAEH----DLWQII------KFHRQAKRVSIPPSMVKSLLW 115
Query: 461 ----GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVD-QTEANT 511
G+ YLH + ++HRDLK +N+L+ + KI D G+AR F + A+
Sbjct: 116 QILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 512 DRVVGT 517
D VV T
Sbjct: 173 DPVVVT 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT 416
+G G +G VY+G + ++A ++ +G EE K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 417 ------LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
+ D+ L+ E+ S+ I + T+ L I I RGL +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
++IHRD+K NVLL + K+ DFG++ +D+T + +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 52/184 (28%), Positives = 96/184 (52%), Gaps = 40/184 (21%)
Query: 356 NKLGEGGFGPVY--RGMLTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
K+G+G FG V+ R T Q +A+K++ ++ G + + E+ ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKT-KQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 411 LLGCCT--------LRDERMLIYEY--------LPNKSLEQFIFDVTRTKFLDWSKRCQI 454
L+ C + L++E+ L NK+++ F ++ K ++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KV 124
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN---T 511
++ + GL Y+H R +I+HRD+KA+N+L+ D K++DFG+ARAF + + T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 512 DRVV 515
+RVV
Sbjct: 182 NRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 53/149 (35%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 357 KLGEGGFGPVYRGM--LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
KLGEG + VY+G LT GQ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLT-GQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
+ L++EYL + L+Q++ D L + + RGL Y HQ R
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARA 501
++HRDLK N+L+ K++DFG+ARA
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 52/147 (35%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG+GGFG V M G+ A K+L+K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRLR 472
+ + L+ + L I++V + C I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMA 499
II+RDLK NVLLDND N +ISD G+A
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 21/170 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKL-Q 404
++ +++ +GEG FG V R M+ +G ++ A+K L + +S +F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKF---------LDWSKR 451
H N++ LLG C R + EY P +L F+ T F L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
Q +A G+ YL S + IHRDL A NVL+ ++ KI+DFG++R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 43/180 (23%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEG-----QEIAVKRLSKSSGQ-GVEEFKNEVL 398
IA + D + + L EG FG ++ G+L + +E+ VK + + + V E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 399 LIAKLQHRNLVRLLGCCT-LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
L+ L H+N++ +L C + ++Y Y+ +L+ F+ ++C++ E
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL------------QQCRLGEA 108
Query: 458 -----------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAK 402
D + F +++G G FG VY + E+ AVK++S S Q E++++ EV + +
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L+H N + GC L+ EY + + + +V + K L + I G +GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAITHGALQGL 134
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
YLH + +IHRD+KA N+LL K++DFG A
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 41/144 (28%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
+LG+G FG VY+ E +A K + S + +E++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ ++ E+ +++ + ++ R L + + + L YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 476 RDLKASNVLLDNDMNPKISDFGMA 499
RDLKA N+L D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 34/164 (20%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---------EVLLIAKL- 403
KLG+G +G V++ + +E+ A+K++ + F+N E++ + +L
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELG 64
Query: 404 QHRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGI 458
H N+V+LL ++ E L++EY+ E + V R L D KR I+ +
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ L Y+H S +IHRDLK SN+LL++D K++DFG+AR+
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 12/144 (8%)
Query: 357 KLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
K+GEG G V + TE G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+ DE ++ E+L +L VT T+ ++ + + + R L YLH +
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 474 IHRDLKASNVLLDNDMNPKISDFG 497
IHRD+K+ ++LL +D K+SDFG
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 279 RKKKKVVIIIICALLATGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELP 338
RK I C L A V+ + F ++ + R + EL ++ N EL
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN-------LELKRVE--NEDGTWELQ 673
Query: 339 MFDWN-----TIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEE 392
FD TI D + +N + G G Y+G + G + VK ++ + E
Sbjct: 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
+ + KLQH N+V+L+G C LI+EY+ K+L + + + L W +R
Sbjct: 734 IAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRR 783
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493
+I GIA+ L +LH ++ +L +++D P +
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLL 412
++G G FG VY E+ A+K++S S Q E++++ EV + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
GC L+ EY + + + +V + K L + + G +GL YLH +
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMA 499
+IHRD+KA N+LL K+ DFG A
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 16/152 (10%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG G FG VY + G+E+AVK++ S+ + + V + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 412 LGCCTLRDERML--IYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
GC +E+ L EY+P S+ +Q T+ + QI++G++ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YLHSN 125
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I+HRD+K +N+L D+ N K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---EVLL 399
TI + + + + +G G +G V T+ G +AVK+LS+ Q + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRL 69
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ-- 453
+ ++H N++ LL T P +SLE+F ++ VT D + +CQ
Sbjct: 70 LKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117
Query: 454 -------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+I I RGL Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 28/171 (16%)
Query: 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLG 413
N++G G G VY+ + G+ A+K + + V + E+ ++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 414 CCTLRDERMLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
E ++ E++ SL EQF+ DV R QI+ GIA YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA----YLH 185
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
R I+HRD+K SN+L+++ N KI+DFG++R + QT + VGT
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGT 231
|
Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 15/171 (8%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
++ ++G G +G VY+ L G+ AVK + G + E+ ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI---IEGIARGLLYLH 466
G R++ + EY SL Q I+ VT QI +GL YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPL-----SELQIAYVCRETLQGLAYLH 123
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
++ HRD+K +N+LL ++ + K++DFG+A + T A +GT
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
+ K+GEG FG +Y ++ + +K L+K + E K EV+L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+V ++ EY L + I F + ++ I+ GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-ISLGLKHIHD 119
Query: 468 DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTE 508
+I+HRD+K+ N+ L N M K+ DFG+AR D E
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQH---RNLVRLL 412
+G G +G VYRG G+ +A+K ++ + V + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 413 GCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
G L+ R+ +I EY S+ + + + II + L Y+H+
Sbjct: 69 GS-YLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+IHRD+KA+N+L+ N N K+ DFG+A + ++ +T VGT
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 18/158 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVE-EFKNEVLLIAKLQHRN 407
+ ++LGEG G V + L I A+K ++ ++ + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 408 LVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIA 459
+V+ G + EY SL D K R +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
+GL YLH +IIHRD+K SN+LL K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKLQHRNLVRLLG 413
KLGEG + VY+G+ GQ +A+K +S + +GV F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
++ ++EY+ + L Q++ + L + + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARA 501
+HRDLK N+L+ K++DFG+ARA
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 16/157 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK----LQHRNLV 409
+LG G FG V +G M + +AVK L + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
R++G C + ML+ E L +F+ + K + +++ ++ G+ YL + +
Sbjct: 60 RMIGICE-AESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
+HRDL A NVLL KISDFG+++A G D+
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 358 LGEGGFGPVYRGMLTEGQ------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+G G FG V+ Q +I V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
M++ EY P +L ++I LD I+ + LL LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDED---TILHFFVQILLALHHVHTK 120
Query: 472 RIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+HRDLK N+LLD + M KI DFG+++ +++A T VVGT
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 357 KLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLGC 414
++G G FG V+ G L + +AVK ++ ++ +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
CT + ++ E + F+ T L + Q++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 475 HRDLKASNVLLDNDMNPKISDFGMAR 500
HRDL A N L+ KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 355 KNKLGEGGFGPVYRGMLT--EGQEI--AVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLV 409
+GEG FG VY+G+ E ++I AVK + V E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 410 RLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+L+G T + + ++ E P L ++ LD + ++ L YL
Sbjct: 71 KLIGVIT--ENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
R +HRD+ A NVL+ + K+ DFG++R
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
DNF K+GEG G V + + G+ +AVK++ Q E NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V + + DE ++ E+L +L VT T+ ++ + + + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLKALSVLHAQ 135
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFG 497
+IHRD+K+ ++LL +D K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 10/158 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 406
D++ KLGEG + VY+G G+ +A+K RL + G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+V L ++ L++EY+ + L Q++ + K + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVK--LFLFQLLRGLSYIH 120
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
Q I+HRDLK N+L+ + K++DFG+ARA V
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 358 LGEGGFGP--VYR----GMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+G FG +YR L +E+ + RLS+ + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 412 LGCCTLRDERMLI-YEYLPNKSLEQFIFDVTRTKFLDWSKRCQI--IEGIARGLLYLHQD 468
+ D +LI EY +L I R K + + + + I + Y+H+
Sbjct: 65 YNH-FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+HRD+K N+ L K+ DFG+++ G + + A T VVGT
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 13/164 (7%)
Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+KLGEG + V++G LTE +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL 68
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
L++EYL + L+Q++ + + K + + RGL Y H +
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVK--IFMFQLLRGLSYCH---KR 122
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+I+HRDLK N+L++ K++DFG+ARA V T+ ++ VV
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV 165
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR-LSKSSGQGVEEFK-NEVLLIAKLQHR 406
D + K+GEG +G VY+ G+ +A+K+ + +G+ E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 407 N-LVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKF---LDWSKRCQIIEG 457
+VRLL + ++ L++EYL + L++F+ D L +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGV 504
+ +G+ + H + ++HRDLK N+L+D KI+D G+ RAF +
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 21/162 (12%)
Query: 358 LGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEFKNEVLLIAKL-QHRNLVRLL 412
+GEG FG V + + + + A+KR+ + +S +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA-----RGLLYLHQ 467
G C R L EY P+ +L F+ +++ L+ I A + LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 468 D--------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
D S+ + IHRDL A N+L+ + KI+DFG++R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 161
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 24/168 (14%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRL 411
+GEG +G V + E GQ +A+K+ +S + K E+ ++ +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 412 LGCCTLRDERMLIYEYLPN---KSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
+ + L++E++ + LE++ D +R + + QI+ GI + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF----QILRGIE----FCH 117
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
+ IIHRD+K N+L+ K+ DFG AR E TD V
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYV 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
K+GEG G V G+++AVK + Q E NEV+++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ +E ++ E+L +L + L+ + + E + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 476 RDLKASNVLLDNDMNPKISDFG 497
RD+K+ ++LL D K+SDFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 405
F+ LG+G FG V L Q++AVK L S +EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 406 RNLVRLLGCCTLRDER------MLIYEYLPNKSLEQFIF--DVTRTKF-LDWSKRCQIIE 456
N+++L+G + M+I ++ + L F+ + F L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YL S IHRDL A N +L+ +M ++DFG+++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 52/163 (31%), Positives = 75/163 (46%), Gaps = 26/163 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS----SGQGVEEFKNEVLLIAKLQ 404
D+F + LG G FG V + A+K LSK+ Q VE NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 405 HRNLVRLLGCCTLRDERML--IYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEG 457
H LV L G + +D+ L + EY+P L + F +F
Sbjct: 60 HPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQ 109
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ L YLH L I++RDLK N+LLD+D KI+DFG A+
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG+GGFG V + G+ A K+L K +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+D+ L+ + L+ I++V F + + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RRI 116
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMA 499
++RDLK NVLLD+ N +ISD G+A
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 49/181 (27%), Positives = 72/181 (39%), Gaps = 33/181 (18%)
Query: 351 NFSWKNKLGEGGFGPV----YRGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
+F +G+G FG V R + A+K ++K V NE ++ +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 404 QHRNLVRLLGCCTLRDER--MLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIE 456
H LV L + +DE L+ + L L ++ F + KF I
Sbjct: 58 NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WIC 107
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
I L YLH IIHRD+K N+LLD + I+DF +A + T G
Sbjct: 108 EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSG 161
Query: 517 T 517
T
Sbjct: 162 T 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 45/150 (30%), Positives = 66/150 (44%), Gaps = 9/150 (6%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIA---VKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
+++G G FG V G G A VK L S+ F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ--IIEGIARGLLYLHQDS 469
LG C +L+ E+ P L+ ++ K + +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
IH DL N L D++ KI D+G+A
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 357 KLGEGGFGPVYRGMLTEG---QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLL 412
++G G FG V G + G ++ VK L S+ Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL--DWSKRCQIIEGIARGLLYLHQDSR 470
G CT +L+ E+ P L+ ++ + + + D + ++ IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMA 499
IH DL N LL D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 28/173 (16%)
Query: 361 GGFGPVY--RGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGCC 415
G +G V+ + T G A+K + K+ V++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 416 TLRDERMLIYEYLPN---KSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
+ L+ EYLP SL + + D + I I L YLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS--- 111
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFG------MARAFGVDQTEANTDRVVGT 517
IIHRDLK N+L+D++ + K++DFG + R ++ E R+VGT
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLS-KSSGQGVEEFKNEVLLI 400
D + LGEG FG V + E +AVK L ++ + + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
+ +H+N++ LLG CT +I EY +L +++ +D+ R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ---HRNLVR 410
++G G +G VY+ G +A+K + + + EV L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 411 LLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
L+ C T R +R L++E++ ++ L ++ D L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
H + I+HRDLK N+L+ + K++DFG+AR +
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 34/170 (20%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL------LIAKLQ------- 404
LGEG FG V ++ E I + +K V+ K++ L+++++
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS-KRCQIIE------- 456
H+N++ LLG CT ++ EY +L +++ R +D+S C++ E
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 457 ------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 33/148 (22%)
Query: 374 GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430
GQ +A+K+LS+ Q V K E++L+ + H+N++ LL T P
Sbjct: 41 GQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT------------PQ 87
Query: 431 KSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRD 477
KSLE+F DV L + CQ+I+ + G+ +LH IIHRD
Sbjct: 88 KSLEEFQ-DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRD 143
Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVD 505
LK SN+++ +D KI DFG+AR G
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 358 LGEGGFGPVYRG--MLTEGQE--IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LG G FG + RG L +E +A+ L S + F E L + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
G T + M++ EY+ N +L+ F+ + + + ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFG 497
S + +H+ L A VL+++D+ KIS F
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
D + + D F +G G +G VY+G + ++A ++ + EE K E+ ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 401 AKL-QHRNLVRLLGCCTLR------DERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRC 452
K HRN+ G + D+ L+ E+ S+ + + DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
I I RGL +LH ++IHRD+K NVLL + K+ DFG++ A D
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---------AQLD 172
Query: 513 RVVG 516
R VG
Sbjct: 173 RTVG 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 44/158 (27%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 357 KLGEGGFGPVY--RGMLTEGQEIAVKRL---SKSSGQGVEEFKNEVLL--IAKLQHRNLV 409
++GEG +G V+ R + G+ +A+KR+ + G + + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 410 RLLGCCTL-RDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
RL CT+ R +R L++E++ ++ L ++ V + + + + + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
LH R++HRDLK N+L+ + K++DFG+AR +
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 50/155 (32%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNE--VLLIA-KLQHRN 407
LG G FG V +L E G+ A+K L K + VE E + A +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLL 463
LV L C D + EY L I F R F C ++ GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY---AACVVL-----GLQ 115
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498
YLH++ +I++RDLK N+LLD + KI+DFG+
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 418 RDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
+ I EY+ SL ++ R+ L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 477 DLKASNVLLDNDMNPKISDFGMAR 500
DL A NVL+ D K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
A + + +LG+G FG VY +G++ + E +A+K +++++ EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--------WSKRC 452
+ ++VRLLG + ++I E + L+ ++ + R + + K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLKKMI 122
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
Q+ IA G+ YL+ + + +HRDL A N ++ D KI DFGM R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+GEG FG R +L + Q+ A+K RL KSS VE+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ EY L Q I F + + ++ + G+ ++H+
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ-MCLGVQHIHEK--- 119
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
R++HRD+K+ N+ L + K+ DFG AR
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 15/155 (9%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVL-------LIAKLQHR 406
+ +LG+G FG VY ++ + + +A +RL V E NE + L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYL 465
+V+ RD +I EY + L+ + ++ T K L ++ C+ + G+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
HQ RI+HRDLKA N+ L N++ KI DFG++R
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 406
NF + K+G G F VYR L + + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-----WSKRCQIIEGIARG 461
N+++ L +E ++ E L Q I + K L W Q+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 42/179 (23%), Positives = 82/179 (45%), Gaps = 23/179 (12%)
Query: 343 NTIADATDNFSWKNK-LGEGGFGPVYRGMLT-EGQEIAVKRL--------SKSSGQGVEE 392
N ++ + K LGEG +G V + T G+ +A+K++ Q V
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 393 FK------NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL 446
E+ ++ +++H N++ L+ D L+ + + L++ + D + +
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVD-RKIRLT 117
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
+ +C I+ I GL LH+ +HRDL +N+ +++ KI+DFG+AR +G
Sbjct: 118 ESQVKC-ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 31/159 (19%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLLGC 414
+G G +G V T Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 415 CTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ---------IIEGIARG 461
T P S+E F ++ VT D + +CQ +I + RG
Sbjct: 83 FT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L Y+H IIHRDLK SNV ++ D +I DFG+AR
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVRL 411
LG+G FG V L E G+ AVK L K VE E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
C D + E++ L +F + +++ D ++ I L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
II+RDLK NVLLD++ + K++DFGM +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 34/170 (20%)
Query: 358 LGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-Q 404
LGEG FG V ++ E ++AVK L S ++ + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEG----- 457
H+N++ LLG CT +I EY +L +++ R +++ E
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 458 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQ-----GVEEFKNEVLLI 400
D + + +GEG +G V G ++A+K++S Q + E K ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 401 AKLQHRNLVRLLGC------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
+ +H N++ +L + D Y+ + +E ++ + +T+ L
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDV------YIVQELMETDLYKLIKTQHLSNDHIQYF 111
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ I RGL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 361 GGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRLLGCC 415
G FG VY + G A+K L KS + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+D L+ EYL I DW+ Q I + G+ LHQ IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWA--KQYIAEVVLGVEDLHQRG---IIH 120
Query: 476 RDLKASNVLLDNDMNPKISDFGMARA 501
RD+K N+L+D + K++DFG++R
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 36/173 (20%)
Query: 344 TIADATDNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLL 399
T+ + T+ + +G G FG V R LT GQ +A+K++ K S+ + E+ L
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKL 62
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIY-----------EYLPNKSLE-QFIFDVTRTKFLD 447
+ L+H N++ L IY L ++ LE QFI FL
Sbjct: 63 LKHLRHENIISL--SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI-----QYFL- 114
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
QI+ RGL Y+H ++HRDLK SN+L++ + + KI DFG+AR
Sbjct: 115 ----YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D+ +G G FG V+ + A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
++RL T D+R L + EY+P L F + +F + + E I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALE 115
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
YLH I++RDLK N+LLD + + K++DFG A+ D+T
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEV 397
M ++ D TD + +G+G +G VY+ +G AVK L S EE + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRT-KFLDWSK 450
++ L H N+V+ G D+ + L+ E S+ + + + + LD +
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG++ + N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 511 TDRVVGT 517
T VGT
Sbjct: 187 TS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 19/174 (10%)
Query: 358 LGEGGFGPVYR-------GMLTEGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAK-LQ 404
LG G FG VY+ L +EI V + + + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
H N+VR D ++ + + L E F + + + I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH++ R I+HRDL +N++L D I+DFG+A+ Q E+ VVGT
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 26/155 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG GGFG V + ++ + A+K + K E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 414 CCTLRDER---MLIYEYLPNKSLEQFIFDVTRT--KFLDWSKR---CQIIEGIARGLLYL 465
T +D++ ML+ EY L + + R F +++ R ++ YL
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFE----YL 109
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
H II+RDLK N+LLD++ K+ DFG A+
Sbjct: 110 H---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 28/157 (17%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
+G G G V T G +AVK+LS+ F+N+ AK +R LV LL C
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVN 78
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARGLL 463
++ L+ + P KSLE+F DV L + CQ+I + G+
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQ-DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+LH IIHRDLK SN+++ +D KI DFG+AR
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 20/153 (13%)
Query: 358 LGEGGFGPVYRGMLTE--GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLG 413
+G G FG V + ML + G +AVKR+ S + + ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 414 CCTLRDERMLIYEYLPNKSLEQF---IFDVTRTKFLDWSKRCQIIEGIA----RGLLYLH 466
R+ I L + SL++F +++V ++ + +I+ IA + L YL
Sbjct: 71 A-LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLK 124
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
++ L+IIHRD+K SN+LLD + N K+ DFG++
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 30/162 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL---LG 413
LG G G V+ + ++ + +AVK++ + Q V+ E+ +I +L H N+V++ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 414 CCTLRDERML--------IY---EYLPN---KSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
+ +Y EY+ LEQ + + Q++
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY----QLL---- 124
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMAR 500
RGL Y+H + ++HRDLK +NV ++ D+ KI DFG+AR
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 53/157 (33%), Positives = 71/157 (45%), Gaps = 29/157 (18%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNL 408
LG+G FG V +L E + AVK L K VE E VL +A +H L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
+L C +D + EY+ L FD R +F I GL
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--------IVLGLQ 110
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+LH+ II+RDLK NVLLD++ + KI+DFGM +
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 44/167 (26%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVRL 411
K+GEG F V + G+ A+K + K + +E+ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 412 L--------GCCTLRDE--RMLIYE-------YLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
+ G L E M +YE LP K ++ +++ Q+
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMY--------------QL 109
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
+ + L ++H++ I HRD+K N+L+ +D K++DFG R
Sbjct: 110 L----KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+ RGL Y+H + +IHRDLK SN+L++ D +I DFGMAR TE
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 59/170 (34%), Positives = 79/170 (46%), Gaps = 33/170 (19%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNL 408
LG+G FG V ML E + A+K L K VE + VL +A +H L
Sbjct: 3 LGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFL 58
Query: 409 VRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARG 461
L CT + + L + EYL L I FD R +F +II G
Sbjct: 59 THLF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG---- 108
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L +LH+ II+RDLK NVLLD D + KI+DFGM + + +A+T
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFK---NEVLLIAKLQHRNLVRLL 412
++G+GG+G V+ + EI A+KR+ KS + E + E ++ + LV+LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGLLYLHQDSRL 471
+ L EY+P + L + R + E + LH L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
IHRDLK N L+D + K++DFG+++
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 19/159 (11%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 409
+LG+G FG VY G + +G+ +AVK +++S S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
RLLG + +++ E + + L+ ++ + R + + R Q+ IA G
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ YL+ + +HRDL A N ++ +D KI DFGM R
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 36/177 (20%)
Query: 356 NKLGEGGFGPVYRGML--TEGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVR 410
+LG G G V + +L G+ +AVK + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVG 63
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ----------IIEGIAR 460
G + + EY+ SL++ + K Q I + +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKIL------------KEVQGRIPERILGKIAVAVLK 111
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GL YLH + +IIHRD+K SN+L+++ K+ DFG++ V+ + A T VGT
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGT 162
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+GGFG V G + +++ KR+ K G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+D L+ + L+ I+ + F + + I GL LHQ+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDLHQE--- 121
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
RI++RDLK N+LLD+ + +ISD G+A QT
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+GGFG V G + +++ KRL K SG+ + + E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+ L+ + L+ I++V + L+ + I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMA 499
I++RD+K NVLLD+ N ++SD G+A
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 28/158 (17%)
Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVRL 411
+G G FG V+ R GQ A+K L KS Q + + E ++A +V+L
Sbjct: 9 IGRGAFGEVWLVR-DKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 412 LGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
+ +DE L + EY+P L + +F +F IA +L
Sbjct: 67 Y--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLA 113
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
L +L IHRD+K N+L+D D + K++DFG+ +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 31/159 (19%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 407
+G G +G V +E +++A+K+++ + F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 408 LVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ-IIEGIARG 461
++ + ++YE L + L Q I ++ L CQ + + RG
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII---RSSQTLS-DDHCQYFLYQLLRG 120
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L Y+H + ++HRDLK SN+LL+ + + KI DFG+AR
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 45/142 (31%), Positives = 72/142 (50%), Gaps = 27/142 (19%)
Query: 375 QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSLE
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 435 QFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRDLKAS 481
+F + +D + CQ+I+ + G+ +LH IIHRDLK S
Sbjct: 100 EFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 155
Query: 482 NVLLDNDMNPKISDFGMARAFG 503
N+++ +D KI DFG+AR G
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 27/142 (19%)
Query: 375 QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSLE
Sbjct: 43 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 435 QFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRDLKAS 481
+F DV L + CQ+I+ + G+ +LH IIHRDLK S
Sbjct: 93 EFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 148
Query: 482 NVLLDNDMNPKISDFGMARAFG 503
N+++ +D KI DFG+AR G
Sbjct: 149 NIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 358 LGEGGFGPVYRGMLTE---------GQEIAVKR-LSKSSGQGVEEFKNEVLLIAKLQHRN 407
LG+G F +Y+G+L GQE++V + S + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LV+L G C +RDE +++ EY+ L+ F+ L W + + + +A L YL
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 468 DSRLRIIHRDLKASNVLL----DNDMNP---KISDFGMARAFG 503
+++H ++ N+L+ N+ K+SD G+
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 16/110 (14%)
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYE-----YLPNKSLEQFIFDVTRTKFLDWSK 450
E +L+ + H +++R+ L+ LP+ S + + + R++ L +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I + I GL YLH RIIHRD+K N+ +++ I D G A+
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 27/156 (17%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-------EVLLIAKLQHRNL 408
K+GEG +G V++ E GQ +A+K+ +S E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 409 VRLLGCCTLRDERM-LIYEYLPN---KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
V L+ R ++ L++EY + LE+ + + +II + + +
Sbjct: 63 VNLIEVFR-RKRKLHLVFEYCDHTVLNELEK------NPRGVPEHLIKKIIWQTLQAVNF 115
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
H+ IHRD+K N+L+ K+ DFG AR
Sbjct: 116 CHK---HNCIHRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 18/176 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 406
NF + K+G G F VYR L +G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-----WSKRCQIIEGIARG 461
N+++ +E ++ E L + I + K L W Q+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 25/58 (43%), Positives = 36/58 (62%), Gaps = 3/58 (5%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
I RGL YLH I+HRD+K N+L++++ KI DFG+AR D+++ T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-08
Identities = 26/81 (32%), Positives = 37/81 (45%), Gaps = 6/81 (7%)
Query: 186 EHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSK-NCSCTAYANADVRGGGSGCLLW 244
+ D F++ + KLP S + S+ C C NCSC ++ G GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 245 -FHDLIDMKVLSEGGQDLYIR 264
L D ++ GG DLY +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNE--VLLIAKLQHRNLVRL 411
LG+G FG V L E+ A+K L K V+ E +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
C +D + EY+ L +F + R++ D + + L++LH+
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+I+RDLK N+LLD + + K++DFGM +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 23/155 (14%)
Query: 357 KLGEGGFGPVYRGML----TEGQEIAVKRL--SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
K+GEG FG + +L +G++ +K + SK S + EE + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-----LDWSKRCQIIEGIARGLLYL 465
++ +Y L + I F LDW + I L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHV 117
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
H +I+HRD+K+ N+ L D K+ DFG+AR
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRLL 412
+GEG +G V + E +EI A+K+ S EE K E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
R + L++EY+ LE + + R I + I + + + H++
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND--- 120
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+HRD+K N+L+ ++ K+ DFG AR + + AN V T
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSK--SSGQGVEEFKNEVLL 399
T+ + + ++ ++G G +G V + G+++A+K+LS+ S + E+ L
Sbjct: 8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67
Query: 400 IAKLQHRNLVRLLGCCT---LRDERMLIYEYLPNKSLEQFIF-DVTRTKFLDWS--KRCQ 453
+ +QH N++ LL T DE Y +P ++ D+ + S K
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQY 121
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
++ + GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 122 LVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 358 LGEGGFGPVYRGMLTE----GQ----EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
LG+G F +++G+ E G+ E+ +K L KS E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
G C DE +++ EY+ SL+ ++ + W + ++ + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 470 RLRIIHRDLKASNVLL-----DNDMNP---KISDFGMA 499
+ H ++ A NVLL NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 32/148 (21%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 353 SWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-- 409
S L G VY L E +K S + + + EV ++ L + L
Sbjct: 1 SSIKLLKGGLTNRVYL--LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVP 56
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
++L L+ E++ ++L++ + + + Q+ E +A+ LHQ
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLDEVS-EEEKEDIAE-----QLAELLAK----LHQLP 106
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFG 497
L + H DL N+L+D+ I D+
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+GGFG V G + + + KR+ K G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+D L+ + L+ I+++ F + E I GL LH+++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN-- 122
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMA 499
++RDLK N+LLD+ + +ISD G+A
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/167 (32%), Positives = 73/167 (43%), Gaps = 27/167 (16%)
Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNLVRL 411
LG+G FG V+ L Q A+K L K VE + VL +A +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61
Query: 412 LGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
CT + + L + EYL L I FD+ R F C GL +
Sbjct: 62 Y--CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--------GLQF 111
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
LH I++RDLK N+LLD D + KI+DFGM + + + T
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 54/159 (33%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE--GQE--IAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
+F++ LG+G FG V ML E G + A+K L K VE E ++A L
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA-L 56
Query: 404 QHRN--LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
+ L +L C D + EY+ L I V KF + E IA G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAE-IAIG 113
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L +LH II+RDLK NV+LD + + KI+DFGM +
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 52/165 (31%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVE--EFKNEVLLIAKLQHRNLVRL 411
LG+G FG V L +G+ AVK L K VE + VL +A ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
++ + E+L L I FD+ R F C GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--------GLQFLH 113
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
II+RDLK NV+LD D + KI+DFGM + A+T
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 29/131 (22%), Positives = 58/131 (44%), Gaps = 12/131 (9%)
Query: 377 IAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
+AVK+ L S + ++ + E++ +LQH N++ + + E ++ + S E
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 435 QFIFDVTRTKFLDWSKR---CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491
+ +T F + I++ + L Y+H IHR +KAS++LL D
Sbjct: 88 DLL----KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKV 140
Query: 492 KISDFGMARAF 502
+S + +
Sbjct: 141 VLSGLRYSVSM 151
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSKSS----GQGVEEFKNEVLLIAK 402
NF LG G +G V+ G + A+K L K++ + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 403 LQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IAR 460
++ + L D ++ LI +Y+ L F R +F + + QI G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKE--QEVQIYSGEIVL 116
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
L +LH +L II+RD+K N+LLD++ + ++DFG+++ F D+ E
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+GGFG V G + +++ KR+ K G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+D L+ + L+ I+++ F D + + GL L ++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDLQRE--- 121
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMA 499
RI++RDLK N+LLD+ + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 21/47 (44%), Positives = 32/47 (68%), Gaps = 2/47 (4%)
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
+I I + L YLH S+L +IHRD+K SNVL++ + K+ DFG++
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 28/163 (17%)
Query: 351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHR 406
+F LG G FG V G+ A+K L K + V+ E ++ +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 407 NLVRLLGCCTLRDERML--IYEYLPN-------KSLEQFIFDVTRTKFLDWSKRCQIIEG 457
+V ++ C+ +DE + + E++ + +F DV KF
Sbjct: 79 FIVNMM--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA--KFYHAE-------- 126
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ YLH II+RDLK N+LLDN + K++DFG A+
Sbjct: 127 LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
+G+G FG V +G+ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
D+ + +Y+ L F + R + F + R E IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
II+RDLK N+LLD+ + ++DFG+ +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 32/160 (20%)
Query: 358 LGEGGFGPVYR--GMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRL 411
+G G FG V R G A+K+L KS Q V + E ++A+ + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKL 66
Query: 412 LGCCTLRDER--MLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
+ +DE LI EYLP + + F + TR F IA +
Sbjct: 67 Y--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY-----------IAETI 111
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+GGFG V G + +++ KR+ K G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSR 470
+D L+ + L+ I+++ F + +R I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFYAAEITCGLEDLH---R 120
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMA 499
RI++RDLK N+LLD+ + +ISD G+A
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 22/51 (43%), Positives = 31/51 (60%), Gaps = 3/51 (5%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
I GL Y+H + ++HRDLK N+L++ D KI DFG+AR F + E
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 31/173 (17%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK--SSGQGVEEFKNEVLLI 400
TI + D + ++G G +G V + G ++A+K+L + S + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK-------- 450
++H N++ LL T P+ SL++F + V D K
Sbjct: 69 KHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS 116
Query: 451 --RCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
R Q ++ + +GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 52/222 (23%)
Query: 305 YMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWK--NKLGEGG 362
K + D+ E + N E+ + N I + + N S+K N +G G
Sbjct: 24 GSGKFEMNDKKLD----EEERSHNNNAGEDEDEEKMIDNDI-NRSPNKSYKLGNIIGNGS 78
Query: 363 FGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK-LQHRNLVRLLGC----CT 416
FG VY + + +++A+K++ + ++KN LLI K L H N++ L C
Sbjct: 79 FGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECF 133
Query: 417 LRDERML----IYEYLP-------------NKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
++E+ + + E++P N +L F+ + + +
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------------LC 180
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMAR 500
R L Y+H I HRDLK N+L+D N K+ DFG A+
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 358 LGEGGFGPVY--RGMLTE--GQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVRL 411
LG+G FG V+ R + GQ A+K L K++ + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 412 LGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
+ LI ++L L ++ +F KF + +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHLH 115
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L II+RDLK N+LLD + + K++DFG+++
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLV 409
LG+GG+G V++ G + A+K L K+ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
L+ + LI EYL L F+ F++ C + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFME-DTACFYLSEISLALEHLHQ-- 118
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
II+RDLK N+LLD + K++DFG+ +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 351 NFSWKNKLGEGGFGPVY----RGMLTEGQEIAVKRLSKSS----GQGVEEFKNE-VLLIA 401
NF LG G +G V+ G G+ A+K L K++ + E + E +L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
+ LV L + LI +Y+ E F R F + R I E I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYV--NGGELFTHLYQREHFTESEVRVYIAE-IVLA 117
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
L +LHQ L II+RD+K N+LLD++ + ++DFG+++ F ++ E
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 38/171 (22%)
Query: 350 DNFSWKNKLGEGGFGPV-YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
++F +G+G FG V G+ A+K L KS E FK + L K + L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDVL 55
Query: 409 --------VRLLGCCTLRDERML--IYEYLPNKSL-------EQFIFDVTRTKFLDWSKR 451
V L + +D + L I E+LP L + F DVTR F
Sbjct: 56 AESDSPWVVSLY--YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR--FY----- 106
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+A +L + +L IHRD+K N+L+D + K+SDFG++ F
Sbjct: 107 ------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 21/171 (12%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIA---VKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLL 412
++G G FG V + +A VK L ++ + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR-CQIIE------GIARGLLYL 465
G C +L++EY L+ ++ W +R Q++ IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA-FGVDQTEANTDRVV 515
H + +H DL N L +D+ K+ D+G+ + + D E D+ V
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV 163
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 54/169 (31%), Positives = 76/169 (44%), Gaps = 17/169 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
+F++ LG+G FG V ML E + A+K L K VE E ++A
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 404 QHRN-LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L +L C D + EY+ L I V KF + E I+ GL
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAE-ISVGL 114
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+LH+ II+RDLK NV+LD++ + KI+DFGM + VD T
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 358 LGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
+G+G FG V ++G AVK L K + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ + +Y+ L F + R + FL+ R E +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
II+RDLK N+LLD+ + ++DFG+ + GV+ E T GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQ--EIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ 404
++F++ LG G FG V +A+KR KS + V+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGI 458
H V L G + +DE Y YL + +F+ FL +KR C I
Sbjct: 90 HPFCVNLYG--SFKDES---YLYL----VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
YL L I++RDLK N+LLD D K++DFG A+
Sbjct: 141 VLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGCC 415
K+G G +G VY+ +G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 416 TLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY-----LHQD 468
+R L+++Y + I R + K Q+ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAF 502
++HRDLK +N+L+ + P KI+D G AR F
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 18/47 (38%), Positives = 31/47 (65%), Gaps = 2/47 (4%)
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
+I + GL YL+ + RI+HRD+K SN+L+++ K+ DFG++
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--- 403
+F++ LG+G FG V ML E + A+K L K +++ E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLA 55
Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
+ L +L C D + EY+ L I V R K IA
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK---EPHAVFYAAEIAI 112
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
GL +LH II+RDLK NV+LD++ + KI+DFGM +
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 20/46 (43%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I +A L YLH+ IIHRDLK N+L+ N+ + K++DFG+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
+++ D +D + +G+G +G V++ + G + AVK L EE + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 401 AKLQ-HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ- 453
L H N+V+ G +D + L+ E S+ + FL +R +
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEE 123
Query: 454 -----IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
I+ GL +LH + + IHRD+K +N+LL + K+ DFG++ +
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 509 ANTDRVVGT 517
NT VGT
Sbjct: 181 RNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 36/179 (20%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLL----- 399
D+F KLGEG FG VY+ L + +K+ + G VE + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 400 -IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL------EQFIFDVTRTKFLD----- 447
A + L + DE L++ Y +L ++F ++V
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 448 --WSKRCQIIEGIARGLLY----LHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMA 499
+ +II+ I R +L+ LH I+HRD+K N++ KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 3/42 (7%)
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
R L Y+H + + HRDLK N+L + D KI DFG+AR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-05
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 13/84 (15%)
Query: 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKN---CSCTAYANADVRGGGSGC 241
C+ L + ++K+ T + D C C KN SC A+ A R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 242 LLW-FHDLIDMKVLSEGGQDLYIR 264
L + F+ + ++ G DLY
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 358 LGEGGFGPVYRGMLTE---GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRL 411
LG+G FG V ++ E G+ A+K L K + V E ++ +H L L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 412 LGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
+D + EY+ L + +F RT+F I L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLH 112
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+I++RDLK N++LD D + KI+DFG+ +
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 29/115 (25%), Positives = 45/115 (39%), Gaps = 29/115 (25%)
Query: 396 EVLLIAKLQHRNLVRLLG--------CCTLRDERMLIYEYLPNKS---LEQFIFDVTRTK 444
E+ ++ + HR ++ L+ C + + ++ Y+ LEQ I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT------ 189
Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
I + L YLH IIHRD+K N+ LD N + DFG A
Sbjct: 190 ---------IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
+G+G FG V ++ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
D+ + +Y+ L + + R + FL+ R E IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASALGYLHS---L 115
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I++RDLK N+LLD+ + ++DFG+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 34/158 (21%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLL---IAKLQHR--NLVRL 411
+G G G VY+ G +AVK++ ++ G +E +L+ + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ--IIEGIA--------RG 461
G + D + I L + L++ KR Q I E I +
Sbjct: 80 YGY-FITDSDVFICMELMSTCLDKL------------LKRIQGPIPEDILGKMTVAIVKA 126
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
L YL + +IHRD+K SN+LLD N K+ DFG++
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 24/179 (13%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ 404
+F K+ +G G FG V R T G A+K + KS + + V F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEGI 458
+ +L +D L+ EY P L FD +F +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------L 108
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
A +L +H ++ +HRD+K NVL+D + K++DFG A ++ N+ VGT
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 35/137 (25%), Positives = 62/137 (45%), Gaps = 23/137 (16%)
Query: 374 GQEIAVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLGCCTLRDERML-IYEYLP 429
G E+A+K L + + + F+ E L A+L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 430 NKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484
++L + + T L Q+++ +A H I+HRDLK N++
Sbjct: 63 GRTLREVLAADGALPAGETGRL----MLQVLDALACA----HNQG---IVHRDLKPQNIM 111
Query: 485 L---DNDMNPKISDFGM 498
+ + K+ DFG+
Sbjct: 112 VSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGCC 415
K+G G +G VY+ +G++ L + G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 416 TLRDERM--LIYEYLPNKSLEQFIFDVT-----RTKFLDWSKRCQIIEGIARGLLYLHQD 468
+R L+++Y + F + L S ++ I G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAF 502
++HRDLK +N+L+ + P KI+D G AR F
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 39/152 (25%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK-NEVLLIAKLQHR----N 407
++LG+G +G VY+ + G +A+K RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+V G + + EY+ SL++ T+ + +I + +GL +L +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
+ IIHRD+K +NVL++ + K+ DFG++
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
+G+G FG V +G+ AVK L K +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
++ + +++ L F + R + + IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
I++RDLK N+LLD+ + ++DFG+ + G+ Q++ T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTT 154
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 20/53 (37%), Positives = 32/53 (60%), Gaps = 10/53 (18%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG--------MARAF 502
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG MA +F
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
E ++ + H ++++L G T LI LP + + + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+ R + YLH++ RIIHRD+KA N+ +++ + + DFG A F VD
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINA 237
|
Length = 391 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I L YLH +++RDLK N++LD D + KI+DFG+ +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 12/148 (8%)
Query: 358 LGEGGFGPV--YRGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LG+G FG V R T G+ A+K L K + V E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
D + EY L F ++R + + I L YLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD--- 115
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMAR 500
+++RD+K N++LD D + KI+DFG+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 351 NFSWKNKLGEGGFGPVYR----GMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAK 402
NF LG G +G V+ G+ A+K L K++ + VE + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 403 LQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
++ + L + ++ LI +Y+ E F R F + R E I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSEDEVRFYSGE-IILA 117
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
L +LH +L I++RD+K N+LLD++ + ++DFG+++ F ++ E
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
I+ L +LH+ II+RDLK NVLLD + + K++D+GM +
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 42/180 (23%)
Query: 358 LGEGGFGPV----YRGMLTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQHRNLVR- 410
+G+G +G V +R T+G++ +K+L+ +S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 411 -------------LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
++G C D L +K EQ + + ++W +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD--------LYHKLKEQKGKLLPENQVVEWFVQ------ 110
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IA L YLH+ I+HRDLK NV L K+ D G+AR A+T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H LV L C + EY+ L +F + R + L I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
LH+ II+RDLK NVLLD++ + K++D+GM +
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 31/133 (23%), Positives = 61/133 (45%), Gaps = 20/133 (15%)
Query: 379 VKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI---YEYLPNKSLEQ 435
+ + K+ + + +NE+L + +L H N++++ +I Y++ L
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYS 251
Query: 436 FIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489
F++D + DW R I++ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 252 FMYD----EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 490 NPKISDFGMARAF 502
+ DFG A F
Sbjct: 305 KIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
LV L C L+ EY+ L +F + R + L I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
II+RDLK NVLLD D + K++D+GM +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 20/154 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG G FG V + + + A+K L K V K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+D + +Y+P + IF +F IA +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELTCAVESV 117
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
+G G FG V Q++ A+K LSK + F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109
Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
C +D++ L + EY+P L + +DV W+K A +L L
Sbjct: 110 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIH 159
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT-EANTDRVVGT 517
+ +IHRD+K N+LLD + K++DFG +D+T D VGT
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGT 206
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 358 LGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEF-----KNEVLLIAKLQHRNLV 409
LG+G FG V ++ E G+ A+K L K +E +N VL ++ H L
Sbjct: 3 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLT 58
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
L D + EY L F ++R + + I L YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+++RDLK N++LD D + KI+DFG+ +
Sbjct: 116 N--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG G FG V + + A+K L K + V K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+D + +Y+P + +F +F IA L +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY-----------IAELTLAIESV 117
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 20/154 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
+G G FG V + + A+K L K+ K E ++A+ + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+D + +Y+P + IF+ +F I + + +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--------IAELTCAIESVH-- 118
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L + IHRD+ A NVLL + KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 23/69 (33%), Positives = 40/69 (57%), Gaps = 10/69 (14%)
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG--------MARAFGVDQTE 508
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG MA +F ++
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168
Query: 509 ANTDRVVGT 517
+ +R+ GT
Sbjct: 169 MSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 18/48 (37%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+I + +GL YL L+I+HRD+K SN+L++ K+ DFG++
Sbjct: 99 RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.93 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.93 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.93 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.92 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.92 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.9 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.9 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.89 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.89 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.89 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.89 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.89 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.89 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.88 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.88 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.88 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.88 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.88 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.88 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.88 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.88 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.88 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.88 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.88 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.88 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.88 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.88 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.88 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.88 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.87 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.87 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.87 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.87 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.87 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.87 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.87 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.87 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.87 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.87 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.86 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.86 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.86 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.86 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.86 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.86 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.86 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.86 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.86 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.85 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.85 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.85 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.85 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.85 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.85 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.85 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.85 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.84 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.84 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.84 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.84 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.84 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.84 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.84 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.84 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.84 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.84 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.84 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.83 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.83 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.83 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.83 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.83 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.82 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.81 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.8 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.79 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.77 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.73 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.72 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.33 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.19 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.16 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.13 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.98 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.82 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.44 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.44 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.85 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.41 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.26 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.26 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| PLN02236 | 344 | choline kinase | 97.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.31 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.27 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.19 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.14 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.07 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.78 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=299.80 Aligned_cols=168 Identities=51% Similarity=0.853 Sum_probs=154.2
Q ss_pred CCCccchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 010146 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415 (517)
Q Consensus 336 ~~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 415 (517)
....|++.++..++++|...+.||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765433155699999999999999999999999
Q ss_pred EeCC-EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 416 TLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 416 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999765443 78999999999999999999999988899999999999999999999999
Q ss_pred cccCceecCC
Q 010146 495 DFGMARAFGV 504 (517)
Q Consensus 495 DFGla~~~~~ 504 (517)
|||+|+..+.
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999977654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=264.86 Aligned_cols=153 Identities=33% Similarity=0.549 Sum_probs=137.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
...+|...+.||+|+||+||+|+++. +.+||||.+.+. .....+.+..|+++|+.++|||||++++++..++..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34678888999999999999999764 899999999775 455667789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC------CCeEEccccC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND------MNPKISDFGM 498 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~DFGl 498 (517)
||||.+|+|.+||+. .+.+++.....++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999954 346999999999999999999999999 9999999999999765 4589999999
Q ss_pred ceecCCCC
Q 010146 499 ARAFGVDQ 506 (517)
Q Consensus 499 a~~~~~~~ 506 (517)
||.+.+..
T Consensus 162 AR~L~~~~ 169 (429)
T KOG0595|consen 162 ARFLQPGS 169 (429)
T ss_pred hhhCCchh
Confidence 99997554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=252.80 Aligned_cols=161 Identities=30% Similarity=0.500 Sum_probs=137.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc-------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 419 (517)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++... .....+++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3467888899999999999999965 599999999976421 12234679999999999999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC---CCeEEccc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDF 496 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DF 496 (517)
..|+||||++||+|.+++-. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999843 445778888899999999999999999 9999999999999766 67999999
Q ss_pred cCceecCCCCcccccCceecC
Q 010146 497 GMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 497 Gla~~~~~~~~~~~~~~~~GT 517 (517)
|+|+..++.+ .+..++||
T Consensus 324 GlAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred chhhccccce---ehhhhcCC
Confidence 9999997543 23345665
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.41 Aligned_cols=160 Identities=32% Similarity=0.477 Sum_probs=146.3
Q ss_pred CCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 67999999999874 3456778999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+|++++|..++. +.+.+++.++..++.||+.||.|||+++ |||||||..|+||+++.+|||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 4567999999999999999999999998 999999999999999999999999999999877
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
..+..| ++||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 655544 6776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=247.30 Aligned_cols=156 Identities=27% Similarity=0.374 Sum_probs=136.8
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-EEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 428 (517)
++..+.||+|..|+||++.++. ++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 4445899999999999999874 889999999544 4455678999999999999999999999999998 599999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
++|+|++++.. .+.+++.....|+.+|++||.|||+ ++ ||||||||+||||+..|+|||+|||.++.+-..
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999954 3569999999999999999999996 55 999999999999999999999999999988544
Q ss_pred ccccCceecC
Q 010146 508 EANTDRVVGT 517 (517)
Q Consensus 508 ~~~~~~~~GT 517 (517)
....++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 23346776
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.21 Aligned_cols=110 Identities=47% Similarity=1.047 Sum_probs=105.3
Q ss_pred EEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCCCeEEEEEeCCCcceeeeeccccccC
Q 010146 51 FRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLIL 130 (517)
Q Consensus 51 w~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~~~~~~~ 130 (517)
||+|||||..|+++|+|....++.+.|+.++++.+++|.+.+.+.++|++||++|++++|.|++..+.|... |.+| .
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~--~~~p-~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVF--WSAP-K 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEE--EEec-c
Confidence 899999999999999999888899999999999999999999999999999999999999999999999999 9999 9
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccCC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPKS 164 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~~ 164 (517)
|+||+|+.||+||+|+.+ ..+.|.||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence 999999999999999876 678899999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=245.55 Aligned_cols=161 Identities=29% Similarity=0.434 Sum_probs=143.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.++||+|+||+||.++.++ ++.+|+|++++. .....+...+|..+|.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999765 899999999875 234567789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+||+.||.|..+| +++..+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 44566999999999999999999999999 99999999999999999999999999997655
Q ss_pred CCcccccCceecC
Q 010146 505 DQTEANTDRVVGT 517 (517)
Q Consensus 505 ~~~~~~~~~~~GT 517 (517)
+.. .|..++||
T Consensus 178 ~~~--~t~tfcGT 188 (357)
T KOG0598|consen 178 DGD--ATRTFCGT 188 (357)
T ss_pred CCC--ccccccCC
Confidence 443 34447887
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=251.76 Aligned_cols=161 Identities=29% Similarity=0.470 Sum_probs=140.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 423 (517)
.+.|+.+++||+|.||.||+|+.. +|+.||+|+++... +....-..+||.+|++|+||||++|.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 345777789999999999999954 59999999997653 44556678999999999999999999998877 68999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|+|||+ -+|.-++. ...-.+++.++..++.||+.||+|+|.++ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMd-hDL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEeccc-chhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999995 67887773 33456999999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCcccccCcee
Q 010146 504 VDQTEANTDRVV 515 (517)
Q Consensus 504 ~~~~~~~~~~~~ 515 (517)
.......|++++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 877766777664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=251.31 Aligned_cols=150 Identities=36% Similarity=0.609 Sum_probs=132.3
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc--CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-EEEEEEEeCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLP 429 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 429 (517)
...+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.... ...||||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344669999999999999985444999999764322 2569999999999999999999999999887 7999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 505 (517)
+|+|.++++.. ....+++..++.++.|||+||.|||++++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999764 45679999999999999999999999874 99999999999999998 9999999999987643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=251.74 Aligned_cols=152 Identities=35% Similarity=0.617 Sum_probs=137.7
Q ss_pred CCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
.+...+.||+|-||.|+.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..++.++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34556899999999999999997779999999764 45567899999999999999999999999998999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.+.+++-
T Consensus 286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999965 34566899999999999999999999998 99999999999999999999999999997766553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=226.98 Aligned_cols=151 Identities=32% Similarity=0.532 Sum_probs=134.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|...++||+|.||.||+|++. +|+.||||+++... ........+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777899999999999999965 59999999997642 1223467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|| ..+|+..+++ +...++..++..++.++++||+|||++. |+||||||.|+||+++|.+||+|||+|+.++...
T Consensus 82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 4899999954 3456899999999999999999999999 9999999999999999999999999999997654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=235.81 Aligned_cols=149 Identities=24% Similarity=0.425 Sum_probs=130.8
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
+.|+...++|+|+||.||+++.++ |+.||||++.... +...+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467778899999999999999876 9999999997542 3334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|++..-|.++- .. ...++...+..++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eLe-~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE-RY--PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH-hc--cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99766555543 22 334889999999999999999999999 99999999999999999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=245.42 Aligned_cols=154 Identities=32% Similarity=0.450 Sum_probs=137.7
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
....+|.+.+.||+|+|++|++|+... ++++|||++.+. .+...+.+..|-.+|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678899999999999999999654 999999999764 234445677888899999 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
|+|+||+++|+|.++|.+ .+.+++.....++.||+.||+|||++| ||||||||+|||||+++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999954 356999999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+++.+
T Consensus 224 l~~~~ 228 (604)
T KOG0592|consen 224 LSPSQ 228 (604)
T ss_pred CChhh
Confidence 97654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=235.45 Aligned_cols=166 Identities=25% Similarity=0.438 Sum_probs=140.3
Q ss_pred CCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEE-EEEeCCE-EEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLG-CCTLRDE-RMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 424 (517)
.+|++.++||+|.||.||++. ..+|..+|.|.+.-. +....+....|+.+|++|+|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788999999999999998 557999999998743 3445667899999999999999999998 4555555 8999
Q ss_pred EEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcC-CCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 425 YEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDS-RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||++.+|+|..++...+ ..+.+++..+++++.|++.||..+|..- +..|+||||||.||+|+.+|.|||+|||++|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997643 3456899999999999999999999832 124999999999999999999999999999999
Q ss_pred CCCCcccccCceecC
Q 010146 503 GVDQTEANTDRVVGT 517 (517)
Q Consensus 503 ~~~~~~~~~~~~~GT 517 (517)
....+- +.+.+||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 766543 3456776
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=224.80 Aligned_cols=157 Identities=31% Similarity=0.405 Sum_probs=139.9
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|+..+.||.|+||.|.+++.+. |..+|+|++++.. ..+.+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 568888999999999999999765 8899999998753 234566789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||.+||.|..+|++ .+.+++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999954 455999999999999999999999998 999999999999999999999999999998543
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
|-.++||
T Consensus 198 -----T~TlCGT 204 (355)
T KOG0616|consen 198 -----TWTLCGT 204 (355)
T ss_pred -----EEEecCC
Confidence 4446666
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=242.73 Aligned_cols=152 Identities=31% Similarity=0.479 Sum_probs=134.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHH--HHHHHHHHhcCC-CCCeeeEEEEEEeCC-EEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQ-HRNLVRLLGCCTLRD-ERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 422 (517)
..++|..+++||.|+||.||+|+.. .+..||||++++.... .++ =++|+..|++|. ||||+++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4568889999999999999999955 4899999999875322 333 368999999999 999999999999888 899
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||| ..+|.+++.+. .+.+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+||.+
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999999 58999999654 677999999999999999999999999 999999999999998889999999999998
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 161 ~Skp 164 (538)
T KOG0661|consen 161 RSKP 164 (538)
T ss_pred ccCC
Confidence 6544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=234.54 Aligned_cols=151 Identities=25% Similarity=0.502 Sum_probs=137.9
Q ss_pred CCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
-+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+++|+++|..|+||||+.++++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4688889999999999999995 56999999999875 4555667899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||..+|.|.+|+. +.+.+++.+..++++||..|+.|+|.++ ++|||||.+|||||.++++||+|||++-.+..+
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 3456999999999999999999999998 999999999999999999999999999988655
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 207 k 207 (668)
T KOG0611|consen 207 K 207 (668)
T ss_pred c
Confidence 3
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=237.66 Aligned_cols=160 Identities=33% Similarity=0.583 Sum_probs=138.5
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhc--CCCCCeeeEEEEEEeCC----EEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLRD----ERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 423 (517)
+..++.++||+|+||.||+|.+. ++.||||++.. +..+.|++|-++.+. ++|+||+++++.-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44556689999999999999997 59999999964 455677888777665 58999999999876655 7899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc------CCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
|+||.+.|+|.+||.. ..++|....+|+..+++||+|||+. .+++|+|||||.+||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999943 4589999999999999999999975 34589999999999999999999999999
Q ss_pred CceecCCCCcccccCceecC
Q 010146 498 MARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 498 la~~~~~~~~~~~~~~~~GT 517 (517)
+|..+.....+..+...+||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eeEEecCCCCCcchhhhhhh
Confidence 99999988877777777776
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=235.71 Aligned_cols=151 Identities=28% Similarity=0.402 Sum_probs=137.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++++.||+|+||.||+|+-++ |..+|+|++++.. ..+.+.++.|-.+|...++|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999665 9999999998763 3456678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||++||++..+| .+...|++..+..++.+++-|++.||+.| +|||||||+|+|||..|++||+||||++-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 44567999999999999999999999999 9999999999999999999999999997654
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 293 ~ 293 (550)
T KOG0605|consen 293 K 293 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=227.65 Aligned_cols=151 Identities=32% Similarity=0.522 Sum_probs=133.4
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--EEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 425 (517)
..+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457777999999999999999765 8999999987653333677999999999999999999999855444 689999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 504 (517)
||+++|+|.+++.+... .+++..+..+.+||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999965432 5999999999999999999999998 999999999999999 79999999999998874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=248.46 Aligned_cols=151 Identities=30% Similarity=0.530 Sum_probs=137.0
Q ss_pred CCccceecccCCeeEEEEEeCC----CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..+.++||.|.||.|++|+++- ...||||.++.. .+.....|+.|+.+|.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999763 357999999876 45567789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
||++|+|+.||+++. ..+++.++..++++|+.||+||-+.+ +|||||.++||||+.+..+|++||||+|.+.++.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999996543 45899999999999999999999988 9999999999999999999999999999997776
Q ss_pred c
Q 010146 507 T 507 (517)
Q Consensus 507 ~ 507 (517)
.
T Consensus 786 ~ 786 (996)
T KOG0196|consen 786 E 786 (996)
T ss_pred C
Confidence 3
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=223.25 Aligned_cols=152 Identities=30% Similarity=0.518 Sum_probs=131.8
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCC------
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRD------ 419 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 419 (517)
..|+..++||+|+||+||+|+.+ +|+.||+|+++.... .......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34566678999999999999965 589999999976533 23456789999999999999 999999998877
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
..++|+||+ .-+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 68999999665432 45777899999999999999999999 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.+.-+
T Consensus 167 Ara~~ip 173 (323)
T KOG0594|consen 167 ARAFSIP 173 (323)
T ss_pred HHHhcCC
Confidence 9987644
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=235.07 Aligned_cols=151 Identities=27% Similarity=0.461 Sum_probs=135.0
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC----Cc-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS----SG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD 419 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 419 (517)
...++|.+.+.||+|+||+|+.|... ++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999865 5899999977653 11 23456778999999999 999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEccccC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGM 498 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGl 498 (517)
..++||||+.+|+|.+++.+ .+.+.+..+..+++|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 455888999999999999999999998 9999999999999999 9999999999
Q ss_pred ceecC
Q 010146 499 ARAFG 503 (517)
Q Consensus 499 a~~~~ 503 (517)
+....
T Consensus 168 s~~~~ 172 (370)
T KOG0583|consen 168 SAISP 172 (370)
T ss_pred ccccC
Confidence 99884
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=238.54 Aligned_cols=159 Identities=29% Similarity=0.481 Sum_probs=140.6
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.. +...+.+++|++++++++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999999764 8899999997653 3446679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+.+ +|..+|. ....++++.+..|+.+++.||.|||+++ |+|||+||+|||++..+.+|++|||+||.+..+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9975 9999994 3456999999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccCceecC
Q 010146 507 TEANTDRVVGT 517 (517)
Q Consensus 507 ~~~~~~~~~GT 517 (517)
. ...++.||
T Consensus 155 ~--vltsikGt 163 (808)
T KOG0597|consen 155 S--VLTSIKGT 163 (808)
T ss_pred e--eeeeccCc
Confidence 2 33456665
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=249.09 Aligned_cols=151 Identities=35% Similarity=0.601 Sum_probs=134.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
..+....+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566789999999999999853 2457999999877554 778999999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 422 MLIYEYLPNKSLEQFIFDVTR-----------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
++|+|||..|+|.+||..... ...++..+.+.|+.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999963221 223889999999999999999999988 999999999999999999
Q ss_pred eEEccccCceec
Q 010146 491 PKISDFGMARAF 502 (517)
Q Consensus 491 ~kl~DFGla~~~ 502 (517)
|||+||||+|.+
T Consensus 642 VKIsDfGLsRdi 653 (774)
T KOG1026|consen 642 VKISDFGLSRDI 653 (774)
T ss_pred EEecccccchhh
Confidence 999999999965
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=220.94 Aligned_cols=152 Identities=29% Similarity=0.426 Sum_probs=130.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 423 (517)
.+.|+..++|++|+||.||+|+++. ++.||+|+++...+ ..--..++||.+|.+++|||||.+-.+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3457788999999999999999764 88999999976432 1223467899999999999999999987643 56899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||++ -+|...|.... ..+...++.-++.|+++||+|||.+. |+||||||+|+|+++.|.+||+|||+||.++
T Consensus 155 VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999995 68999885433 46889999999999999999999999 9999999999999999999999999999998
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 229 sp~ 231 (419)
T KOG0663|consen 229 SPL 231 (419)
T ss_pred CCc
Confidence 763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=226.15 Aligned_cols=150 Identities=31% Similarity=0.487 Sum_probs=129.4
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--------------ccCHHHHHHHHHHHhcCCCCCeeeE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--------------GQGVEEFKNEVLLIAKLQHRNLVRL 411 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~l 411 (517)
...++|++++.||+|.||.|-+|+.. +++.||||++.+.. ....+..++|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45578999999999999999999965 58999999986531 1123678999999999999999999
Q ss_pred EEEEEeC--CEEEEEEEeCCCCCHHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC
Q 010146 412 LGCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488 (517)
Q Consensus 412 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 488 (517)
+++..+. +..|||+||+..|.+... ..... +++.+++.++++++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998654 568999999998877432 23334 899999999999999999999999 9999999999999999
Q ss_pred CCeEEccccCceecC
Q 010146 489 MNPKISDFGMARAFG 503 (517)
Q Consensus 489 ~~~kl~DFGla~~~~ 503 (517)
++|||+|||.+-...
T Consensus 247 g~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFP 261 (576)
T ss_pred CcEEeeccceeeecc
Confidence 999999999998773
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=235.33 Aligned_cols=149 Identities=36% Similarity=0.554 Sum_probs=131.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCC--C--CE-EEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE--G--QE-IAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
.++..+.++||+|+||.||+|.++. + .. ||||..+.. ......++.+|++++++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445556899999999999999653 2 23 899998752 45667889999999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
++||||++.||+|.++|.+... .++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999965432 5999999999999999999999998 9999999999999999999999999988
Q ss_pred ec
Q 010146 501 AF 502 (517)
Q Consensus 501 ~~ 502 (517)
.-
T Consensus 311 ~~ 312 (474)
T KOG0194|consen 311 AG 312 (474)
T ss_pred CC
Confidence 54
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=211.76 Aligned_cols=151 Identities=33% Similarity=0.457 Sum_probs=135.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999965 4789999999764 234456899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+||.+.|+|...|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+-.-+
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999542 4456889999999999999999999988 9999999999999999999999999987654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=219.92 Aligned_cols=155 Identities=23% Similarity=0.399 Sum_probs=139.3
Q ss_pred hcCCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..+.|++.+.||.|..++||+|+. +.+..||||++.-.. ....+.+++|+..++.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 347899999999999999999994 458999999997642 344689999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.||.+|++.++++..-..+ +++..+..|++++++||.|||++| .||||||+.||||+++|.|||+|||.+-.+-..
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997654443 899999999999999999999999 999999999999999999999999988777554
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 180 G 180 (516)
T KOG0582|consen 180 G 180 (516)
T ss_pred C
Confidence 3
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=231.16 Aligned_cols=160 Identities=32% Similarity=0.513 Sum_probs=143.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
...|....+||+|+.|.||.|... +++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 345677789999999999999854 5899999999887666677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|++|+|.+.+.. ..+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+...+.
T Consensus 352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998833 34899999999999999999999999 99999999999999999999999999999988776
Q ss_pred ccccCceecC
Q 010146 508 EANTDRVVGT 517 (517)
Q Consensus 508 ~~~~~~~~GT 517 (517)
...| ++||
T Consensus 425 KR~T--mVGT 432 (550)
T KOG0578|consen 425 KRST--MVGT 432 (550)
T ss_pred cccc--ccCC
Confidence 4433 6776
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=228.27 Aligned_cols=155 Identities=32% Similarity=0.543 Sum_probs=137.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
+.+...+.++||+|-||.|.++....+..||||.++..... ...+|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 44567788999999999999999988899999999876544 45799999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
||++|+|.+||..+.... +.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||++|-+-...
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997653332 455667789999999999999988 9999999999999999999999999999664443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.91 Aligned_cols=152 Identities=33% Similarity=0.535 Sum_probs=131.4
Q ss_pred CCCCccceecccCCeeEEEEEeCC-----------------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRL 411 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 411 (517)
++|.+.++||+|+||.||++...+ +..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 3469999987642 3345678999999999999999999
Q ss_pred EEEEEeCCEEEEEEEeCCCCCHHHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEe
Q 010146 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVT----------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475 (517)
Q Consensus 412 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 475 (517)
++++...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985421 1124688899999999999999999988 999
Q ss_pred cCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 476 RDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 476 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||||+|||+++++.+||+|||+++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=226.90 Aligned_cols=154 Identities=30% Similarity=0.450 Sum_probs=129.9
Q ss_pred hcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346789999999999999999974 225689999997543 23345789999999999 8999999999887644
Q ss_pred -EEEEEEEeCCCCCHHHHHhccCC--------------------------------------------------------
Q 010146 420 -ERMLIYEYLPNKSLEQFIFDVTR-------------------------------------------------------- 442 (517)
Q Consensus 420 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 442 (517)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 443 ---TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 443 ---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 124778889999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.03 Aligned_cols=148 Identities=25% Similarity=0.365 Sum_probs=132.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999876 48899999997532 233456888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999954 345899999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=233.52 Aligned_cols=160 Identities=31% Similarity=0.476 Sum_probs=138.5
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC------EEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ERML 423 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l 423 (517)
|...+.||+|+||.||+++.+ .|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455689999999999999965 5999999999874 3456678899999999999999999999865443 5689
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC--CCC--CeEEccccCc
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDM--NPKISDFGMA 499 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~DFGla 499 (517)
|||||.+|+|...|.+..+...|++.+.+.++.+++.||.|||+++ |+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987777778999999999999999999999998 99999999999983 334 3799999999
Q ss_pred eecCCCCcccccCceecC
Q 010146 500 RAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 500 ~~~~~~~~~~~~~~~~GT 517 (517)
|.+++++ ...+++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9998776 35568887
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=227.34 Aligned_cols=152 Identities=22% Similarity=0.256 Sum_probs=134.4
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
....++|++.+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3345789999999999999999999764 889999998642 223345688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999843 24788999999999999999999988 99999999999999999999999999998
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 192 ~~~ 194 (370)
T cd05621 192 MDE 194 (370)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=223.42 Aligned_cols=150 Identities=25% Similarity=0.355 Sum_probs=134.1
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++.+..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 568888999999999999999764 889999998653 2234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999854 345888999999999999999999998 999999999999999999999999999987543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=227.37 Aligned_cols=149 Identities=27% Similarity=0.374 Sum_probs=133.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 48999999997532 234456788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999854 345899999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=227.73 Aligned_cols=147 Identities=26% Similarity=0.348 Sum_probs=131.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999865 5899999998653 2234467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999853 345889999999999999999999998 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=223.43 Aligned_cols=149 Identities=26% Similarity=0.401 Sum_probs=133.3
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 8999999987542 234457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999943 345889999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=216.10 Aligned_cols=150 Identities=32% Similarity=0.488 Sum_probs=124.4
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-----EEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-----RMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 424 (517)
.|...+++|.|+||.||+|.+.+ ++.||||++-.... .--+|+.+|++++|||||+++-++..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45666899999999999999765 79999999865432 12468899999999999999998865432 3589
Q ss_pred EEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEccccCceec
Q 010146 425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAF 502 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~ 502 (517)
||||+ .+|.+.++.. ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99995 7899888643 22345788888889999999999999988 9999999999999976 88999999999999
Q ss_pred CCCCcc
Q 010146 503 GVDQTE 508 (517)
Q Consensus 503 ~~~~~~ 508 (517)
..++..
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 777653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=226.78 Aligned_cols=146 Identities=25% Similarity=0.373 Sum_probs=130.7
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999965 48899999997532 2334578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999854 345889999999999999999999988 999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=218.62 Aligned_cols=154 Identities=32% Similarity=0.480 Sum_probs=132.1
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.||+|.||+||-|+.+ +|+.||||++.+. ......++++|+.+|++++||.||.+.-.|++.+..++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 78999999999999965 5999999999765 3455678999999999999999999999999999999999999 455
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC---CCeEEccccCceecCCCCccc
Q 010146 433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARAFGVDQTEA 509 (517)
Q Consensus 433 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~ 509 (517)
..++|.... ...+++....-++.||+.||.|||.++ |+|+||||+||||.+. -++||+|||+||.+++.+.+.
T Consensus 649 MLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 649 MLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred HHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 555554433 445899888899999999999999999 9999999999999654 369999999999998876543
Q ss_pred ccCceecC
Q 010146 510 NTDRVVGT 517 (517)
Q Consensus 510 ~~~~~~GT 517 (517)
.++||
T Consensus 725 ---sVVGT 729 (888)
T KOG4236|consen 725 ---SVVGT 729 (888)
T ss_pred ---hhcCC
Confidence 35665
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=215.28 Aligned_cols=151 Identities=29% Similarity=0.474 Sum_probs=132.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-----CC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-----RD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 419 (517)
....|...+.||+|+||.|..+..+ +|+.||+|++... .....++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666799999999999999976 4899999999743 45566788999999999999999999999865 35
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..|+|+|+| +.+|.+.++ .++.++......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 688999984 3444899999999999999999999999 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
|.....
T Consensus 173 R~~~~~ 178 (359)
T KOG0660|consen 173 RYLDKF 178 (359)
T ss_pred eecccc
Confidence 998654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=228.90 Aligned_cols=151 Identities=32% Similarity=0.560 Sum_probs=133.0
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
+.+...+...+.+.||+|.||+||+|.+. ..||||+++.. .....++|++|+..+++-+|.||+-+.|+|..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33344455667799999999999999986 47999999765 34567899999999999999999999999998777
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
.||+.+++|-+|..+|+.. ...++..+.+.|++||++||.|||.++ |||||||..||+|.++++|||+||||+..
T Consensus 463 AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999643 345889999999999999999999999 99999999999999999999999999874
Q ss_pred c
Q 010146 502 F 502 (517)
Q Consensus 502 ~ 502 (517)
-
T Consensus 538 k 538 (678)
T KOG0193|consen 538 K 538 (678)
T ss_pred e
Confidence 3
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=220.28 Aligned_cols=149 Identities=25% Similarity=0.346 Sum_probs=132.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 48999999986432 234556889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999854 345889999999999999999999998 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=225.64 Aligned_cols=146 Identities=23% Similarity=0.379 Sum_probs=130.9
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
+|++.+.||+|+||.||++.... ++.||+|++.... ......+.+|++++++++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999654 8999999986532 2345668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999954 345888999999999999999999998 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=225.70 Aligned_cols=163 Identities=29% Similarity=0.422 Sum_probs=140.6
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE 420 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 420 (517)
....++|.+.++||+|.||+|+++..+. ++.+|||.+++. .....+..+.|-+++.... ||.+++++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3455789999999999999999999875 889999999886 3556778888988888775 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||..||++.. ......+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~----~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMH----HIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEE----EEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999432 234456999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCCcccccCceecC
Q 010146 501 AFGVDQTEANTDRVVGT 517 (517)
Q Consensus 501 ~~~~~~~~~~~~~~~GT 517 (517)
.---... .|..++||
T Consensus 517 e~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGT 531 (694)
T ss_pred ccCCCCC--ccccccCC
Confidence 7543332 45568887
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=223.94 Aligned_cols=163 Identities=25% Similarity=0.403 Sum_probs=143.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-EEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-RMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 424 (517)
.++|...+.+|+|+||.++..+.+. ++.+++|.+.-. .....+...+|+.++++++|||||.+.+.+..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3678889999999999999998664 788999988754 34445578899999999999999999999999988 8999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+|++||+|.+.|.+.+ +..++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..|||.|||+|+.++.
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999996644 567999999999999999999999887 99999999999999999999999999999988
Q ss_pred CCcccccCceecC
Q 010146 505 DQTEANTDRVVGT 517 (517)
Q Consensus 505 ~~~~~~~~~~~GT 517 (517)
+...+. .++||
T Consensus 159 ~~~~a~--tvvGT 169 (426)
T KOG0589|consen 159 EDSLAS--TVVGT 169 (426)
T ss_pred chhhhh--eecCC
Confidence 764333 36776
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=194.15 Aligned_cols=149 Identities=29% Similarity=0.521 Sum_probs=131.6
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|...++||+|.||+||+|+..+ ++.||+|+++.. ++.......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999664 889999988754 333456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+ ..+|..+.... .+.++.+....++.|+++||.|.|+++ +.||||||+|.||+.+|++|++|||+||.++-+
T Consensus 83 c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9 57888887543 345899999999999999999999999 999999999999999999999999999988755
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=219.64 Aligned_cols=141 Identities=27% Similarity=0.319 Sum_probs=126.1
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 58999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999843 345899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=221.77 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=133.0
Q ss_pred cCCCCccceecccCCeeEEEEEeCC--CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+|..+. +..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998653 368999998643 23345678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999953 345899999999999999999999998 9999999999999999999999999999875
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 4
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=214.81 Aligned_cols=174 Identities=27% Similarity=0.423 Sum_probs=142.1
Q ss_pred cCCCCCccchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhc--CCCCCeee
Q 010146 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVR 410 (517)
Q Consensus 333 ~~~~~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~ 410 (517)
...++|.+-...++ .+..+.+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.++.+. |+|+||+.
T Consensus 197 SGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCCchhHhHHhhh---heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhh
Confidence 34566666555544 56788899999999999999998 899999999653 44567788888765 59999999
Q ss_pred EEEEEEeCC----EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-----cCCCceEecCCCCC
Q 010146 411 LLGCCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-----DSRLRIIHRDLKAS 481 (517)
Q Consensus 411 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~~~~iiH~Dlkp~ 481 (517)
+++.-..++ +++||++|.+.|+|.+||.. ..++....++++..+|.||++||. ++++.|.|||||..
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 998865443 57999999999999999943 458999999999999999999996 47788999999999
Q ss_pred cEEECCCCCeEEccccCceecCCCCcc--cccCceecC
Q 010146 482 NVLLDNDMNPKISDFGMARAFGVDQTE--ANTDRVVGT 517 (517)
Q Consensus 482 NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~GT 517 (517)
||||.+++.+.|+|+|||-....+... ...+.-+||
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccce
Confidence 999999999999999999988766432 233334554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=218.99 Aligned_cols=151 Identities=24% Similarity=0.311 Sum_probs=133.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999764 899999998642 2234456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999542 345889999999999999999999998 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=225.95 Aligned_cols=146 Identities=25% Similarity=0.382 Sum_probs=130.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999975 48899999987532 2334578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999854 245888999999999999999999998 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=229.06 Aligned_cols=152 Identities=18% Similarity=0.230 Sum_probs=133.8
Q ss_pred CCCccceecccCCeeEEEEEeC-C-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-E-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999854 3 5788899876555455567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++++|.++|.+. .....+++..+..++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999988543 23446889999999999999999999988 999999999999999999999999999987554
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=223.26 Aligned_cols=156 Identities=22% Similarity=0.253 Sum_probs=136.2
Q ss_pred hHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC
Q 010146 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418 (517)
Q Consensus 343 ~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 418 (517)
.++....++|++.+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3444556889999999999999999999764 889999998642 223345678899999999999999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999999843 23788889999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.+...
T Consensus 189 a~~~~~~ 195 (371)
T cd05622 189 CMKMNKE 195 (371)
T ss_pred eeEcCcC
Confidence 9987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=218.44 Aligned_cols=141 Identities=28% Similarity=0.348 Sum_probs=126.4
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 4899999999754 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988843 345899999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=218.71 Aligned_cols=151 Identities=25% Similarity=0.328 Sum_probs=134.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|.+.+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 48999999997542 234556889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999543 245899999999999999999999998 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=224.07 Aligned_cols=151 Identities=24% Similarity=0.280 Sum_probs=133.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4467899999999999999999976 4889999998643 22334557889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999843 24788889999999999999999988 9999999999999999999999999998875
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 194 ~~ 195 (370)
T cd05596 194 AN 195 (370)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=212.73 Aligned_cols=149 Identities=28% Similarity=0.396 Sum_probs=131.1
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667799999999999999964 58999999986532 22344678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998885432 335899999999999999999999988 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=217.72 Aligned_cols=151 Identities=23% Similarity=0.278 Sum_probs=133.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 4789999998652 2233456788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999542 235889999999999999999999988 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=213.17 Aligned_cols=148 Identities=29% Similarity=0.478 Sum_probs=130.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 48899999987542 23345778999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 97 5899988532 335788999999999999999999988 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=217.90 Aligned_cols=141 Identities=26% Similarity=0.331 Sum_probs=125.9
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999975 5899999998753 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 345899999999999999999999998 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=216.31 Aligned_cols=140 Identities=24% Similarity=0.297 Sum_probs=125.5
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++...+ ++.||+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999764 889999998653 233456788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999853 345899999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=232.48 Aligned_cols=153 Identities=30% Similarity=0.426 Sum_probs=134.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCC-CEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEE-Ee------C
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCC-TL------R 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~~------~ 418 (517)
..-++++.+.|.+|||+.||.|.+..+ ..+|+|++-..++...+.+++|+++|++|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 334567889999999999999998775 999999998878888999999999999998 99999999932 11 1
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
-+.+|+||||++|.|-++|....... |++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35789999999999999997554444 999999999999999999999986 7899999999999999999999999998
Q ss_pred ceec
Q 010146 499 ARAF 502 (517)
Q Consensus 499 a~~~ 502 (517)
|.-.
T Consensus 193 att~ 196 (738)
T KOG1989|consen 193 ATTK 196 (738)
T ss_pred cccc
Confidence 8643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=239.28 Aligned_cols=151 Identities=35% Similarity=0.602 Sum_probs=134.3
Q ss_pred CCCCccceecccCCeeEEEEEeCC--CC----EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE--GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
+..+..+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999999654 43 4899999876 4566778999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 423 LIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
|++|||++|+|..||++.+. ...++..+.+.++.|||+|+.||++++ +|||||.++|+||+....|||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976422 346889999999999999999999998 99999999999999999999999999
Q ss_pred ceecC
Q 010146 499 ARAFG 503 (517)
Q Consensus 499 a~~~~ 503 (517)
||.+-
T Consensus 849 ArDiy 853 (1025)
T KOG1095|consen 849 ARDIY 853 (1025)
T ss_pred hHhhh
Confidence 99553
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=221.15 Aligned_cols=151 Identities=26% Similarity=0.399 Sum_probs=135.4
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 58999999987532 244567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 45899999999999999999999988 999999999999999999999999999987654
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 155 ~ 155 (350)
T cd05573 155 K 155 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=220.31 Aligned_cols=148 Identities=26% Similarity=0.372 Sum_probs=132.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 4899999998653 2334567888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999853 345899999999999999999999998 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.11 Aligned_cols=154 Identities=32% Similarity=0.480 Sum_probs=132.4
Q ss_pred cCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
.++|++.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999973 235689999997542 33456788999999999 89999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC----------------------------------------------------------
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------- 442 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 442 (517)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 443 --------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 443 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=215.23 Aligned_cols=142 Identities=27% Similarity=0.318 Sum_probs=125.6
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||++... +++.||+|.+... .......+.+|++++..++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 5899999998753 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99998843 3458999999999999999999997 56 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=204.35 Aligned_cols=157 Identities=29% Similarity=0.454 Sum_probs=136.9
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC----cc----CHHHHHHHHHHHhcCC-CCCeeeEEEE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS----GQ----GVEEFKNEVLLIAKLQ-HRNLVRLLGC 414 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~----~~~~~~~e~~~l~~l~-h~niv~l~~~ 414 (517)
-...-..|...+.||+|..+.|-++..+ +|++.|+|++.... .. -.++-++|+.+|+++. ||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445567888899999999999998865 48899999886431 11 2345678999999985 9999999999
Q ss_pred EEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 415 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
++.+...++|+|.|+.|.|.++| ...-.++++...+|++|+..|+.|||..+ ||||||||+|||++++.++||+
T Consensus 92 yes~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 99999999999999999999999 44556899999999999999999999998 9999999999999999999999
Q ss_pred cccCceecCCCCc
Q 010146 495 DFGMARAFGVDQT 507 (517)
Q Consensus 495 DFGla~~~~~~~~ 507 (517)
|||+|..+.+++.
T Consensus 166 DFGFa~~l~~Gek 178 (411)
T KOG0599|consen 166 DFGFACQLEPGEK 178 (411)
T ss_pred ccceeeccCCchh
Confidence 9999999988764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=210.58 Aligned_cols=150 Identities=26% Similarity=0.316 Sum_probs=134.9
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||.|.-|+||++.+++ +..+|+|++.+.. .....+.+.|-+||+.++||.++.|+..++.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677899999999999999886 6899999998753 344557788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+||+|..++++ +..+.+++..+.-++.+|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999998854 55677999999999999999999999988 9999999999999999999999999998774
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=216.74 Aligned_cols=148 Identities=26% Similarity=0.358 Sum_probs=129.8
Q ss_pred CCCccceecccCCeeEEEEEeC----CCCEEEEEEccCC----CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998852 4789999998653 123345678899999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999853 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=211.86 Aligned_cols=149 Identities=31% Similarity=0.464 Sum_probs=130.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 58899999987543 2334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 995 7888887542 345888999999999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=215.48 Aligned_cols=150 Identities=20% Similarity=0.267 Sum_probs=132.2
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++..+. ++.+|+|.+.+. .......+.+|+.++..++|++|+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999765 788999998642 2233445888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999542 235889999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=222.24 Aligned_cols=150 Identities=30% Similarity=0.433 Sum_probs=134.8
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.-|.+.+.||.|+.|.|-+|+.. +|+.+|||++.+. .......+.+|+.+|+.|.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999965 5999999999765 2334567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|.|.++|. ..+.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 3456999999999999999999999998 999999999999999999999999999865443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=216.55 Aligned_cols=161 Identities=30% Similarity=0.445 Sum_probs=140.7
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc---cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDER 421 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 421 (517)
.....|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 355678899999999999999999876 99999999977533 24568999999999999 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC----CCeEEcccc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND----MNPKISDFG 497 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFG 497 (517)
++|||++.||.|.+.+... .+++..+..++.|++.|++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999654 2999999999999999999999988 9999999999999643 479999999
Q ss_pred CceecCCCCcccccCceecC
Q 010146 498 MARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 498 la~~~~~~~~~~~~~~~~GT 517 (517)
+|+.+..+ .....++||
T Consensus 185 la~~~~~~---~~~~~~~Gt 201 (382)
T KOG0032|consen 185 LAKFIKPG---ERLHTIVGT 201 (382)
T ss_pred CceEccCC---ceEeeecCC
Confidence 99999772 223345665
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=219.61 Aligned_cols=155 Identities=31% Similarity=0.443 Sum_probs=132.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 419 (517)
..++|.+.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+++++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35688899999999999999998531 3479999997543 233467899999999996 999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC---------------------------------------------------------
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR--------------------------------------------------------- 442 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 442 (517)
..+|||||+++|+|.++|.+...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 443 ------------------------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 443 ------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
...+++.+++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124778888999999999999999988 99999999999999
Q ss_pred CCCCeEEccccCceecCCC
Q 010146 487 NDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~~ 505 (517)
+++.+||+|||+++.+...
T Consensus 272 ~~~~~kL~DfGla~~~~~~ 290 (400)
T cd05105 272 QGKIVKICDFGLARDIMHD 290 (400)
T ss_pred CCCEEEEEeCCcceecccc
Confidence 9999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=210.88 Aligned_cols=149 Identities=26% Similarity=0.412 Sum_probs=130.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||.||+++.+. ++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468889999999999999999864 8899999987542 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|++++.|..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999877765542 2345899999999999999999999988 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=220.76 Aligned_cols=154 Identities=34% Similarity=0.504 Sum_probs=131.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
.++|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++.+...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999998842 24579999997543 23345788999999999 89999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC----------------------------------------------------------
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------- 442 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 442 (517)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 443 ---------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 443 ---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+..+
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 124788889999999999999999988 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=213.46 Aligned_cols=144 Identities=28% Similarity=0.328 Sum_probs=127.0
Q ss_pred ceecccCCeeEEEEEe----CCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 356 NKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
+.||+|+||.||++.. .+++.+|+|++.... ......+.+|++++++++||||+++++.+...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 247899999997532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999843 345899999999999999999999998 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=213.81 Aligned_cols=142 Identities=30% Similarity=0.425 Sum_probs=125.2
Q ss_pred ceecccCCeeEEEEEeC----CCCEEEEEEccCC----CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+.||+|+||.||++... .++.||+|.+... .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999852 4789999998753 123345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999999843 345788889999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=213.35 Aligned_cols=146 Identities=31% Similarity=0.400 Sum_probs=128.0
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCC-CeeeEEEEEEeCCEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHR-NLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 425 (517)
+|++.+.||+|+||.||+|.... ++.||+|++... .....+.+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999764 789999998753 233456788899999999765 5888999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999999843 345889999999999999999999988 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=218.79 Aligned_cols=141 Identities=21% Similarity=0.335 Sum_probs=126.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+|++.+.||+|+||.||++... +++.||+|.... ..+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999975 488999997542 3467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+. ++|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 94 788888843 345889999999999999999999988 999999999999999999999999999764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=212.31 Aligned_cols=142 Identities=33% Similarity=0.421 Sum_probs=122.9
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|.... ++.||+|.++... ....+.+..|..++.. .+||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 8899999987532 2334556667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999998853 345899999999999999999999988 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=213.27 Aligned_cols=151 Identities=24% Similarity=0.320 Sum_probs=133.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999976 48899999987542 2345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999854 335889999999999999999999853 399999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=213.33 Aligned_cols=141 Identities=25% Similarity=0.355 Sum_probs=125.3
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++... +++.||+|+++.. .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999976 4889999999753 223345688899999988 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999988843 345899999999999999999999998 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=212.98 Aligned_cols=144 Identities=31% Similarity=0.453 Sum_probs=125.3
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHH---hcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLI---AKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999976 48999999997532 23345666776654 567899999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|||+++++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988732 35899999999999999999999988 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=212.69 Aligned_cols=141 Identities=26% Similarity=0.372 Sum_probs=124.5
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 789999998754 223345677888888776 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999988843 345899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=211.60 Aligned_cols=147 Identities=31% Similarity=0.386 Sum_probs=127.8
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+|.+.+.||+|+||.||++.... ++.||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999764 7899999987542 23344567788888777 5899999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999998843 345889999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=212.13 Aligned_cols=142 Identities=29% Similarity=0.418 Sum_probs=124.8
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|.... ++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999764 789999998753 233445677888888866 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 999998843 345889999999999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=217.25 Aligned_cols=145 Identities=27% Similarity=0.442 Sum_probs=127.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34666789999999999999976 58999999986542 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+.. ..++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986432 3567788899999999999999998 99999999999999999999999999987753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=203.97 Aligned_cols=151 Identities=30% Similarity=0.516 Sum_probs=136.0
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4568888999999999999999877889999998754 344677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999995433 345899999999999999999999988 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=213.61 Aligned_cols=146 Identities=25% Similarity=0.440 Sum_probs=126.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DERM 422 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 422 (517)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 5899999998743 223345688999999999999999999987543 2479
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 789998843 345899999999999999999999998 999999999999999999999999999865
Q ss_pred C
Q 010146 503 G 503 (517)
Q Consensus 503 ~ 503 (517)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=206.27 Aligned_cols=148 Identities=28% Similarity=0.464 Sum_probs=130.9
Q ss_pred CCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|.++ .+..||+|.++... ....+.+.+|+..+.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999853 35689999997643 23345788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999998543 235899999999999999999999988 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=224.10 Aligned_cols=159 Identities=21% Similarity=0.295 Sum_probs=134.8
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD- 419 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 419 (517)
+.....++|.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445679999999999999999999865 5899999998654 2344567889999999999999999988765432
Q ss_pred -------EEEEEEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 420 -------ERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 420 -------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||||++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 3689999999999999986432 2356899999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCCC
Q 010146 492 KISDFGMARAFGVD 505 (517)
Q Consensus 492 kl~DFGla~~~~~~ 505 (517)
||+|||+++.+...
T Consensus 183 kL~DFGls~~~~~~ 196 (496)
T PTZ00283 183 KLGDFGFSKMYAAT 196 (496)
T ss_pred EEEecccCeecccc
Confidence 99999999987543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=207.06 Aligned_cols=150 Identities=29% Similarity=0.408 Sum_probs=131.6
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777899999999999999965 58899999986532 2223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888543 2345899999999999999999999988 99999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=211.80 Aligned_cols=150 Identities=31% Similarity=0.556 Sum_probs=129.6
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.+|++.+.||+|+||.||+|.+.. ++ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468888999999999999998643 33 48999987543 34456789999999999999999999998764 5789
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++||+++|+|.+++.+. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999643 335889999999999999999999988 9999999999999999999999999999876
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=206.67 Aligned_cols=145 Identities=34% Similarity=0.469 Sum_probs=127.1
Q ss_pred ecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 58899999986532 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 434 EQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 434 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 98875432 3446899999999999999999999988 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=212.47 Aligned_cols=150 Identities=23% Similarity=0.328 Sum_probs=132.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999976 4888999988754 22344678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999954 345889999999999999999999742 39999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=203.58 Aligned_cols=149 Identities=30% Similarity=0.491 Sum_probs=133.2
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||++..+++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999985432 35889999999999999999999988 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=211.22 Aligned_cols=141 Identities=33% Similarity=0.467 Sum_probs=124.7
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++..+. ++.||+|++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 889999998753 233456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999998853 345899999999999999999999988 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=206.25 Aligned_cols=152 Identities=34% Similarity=0.553 Sum_probs=131.5
Q ss_pred CCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|.. ..++.+++|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 236789999997532 3344678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC
Q 010146 424 IYEYLPNKSLEQFIFDVTR--------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 489 (517)
+|||+++++|.+++..... ...+++.+++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 234788999999999999999999988 99999999999999999
Q ss_pred CeEEccccCceecCC
Q 010146 490 NPKISDFGMARAFGV 504 (517)
Q Consensus 490 ~~kl~DFGla~~~~~ 504 (517)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=203.50 Aligned_cols=152 Identities=34% Similarity=0.522 Sum_probs=135.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3568888999999999999999888889999998653 334678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999998653 2345888999999999999999999988 999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=203.01 Aligned_cols=150 Identities=26% Similarity=0.463 Sum_probs=134.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357899999999999999999964 5889999999765545566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 999999999843 345899999999999999999999988 99999999999999999999999999987743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=210.74 Aligned_cols=141 Identities=26% Similarity=0.354 Sum_probs=121.4
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHH-HHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++... +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 48899999986532 222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999988843 345888899999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=202.42 Aligned_cols=150 Identities=31% Similarity=0.527 Sum_probs=133.6
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|.+.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457788999999999999999877778999998753 3445779999999999999999999999998888999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..+
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999985432 25899999999999999999999988 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=210.86 Aligned_cols=141 Identities=26% Similarity=0.349 Sum_probs=121.9
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHH-HHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++... +|+.+|+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 58999999986531 223345555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999988843 345899999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=205.59 Aligned_cols=151 Identities=31% Similarity=0.570 Sum_probs=132.4
Q ss_pred CCCCccceecccCCeeEEEEEeC-----CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 422 (517)
++|++.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888899999999999999742 4789999999776555667899999999999999999999987543 4678
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.+. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 235899999999999999999999988 999999999999999999999999999987
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 159 ~~~ 161 (284)
T cd05081 159 PQD 161 (284)
T ss_pred cCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.25 Aligned_cols=141 Identities=28% Similarity=0.366 Sum_probs=121.8
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHH-HHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++... +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999976 58999999986532 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999843 345889999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=213.80 Aligned_cols=154 Identities=27% Similarity=0.446 Sum_probs=136.8
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.....|.+.+.||+|.|+.|.+++.. ++..||+|.+.+.. ....+.+.+|+++|..|.|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567889999999999999999965 49999999998753 2334568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||..+|.+.++|.++. .+.+..+..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999996543 3555888899999999999999999 9999999999999999999999999999987
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
.+.
T Consensus 207 ~~~ 209 (596)
T KOG0586|consen 207 YGL 209 (596)
T ss_pred ccc
Confidence 554
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=227.76 Aligned_cols=150 Identities=23% Similarity=0.345 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.++||+|+||.||+|.... ++.||+|++.... ....+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999764 8999999997542 223457899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 426 EYLPNKSLEQFIFDVTR--------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 223567788999999999999999988 9999999999999999999999999
Q ss_pred Cceec
Q 010146 498 MARAF 502 (517)
Q Consensus 498 la~~~ 502 (517)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=217.79 Aligned_cols=145 Identities=22% Similarity=0.288 Sum_probs=128.2
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999765 78999996432 3457899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+ .++|.+++... ...+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 242 ~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 Y-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9 47898888532 235899999999999999999999988 999999999999999999999999999987543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=230.20 Aligned_cols=150 Identities=35% Similarity=0.565 Sum_probs=131.6
Q ss_pred ccceecccCCeeEEEEEe-CCC----CEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 354 WKNKLGEGGFGPVYRGML-TEG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++||+|+||+||+|.+ +.| -+||+|++... ..+...++++|+-+|.+++|||+++|+++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 347999999999999984 334 37899988764 4456789999999999999999999999998665 8899999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|+.|.|.++++.++ ..+-.+..+.+..|||+||.|||++. ++||||.++||||.+-..+||.|||+|+.+..+..
T Consensus 779 mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999997643 44788899999999999999999887 99999999999999999999999999999988765
Q ss_pred cc
Q 010146 508 EA 509 (517)
Q Consensus 508 ~~ 509 (517)
+-
T Consensus 854 ey 855 (1177)
T KOG1025|consen 854 EY 855 (1177)
T ss_pred cc
Confidence 43
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=205.10 Aligned_cols=153 Identities=29% Similarity=0.542 Sum_probs=138.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
...+|++.+.||+|+||.||+|...+++.+|+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999999876555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.+. ....+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999653 2345899999999999999999999988 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=210.32 Aligned_cols=147 Identities=30% Similarity=0.403 Sum_probs=127.7
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 425 (517)
+|+..+.||+|+||.||++... +++.||+|++... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667799999999999999976 4889999998753 2234456788888888886 577888999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999999843 345899999999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=209.89 Aligned_cols=141 Identities=27% Similarity=0.358 Sum_probs=125.0
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++.... ++.+|+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 7899999997542 23345688899999888 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999988843 345899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=201.45 Aligned_cols=149 Identities=30% Similarity=0.488 Sum_probs=132.8
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.+|++.+.||+|+||.||++..+++..+|+|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 357788999999999999999877778999998653 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999985432 35899999999999999999999998 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=216.73 Aligned_cols=138 Identities=32% Similarity=0.503 Sum_probs=125.5
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHH
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 434 (517)
.+-||.|+.|.||+|++. ++.||||+++... ..+|+.|++|+|+||+.+.|+|.....++|||||++.|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 368999999999999998 7899999986432 35788999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 435 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+.|+ .+..+.......+..+||.||.|||.+. |||||||.-||||+.+..|||+|||.++.+.+..
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 9994 4556888999999999999999999998 9999999999999999999999999999886653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=209.00 Aligned_cols=141 Identities=33% Similarity=0.436 Sum_probs=123.5
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++..+. ++.||+|.++... ....+.+..|..++.. ++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999764 8899999987532 2344567778888775 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999998843 345889999999999999999999998 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=207.38 Aligned_cols=149 Identities=31% Similarity=0.501 Sum_probs=130.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 47899999987543 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 86 LD-KDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 96 5888887543 335788999999999999999999988 99999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=207.86 Aligned_cols=141 Identities=32% Similarity=0.445 Sum_probs=123.5
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|.... ++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999765 7899999987541 2334556778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|.+++.+ ...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999853 345889999999999999999999988 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=209.29 Aligned_cols=142 Identities=26% Similarity=0.341 Sum_probs=120.8
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHH-HHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEV-LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++.... ++.||+|++.... ......+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999764 7889999986532 12223444444 456789999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999853 345788888899999999999999998 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=203.28 Aligned_cols=144 Identities=29% Similarity=0.443 Sum_probs=123.4
Q ss_pred ceecccCCeeEEEEEeCC---CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4578888876542 233456889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 432 SLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 432 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999965432 233567888999999999999999988 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=202.00 Aligned_cols=149 Identities=32% Similarity=0.555 Sum_probs=132.3
Q ss_pred CCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|.... ...||+|.++... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998753 4579999987543 33345788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998543 235899999999999999999999988 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=203.80 Aligned_cols=151 Identities=27% Similarity=0.500 Sum_probs=124.7
Q ss_pred CCCCccceecccCCeeEEEEEeC--CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEe-----
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTL----- 417 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 417 (517)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 36889999886532 22334566777776665 69999999999853
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
....++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999996 69999985432 334899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+++.+...
T Consensus 156 ~~~~~~~~ 163 (290)
T cd07862 156 LARIYSFQ 163 (290)
T ss_pred ceEeccCC
Confidence 99877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=205.85 Aligned_cols=158 Identities=28% Similarity=0.500 Sum_probs=139.7
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
-|++.++||+|+||.||+|.++. |+.+|+|.+.. ....+++..|+.++++.+.|++|+++|.+.....++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 36677899999999999999775 99999999875 4567899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCccc
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 509 (517)
.|++.++++- +.+.+++.++..+++..++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+.-...
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999953 4567999999999999999999999877 8999999999999999999999999999886543333
Q ss_pred ccCceecC
Q 010146 510 NTDRVVGT 517 (517)
Q Consensus 510 ~~~~~~GT 517 (517)
+.++||
T Consensus 187 --NTVIGT 192 (502)
T KOG0574|consen 187 --NTVIGT 192 (502)
T ss_pred --CccccC
Confidence 336776
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=213.17 Aligned_cols=148 Identities=26% Similarity=0.426 Sum_probs=128.9
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----EEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERM 422 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 422 (517)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999965 5899999998653 2234467889999999999999999999998776 789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999995 688887733 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 154 ~~~ 156 (372)
T cd07853 154 EPD 156 (372)
T ss_pred ccC
Confidence 543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=217.44 Aligned_cols=153 Identities=31% Similarity=0.529 Sum_probs=138.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+....++||-|.||.||.|.++. .-.||||.++. +....++|+.|..+|+.++|||+|+|+|+|......|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456677899999999999999886 67899999976 456788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|..|+|.+||++..+. .++.-..+.++.||..||+||..++ +|||||.++|+|+.++..|||+||||+|++..+.
T Consensus 345 M~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999775543 4788888999999999999999998 9999999999999999999999999999997664
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=203.77 Aligned_cols=154 Identities=29% Similarity=0.511 Sum_probs=132.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
..++|++.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 25679999986532 2334568899999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
.++||||+++++|.+++.+... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 224678889999999999999999988 999999999999999999999
Q ss_pred ccccCceecCC
Q 010146 494 SDFGMARAFGV 504 (517)
Q Consensus 494 ~DFGla~~~~~ 504 (517)
+|||+++.+..
T Consensus 161 ~dfg~~~~~~~ 171 (277)
T cd05062 161 GDFGMTRDIYE 171 (277)
T ss_pred CCCCCccccCC
Confidence 99999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=215.40 Aligned_cols=148 Identities=26% Similarity=0.414 Sum_probs=130.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-C-----CCeeeEEEEEEeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-H-----RNLVRLLGCCTLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 423 (517)
+|.+.+.||+|+||.|.+|.+. +++.||||+++.. .....+...|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999965 4999999999874 455667788999999997 4 489999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC--CeEEccccCcee
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM--NPKISDFGMARA 501 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~DFGla~~ 501 (517)
|+|.+ ..+|.++|+.... ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+.. .+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 6899999976544 44899999999999999999999988 99999999999997543 699999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
...
T Consensus 341 ~~q 343 (586)
T KOG0667|consen 341 ESQ 343 (586)
T ss_pred cCC
Confidence 644
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=202.97 Aligned_cols=157 Identities=16% Similarity=0.277 Sum_probs=131.1
Q ss_pred CCCccchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccC---HHHHHHHHHHHhcCCCCCeeeEE
Q 010146 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLL 412 (517)
Q Consensus 336 ~~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~ 412 (517)
++..++.+++. ......|++|+++.||+|.. +|+.||||.++...... .+.+.+|+.++.+++||||++++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34445555552 22226899999999999998 48999999997653333 46788999999999999999999
Q ss_pred EEEEe----CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECC
Q 010146 413 GCCTL----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDN 487 (517)
Q Consensus 413 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~ 487 (517)
+++.+ ....++||||+++|+|.+++.+ ...+++...+.++.|++.||.|||+. + ++||||||+|||+++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECC
Confidence 99876 3467899999999999999954 34588999999999999999999984 5 889999999999999
Q ss_pred CCCeEEccccCceecCC
Q 010146 488 DMNPKISDFGMARAFGV 504 (517)
Q Consensus 488 ~~~~kl~DFGla~~~~~ 504 (517)
++.+||+|||+++.+..
T Consensus 159 ~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 159 NYKLKIICHGLEKILSS 175 (283)
T ss_pred CCcEEEcccchHhhhcc
Confidence 99999999999987643
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=213.79 Aligned_cols=153 Identities=29% Similarity=0.453 Sum_probs=130.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 420 (517)
.++|.+.+.||+|+||.||+|.+. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++.+...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 246899999976432 23457889999999997 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC----------------------------------------------------------
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------- 442 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 442 (517)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 443 -------------------------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 443 -------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 123677888999999999999999987 9999999999999
Q ss_pred CCCCCeEEccccCceecCC
Q 010146 486 DNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~ 504 (517)
++++.+||+|||+++.+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 273 CEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eCCCEEEEEecCcceeccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=199.26 Aligned_cols=152 Identities=27% Similarity=0.437 Sum_probs=134.3
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD 419 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 419 (517)
+.++...++ +.||+|+++.|-.+. +.+|.++|||++.+.......++.+|++++.+.+ |+||++++++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 445555443 689999999999988 6779999999999887778889999999999986 999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEccc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDF 496 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DF 496 (517)
..|||||-|.||+|...|.+ .+.+++.++.++..+|+.||.|||.++ |.||||||+|||-.+... +||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999954 456999999999999999999999999 999999999999976554 899999
Q ss_pred cCceecCC
Q 010146 497 GMARAFGV 504 (517)
Q Consensus 497 Gla~~~~~ 504 (517)
.++.-+..
T Consensus 224 DLgSg~k~ 231 (463)
T KOG0607|consen 224 DLGSGIKL 231 (463)
T ss_pred cccccccc
Confidence 98876543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=204.52 Aligned_cols=153 Identities=28% Similarity=0.494 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++||||+++++.+...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997532 4589999886542 2233467889999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
.++||||+++++|.+++.+... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 233567788999999999999999988 999999999999999999999
Q ss_pred ccccCceecC
Q 010146 494 SDFGMARAFG 503 (517)
Q Consensus 494 ~DFGla~~~~ 503 (517)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=194.07 Aligned_cols=156 Identities=29% Similarity=0.351 Sum_probs=138.7
Q ss_pred HhcCCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
...++|.+.+.||+|+|+-||.++ ..+++.+|+|++.....++.+..++|++..++++||||++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 566899999999887778888999999999999999999999876433 34
Q ss_pred EEEEEEeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
.||+++|...|+|.+.+..... +..+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999976543 447999999999999999999999986 57999999999999999999999999998
Q ss_pred eecC
Q 010146 500 RAFG 503 (517)
Q Consensus 500 ~~~~ 503 (517)
....
T Consensus 177 ~~a~ 180 (302)
T KOG2345|consen 177 TQAP 180 (302)
T ss_pred cccc
Confidence 8653
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=203.93 Aligned_cols=152 Identities=33% Similarity=0.573 Sum_probs=133.5
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999852 245689999876555556789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 424 IYEYLPNKSLEQFIFDVT----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999999
Q ss_pred ccccCceecCC
Q 010146 494 SDFGMARAFGV 504 (517)
Q Consensus 494 ~DFGla~~~~~ 504 (517)
+|||+++.+..
T Consensus 162 ~dfg~~~~~~~ 172 (288)
T cd05093 162 GDFGMSRDVYS 172 (288)
T ss_pred ccCCccccccC
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=205.62 Aligned_cols=152 Identities=32% Similarity=0.496 Sum_probs=130.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC---------------CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE---------------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~ 413 (517)
++|++.+.||+|+||.||++.... ...||+|.++.. .....+.+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987542 235899998754 2334567899999999999999999999
Q ss_pred EEEeCCEEEEEEEeCCCCCHHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEE
Q 010146 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTR---------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484 (517)
Q Consensus 414 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 484 (517)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854221 123688999999999999999999988 999999999999
Q ss_pred ECCCCCeEEccccCceecCC
Q 010146 485 LDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~ 504 (517)
+++++.+||+|||+++.+..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~ 181 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYS 181 (295)
T ss_pred EcCCCcEEeccccccccccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=201.43 Aligned_cols=150 Identities=33% Similarity=0.574 Sum_probs=132.6
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999976 58999999986532 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++ ++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.++.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 97 689998865444466899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-25 Score=200.45 Aligned_cols=152 Identities=30% Similarity=0.477 Sum_probs=132.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..+.|++.+.||+|.|+.|+++... +|+.+|+|+++.. +....+++.+|+++.+.|+||||+++.....+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999998854 5999999988643 445788999999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC---CCeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~ 501 (517)
+|+|.|++|..-|-. ....++..+-..++||++||.|.|.++ |||||+||+|+|+.+. .-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999766532 245788899999999999999999999 9999999999999643 3499999999999
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
++..
T Consensus 163 l~~g 166 (355)
T KOG0033|consen 163 VNDG 166 (355)
T ss_pred eCCc
Confidence 9843
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=202.38 Aligned_cols=152 Identities=37% Similarity=0.628 Sum_probs=131.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....++.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999998643 2579999987543 233467899999999999999999999999989999
Q ss_pred EEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC
Q 010146 423 LIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 489 (517)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999964321 145788999999999999999999998 99999999999999999
Q ss_pred CeEEccccCceecCC
Q 010146 490 NPKISDFGMARAFGV 504 (517)
Q Consensus 490 ~~kl~DFGla~~~~~ 504 (517)
.+||+|||+++.+..
T Consensus 162 ~~~L~dfg~~~~~~~ 176 (283)
T cd05048 162 TVKISDFGLSRDIYS 176 (283)
T ss_pred cEEECCCcceeeccc
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=200.51 Aligned_cols=145 Identities=32% Similarity=0.465 Sum_probs=124.7
Q ss_pred ceecccCCeeEEEEEeCC---CCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799999876432 33457889999999999999999999999989999999999999
Q ss_pred CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 432 SLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 432 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+|.+++..... ....++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999964322 234677788899999999999999988 9999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=206.35 Aligned_cols=141 Identities=34% Similarity=0.450 Sum_probs=124.9
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++.... ++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 789999998753 233455677888888887 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.+ ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999998843 335899999999999999999999988 999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=199.27 Aligned_cols=143 Identities=31% Similarity=0.518 Sum_probs=127.2
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999975 58999999886532 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
.+++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9998532 335889999999999999999999988 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=201.45 Aligned_cols=145 Identities=40% Similarity=0.654 Sum_probs=126.3
Q ss_pred ccceecccCCeeEEEEEeC-----CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 354 WKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 2568999999653 233468899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+++|+|.++|... ....+++.+++.|+.||++||+|||+++ ++|+||+|+|||+++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999764 2345899999999999999999999988 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=225.23 Aligned_cols=150 Identities=27% Similarity=0.400 Sum_probs=133.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|.+.++||+|+||.||+|... +++.||||++.... ......+..|+.+++.++|+||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999976 58999999987542 22346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.. ...+++..++.++.||+.||+|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999999853 235788999999999999999999988 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=203.17 Aligned_cols=153 Identities=34% Similarity=0.534 Sum_probs=133.2
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-----------------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeee
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVR 410 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 410 (517)
.++|++.+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999988643 2468999987643 334567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEeCCCCCHHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCc
Q 010146 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVT--------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482 (517)
Q Consensus 411 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 482 (517)
+++++..++..+++|||+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996533 1225899999999999999999999988 9999999999
Q ss_pred EEECCCCCeEEccccCceecCC
Q 010146 483 VLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~~~~ 504 (517)
|++++++.++|+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=202.39 Aligned_cols=151 Identities=34% Similarity=0.597 Sum_probs=133.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
++|.+.+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998643 478999998765433 4568999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 423 LIYEYLPNKSLEQFIFDVT-----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
+||||+++++|.+++.... ....+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 1245788999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecC
Q 010146 492 KISDFGMARAFG 503 (517)
Q Consensus 492 kl~DFGla~~~~ 503 (517)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=204.52 Aligned_cols=153 Identities=30% Similarity=0.510 Sum_probs=132.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR 418 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 418 (517)
.++|.+.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888899999999999999741 24579999987532 34456789999999999 799999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
...+++|||+++++|.+++.+... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999965321 235788899999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCC
Q 010146 486 DNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~ 504 (517)
++++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=200.24 Aligned_cols=151 Identities=31% Similarity=0.538 Sum_probs=134.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.+|++.+.||+|++|.||+|...+ ++.||+|.+... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357778999999999999999764 889999998753 344667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+...
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999985432 345899999999999999999999988 999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=200.51 Aligned_cols=151 Identities=29% Similarity=0.508 Sum_probs=132.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.+|++.+.||+|+||.||+|.... +..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998642 3379999987542 23356789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999543 245899999999999999999999988 99999999999999999999999999998754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=198.04 Aligned_cols=152 Identities=32% Similarity=0.539 Sum_probs=136.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++|.+.+.||+|+||.||++..++++.+|||.+... ....+++.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34678899999999999999999888889999998753 34567899999999999999999999999988999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.+. ....+++..+..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999553 2345899999999999999999999988 99999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=201.65 Aligned_cols=145 Identities=34% Similarity=0.569 Sum_probs=128.8
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCH--HHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
|++.+.||+|+||.||++.... ++.+|+|.+........ ....+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5667899999999999999775 67899999987543322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++++|.+++. ....+++..+..++.|+++||++||+.+ |+|+||||+||++++++.++|+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 2345899999999999999999999998 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=201.08 Aligned_cols=150 Identities=32% Similarity=0.507 Sum_probs=126.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCC----EEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|... +++ .+++|.+.... .....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46777899999999999999964 344 47888876432 233467888888999999999999999875 456788
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999542 345899999999999999999999988 9999999999999999999999999999775
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=204.21 Aligned_cols=148 Identities=24% Similarity=0.319 Sum_probs=131.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999966 47889999886542 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+ ++|+||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999543 458899999999999999999997 45 9999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=199.34 Aligned_cols=151 Identities=29% Similarity=0.533 Sum_probs=132.0
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.++||+|+||.||+|...+...||+|++... ....+.+.+|+.++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 3568899999999999999999877778999999753 334567899999999999999999999874 45679999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++++|.+++.+. ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999543 2345789999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=209.69 Aligned_cols=152 Identities=30% Similarity=0.453 Sum_probs=128.3
Q ss_pred cCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC-C
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR-D 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 419 (517)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999973 246889999997543 23345788999999999 689999999988654 4
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC---------------------------------------------------------
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR--------------------------------------------------------- 442 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 442 (517)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 443 -------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 443 -------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
...+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999988 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=198.01 Aligned_cols=150 Identities=30% Similarity=0.531 Sum_probs=134.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888899999999999999876 78999999976543 5678999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence 9999999995432 235899999999999999999999998 99999999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=203.63 Aligned_cols=154 Identities=30% Similarity=0.510 Sum_probs=133.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
..++|++.+.||+|+||.||++.... ...+|+|.+... .......+.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44578888999999999999998642 368999998754 223345688999999999 7999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDV-------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
..+++|||+++++|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 22346899999999999999999999988 99999999999999
Q ss_pred CCCCeEEccccCceecCC
Q 010146 487 NDMNPKISDFGMARAFGV 504 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~ 504 (517)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-23 Score=199.83 Aligned_cols=144 Identities=28% Similarity=0.406 Sum_probs=125.1
Q ss_pred ecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++..+ +|+.+|+|.+.... ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 48999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 98885432 334889999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=202.28 Aligned_cols=151 Identities=28% Similarity=0.492 Sum_probs=136.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3467899999999999999999964 589999999976555556778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999843 34788999999999999999999988 999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=202.95 Aligned_cols=153 Identities=31% Similarity=0.517 Sum_probs=131.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-----------------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeee
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-----------------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVR 410 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 410 (517)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356889999999999999998532 23468999987542 334567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEeCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCc
Q 010146 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR--------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482 (517)
Q Consensus 411 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 482 (517)
+++++...+..+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134778899999999999999999998 9999999999
Q ss_pred EEECCCCCeEEccccCceecCC
Q 010146 483 VLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred EEEcCCCCEEeccCcccccccC
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=212.73 Aligned_cols=146 Identities=22% Similarity=0.364 Sum_probs=128.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC---CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..+|.+.+.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++.+......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999754 2578999988643 23568999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|++. ++|.+++. ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 78888883 3346899999999999999999999988 999999999999999999999999999877654
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 239 ~ 239 (392)
T PHA03207 239 P 239 (392)
T ss_pred c
Confidence 3
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=207.37 Aligned_cols=139 Identities=25% Similarity=0.326 Sum_probs=119.7
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
||+|+||.||+|.... ++.||+|++.... ......+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999764 8999999986532 12233455566666655 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|..++.+ ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999998843 345899999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=202.24 Aligned_cols=150 Identities=32% Similarity=0.417 Sum_probs=133.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999976 48999999986532 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||||++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=201.73 Aligned_cols=151 Identities=30% Similarity=0.498 Sum_probs=129.7
Q ss_pred CCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
+|++.+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998532 3578899886543 2335678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCc
Q 010146 424 IYEYLPNKSLEQFIFDVT---------------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 482 (517)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1234788999999999999999999988 9999999999
Q ss_pred EEECCCCCeEEccccCceecCC
Q 010146 483 VLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++.+||+|||+++.+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~ 179 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYE 179 (290)
T ss_pred EEEcCCCcEEeccccccccccC
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=209.05 Aligned_cols=154 Identities=31% Similarity=0.466 Sum_probs=129.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC-C
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR-D 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 419 (517)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999742 24789999987542 22345678899999999 799999999988654 5
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC---------------------------------------------------------
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR--------------------------------------------------------- 442 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 442 (517)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999854221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 443 -TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 443 -~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 226 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence 125789999999999999999999988 999999999999999999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=202.30 Aligned_cols=152 Identities=31% Similarity=0.538 Sum_probs=132.9
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999742 345789999876555556789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 424 IYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996432 1234899999999999999999999998 999999999999999999
Q ss_pred eEEccccCceecCC
Q 010146 491 PKISDFGMARAFGV 504 (517)
Q Consensus 491 ~kl~DFGla~~~~~ 504 (517)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=199.31 Aligned_cols=149 Identities=30% Similarity=0.572 Sum_probs=125.6
Q ss_pred CccceecccCCeeEEEEEeCC-CC--EEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------CEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------DER 421 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 421 (517)
.+.+.||+|+||.||+|.... +. .+|+|.++.. .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456899999999999999765 33 6899988653 234456788999999999999999999987532 246
Q ss_pred EEEEEeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 422 MLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
+++|||+++++|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874321 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=200.76 Aligned_cols=149 Identities=26% Similarity=0.490 Sum_probs=133.8
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778899999999999999965 48899999987655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999843 345899999999999999999999998 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=197.38 Aligned_cols=149 Identities=34% Similarity=0.546 Sum_probs=132.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.++||+|+||.||+|..++++.||+|.+... ....+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 4578889999999999999999888999999998753 344578999999999999999999999864 56789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.+.
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999985433 345899999999999999999999988 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=200.18 Aligned_cols=149 Identities=28% Similarity=0.382 Sum_probs=130.3
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999975 58899999986532 22334578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999998885432 335899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-23 Score=198.07 Aligned_cols=155 Identities=28% Similarity=0.386 Sum_probs=133.3
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+.+++.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344556666679999999999999965 4788999998776555667899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~ 503 (517)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999964322212378888999999999999999988 999999999999976 6789999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-23 Score=198.37 Aligned_cols=151 Identities=29% Similarity=0.509 Sum_probs=128.9
Q ss_pred CCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-----
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----- 420 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 420 (517)
|.+.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998643 3679999987542 2345678999999999999999999998876554
Q ss_pred -EEEEEEeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 421 -RMLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 421 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 2346899999999999999999999988 999999999999999999999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 158 g~~~~~~~~ 166 (273)
T cd05035 158 GLSKKIYSG 166 (273)
T ss_pred cceeecccc
Confidence 999977543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=200.73 Aligned_cols=153 Identities=27% Similarity=0.484 Sum_probs=132.6
Q ss_pred cCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|.+.+.||+|+||.||++.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998653 3689999987543 23345788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999964322 234788999999999999999999988 9999999999999999999999
Q ss_pred cccCceecCC
Q 010146 495 DFGMARAFGV 504 (517)
Q Consensus 495 DFGla~~~~~ 504 (517)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999987644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=199.85 Aligned_cols=149 Identities=30% Similarity=0.403 Sum_probs=130.3
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999976 48899999986542 22234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999885432 335899999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=197.29 Aligned_cols=150 Identities=30% Similarity=0.544 Sum_probs=132.5
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 5688889999999999999998888899999987643 34567999999999999999999999875 556899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999998643 2345899999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=200.38 Aligned_cols=152 Identities=32% Similarity=0.535 Sum_probs=133.3
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|+..++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999742 356899999877666666789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 424 IYEYLPNKSLEQFIFDVTR------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 134789999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCC
Q 010146 492 KISDFGMARAFGV 504 (517)
Q Consensus 492 kl~DFGla~~~~~ 504 (517)
||+|||+++.+..
T Consensus 162 kL~dfg~~~~~~~ 174 (280)
T cd05092 162 KIGDFGMSRDIYS 174 (280)
T ss_pred EECCCCceeEcCC
Confidence 9999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=197.24 Aligned_cols=152 Identities=22% Similarity=0.411 Sum_probs=133.4
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999965 5899999987642 2233456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998854322 345789999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=200.83 Aligned_cols=154 Identities=26% Similarity=0.474 Sum_probs=133.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 420 (517)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678888999999999999999765 6889999887542 3345678899999999999999999998776 467
Q ss_pred EEEEEEeCCCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRT-----KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
.++++||+++++|.+++...... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999988 99999999999999999999999
Q ss_pred ccCceecCC
Q 010146 496 FGMARAFGV 504 (517)
Q Consensus 496 FGla~~~~~ 504 (517)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=199.74 Aligned_cols=149 Identities=30% Similarity=0.493 Sum_probs=134.5
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+.|++.+.||+|+||.||++.... ++.+++|.+........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999999765 8899999998766566778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++++|..++.+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999887543 235899999999999999999999988 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=208.69 Aligned_cols=160 Identities=26% Similarity=0.448 Sum_probs=141.4
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..|...+.||+|.||.||+|.+.. ++.||+|++.-. .....+.+++|+.++..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999999764 899999999865 455678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
+.+|++.+.| .....+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.|||+|||.|-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 34445588888889999999999999998 99999999999999999999999999999977665
Q ss_pred ccccCceecC
Q 010146 508 EANTDRVVGT 517 (517)
Q Consensus 508 ~~~~~~~~GT 517 (517)
.. ..++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 44 457887
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.75 Aligned_cols=150 Identities=25% Similarity=0.402 Sum_probs=132.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 48999999886432 2334568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|++++.|..++.. ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887632 335899999999999999999999988 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=199.98 Aligned_cols=151 Identities=32% Similarity=0.561 Sum_probs=131.0
Q ss_pred CCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
..|++.+.||+|+||.||++.. .++..||+|.++... ....+.+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 247889999987543 34456799999999999999999999998775 568
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++.+. ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998543 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 159 ~~~~ 162 (284)
T cd05079 159 IETD 162 (284)
T ss_pred cccC
Confidence 7543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=201.14 Aligned_cols=150 Identities=28% Similarity=0.496 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
...+|++.+.||+|++|.||++... +++.|++|.+........+.+.+|+.+++.+.|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3467888899999999999999964 588999999977655556788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++.+ ..+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999843 34789999999999999999999988 99999999999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=198.52 Aligned_cols=153 Identities=32% Similarity=0.520 Sum_probs=132.9
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC------
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 418 (517)
.+.+.|++.+.||+|+||.||+|...+ ++.||+|.+... ......+.+|+.++.++ +|+||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456778888999999999999999764 889999998654 34556788999999998 699999999998753
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4579999999999999998643 2345899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
++.+..
T Consensus 158 ~~~~~~ 163 (272)
T cd06637 158 SAQLDR 163 (272)
T ss_pred ceeccc
Confidence 987643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=202.86 Aligned_cols=152 Identities=31% Similarity=0.503 Sum_probs=131.8
Q ss_pred CCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
++|.+.+.||+|+||.||++... ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999999753 13579999997542 33456788899999999 7999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 235889999999999999999999988 99999999999999
Q ss_pred CCCCeEEccccCceecCC
Q 010146 487 NDMNPKISDFGMARAFGV 504 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~ 504 (517)
+++.+||+|||+++.+..
T Consensus 175 ~~~~~kL~dfg~a~~~~~ 192 (307)
T cd05098 175 EDNVMKIADFGLARDIHH 192 (307)
T ss_pred CCCcEEECCCcccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=195.65 Aligned_cols=152 Identities=23% Similarity=0.437 Sum_probs=135.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|++|.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999977 6899999988642 2334568899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.+.. ....+++.+++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2345899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=213.65 Aligned_cols=150 Identities=31% Similarity=0.453 Sum_probs=131.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccC---HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|...+.||.|+||.||.|++. +.+.||||++.-...+. ...+..|++.|.++.|||++.+-|++......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3556689999999999999965 57899999998654443 4578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|| -|+-.+++.-. .+++.+-++..|..+.+.||+|||+++ .||||||+.||||++.|.|||+|||.|....+..
T Consensus 107 YC-lGSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HH-hccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 99 57877877432 345888999999999999999999999 9999999999999999999999999999886654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=197.92 Aligned_cols=145 Identities=22% Similarity=0.369 Sum_probs=128.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 5889999998654 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999997553 3678889999999999999999988 99999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=201.52 Aligned_cols=151 Identities=24% Similarity=0.418 Sum_probs=133.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 5899999988653 233356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999986533334689999999999999999999974 5 9999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=198.39 Aligned_cols=150 Identities=29% Similarity=0.518 Sum_probs=131.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-C---CEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..|++.+.||+|+||.||+|.... + ..||+|.+... .....+++..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347788999999999999999753 3 36999998754 334456899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998543 345899999999999999999999988 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=201.23 Aligned_cols=150 Identities=27% Similarity=0.455 Sum_probs=135.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|++|.||++... +++.+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888999999999999999975 5889999999766555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998543 235899999999999999999999998 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=199.62 Aligned_cols=141 Identities=22% Similarity=0.330 Sum_probs=120.9
Q ss_pred eecccCCeeEEEEEeCC-------------------------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeE
Q 010146 357 KLGEGGFGPVYRGMLTE-------------------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 411 (517)
.||+|+||.||+|.... ...|++|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588999876544445678899999999999999999
Q ss_pred EEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC--
Q 010146 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-- 489 (517)
Q Consensus 412 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-- 489 (517)
++++......++||||+++++|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998542 345889999999999999999999988 99999999999997643
Q ss_pred -----CeEEccccCceec
Q 010146 490 -----NPKISDFGMARAF 502 (517)
Q Consensus 490 -----~~kl~DFGla~~~ 502 (517)
.+||+|||++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=196.49 Aligned_cols=149 Identities=30% Similarity=0.515 Sum_probs=132.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999965 48999999886432 1234568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999854 235888999999999999999999988 9999999999999999999999999998764
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=195.37 Aligned_cols=150 Identities=30% Similarity=0.530 Sum_probs=131.2
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|.+.+.||+|++|.||++....+..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 458888999999999999999887778999988653 334567899999999999999999998875 556899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999653 2345789999999999999999999988 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=201.56 Aligned_cols=151 Identities=33% Similarity=0.543 Sum_probs=129.9
Q ss_pred CCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
+|.+.+.||+|+||.||+|...+ ++.||+|++..... ...+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998632 57899999975432 234578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 424 IYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999984211 1234788899999999999999999988 999999999999999999
Q ss_pred eEEccccCceecCC
Q 010146 491 PKISDFGMARAFGV 504 (517)
Q Consensus 491 ~kl~DFGla~~~~~ 504 (517)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=195.01 Aligned_cols=151 Identities=28% Similarity=0.424 Sum_probs=134.2
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||++... +++.|++|.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677899999999999999976 4899999988643 334566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999653 2346899999999999999999999988 999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=199.83 Aligned_cols=161 Identities=25% Similarity=0.411 Sum_probs=136.8
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEE-
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT- 416 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 416 (517)
+.++.+..+.++|++.+.||+|+||.||++.... ++.+|+|.+... ......+.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3445566788899999999999999999999754 889999988653 23346788899999999 6999999999874
Q ss_pred ----eCCEEEEEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 417 ----LRDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 417 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999988542 23345889999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCC
Q 010146 492 KISDFGMARAFGV 504 (517)
Q Consensus 492 kl~DFGla~~~~~ 504 (517)
||+|||+++.+..
T Consensus 164 kl~dfg~~~~~~~ 176 (286)
T cd06638 164 KLVDFGVSAQLTS 176 (286)
T ss_pred EEccCCceeeccc
Confidence 9999999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.89 Aligned_cols=148 Identities=30% Similarity=0.494 Sum_probs=130.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999976 48899999987542 33345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 96 6898888543 335789999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=202.58 Aligned_cols=150 Identities=33% Similarity=0.609 Sum_probs=128.8
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC--EEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|..+. +. .+++|.+... .......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999999653 44 4677777643 233456788999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
|||+++++|.+++.... ....+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996432 1235789999999999999999999988 9999999999999999999
Q ss_pred EEccccCceec
Q 010146 492 KISDFGMARAF 502 (517)
Q Consensus 492 kl~DFGla~~~ 502 (517)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=194.18 Aligned_cols=144 Identities=31% Similarity=0.511 Sum_probs=128.0
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 434 (517)
++||+|+||.||++...+++.+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876532 23446889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 435 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 998542 234789999999999999999999988 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.56 Aligned_cols=147 Identities=28% Similarity=0.489 Sum_probs=131.9
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999999765 778899998765555667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++|..++.+. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999987532 345899999999999999999999988 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-24 Score=196.48 Aligned_cols=154 Identities=28% Similarity=0.422 Sum_probs=129.6
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-----CCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 420 (517)
...|+....||+|.||.||+|.-++ .+.+|+|+++.... .......+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999997432 23789999976422 223456789999999999999999998877 778
Q ss_pred EEEEEEeCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC----CCeEEc
Q 010146 421 RMLIYEYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND----MNPKIS 494 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~ 494 (517)
.++++||.+ -+|..+|+-+ .+.+.++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 899999995 6788887533 33467899999999999999999999999 9999999999999877 899999
Q ss_pred cccCceecCCCC
Q 010146 495 DFGMARAFGVDQ 506 (517)
Q Consensus 495 DFGla~~~~~~~ 506 (517)
|||+||.+...-
T Consensus 179 DlGlaR~~~~pl 190 (438)
T KOG0666|consen 179 DLGLARLFNNPL 190 (438)
T ss_pred cccHHHHhhccc
Confidence 999999987654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=195.81 Aligned_cols=142 Identities=25% Similarity=0.453 Sum_probs=123.3
Q ss_pred ceecccCCeeEEEEEeCCCC-----------EEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTEGQ-----------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999976532 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-------CeEEcccc
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-------NPKISDFG 497 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~DFG 497 (517)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999995432 25899999999999999999999988 99999999999999887 79999999
Q ss_pred CceecCC
Q 010146 498 MARAFGV 504 (517)
Q Consensus 498 la~~~~~ 504 (517)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9997644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=198.14 Aligned_cols=149 Identities=30% Similarity=0.524 Sum_probs=128.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCC----EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|... +++ .||+|.+... .....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999853 344 4899998754 33345678899999999999999999999875 45789
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998542 345899999999999999999999988 9999999999999999999999999999875
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=194.41 Aligned_cols=147 Identities=37% Similarity=0.611 Sum_probs=131.4
Q ss_pred ceecccCCeeEEEEEeCC----CCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++.+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 789999999765333 367899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 431 KSLEQFIFDVTR------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 431 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++|.+++..... ...+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||.++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965421 356899999999999999999999988 99999999999999999999999999998865
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=194.68 Aligned_cols=143 Identities=31% Similarity=0.575 Sum_probs=123.7
Q ss_pred eecccCCeeEEEEEeC---CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 357 KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999987653 233467899999999999999999999875 457899999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 433 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 99998532 345899999999999999999999988 999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.22 Aligned_cols=152 Identities=34% Similarity=0.520 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
++|.+.+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +|+||+++++.+...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888899999999999999742 24589999987543 33346789999999999 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+++ |+|+||||+|||+++++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999985422 234899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 191 ~~~~ 194 (302)
T cd05055 191 IMND 194 (302)
T ss_pred ccCC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=199.81 Aligned_cols=149 Identities=32% Similarity=0.503 Sum_probs=131.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc-----CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-----GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+|++.+.||+|++|.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 5899999999764322 234677899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+++ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999995422 35899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 155 ~ 155 (298)
T cd07841 155 P 155 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=206.46 Aligned_cols=148 Identities=30% Similarity=0.456 Sum_probs=126.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----- 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 419 (517)
..++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999975 4899999998653 2334567889999999999999999999986543
Q ss_pred -EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 420 -ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 420 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
..++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 4799999996 56666662 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
++....
T Consensus 170 a~~~~~ 175 (359)
T cd07876 170 ARTACT 175 (359)
T ss_pred cccccc
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=192.99 Aligned_cols=150 Identities=27% Similarity=0.399 Sum_probs=132.9
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 4889999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988542 3345789999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=194.95 Aligned_cols=148 Identities=33% Similarity=0.559 Sum_probs=130.6
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc---------CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ---------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999865 4889999988654221 22568899999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999943 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 8753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=196.03 Aligned_cols=150 Identities=31% Similarity=0.582 Sum_probs=131.8
Q ss_pred CCCCccceecccCCeeEEEEEeCC-C---CEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|+..+.||+|+||.||+|.... + ..+|+|.+.... ....+.+.+|++++++++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778999999999999999753 3 379999987542 33456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 245899999999999999999999988 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=193.33 Aligned_cols=152 Identities=22% Similarity=0.339 Sum_probs=134.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|+..+.||+|+||.||.+... +++.+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999865 4889999988653 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++++|.+++.+.. ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996432 345899999999999999999999988 9999999999999999999999999998775443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=200.35 Aligned_cols=150 Identities=33% Similarity=0.601 Sum_probs=129.2
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC--EEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 33 4788888643 233456789999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996432 1135889999999999999999999988 9999999999999999999
Q ss_pred EEccccCceec
Q 010146 492 KISDFGMARAF 502 (517)
Q Consensus 492 kl~DFGla~~~ 502 (517)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=202.93 Aligned_cols=145 Identities=23% Similarity=0.265 Sum_probs=117.4
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC--CCCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCCCCCeee-EEEEE
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVR-LLGCC 415 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~-l~~~~ 415 (517)
.+....++|.+.+.||+|+||+||+|... +++.+|||++.... ....+.+.+|+++|++++|+|++. +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34456688999999999999999999865 47788999875321 123456899999999999999985 443
Q ss_pred EeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCC-CCCcEEECCCCCeEEc
Q 010146 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNDMNPKIS 494 (517)
Q Consensus 416 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~ 494 (517)
.+..++||||+++++|.. + ... . ...++.|+++||.|||+++ |+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~---~~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-A---RPH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-h---Ccc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 246799999999999963 2 111 1 1467889999999999988 999999 9999999999999999
Q ss_pred cccCceecCCC
Q 010146 495 DFGMARAFGVD 505 (517)
Q Consensus 495 DFGla~~~~~~ 505 (517)
|||+|+.+...
T Consensus 155 DFGlA~~~~~~ 165 (365)
T PRK09188 155 DFQLASVFRRR 165 (365)
T ss_pred ECccceecccC
Confidence 99999987654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=194.25 Aligned_cols=149 Identities=32% Similarity=0.504 Sum_probs=132.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 68999999886532 23456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998542 34889999999999999999999988 99999999999999999999999999987644
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 155 ~ 155 (258)
T cd06632 155 F 155 (258)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=197.87 Aligned_cols=147 Identities=37% Similarity=0.594 Sum_probs=127.5
Q ss_pred CC-CccceecccCCeeEEEEEe-----CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 351 NF-SWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 351 ~y-~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
+| +..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988653 347889999987543 23456788999999999999999999988654 357
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+++|||+++++|.+++.. ..+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 899999999999999843 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 157 ~~~ 159 (283)
T cd05080 157 VPE 159 (283)
T ss_pred cCC
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=194.81 Aligned_cols=151 Identities=26% Similarity=0.489 Sum_probs=136.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367888999999999999999975 4789999999876555678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++... ...+++.++..++.|++.||+|||+++ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999998542 245899999999999999999999988 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=205.59 Aligned_cols=151 Identities=30% Similarity=0.448 Sum_probs=129.2
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR----- 418 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 418 (517)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999965 58899999987532 23345678899999999999999999887543
Q ss_pred -CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 419 -DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 419 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 789988873 235899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+++.....
T Consensus 164 ~~~~~~~~ 171 (343)
T cd07878 164 LARQADDE 171 (343)
T ss_pred cceecCCC
Confidence 99976543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=195.27 Aligned_cols=144 Identities=22% Similarity=0.384 Sum_probs=123.8
Q ss_pred ceecccCCeeEEEEEeCC-------------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE-------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-------eEEcc
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-------PKISD 495 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~D 495 (517)
+||||+++++|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988432 345899999999999999999999988 999999999999987664 89999
Q ss_pred ccCceecCC
Q 010146 496 FGMARAFGV 504 (517)
Q Consensus 496 FGla~~~~~ 504 (517)
||++..+..
T Consensus 156 ~g~~~~~~~ 164 (262)
T cd05077 156 PGIPITVLS 164 (262)
T ss_pred CCCCccccC
Confidence 999986643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=197.06 Aligned_cols=150 Identities=29% Similarity=0.451 Sum_probs=131.7
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
++|++.+.||+|+||.||+|..+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999964 2467999988764333 4568999999999999999999999999889999
Q ss_pred EEEEeCCCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 423 LIYEYLPNKSLEQFIFDVTRT------KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654322 25899999999999999999999988 999999999999999999999999
Q ss_pred cCceec
Q 010146 497 GMARAF 502 (517)
Q Consensus 497 Gla~~~ 502 (517)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=202.70 Aligned_cols=152 Identities=30% Similarity=0.492 Sum_probs=131.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC--------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
.+|.+.+.||+|+||.||++.... ...||+|.+.... ....+++.+|+.+++++ +|+||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997421 2368999887542 33456889999999999 7999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
..+++|||+++++|.+++.+.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999996432 1235788999999999999999999988 99999999999999
Q ss_pred CCCCeEEccccCceecCC
Q 010146 487 NDMNPKISDFGMARAFGV 504 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~ 504 (517)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=200.78 Aligned_cols=152 Identities=33% Similarity=0.523 Sum_probs=131.0
Q ss_pred CCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
++|.+.+.||+|+||.||++... ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24578999987542 33456788999999999 5999999999999989
Q ss_pred EEEEEEEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
..+++|||+++++|.+++.... ....+++.++..++.|++.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 1245889999999999999999999988 99999999999999
Q ss_pred CCCCeEEccccCceecCC
Q 010146 487 NDMNPKISDFGMARAFGV 504 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~ 504 (517)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 169 EDNVMKIADFGLARGVHD 186 (314)
T ss_pred CCCcEEEccccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=200.31 Aligned_cols=146 Identities=21% Similarity=0.351 Sum_probs=130.5
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999764 7899999987542 233457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999954 245899999999999999999999988 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=196.45 Aligned_cols=150 Identities=31% Similarity=0.557 Sum_probs=130.4
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.+|++.+.||+|+||.||+|..+. +. .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998643 33 689998876532 345678899999999999999999999886 78899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++.+. ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 234899999999999999999999988 9999999999999999999999999998875
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 161 ~~ 162 (279)
T cd05057 161 VD 162 (279)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=196.09 Aligned_cols=147 Identities=31% Similarity=0.483 Sum_probs=129.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc----------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG----------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 419 (517)
+|...+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677799999999999999865 589999998753211 11346788999999999999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45899999999999999999999988 999999999999999999999999999
Q ss_pred eecC
Q 010146 500 RAFG 503 (517)
Q Consensus 500 ~~~~ 503 (517)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=195.89 Aligned_cols=147 Identities=32% Similarity=0.566 Sum_probs=130.6
Q ss_pred CCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 2235688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999542 34789999999999999999999988 9999999999999999999999999998653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=197.05 Aligned_cols=143 Identities=24% Similarity=0.402 Sum_probs=121.6
Q ss_pred ceecccCCeeEEEEEeCCC---CEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 356 NKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 356677765432 334568999999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 432 SLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 432 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+|.+++.+... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 99999965322 234677788899999999999999988 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=197.63 Aligned_cols=149 Identities=32% Similarity=0.495 Sum_probs=130.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|++|.||++..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367888999999999999999976 588999999865422 233457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 84 YLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred cCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccC
Confidence 997 59999885432 35889999999999999999999988 9999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=193.77 Aligned_cols=150 Identities=31% Similarity=0.491 Sum_probs=133.0
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678899999999999999999877888999988753 3345678999999999999999999999877 7789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999653 2345788999999999999999999988 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=211.19 Aligned_cols=156 Identities=29% Similarity=0.477 Sum_probs=130.4
Q ss_pred ccceecccCCeeEEEEEeCC-CCEEEEEEc--cC--CCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE--EEEEEE
Q 010146 354 WKNKLGEGGFGPVYRGMLTE-GQEIAVKRL--SK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE--RMLIYE 426 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~--~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 426 (517)
....||+|+|-+||+|.+.. |-+||--.+ +. ..+...++|..|+++|+.|+||||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 44799999999999999764 777763222 11 144556899999999999999999999999987765 788999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~ 505 (517)
.|..|+|..|+.+. +.++.+.+..+++||++||.|||++. +||||||||-+||+|+. .|.|||+|+|||+.+...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999654 34788999999999999999999987 78999999999999975 578999999999998665
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
... .++||
T Consensus 200 ~ak----svIGT 207 (632)
T KOG0584|consen 200 HAK----SVIGT 207 (632)
T ss_pred ccc----eeccC
Confidence 432 36776
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=202.57 Aligned_cols=143 Identities=22% Similarity=0.320 Sum_probs=126.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
...+|.+.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 44679999999999999999999764 778999975432 23568999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++ .++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 138 ~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred cc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 99 4788888854 2345899999999999999999999998 999999999999999999999999999854
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=198.59 Aligned_cols=150 Identities=29% Similarity=0.522 Sum_probs=135.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+|+..+.||.|++|.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 356888999999999999999864 5899999999765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|..++.+ ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999998843 34899999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=196.89 Aligned_cols=152 Identities=22% Similarity=0.414 Sum_probs=133.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|++|.||++... +++.+|||.+.... .....++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999964 68999999876432 233457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986432 2346899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.51 Aligned_cols=150 Identities=24% Similarity=0.430 Sum_probs=124.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-------- 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 418 (517)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999975 48899999885432 2345799999999999999999886432
Q ss_pred CEEEEEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccc
Q 010146 419 DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDF 496 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DF 496 (517)
...++||||++ ++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 23678999997 5777776432 23456899999999999999999999998 99999999999998665 6999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+|+.+...
T Consensus 216 Gla~~~~~~ 224 (440)
T PTZ00036 216 GSAKNLLAG 224 (440)
T ss_pred ccchhccCC
Confidence 999977543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=192.16 Aligned_cols=148 Identities=28% Similarity=0.480 Sum_probs=129.6
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEE-eCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT-LRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 428 (517)
++|++.+.||+|+||.||++... +..+|+|.+... ...+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999876 788999998643 33567899999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.+.. ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999986432 335889999999999999999999988 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=194.14 Aligned_cols=142 Identities=32% Similarity=0.583 Sum_probs=123.9
Q ss_pred eecccCCeeEEEEEeC---CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 357 KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
.||+|+||.||+|.++ +++.+|+|++.... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 47899999986543 234567899999999999999999999875 55678999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 345899999999999999999999988 999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=224.64 Aligned_cols=169 Identities=24% Similarity=0.267 Sum_probs=145.4
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 417 (517)
..+++-..++|.+.++||+|+||.|..++.+. ++.+|+|++++- .......|..|-.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34555566889999999999999999999865 889999999873 34455678899999999999999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
...+|+|||||+||+|..+|.+.. .+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999995433 6999999999999999999999988 9999999999999999999999999
Q ss_pred CceecCCCCcccccCceecC
Q 010146 498 MARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 498 la~~~~~~~~~~~~~~~~GT 517 (517)
.+-.+..+.+-. ....+||
T Consensus 221 sClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEE-eccccCC
Confidence 999888655422 2224666
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=194.99 Aligned_cols=148 Identities=29% Similarity=0.491 Sum_probs=128.2
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
.+|++.+.||+|+||.||++...+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999754 8999999875321 12345788899999999999999999988764 467
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+++|||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998532 34788899999999999999999988 99999999999999999999999999986
Q ss_pred cC
Q 010146 502 FG 503 (517)
Q Consensus 502 ~~ 503 (517)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=197.84 Aligned_cols=152 Identities=30% Similarity=0.567 Sum_probs=132.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999864 36789999987543 23356789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCc
Q 010146 422 MLIYEYLPNKSLEQFIFDVT-------------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 482 (517)
+++|||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996321 1124788899999999999999999988 9999999999
Q ss_pred EEECCCCCeEEccccCceecC
Q 010146 483 VLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~~~ 503 (517)
||+++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=196.07 Aligned_cols=152 Identities=34% Similarity=0.542 Sum_probs=131.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|.+.+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999999753 5688999886543 33345689999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---CeEEc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKIS 494 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 494 (517)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865322 235899999999999999999999988 99999999999998754 59999
Q ss_pred cccCceecC
Q 010146 495 DFGMARAFG 503 (517)
Q Consensus 495 DFGla~~~~ 503 (517)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=199.54 Aligned_cols=145 Identities=26% Similarity=0.417 Sum_probs=120.4
Q ss_pred cceecccCCeeEEEEEeC---CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEEEEEeCC
Q 010146 355 KNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIYEYLP 429 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 429 (517)
.++||+|+||.||+|... +++.+|+|.+... .....+.+|+.++++++||||+++++.+.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 3678999998653 233567889999999999999999998854 456789999985
Q ss_pred CCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE----CCCCCeEEccccCc
Q 010146 430 NKSLEQFIFDVT------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMA 499 (517)
Q Consensus 430 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla 499 (517)
++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888874321 1235889999999999999999999998 9999999999999 45678999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07868 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=193.71 Aligned_cols=144 Identities=36% Similarity=0.529 Sum_probs=128.0
Q ss_pred ceecccCCeeEEEEEeCC--C--CEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE--G--QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998653 3 3689999987654 556789999999999999999999999987 889999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++|.+++.+... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999965432 46899999999999999999999988 99999999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-22 Score=191.80 Aligned_cols=153 Identities=29% Similarity=0.485 Sum_probs=136.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+++++.++|+||+++++.+..++..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 48899999987542 33567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999965433356899999999999999999999988 999999999999999999999999999877554
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=195.57 Aligned_cols=150 Identities=31% Similarity=0.560 Sum_probs=132.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999976 48899999987643 234567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+ ++|.+++........+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 7 589888865444456899999999999999999999988 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=196.70 Aligned_cols=161 Identities=28% Similarity=0.429 Sum_probs=137.8
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL 417 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 417 (517)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666777899999999999999999999975 5889999998653 23346778899999998 79999999999875
Q ss_pred C-----CEEEEEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 418 R-----DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 418 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
. +..++||||+++++|.+++... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999988542 23446899999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCC
Q 010146 492 KISDFGMARAFGV 504 (517)
Q Consensus 492 kl~DFGla~~~~~ 504 (517)
||+|||+++.+..
T Consensus 168 kl~dfg~~~~~~~ 180 (291)
T cd06639 168 KLVDFGVSAQLTS 180 (291)
T ss_pred EEeecccchhccc
Confidence 9999999987643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=205.23 Aligned_cols=148 Identities=29% Similarity=0.444 Sum_probs=126.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
..++|++.+.||+|+||.||++... .++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 48899999987542 23346778899999999999999999988643
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 34699999996 56777663 23788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=195.72 Aligned_cols=150 Identities=32% Similarity=0.550 Sum_probs=131.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-----CCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 421 (517)
++|++.+.||+|+||.||++... .+..+|+|.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3679999999765432 46789999999999999999999999877 5578
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999995432 25899999999999999999999988 99999999999999999999999999998
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 159 ~~~ 161 (284)
T cd05038 159 LPE 161 (284)
T ss_pred ccc
Confidence 763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=220.00 Aligned_cols=160 Identities=23% Similarity=0.365 Sum_probs=132.4
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDE 420 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 420 (517)
....++|.+.+.||+|+||.||++.... +..+|+|.+... .......+..|+.++++|+||||+++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999999765 778999988653 23345678999999999999999999998854 356
Q ss_pred EEEEEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCC----CceEecCCCCCcEEECCC-------
Q 010146 421 RMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSR----LRIIHRDLKASNVLLDND------- 488 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~iiH~Dlkp~NIll~~~------- 488 (517)
.+|||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986532 23468999999999999999999998531 249999999999999642
Q ss_pred ----------CCeEEccccCceecCCC
Q 010146 489 ----------MNPKISDFGMARAFGVD 505 (517)
Q Consensus 489 ----------~~~kl~DFGla~~~~~~ 505 (517)
..+||+|||+++.+...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc
Confidence 34899999999877543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=196.27 Aligned_cols=150 Identities=31% Similarity=0.463 Sum_probs=129.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999865 48899999986543 233346788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 7787776432 234788888999999999999999988 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=200.98 Aligned_cols=153 Identities=26% Similarity=0.366 Sum_probs=135.4
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.-|++.+.||+|.|+.|-+|++- .|..||||++.+. +......+.+|++.|+.++|||||+++++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45788899999999999999843 5999999999875 33445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE-CCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~~~~~ 505 (517)
.-.+|+|.+||.++.. .+.+....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-|||.|||++-.+.++
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976544 4899999999999999999999988 9999999999877 45678999999999999777
Q ss_pred Cc
Q 010146 506 QT 507 (517)
Q Consensus 506 ~~ 507 (517)
+.
T Consensus 173 ~k 174 (864)
T KOG4717|consen 173 KK 174 (864)
T ss_pred ch
Confidence 54
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=191.12 Aligned_cols=143 Identities=34% Similarity=0.546 Sum_probs=128.6
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 434 (517)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765333 4568899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 435 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++.+. ...+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998543 235789999999999999999999988 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=191.39 Aligned_cols=149 Identities=29% Similarity=0.521 Sum_probs=132.7
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.+|++.+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999999877889999998753 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999998542 234789999999999999999999988 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=195.16 Aligned_cols=149 Identities=28% Similarity=0.477 Sum_probs=133.4
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 58999999987643 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999985433 45899999999999999999999988 999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=195.31 Aligned_cols=149 Identities=28% Similarity=0.505 Sum_probs=123.6
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEe-----CC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTL-----RD 419 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 419 (517)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 48899999987532 22233556677776655 69999999998764 24
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..+++|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999997 58988885432 344899999999999999999999998 999999999999999999999999999
Q ss_pred eecCC
Q 010146 500 RAFGV 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=197.85 Aligned_cols=151 Identities=27% Similarity=0.333 Sum_probs=134.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999765 89999999976432 24567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+|+.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998542 3356899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=192.74 Aligned_cols=149 Identities=30% Similarity=0.514 Sum_probs=133.7
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|+..+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999965 589999999876543 2567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999853 334788999999999999999999988 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=203.68 Aligned_cols=148 Identities=28% Similarity=0.446 Sum_probs=127.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 4889999998753 233456788999999999999999999987543
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++||||++ ++|.+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 35799999996 57777773 23788899999999999999999988 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=194.87 Aligned_cols=151 Identities=26% Similarity=0.383 Sum_probs=127.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHH-HhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLL-IAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||.||++... +|+.||+|+++... ......+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999976 48999999987542 2233455566665 566789999999999999999999999
Q ss_pred eCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+|||+++++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7888887543 2335689999999999999999999986 6 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=197.42 Aligned_cols=149 Identities=28% Similarity=0.465 Sum_probs=131.5
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||.||++..++ ++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 89999998865322 235578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++++|..+... ...+++.+++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999988887632 234899999999999999999999988 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=198.86 Aligned_cols=145 Identities=19% Similarity=0.281 Sum_probs=126.0
Q ss_pred ccceeccc--CCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 354 WKNKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 354 ~~~~Ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+.++||+| +|++||++..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999875 58999999997542 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999985432 234899999999999999999999988 999999999999999999999999865543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=194.05 Aligned_cols=149 Identities=29% Similarity=0.498 Sum_probs=130.5
Q ss_pred CCCccceecccCCeeEEEEEe-CCCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
+|+..+.||+|++|.||++.. .+++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 4589999999865321 134678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceec
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAF 502 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~ 502 (517)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999854 235889999999999999999999998 99999999999998776 5999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 155 ~~~ 157 (268)
T cd06630 155 AAK 157 (268)
T ss_pred ccc
Confidence 543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=204.17 Aligned_cols=152 Identities=27% Similarity=0.528 Sum_probs=132.6
Q ss_pred cCCCCccceecccCCeeEEEEEeCC---CC--EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE---GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
.+.....+.||.|-||.||+|...+ |. .||||.-+.+ .....+.|+.|..+|++++||||++++|+|. ....+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-cccee
Confidence 3445566899999999999999643 33 5888988764 4566889999999999999999999999997 56789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||||.++-|.|..||... ...++......++.||+.||+|||+.. +|||||..+|||+.+..-|||+|||++|-+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999654 345888999999999999999999988 999999999999999999999999999998
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
.++.
T Consensus 542 ed~~ 545 (974)
T KOG4257|consen 542 EDDA 545 (974)
T ss_pred cccc
Confidence 7654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=195.11 Aligned_cols=149 Identities=27% Similarity=0.360 Sum_probs=130.4
Q ss_pred CCCccceecccCCeeEEEEEe----CCCCEEEEEEccCCC----ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999986 358899999987532 22346788999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 345888999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+..+
T Consensus 155 ~~~~ 158 (290)
T cd05613 155 FHED 158 (290)
T ss_pred cccc
Confidence 7543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=193.65 Aligned_cols=150 Identities=26% Similarity=0.446 Sum_probs=129.6
Q ss_pred CCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 2468999887654 3455689999999999999999999998864 567899
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999543 234899999999999999999999988 99999999999999999999999999987644
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 160 ~ 160 (270)
T cd05056 160 E 160 (270)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=191.58 Aligned_cols=148 Identities=30% Similarity=0.508 Sum_probs=128.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 421 (517)
.+|+..+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++++++||||+++++.+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999975 48899999886432 1234568899999999999999999998875 3567
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 234889999999999999999999988 99999999999999999999999999987
Q ss_pred cC
Q 010146 502 FG 503 (517)
Q Consensus 502 ~~ 503 (517)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=190.04 Aligned_cols=150 Identities=39% Similarity=0.643 Sum_probs=132.2
Q ss_pred CCccceecccCCeeEEEEEeCC-----CCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+++.+.||+|+||.||++.... +..||+|.+...... ..+.+..|+..+..++|+||+++++.+...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999999764 388999999765433 5678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 22899999999999999999999988 999999999999999999999999999877654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=190.96 Aligned_cols=146 Identities=32% Similarity=0.540 Sum_probs=128.1
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||++.. .++.+|+|.+... ...+.+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4588889999999999999975 4788999998653 234678999999999999999999999865 45799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999996532 345889999999999999999999988 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=192.81 Aligned_cols=149 Identities=26% Similarity=0.448 Sum_probs=133.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999976 48899999987543 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998432 6899999999999999999999988 999999999999999999999999999988654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=191.89 Aligned_cols=143 Identities=34% Similarity=0.620 Sum_probs=123.6
Q ss_pred ceecccCCeeEEEEEeCC-CC--EEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999764 43 5688888743 234456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 431 KSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 431 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1234789999999999999999999988 9999999999999999999999999
Q ss_pred Ccee
Q 010146 498 MARA 501 (517)
Q Consensus 498 la~~ 501 (517)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=194.11 Aligned_cols=149 Identities=28% Similarity=0.348 Sum_probs=133.7
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
+|++.+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 48999999997542 2346788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++++|.+++... ..+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998542 46899999999999999999999988 999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=196.73 Aligned_cols=150 Identities=34% Similarity=0.623 Sum_probs=127.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCC----EEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|+..+.||+|+||.||++... ++. .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777899999999999999864 344 578898875432 2334788999999999999999999998754 5679
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998542 235889999999999999999999988 9999999999999999999999999999775
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 161 ~~ 162 (303)
T cd05110 161 GD 162 (303)
T ss_pred Cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=195.95 Aligned_cols=151 Identities=27% Similarity=0.425 Sum_probs=129.5
Q ss_pred CCCccceecccCCeeEEEEEeCC---CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERM 422 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 422 (517)
+|++.+.||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999997632 34456788999999999999999999999988 7899
Q ss_pred EEEEeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC----CCCeEEccc
Q 010146 423 LIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----DMNPKISDF 496 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 496 (517)
+||||++ ++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 577777643322 236889999999999999999999988 999999999999999 899999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 157 g~~~~~~~~ 165 (316)
T cd07842 157 GLARLFNAP 165 (316)
T ss_pred ccccccCCC
Confidence 999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=189.77 Aligned_cols=150 Identities=28% Similarity=0.489 Sum_probs=135.4
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||++...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999775 78999999875432 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999998532 345899999999999999999999988 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=195.09 Aligned_cols=144 Identities=28% Similarity=0.430 Sum_probs=119.8
Q ss_pred ceecccCCeeEEEEEeCC---CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 430 (517)
.+||+|+||.||+|...+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 689999999999999653 5789999986532 33567889999999999999999998854 456799999986
Q ss_pred CCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE----CCCCCeEEccccCce
Q 010146 431 KSLEQFIFDV------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR 500 (517)
Q Consensus 431 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 500 (517)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5787777421 12235889999999999999999999988 9999999999999 566789999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 161 ~~~~~ 165 (317)
T cd07867 161 LFNSP 165 (317)
T ss_pred ccCCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=185.19 Aligned_cols=143 Identities=16% Similarity=0.133 Sum_probs=110.3
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCcc--C-------HH-----------------HHHHHHHHHhcCCCCCe
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--G-------VE-----------------EFKNEVLLIAKLQHRNL 408 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h~ni 408 (517)
...||+|++|.||+|...+|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 11 22349999999987776
Q ss_pred eeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCceEecCCCCCcEEECC
Q 010146 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN 487 (517)
Q Consensus 409 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~Dlkp~NIll~~ 487 (517)
.....+.. ...+|||||+++++|...+.. ...++..+...++.|++.+|.+| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 44333222 223899999998877654322 24588999999999999999999 6877 999999999999984
Q ss_pred CCCeEEccccCceecCCCC
Q 010146 488 DMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 488 ~~~~kl~DFGla~~~~~~~ 506 (517)
+.++|+|||+|...+.+.
T Consensus 154 -~~v~LiDFG~a~~~~~~~ 171 (190)
T cd05147 154 -GKLYIIDVSQSVEHDHPH 171 (190)
T ss_pred -CcEEEEEccccccCCCcC
Confidence 689999999998765443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=198.20 Aligned_cols=145 Identities=28% Similarity=0.456 Sum_probs=129.1
Q ss_pred CccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
.....||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|+||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999975 48899999987655555667899999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++..+..
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99998832 34889999999999999999999988 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=189.77 Aligned_cols=151 Identities=26% Similarity=0.398 Sum_probs=136.1
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|++|.||++.... ++.|++|++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999775 89999999876543 4467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999543 558999999999999999999999 88 9999999999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=194.11 Aligned_cols=150 Identities=29% Similarity=0.509 Sum_probs=134.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888999999999999999864 5889999998765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+...
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999843 24788999999999999999999998 999999999999999999999999998866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=188.96 Aligned_cols=150 Identities=25% Similarity=0.403 Sum_probs=132.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999965 4889999998643 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988542 2235789999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=195.74 Aligned_cols=148 Identities=28% Similarity=0.514 Sum_probs=129.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 48999999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.++.
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 96 6888877532 345899999999999999999999988 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=190.84 Aligned_cols=147 Identities=29% Similarity=0.481 Sum_probs=130.5
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999865 58899999886432 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999842 34889999999999999999999988 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=190.85 Aligned_cols=148 Identities=28% Similarity=0.472 Sum_probs=131.8
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 425 (517)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999964 5899999998754 3345567889999999986 999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 25899999999999999999999988 999999999999999999999999999887554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=189.31 Aligned_cols=144 Identities=38% Similarity=0.609 Sum_probs=125.0
Q ss_pred ceecccCCeeEEEEEeCC----CCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899999876533 24567899999999999999999999875 5568999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++|.+++.+. ..+++..+..++.|++.||+|||..+ ++|+||||+|||+++++.+||+|||+++.+....
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 9999999543 35899999999999999999999988 9999999999999999999999999999775443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=203.99 Aligned_cols=156 Identities=30% Similarity=0.448 Sum_probs=134.5
Q ss_pred eecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHH
Q 010146 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ 435 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 435 (517)
+||+|.||+||.|++.+ ...+|||.+........+-+.+|+.+.++|+|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 66899999988777778889999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCCCCcccccCce
Q 010146 436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQTEANTDRV 514 (517)
Q Consensus 436 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 514 (517)
+|...-..-.-.+.+.-.+..||++||.|||++. |||||||-+||||+. .|.+||+|||.++++..-.. .|..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccccc
Confidence 9964332222377888889999999999999998 999999999999964 78899999999999854332 34446
Q ss_pred ecC
Q 010146 515 VGT 517 (517)
Q Consensus 515 ~GT 517 (517)
.||
T Consensus 737 TGT 739 (1226)
T KOG4279|consen 737 TGT 739 (1226)
T ss_pred ccc
Confidence 665
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=188.19 Aligned_cols=150 Identities=24% Similarity=0.373 Sum_probs=130.2
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 426 (517)
+|++.+.||+|++|.||++.... ++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999764 7899999986532 3345678899999999999999999988764 446789999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++... ....+++.+++.++.|++.||++||+.+ ++|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998653 2345899999999999999999999998 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=193.35 Aligned_cols=150 Identities=29% Similarity=0.454 Sum_probs=128.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCE-----
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE----- 420 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 420 (517)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999976 48999999886542 223467888999999995 6999999999887665
Q ss_pred EEEEEEeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEcccc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFG 497 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFG 497 (517)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 89888854322 345899999999999999999999988 999999999999998 8899999999
Q ss_pred CceecC
Q 010146 498 MARAFG 503 (517)
Q Consensus 498 la~~~~ 503 (517)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=194.05 Aligned_cols=150 Identities=31% Similarity=0.450 Sum_probs=130.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 424 (517)
++|++.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999976 48899999987542 22334567899999999999999999998877 889999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 59999885432 35899999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=190.60 Aligned_cols=150 Identities=29% Similarity=0.501 Sum_probs=126.2
Q ss_pred CCccceecccCCeeEEEEEeC----CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC------
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ 419 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 419 (517)
|.+.+.||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999854 3688999998754 2334567889999999999999999999886542
Q ss_pred EEEEEEEeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 1234788999999999999999999988 999999999999999999999999
Q ss_pred cCceecCC
Q 010146 497 GMARAFGV 504 (517)
Q Consensus 497 Gla~~~~~ 504 (517)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99997754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=217.33 Aligned_cols=152 Identities=31% Similarity=0.472 Sum_probs=124.9
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-----
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----- 417 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 417 (517)
..+...+|+..+.||+|+||.||+++.+ ||+.+|||++... +......+.+|+.+|++|+|||||+++..+.+
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3456778889999999999999999966 6999999999765 33445578899999999999999987752100
Q ss_pred --------------------------------------------------------------------------------
Q 010146 418 -------------------------------------------------------------------------------- 417 (517)
Q Consensus 418 -------------------------------------------------------------------------------- 417 (517)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH
Q 010146 418 --------------------------R--------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463 (517)
Q Consensus 418 --------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~ 463 (517)
. ..+||-||||+...|.+++.+..... .....++++++|+.||+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 0 12478899998888888884432211 46678899999999999
Q ss_pred HhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 464 ~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
|+|+++ ||||||||.||+|+++..|||+|||+|+.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 999998 99999999999999999999999999997
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=226.28 Aligned_cols=143 Identities=26% Similarity=0.499 Sum_probs=122.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
...+...+.||+|+||.||+|... ++..||||++...... ...|++.+++++||||+++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345777789999999999999974 6899999998754322 23468889999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+++|+|.+++. .++|.++..++.|+++||+|||.....+|+||||||+||+++.++.+++. ||.+...
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999993 27899999999999999999996644569999999999999999888875 6665443
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=194.34 Aligned_cols=148 Identities=21% Similarity=0.315 Sum_probs=131.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778899999999999999965 48899999886542 34457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++.+ ...+++..+..++.+++.||.|||+ ++ ++|+||||+||++++++.++|+|||+++.+.
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999998843 3458999999999999999999997 45 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=196.73 Aligned_cols=145 Identities=29% Similarity=0.450 Sum_probs=129.5
Q ss_pred CccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++.+..++..+++|||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33468999999999999975 58999999987655555677889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99998732 34889999999999999999999988 99999999999999999999999999986644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=195.04 Aligned_cols=147 Identities=29% Similarity=0.484 Sum_probs=130.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556688999999999999865 47899999987542 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++.. ..+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998832 35889999999999999999999988 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=191.18 Aligned_cols=149 Identities=27% Similarity=0.472 Sum_probs=132.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++++.|+||+++++.+..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677789999999999999976 48899999887542 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999843 34788999999999999999999988 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=193.46 Aligned_cols=144 Identities=27% Similarity=0.465 Sum_probs=124.2
Q ss_pred ceecccCCeeEEEEEeCC--------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888665545567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC--------eEEccccCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--------PKISDFGMA 499 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~DFGla 499 (517)
+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999995432 35899999999999999999999988 999999999999987765 699999998
Q ss_pred eecCC
Q 010146 500 RAFGV 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
..+..
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=211.39 Aligned_cols=153 Identities=22% Similarity=0.396 Sum_probs=121.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC--CCEEEEE------------------EccCCCccCHHHHHHHHHHHhcCCCCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVK------------------RLSKSSGQGVEEFKNEVLLIAKLQHRN 407 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 407 (517)
..++|++.+.||+|+||.||++..+. +...+.| .+.. .......+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 1111 1223456889999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 408 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
|+++++++...+..++|+|++ .++|.+++..... .......++..++.||+.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 4677777643211 122345677789999999999999988 9999999999999
Q ss_pred CCCCCeEEccccCceecCCC
Q 010146 486 DNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~ 505 (517)
+.++.+||+|||+|+.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999988654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=193.36 Aligned_cols=151 Identities=26% Similarity=0.410 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|++|.||+|...+ ++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999764 889999988753 23345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|++++.|..++.+ ...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9988777665532 344899999999999999999999988 9999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=189.82 Aligned_cols=148 Identities=30% Similarity=0.512 Sum_probs=128.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-----CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
.+|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999975 4899999987532 123345788999999999999999999998764 457
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 234788999999999999999999988 99999999999999999999999999987
Q ss_pred cC
Q 010146 502 FG 503 (517)
Q Consensus 502 ~~ 503 (517)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=186.45 Aligned_cols=150 Identities=32% Similarity=0.526 Sum_probs=134.4
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999876 478999999976543 4556899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998543 45899999999999999999999988 9999999999999999999999999999876543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=192.87 Aligned_cols=149 Identities=30% Similarity=0.538 Sum_probs=130.7
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|+..+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 48999999987542 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.++.
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 95 68998885432 345899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=209.45 Aligned_cols=162 Identities=26% Similarity=0.472 Sum_probs=139.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.+.|.++..||.|+||.||+|..++ +-..|.|++...+....+.++-|+++|+..+||+||+|++.+...+.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3457777899999999999999776 445678888877788889999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|.||-...++... +..|.+.++.-++.|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999999988654 456999999999999999999999998 99999999999999999999999998875533221
Q ss_pred ccccCceecC
Q 010146 508 EANTDRVVGT 517 (517)
Q Consensus 508 ~~~~~~~~GT 517 (517)
.-..++||
T Consensus 186 --kRDsFIGT 193 (1187)
T KOG0579|consen 186 --KRDSFIGT 193 (1187)
T ss_pred --hhccccCC
Confidence 22346665
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=205.61 Aligned_cols=152 Identities=36% Similarity=0.546 Sum_probs=134.2
Q ss_pred CCccceecccCCeeEEEEEeCC--CC--EEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE--GQ--EIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..+.++||+|.||.|++|.++. |+ .||||.++..... ....|++|+.+|.+|+|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445899999999999999764 44 6899999876443 67899999999999999999999999876 77899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
.++.|+|.+.|++ .....+.......++.|||.||.||..+. +|||||..+|+||...-.|||+||||.|.++.++
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999977 44556778888999999999999999998 9999999999999999899999999999998776
Q ss_pred cc
Q 010146 507 TE 508 (517)
Q Consensus 507 ~~ 508 (517)
..
T Consensus 267 d~ 268 (1039)
T KOG0199|consen 267 DM 268 (1039)
T ss_pred cc
Confidence 43
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=191.09 Aligned_cols=158 Identities=30% Similarity=0.481 Sum_probs=134.8
Q ss_pred chhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe-
Q 010146 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL- 417 (517)
Q Consensus 341 ~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 417 (517)
+..++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566788999999999999999999975 4889999988653 33446788899999998 69999999999853
Q ss_pred -----CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeE
Q 010146 418 -----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK 492 (517)
Q Consensus 418 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 492 (517)
.+..+++|||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999985432 345788889999999999999999988 99999999999999999999
Q ss_pred EccccCceecC
Q 010146 493 ISDFGMARAFG 503 (517)
Q Consensus 493 l~DFGla~~~~ 503 (517)
|+|||+++.+.
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=190.41 Aligned_cols=154 Identities=29% Similarity=0.491 Sum_probs=133.8
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC-----
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD----- 419 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 419 (517)
.+.++|++.+.||+|++|.||+|..+ +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999976 47899999987643 3456789999999999 6999999999997644
Q ss_pred -EEEEEEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 420 -ERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 420 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999985432 2356899999999999999999999988 9999999999999999999999999
Q ss_pred CceecCC
Q 010146 498 MARAFGV 504 (517)
Q Consensus 498 la~~~~~ 504 (517)
++..+..
T Consensus 159 ~~~~~~~ 165 (275)
T cd06608 159 VSAQLDS 165 (275)
T ss_pred cceeccc
Confidence 9987643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=179.39 Aligned_cols=143 Identities=19% Similarity=0.209 Sum_probs=113.1
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCcc--C------------------------HHHHHHHHHHHhcCCCCCe
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--G------------------------VEEFKNEVLLIAKLQHRNL 408 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 408 (517)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999998764211 0 1123578899999999887
Q ss_pred eeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECC
Q 010146 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 487 (517)
Q Consensus 409 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~ 487 (517)
.....+... ..+|||||++++++...... ...++..+...++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 34899999988865443211 2347788999999999999999999 88 99999999999999
Q ss_pred CCCeEEccccCceecCCCC
Q 010146 488 DMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 488 ~~~~kl~DFGla~~~~~~~ 506 (517)
++.++|+|||+|+.+..+.
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 7899999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=188.62 Aligned_cols=143 Identities=31% Similarity=0.537 Sum_probs=121.5
Q ss_pred ceecccCCeeEEEEEeCC----CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCEEEEEEEeCC
Q 010146 356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDERMLIYEYLP 429 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 429 (517)
+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 457999998643 23345678899999999999999999998763 456799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++|.+++.+. ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999543 234677888999999999999999988 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=183.89 Aligned_cols=151 Identities=32% Similarity=0.568 Sum_probs=136.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999976 588999999987655567789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999985432 45899999999999999999999988 9999999999999999999999999998876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=190.25 Aligned_cols=143 Identities=32% Similarity=0.434 Sum_probs=125.6
Q ss_pred ecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 48899999986532 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
.+++.+... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999865332 35899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=186.75 Aligned_cols=151 Identities=25% Similarity=0.383 Sum_probs=131.9
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|+..+.||+|++|.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999975 4889999998654 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.+.. ...+++..+..++.|+++||+|||+++ ++|+||+|+||+++++. .+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999996432 345899999999999999999999988 99999999999998654 5899999999987544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=191.99 Aligned_cols=150 Identities=30% Similarity=0.444 Sum_probs=130.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.+.|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999975 489999998864322 2335688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 6777776432 235899999999999999999999988 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=190.68 Aligned_cols=151 Identities=26% Similarity=0.370 Sum_probs=130.4
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 425 (517)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999985 488999999875422 3456789999999999999999999988654 4689999
Q ss_pred EeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999875422 3445889999999999999999999988 9999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=191.97 Aligned_cols=152 Identities=28% Similarity=0.485 Sum_probs=130.7
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD---- 419 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 419 (517)
...++|++.+.||+|+||.||+|..+. ++.||+|.++... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999864 8899999987542 233456788999999999999999999987654
Q ss_pred ------EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 420 ------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 420 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
..++|+||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777777432 335899999999999999999999988 999999999999999999999
Q ss_pred ccccCceecCC
Q 010146 494 SDFGMARAFGV 504 (517)
Q Consensus 494 ~DFGla~~~~~ 504 (517)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=189.94 Aligned_cols=149 Identities=26% Similarity=0.403 Sum_probs=132.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|+..+.||+|++|.||++..+ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777899999999999999976 48999999987653 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985432 568899999999999999999999 77 9999999999999999999999999987664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=201.81 Aligned_cols=172 Identities=28% Similarity=0.460 Sum_probs=147.3
Q ss_pred ccchhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEE
Q 010146 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT 416 (517)
Q Consensus 339 ~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 416 (517)
...++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++... ....+++..|.++++.. +|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3455666777888999999999999999999954 5899999998764 45567788899999888 5999999999986
Q ss_pred e-----CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 417 L-----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 417 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
. ++.++||||||.+|+..+++.+.. ...+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 3 568999999999999999997765 677999999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCCCCcccccCceecC
Q 010146 492 KISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 492 kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
||.|||.+..+.....+. +..+||
T Consensus 163 KLvDFGvSaQldsT~grR--nT~iGt 186 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRR--NTFIGT 186 (953)
T ss_pred EEeeeeeeeeeecccccc--cCcCCC
Confidence 999999999986544333 335665
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=187.44 Aligned_cols=142 Identities=27% Similarity=0.363 Sum_probs=127.0
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||.|++|.||++.... ++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999764 8899999987542 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.+++.+ ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999954 234899999999999999999999988 999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=184.18 Aligned_cols=150 Identities=31% Similarity=0.517 Sum_probs=134.6
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 425 (517)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677799999999999999977 589999999876432 4567899999999999999999999999988 8899999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999988 999999999999999999999999999988655
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-21 Score=187.31 Aligned_cols=152 Identities=24% Similarity=0.445 Sum_probs=129.2
Q ss_pred CCCccceecccCCeeEEEEEeCC--CCEEEEEEccCC----------CccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKS----------SGQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTL 417 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 417 (517)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 688999987532 12234557788888865 799999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 234468999999999999999999996 45 99999999999999999999999
Q ss_pred ccCceecCCC
Q 010146 496 FGMARAFGVD 505 (517)
Q Consensus 496 FGla~~~~~~ 505 (517)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=190.04 Aligned_cols=152 Identities=30% Similarity=0.503 Sum_probs=136.3
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
...+.|+..+.||+|++|.||++..+ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999987 588999999976443 5678899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999996532 36899999999999999999999988 99999999999999999999999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=188.63 Aligned_cols=142 Identities=27% Similarity=0.344 Sum_probs=118.6
Q ss_pred eecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHH---HhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 357 KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLL---IAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+ +...+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 488999998865321 112233444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++..+..
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 9999998853 345899999999999999999999998 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=189.12 Aligned_cols=146 Identities=37% Similarity=0.589 Sum_probs=125.9
Q ss_pred ceecccCCeeEEEEEeCC-------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+.||+|+||.||++...+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886542 24466889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-----CeEEccccC
Q 010146 428 LPNKSLEQFIFDVT----RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-----NPKISDFGM 498 (517)
Q Consensus 428 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DFGl 498 (517)
+++++|.+++.+.. ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++++. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996432 2234788999999999999999999988 99999999999999877 899999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
++.+..
T Consensus 158 ~~~~~~ 163 (269)
T cd05044 158 ARDIYK 163 (269)
T ss_pred cccccc
Confidence 986643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=191.50 Aligned_cols=151 Identities=34% Similarity=0.525 Sum_probs=129.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 423 (517)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999976 48999999986432 22234567899999999999999999998755 56899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+. ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 5898888543 245899999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 160 ~~ 161 (309)
T cd07845 160 LP 161 (309)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=188.60 Aligned_cols=150 Identities=31% Similarity=0.497 Sum_probs=128.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999976 58899999986542 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 504 (517)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+++ ++|+||+|+||++++ ++.+||+|||+++.++.
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 68888774322 234678888899999999999999988 999999999999985 45799999999987643
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=186.79 Aligned_cols=153 Identities=25% Similarity=0.466 Sum_probs=130.9
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIY 425 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 425 (517)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++.+|+.++++++|+||+++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 5889999988653 23345678899999999999999999998764 45679999
Q ss_pred EeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 426 EYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLH-----QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 426 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22456899999999999999999999 665 999999999999999999999999999
Q ss_pred eecCCCC
Q 010146 500 RAFGVDQ 506 (517)
Q Consensus 500 ~~~~~~~ 506 (517)
+.+....
T Consensus 158 ~~~~~~~ 164 (265)
T cd08217 158 KILGHDS 164 (265)
T ss_pred ccccCCc
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=187.89 Aligned_cols=146 Identities=27% Similarity=0.449 Sum_probs=130.2
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999965 5889999998755445566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||++++++.++|+|||+++.+..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999854 34889999999999999999999988 99999999999999999999999999886644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=188.07 Aligned_cols=148 Identities=30% Similarity=0.502 Sum_probs=130.5
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIYE 426 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 426 (517)
|++.+.||+|++|.||+|...+ ++.+|+|++.... ......+.+|+.++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999764 8899999998653 33456788999999999999999999999888 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|++ ++|.+++.+. ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 5898888543 246899999999999999999999988 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=194.72 Aligned_cols=152 Identities=26% Similarity=0.443 Sum_probs=130.2
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC---
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--- 419 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 419 (517)
....++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999865 58999999986432 223456889999999999999999999987553
Q ss_pred ---EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 420 ---ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 420 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 7899888742 35899999999999999999999988 999999999999999999999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 163 g~~~~~~~~ 171 (343)
T cd07880 163 GLARQTDSE 171 (343)
T ss_pred ccccccccC
Confidence 999876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=188.44 Aligned_cols=162 Identities=28% Similarity=0.344 Sum_probs=137.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|+..++||+|.||+|.+++-+ .++.+|+|++++..- .....-..|-++|+..+||.+..+--.+...+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888899999999999999966 489999999987633 333445678899999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||..||.|.-+| .+.+.+++....-+..+|+.||.|||+++ ||.||||.+|+|||.+|++||+|||+++.--
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998887 44566888888889999999999999998 9999999999999999999999999998643
Q ss_pred CCCcccccCceecC
Q 010146 504 VDQTEANTDRVVGT 517 (517)
Q Consensus 504 ~~~~~~~~~~~~GT 517 (517)
... +.+..++||
T Consensus 320 ~~g--~t~kTFCGT 331 (516)
T KOG0690|consen 320 KYG--DTTKTFCGT 331 (516)
T ss_pred ccc--ceeccccCC
Confidence 222 334456776
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=190.60 Aligned_cols=151 Identities=27% Similarity=0.504 Sum_probs=127.9
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----- 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 419 (517)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999976 48999999886432 223345678999999999999999999987654
Q ss_pred ---EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 420 ---ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 420 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
..++||||+. ++|.+++... ...+++.+++.++.||+.||+|||+++ ++|+||||+||++++++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999996 5888887432 235899999999999999999999998 999999999999999999999999
Q ss_pred cCceecCC
Q 010146 497 GMARAFGV 504 (517)
Q Consensus 497 Gla~~~~~ 504 (517)
|++..+..
T Consensus 164 g~~~~~~~ 171 (310)
T cd07865 164 GLARAFSL 171 (310)
T ss_pred CCcccccC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=190.95 Aligned_cols=150 Identities=34% Similarity=0.492 Sum_probs=133.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 424 (517)
++|.+.+.||+|++|.||++... +++.||+|++... .....+.+.+|+.++.+++ |+||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 5899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||++++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 336999999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=188.64 Aligned_cols=141 Identities=30% Similarity=0.456 Sum_probs=126.5
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999875432 4556789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9999543 25899999999999999999999988 99999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=201.45 Aligned_cols=153 Identities=22% Similarity=0.291 Sum_probs=122.7
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCC------CCCeeeEEEE
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ------HRNLVRLLGC 414 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~ 414 (517)
.+++....++|++.++||+|+||.||+|.... ++.||||+++.. ......+..|+.++++++ |.++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 34444567889999999999999999999754 789999999653 223345566777776665 4568899998
Q ss_pred EEeC-CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCC---
Q 010146 415 CTLR-DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDM--- 489 (517)
Q Consensus 415 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~--- 489 (517)
+... .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 8754 5688999988 7889888854 24589999999999999999999974 6 99999999999998765
Q ss_pred -------------CeEEccccCceec
Q 010146 490 -------------NPKISDFGMARAF 502 (517)
Q Consensus 490 -------------~~kl~DFGla~~~ 502 (517)
.+||+|||++...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred ccccccccCCCCceEEECCCCccccC
Confidence 4999999988653
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=187.72 Aligned_cols=148 Identities=31% Similarity=0.536 Sum_probs=129.8
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
|++.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999975 59999999987543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+ ++|.+++.... ...+++..++.++.|+++||+|||+++ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 4 78999885432 235899999999999999999999988 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=189.20 Aligned_cols=143 Identities=28% Similarity=0.463 Sum_probs=128.2
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHH
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 434 (517)
.+||+|+||.||++... +++.||+|++........+.+.+|+.++++++|+||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 68999999999999875 58999999986554455667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 435 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 98732 24789999999999999999999988 999999999999999999999999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-22 Score=192.18 Aligned_cols=156 Identities=28% Similarity=0.367 Sum_probs=139.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+.|..-++||+|+||.||-++.+. |+-+|.|++.+. ...+....++|-.+|.+++.+.||.+--.+++.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457777999999999999998664 999999988654 3455667889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
..|.||+|.-+|.+... ..+++..++-++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+.++
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999998876554 45999999999999999999999988 999999999999999999999999999999887
Q ss_pred Cccc
Q 010146 506 QTEA 509 (517)
Q Consensus 506 ~~~~ 509 (517)
+..+
T Consensus 341 ~~~~ 344 (591)
T KOG0986|consen 341 KPIR 344 (591)
T ss_pred Cccc
Confidence 7643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-22 Score=196.43 Aligned_cols=152 Identities=27% Similarity=0.377 Sum_probs=130.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--------ccCHHHHHHHHHHHhcCC---CCCeeeEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCT 416 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 416 (517)
...|...+.+|+|+||.|+.|.++. ..+|+||.+.+.. ....-.+-.|+.+|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3458889999999999999999875 6789999887642 112223556999999997 999999999999
Q ss_pred eCCEEEEEEEeC-CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 417 LRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 417 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
+++..||+||-. ++.+|.++|. ....+++.+...|+.||+.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999976 4678999993 3455899999999999999999999999 99999999999999999999999
Q ss_pred ccCceecCCCC
Q 010146 496 FGMARAFGVDQ 506 (517)
Q Consensus 496 FGla~~~~~~~ 506 (517)
||.|.....+.
T Consensus 714 fgsaa~~ksgp 724 (772)
T KOG1152|consen 714 FGSAAYTKSGP 724 (772)
T ss_pred ccchhhhcCCC
Confidence 99998776554
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=194.11 Aligned_cols=150 Identities=28% Similarity=0.541 Sum_probs=128.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC--CEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 421 (517)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999976 4889999988543 233445677899999999 999999999998654 368
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||++ ++|.+++.. . .+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~---~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA---N-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc---C-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 699988843 2 5789999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 157 ~~~~ 160 (337)
T cd07852 157 LSEL 160 (337)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-22 Score=172.54 Aligned_cols=157 Identities=24% Similarity=0.368 Sum_probs=131.5
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
++...+...-...||+|++|.|-+-++. +|+.+|+|++... ..+..++.++|+.+..+. ..|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4444556666789999999999888754 5999999999765 345566788888877665 699999999999889999
Q ss_pred EEEEEeCCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 422 MLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
+|.||.| ..+|..+-.+ ..++..+++..+-+|+..+.+||.|||++ +.+||||+||+||||+.+|+|||+|||++.
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 5788877543 24566789999999999999999999995 469999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
.+.+
T Consensus 198 ~L~d 201 (282)
T KOG0984|consen 198 YLVD 201 (282)
T ss_pred eehh
Confidence 7744
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-22 Score=198.00 Aligned_cols=147 Identities=25% Similarity=0.391 Sum_probs=130.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.-|..++.||-|+||.|.++.-. +...+|+|.+++.+ ......++.|-.||+..+.+-||+|+-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34677789999999999999844 46789999998753 344556788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||++||++-.+| .+.+.+++..+..++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.-+
T Consensus 709 dYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 709 DYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 999999999998 34456888888889999999999999888 999999999999999999999999998754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=194.61 Aligned_cols=149 Identities=24% Similarity=0.453 Sum_probs=128.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 421 (517)
.++|++.+.||+|++|.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999966 48999999987542 2345678889999999999999999988753 3468
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 689888843 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-21 Score=182.13 Aligned_cols=152 Identities=25% Similarity=0.410 Sum_probs=135.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 488999999876432 4566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.+.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986532 2356899999999999999999999988 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=193.37 Aligned_cols=148 Identities=27% Similarity=0.461 Sum_probs=127.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 421 (517)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 5899999998643 233456688899999999999999999987644 357
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++++||++ ++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 58887773 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=183.15 Aligned_cols=151 Identities=23% Similarity=0.303 Sum_probs=124.0
Q ss_pred HHHHhcCCCCcccee--cccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEeCC
Q 010146 344 TIADATDNFSWKNKL--GEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 344 ~i~~~~~~y~~~~~I--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 419 (517)
++....++|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+..... .+||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455677777776 99999999999965 488899999865322111 2222221 26999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGM 498 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGl 498 (517)
..++||||+++++|.+++... ..+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999542 36899999999999999999999988 99999999999999998 999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
++.+...
T Consensus 157 ~~~~~~~ 163 (267)
T PHA03390 157 CKIIGTP 163 (267)
T ss_pred ceecCCC
Confidence 9877544
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-21 Score=185.10 Aligned_cols=141 Identities=28% Similarity=0.342 Sum_probs=118.5
Q ss_pred eecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHH---HHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 357 KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEV---LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.||+|+||.||++... +++.||+|.+..... .....+..|. .+++...||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 488999999865321 1122233443 34445679999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999998843 345899999999999999999999988 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=193.07 Aligned_cols=149 Identities=31% Similarity=0.467 Sum_probs=128.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
..++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 5899999998643 233445678899999999999999999987643
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999995 688887732 2888999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
++.....
T Consensus 165 ~~~~~~~ 171 (353)
T cd07850 165 ARTAGTS 171 (353)
T ss_pred ceeCCCC
Confidence 9987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=184.66 Aligned_cols=151 Identities=26% Similarity=0.441 Sum_probs=131.7
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|+||.||++..+. +..+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999764 889999998653 223456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-eEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-PKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||.+..+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999985432 335799999999999999999999988 999999999999998854 699999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=188.24 Aligned_cols=148 Identities=30% Similarity=0.459 Sum_probs=128.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|...+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++|+|++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999965 588999999865322 234578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|++ ++|.+.+... ...+++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 5787777432 345899999999999999999999988 99999999999999999999999999886654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=199.56 Aligned_cols=154 Identities=25% Similarity=0.410 Sum_probs=120.7
Q ss_pred hcCCCCccceecccCCeeEEEEEe-----------------CCCCEEEEEEccCCCccCHHH--------------HHHH
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML-----------------TEGQEIAVKRLSKSSGQGVEE--------------FKNE 396 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 396 (517)
..++|++.++||+|+||.||+|.. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235689999987543322223 3346
Q ss_pred HHHHhcCCCCCe-----eeEEEEEEe--------CCEEEEEEEeCCCCCHHHHHhccCC---------------------
Q 010146 397 VLLIAKLQHRNL-----VRLLGCCTL--------RDERMLIYEYLPNKSLEQFIFDVTR--------------------- 442 (517)
Q Consensus 397 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 442 (517)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 677777653 3568999999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 443 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 123467788999999999999999988 99999999999999999999999999986643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=191.64 Aligned_cols=155 Identities=30% Similarity=0.437 Sum_probs=131.4
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 418 (517)
..++....++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667899999999999999999999864 58899999987532 22346788899999999999999999988643
Q ss_pred ------CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeE
Q 010146 419 ------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK 492 (517)
Q Consensus 419 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 492 (517)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3367888877 7899888732 34899999999999999999999988 99999999999999999999
Q ss_pred EccccCceecCC
Q 010146 493 ISDFGMARAFGV 504 (517)
Q Consensus 493 l~DFGla~~~~~ 504 (517)
|+|||+++....
T Consensus 161 l~dfg~~~~~~~ 172 (345)
T cd07877 161 ILDFGLARHTDD 172 (345)
T ss_pred Eecccccccccc
Confidence 999999987643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=182.64 Aligned_cols=142 Identities=30% Similarity=0.376 Sum_probs=120.4
Q ss_pred ceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHH-HhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLL-IAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++.+..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999975 489999999875421 122334455444 4456899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999853 235889999999999999999999988 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=191.34 Aligned_cols=148 Identities=26% Similarity=0.383 Sum_probs=127.6
Q ss_pred cCCCC-ccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccC--------------HHHHHHHHHHHhcCCCCCeeeEE
Q 010146 349 TDNFS-WKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQG--------------VEEFKNEVLLIAKLQHRNLVRLL 412 (517)
Q Consensus 349 ~~~y~-~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~ 412 (517)
.++|. +.+.||+|+||.||+|... +++.||+|.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 3477999999999999976 58999999886532211 12577899999999999999999
Q ss_pred EEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeE
Q 010146 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK 492 (517)
Q Consensus 413 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 492 (517)
+++...+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999996 689998843 345899999999999999999999988 99999999999999999999
Q ss_pred EccccCceecC
Q 010146 493 ISDFGMARAFG 503 (517)
Q Consensus 493 l~DFGla~~~~ 503 (517)
|+|||+++.+.
T Consensus 160 l~dfg~~~~~~ 170 (335)
T PTZ00024 160 IADFGLARRYG 170 (335)
T ss_pred ECCccceeecc
Confidence 99999998775
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=189.76 Aligned_cols=152 Identities=28% Similarity=0.446 Sum_probs=130.5
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDE 420 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 420 (517)
+....++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999966 5899999988643 22345678899999999999999999999865 557
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++++||+ +++|.+++.. ..+++.....++.|++.||+|||+.+ |+|+||+|+|||+++++.+||+|||+++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 5789888732 34788888899999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
....
T Consensus 157 ~~~~ 160 (328)
T cd07856 157 IQDP 160 (328)
T ss_pred ccCC
Confidence 6643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=187.48 Aligned_cols=149 Identities=28% Similarity=0.385 Sum_probs=129.0
Q ss_pred CCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCC----ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
+|++.+.||+|++|.||++... +++.+|||.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999998843 47889999986432 23345688999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999843 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 155 ~~~~ 158 (288)
T cd05583 155 FLAE 158 (288)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=184.49 Aligned_cols=146 Identities=25% Similarity=0.371 Sum_probs=124.3
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeC--CEEEEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR--DERMLIYE 426 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 426 (517)
|++.+.||+|+||.||++... +++.+|+|+++... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999965 48899999987542 222234457888888885 99999999999887 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 6888887442 245899999999999999999999988 999999999999999 9999999999987744
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=191.51 Aligned_cols=150 Identities=25% Similarity=0.468 Sum_probs=129.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
.++|.+.+.||+|+||.||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999965 4899999998753 233455678899999999999999999987644 34
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 789888843 345899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.....
T Consensus 157 ~~~~~ 161 (337)
T cd07858 157 TTSEK 161 (337)
T ss_pred ccCCC
Confidence 76543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-22 Score=190.12 Aligned_cols=155 Identities=30% Similarity=0.411 Sum_probs=129.5
Q ss_pred cCCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCCC-------ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-C
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS-------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-D 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 419 (517)
.++|-+..+||+|+|+.||+|.+ ...+.||||+-.... ....+...+|.++.+.|+||.||++++++.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35677788999999999999985 447889999754321 11233467899999999999999999999755 5
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDF 496 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DF 496 (517)
..+-|+||++|.+|.-||.. .+.++++++..|+.||+.||.||.+.. +||||-||||.||||.+ -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 57899999999999999943 456899999999999999999999885 78999999999999954 467999999
Q ss_pred cCceecCCCCc
Q 010146 497 GMARAFGVDQT 507 (517)
Q Consensus 497 Gla~~~~~~~~ 507 (517)
|+++.++.+..
T Consensus 618 GLSKIMdddSy 628 (775)
T KOG1151|consen 618 GLSKIMDDDSY 628 (775)
T ss_pred chhhhccCCcc
Confidence 99999977653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=191.26 Aligned_cols=163 Identities=24% Similarity=0.335 Sum_probs=139.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 424 (517)
....|++.++||+||.+.||++...+.+.+|+|++... +.+...-|.+|+.+|.+|+ |.+||+|++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34568999999999999999999888888999877543 5566788999999999996 99999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||= ..+|..+|.+... .++.-.+..+..|++.|+.++|+++ |||.||||.|+|+-+. .+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence 9987 6899999965332 2332377789999999999999999 9999999999999754 899999999999999
Q ss_pred CCcccccCceecC
Q 010146 505 DQTEANTDRVVGT 517 (517)
Q Consensus 505 ~~~~~~~~~~~GT 517 (517)
+.+...-...+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 8877665666776
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=188.18 Aligned_cols=147 Identities=28% Similarity=0.424 Sum_probs=124.0
Q ss_pred CCCccceecccCCeeEEEEEeC-C--CCEEEEEEccCCC--ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC----CE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-E--GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR----DE 420 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 420 (517)
+|++.+.||+|+||.||++... . +..||+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999965 3 6789999987532 22355788899999999 599999999875433 45
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899885 789998843 345899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=190.88 Aligned_cols=148 Identities=29% Similarity=0.493 Sum_probs=130.8
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----EEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERM 422 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 422 (517)
+|++.+.||+|++|.||++.... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999764 8999999987643 345567899999999999999999999988775 789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
++|||++ ++|.+++.+ ...+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 589888843 336899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=185.07 Aligned_cols=148 Identities=33% Similarity=0.454 Sum_probs=128.7
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc-cCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
|++.+.||+|++|.||+|...+ ++.|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999864 78999999875422 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++|.+++.... ...+++.+++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889999885432 245899999999999999999999988 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=213.93 Aligned_cols=154 Identities=29% Similarity=0.436 Sum_probs=134.7
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
...+-+|+....||.|.||.||.|... +|...|||-+... .......+.+|+.++..|+|||+|+++|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 334556777889999999999999954 5899999987653 3345567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|.||||++|+|.+.+. .+...++.....+..|++.|++|||+++ ||||||||+||+|+.+|.+|++|||.|+.+
T Consensus 1311 IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999983 3444677777788999999999999999 999999999999999999999999999998
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
..+
T Consensus 1385 ~~~ 1387 (1509)
T KOG4645|consen 1385 KNN 1387 (1509)
T ss_pred cCc
Confidence 665
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=182.42 Aligned_cols=152 Identities=28% Similarity=0.446 Sum_probs=133.1
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|++.+.||+|++|.||++... +++.+++|.+.... .....++.+|++++++++|+||+++++.+......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 58899999987532 23455778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999985532 2345899999999999999999999988 999999999999999999999999999877554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-23 Score=184.48 Aligned_cols=150 Identities=29% Similarity=0.564 Sum_probs=124.0
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccC--CCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--------
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-------- 418 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 418 (517)
..|....+||+|.||.||+|+.++ |+.||+|++-- .....-....+|+++|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 445566899999999999999765 78889886633 2233345568899999999999999999887532
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++|+++++ -+|..+|.+ ....++..++.+++.+++.||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 34799999995 678888833 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
||.+...
T Consensus 171 ar~fs~~ 177 (376)
T KOG0669|consen 171 ARAFSTS 177 (376)
T ss_pred ccceecc
Confidence 9887543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=188.90 Aligned_cols=147 Identities=29% Similarity=0.502 Sum_probs=125.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------C
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------D 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 419 (517)
.++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468988999999999999999965 5899999998653 223345688999999999999999999998654 3
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++|+||+. .+|..++ ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4689999995 5777665 234889999999999999999999988 999999999999999999999999999
Q ss_pred eecCC
Q 010146 500 RAFGV 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
+....
T Consensus 165 ~~~~~ 169 (342)
T cd07879 165 RHADA 169 (342)
T ss_pred cCCCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=183.59 Aligned_cols=149 Identities=29% Similarity=0.496 Sum_probs=130.5
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999975 588999999875432 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+....
T Consensus 81 ~-~~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 6 4888887542 245899999999999999999999998 9999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=187.85 Aligned_cols=142 Identities=24% Similarity=0.327 Sum_probs=123.2
Q ss_pred ceeccc--CCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
..||+| +||+||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 89999999975 59999999987532 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++|.+++.+.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 99999986533 234889999999999999999999988 99999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=184.11 Aligned_cols=150 Identities=22% Similarity=0.395 Sum_probs=126.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|++|.||++...+ ++.||||.+.... .....++..|+.++.+.. |+||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999875 8999999997542 233455677877776665 999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+. ++|.+++... ...+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9984 5787776442 2368999999999999999999997 46 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=184.29 Aligned_cols=150 Identities=24% Similarity=0.372 Sum_probs=125.2
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+|...+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566899999999999999764 8999999987542 234557889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+. ++|.++... ......+++..+..++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 566554321 12235689999999999999999999975 6 99999999999999999999999999986643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=179.07 Aligned_cols=148 Identities=26% Similarity=0.353 Sum_probs=123.2
Q ss_pred hcCCCCcc-ceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe----CCE
Q 010146 348 ATDNFSWK-NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL----RDE 420 (517)
Q Consensus 348 ~~~~y~~~-~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 420 (517)
.+++|++. ++||-|-.|.|..+..+. ++.+|+|++... ...++|+++.-.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566544 689999999999998764 889999998653 3457788876555 59999999998754 356
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEcccc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFG 497 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFG 497 (517)
+++|||.|+||.|.+.+.+. ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999999653 3456999999999999999999999998 999999999999964 4569999999
Q ss_pred CceecCC
Q 010146 498 MARAFGV 504 (517)
Q Consensus 498 la~~~~~ 504 (517)
+|+.-..
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9997654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=186.37 Aligned_cols=143 Identities=19% Similarity=0.239 Sum_probs=121.4
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
+.+|.|+++.|+++.. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4444455555555544 5899999998754 344567899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 99996532 234889999999999999999999998 9999999999999999999999999987663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=182.58 Aligned_cols=149 Identities=21% Similarity=0.346 Sum_probs=112.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCCccCH-----------HHHHHHHHHHhcCCCCCeeeEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGV-----------EEFKNEVLLIAKLQHRNLVRLLG 413 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~ 413 (517)
.++|.+.+.||+|+||.||+|...+ +..+|+|.......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999654 34566665433221111 11223344566778999999999
Q ss_pred EEEeCC----EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC
Q 010146 414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489 (517)
Q Consensus 414 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 489 (517)
++.... ..++++|++ ..++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766543 347788877 3567666632 223578888999999999999999988 99999999999999999
Q ss_pred CeEEccccCceecCC
Q 010146 490 NPKISDFGMARAFGV 504 (517)
Q Consensus 490 ~~kl~DFGla~~~~~ 504 (517)
.+||+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999998754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=186.41 Aligned_cols=150 Identities=30% Similarity=0.480 Sum_probs=126.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 419 (517)
.++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 48899999886432 222346788999999999999999999875433
Q ss_pred --EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 420 --ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 420 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
..++||||+. ++|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 4699999996 577777643 2345899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCC
Q 010146 498 MARAFGV 504 (517)
Q Consensus 498 la~~~~~ 504 (517)
+++.+..
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=180.45 Aligned_cols=149 Identities=29% Similarity=0.505 Sum_probs=125.5
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc--cCHHHHHHHHHHHhcC---CCCCeeeEEEEEEeCCE-----
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDE----- 420 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 420 (517)
|++.+.||+|+||.||++..+. ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 89999999974322 2234566777776655 69999999999988776
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 58998885432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=183.95 Aligned_cols=150 Identities=31% Similarity=0.468 Sum_probs=128.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+.|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666789999999999999975 4789999988642 2233456788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..+...
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 6887777432 334889999999999999999999988 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=182.53 Aligned_cols=148 Identities=32% Similarity=0.535 Sum_probs=130.6
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
|+..+.||+|.+|.||+|.... ++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566889999999999999764 8999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+ ++|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 7 68999996432 35899999999999999999999998 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=188.33 Aligned_cols=147 Identities=27% Similarity=0.454 Sum_probs=126.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC---------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--------- 418 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 418 (517)
..+|.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 467899999999999999999975 4889999998766556667889999999999999999999776543
Q ss_pred -----CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeE
Q 010146 419 -----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPK 492 (517)
Q Consensus 419 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~k 492 (517)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999996 689888732 34889999999999999999999988 999999999999974 55789
Q ss_pred EccccCceecC
Q 010146 493 ISDFGMARAFG 503 (517)
Q Consensus 493 l~DFGla~~~~ 503 (517)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=181.25 Aligned_cols=146 Identities=32% Similarity=0.486 Sum_probs=126.0
Q ss_pred CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|||++++++++...+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 488999999865322 2335688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 95 6787777432 345899999999999999999999988 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=177.79 Aligned_cols=142 Identities=30% Similarity=0.416 Sum_probs=126.7
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
||+|+||.||++...+ ++.+++|.+..... ...+.+..|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 89999999876432 2456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999542 35899999999999999999999988 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=188.53 Aligned_cols=150 Identities=30% Similarity=0.476 Sum_probs=129.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE----
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE---- 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 420 (517)
..++|++.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999976 4889999998653 22334567889999999999999999988766554
Q ss_pred --EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 421 --RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 421 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799998843 35899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
+..+...
T Consensus 165 ~~~~~~~ 171 (343)
T cd07851 165 ARHTDDE 171 (343)
T ss_pred ccccccc
Confidence 9877543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=179.05 Aligned_cols=150 Identities=30% Similarity=0.447 Sum_probs=125.2
Q ss_pred CCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC-----CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998654 445555555432 122344577899999999999999999999989999999
Q ss_pred EEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988643 23456899999999999999999999988 999999999999976 469999999998764
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-22 Score=182.15 Aligned_cols=153 Identities=26% Similarity=0.436 Sum_probs=127.2
Q ss_pred CccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----EEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERMLI 424 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 424 (517)
+..+.||-|+||.||.+++. +|+.||.|++... .-...+.+.+|+++|.-++|.|++..++...-.. ++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34479999999999999965 5999999998653 2234567899999999999999999888765432 45788
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+|.| ..+|..+| -....++...+.-++.||++||+|||+.+ |+||||||.|.|++++..+||+|||+||.-+.
T Consensus 136 TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8888 56787777 34456888899999999999999999998 99999999999999999999999999998877
Q ss_pred CCcccccC
Q 010146 505 DQTEANTD 512 (517)
Q Consensus 505 ~~~~~~~~ 512 (517)
++....|.
T Consensus 209 d~~~hMTq 216 (449)
T KOG0664|consen 209 RDRLNMTH 216 (449)
T ss_pred hhhhhhHH
Confidence 76554443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-22 Score=179.09 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=124.6
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.+....||.|+||+|++-.++. |+.+|||+++... ....++++.|.+...+- +.||||+++|.+..++..++.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3344789999999999998764 9999999998753 35567888898876665 6899999999999999999999999
Q ss_pred CCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
..+|..+-.. ..+...+++..+-+|....++||.||... +.|||||+||+||||+..|.+||+|||++..+.+
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 5777665421 12334588888889999999999999875 4699999999999999999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=166.89 Aligned_cols=138 Identities=21% Similarity=0.323 Sum_probs=107.1
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-----CCCCeeeEEEEEEeCC---EE-EE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-----QHRNLVRLLGCCTLRD---ER-ML 423 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~-~l 423 (517)
...+.||+|+||.||. .+.....+||++........+.+.+|+.+++.+ +||||+++++++.++. .. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 443233379988765455667899999999999 5799999999998874 33 37
Q ss_pred EEEe--CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHhHhcCCCceEecCCCCCcEEECC----CCCeEEcc-
Q 010146 424 IYEY--LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----DMNPKISD- 495 (517)
Q Consensus 424 v~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~D- 495 (517)
|+|| ..+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999431 25554 35678888777 9999998 999999999999974 33799999
Q ss_pred ccCcee
Q 010146 496 FGMARA 501 (517)
Q Consensus 496 FGla~~ 501 (517)
||.+..
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 454444
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=171.11 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=124.8
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.+.+..||.|+.|.|++++.+. |..+|||.+.... ....++++..+.++.+-+ .|.||+.+|+|..+...+|.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 4455789999999999999765 8999999998753 344567788888776665 899999999999999999999998
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
. .-++.++... .+++++..+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||++..+-+...
T Consensus 174 s-~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 S-TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred H-HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 3 4455555332 345888888899999999999999865 699999999999999999999999999988865443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=173.43 Aligned_cols=133 Identities=25% Similarity=0.208 Sum_probs=115.3
Q ss_pred cCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhc
Q 010146 361 GGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD 439 (517)
Q Consensus 361 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 439 (517)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++...+..+++|||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999976 48999999997642 233455555666799999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 440 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..+..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 3 34899999999999999999999988 99999999999999999999999998876643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-20 Score=163.68 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=127.8
Q ss_pred hcCCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC-CCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 425 (517)
...+|.++++||.|+||.+|.|. ..+|.+||+|.-+.... ..++..|.++...|++ ..|..+..+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 56799999998765432 2457778889998875 67888888888899999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~ 502 (517)
|.+ |.+|++++.-.. ..++..+++-++-|++.-++|+|.++ +|||||||+|.|+.- ..++.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 899999874332 34889999999999999999999999 999999999999953 346999999999998
Q ss_pred CCCCc
Q 010146 503 GVDQT 507 (517)
Q Consensus 503 ~~~~~ 507 (517)
-+..+
T Consensus 165 ~d~~t 169 (341)
T KOG1163|consen 165 RDIRT 169 (341)
T ss_pred ccccc
Confidence 66544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=195.29 Aligned_cols=158 Identities=31% Similarity=0.458 Sum_probs=134.9
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCC--------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCC 415 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 415 (517)
+...++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3444555666799999999999998531 3579999998653 34567899999999998 599999999999
Q ss_pred EeCCEEEEEEEeCCCCCHHHHHhccC-----------CC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCc
Q 010146 416 TLRDERMLIYEYLPNKSLEQFIFDVT-----------RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482 (517)
Q Consensus 416 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 482 (517)
...+..++|+||++.|+|.++|++.+ .. ..++..+.+.++.|||.||+||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999997654 01 23888999999999999999999987 9999999999
Q ss_pred EEECCCCCeEEccccCceecCCCC
Q 010146 483 VLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~~~~~~ 506 (517)
|||.++..+||+|||+||......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred EEecCCCEEEEccccceeccCCCC
Confidence 999999999999999999765544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-21 Score=168.50 Aligned_cols=147 Identities=25% Similarity=0.481 Sum_probs=127.5
Q ss_pred cCCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCC--EEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD--ERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 424 (517)
.++|++.+++|+|.++.||.|. ..+.+.++||++++ ...+.+.+|+.+|..|. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999998 45688999999975 34567899999999998 999999999987654 46899
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 503 (517)
+||+.+.+...+. ..++...+..++.+++.||.|+|+.| |.|||+||.|++||... .++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887765 23777788899999999999999999 99999999999999754 59999999999987
Q ss_pred CCCc
Q 010146 504 VDQT 507 (517)
Q Consensus 504 ~~~~ 507 (517)
++..
T Consensus 185 p~~e 188 (338)
T KOG0668|consen 185 PGKE 188 (338)
T ss_pred CCce
Confidence 7654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-19 Score=166.60 Aligned_cols=149 Identities=36% Similarity=0.506 Sum_probs=133.3
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999875444 57789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999854322 1789999999999999999999987 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=179.38 Aligned_cols=161 Identities=31% Similarity=0.388 Sum_probs=133.5
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 423 (517)
..+|..+.+||+|+||.|.+|..+. .+.+|||++++.. ....+--+.|-++|+... -|.+++++.++.+-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3568888999999999999999765 6789999998752 334455566777777764 6789999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+.||+|--.+++ -..+.+..+.-++.+|+-||-|||+++ ||.||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888854 344778888899999999999999999 9999999999999999999999999998643
Q ss_pred CCCcccccCceecC
Q 010146 504 VDQTEANTDRVVGT 517 (517)
Q Consensus 504 ~~~~~~~~~~~~GT 517 (517)
-+. ..|..++||
T Consensus 502 ~~~--~TTkTFCGT 513 (683)
T KOG0696|consen 502 FDG--VTTKTFCGT 513 (683)
T ss_pred cCC--cceeeecCC
Confidence 322 234456776
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=191.78 Aligned_cols=150 Identities=26% Similarity=0.361 Sum_probs=107.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-----CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEE------EE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC------CT 416 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 416 (517)
..++|++.+.||+|+||.||+|.+.+ +..||+|++..... .+....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 68999998864321 1212211 1122222222222111 24
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVTRT-----------------KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
.+...++||||+++++|.+++...... .......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998542210 01123446679999999999999988 9999999
Q ss_pred CCcEEECC-CCCeEEccccCceecCC
Q 010146 480 ASNVLLDN-DMNPKISDFGMARAFGV 504 (517)
Q Consensus 480 p~NIll~~-~~~~kl~DFGla~~~~~ 504 (517)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999986 57899999999987643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=187.88 Aligned_cols=149 Identities=32% Similarity=0.462 Sum_probs=120.5
Q ss_pred CCccceecccCCee-EEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 352 FSWKNKLGEGGFGP-VYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 352 y~~~~~Ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
|...+.+|.|+.|+ ||+|... +++||||++-. ....-..+|+..|+.-+ |||||++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34456789998876 7999986 89999999854 33456788999998874 999999999999999999999999
Q ss_pred CCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---C--CCeEEccccCceecC
Q 010146 430 NKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---D--MNPKISDFGMARAFG 503 (517)
Q Consensus 430 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~DFGla~~~~ 503 (517)
..+|.+++...... ....-...+.+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.++
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 68999999653111 11111345678999999999999987 999999999999976 3 469999999999998
Q ss_pred CCCcc
Q 010146 504 VDQTE 508 (517)
Q Consensus 504 ~~~~~ 508 (517)
.+.+.
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 87653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-18 Score=157.85 Aligned_cols=143 Identities=36% Similarity=0.603 Sum_probs=127.6
Q ss_pred ecccCCeeEEEEEeCC-CCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHH
Q 010146 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ 435 (517)
Q Consensus 358 Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 435 (517)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999765332 35789999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCCC
Q 010146 436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 436 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~ 505 (517)
++.... ..+++..+..++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 985432 35889999999999999999999998 999999999999999 899999999999977554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-19 Score=162.91 Aligned_cols=142 Identities=13% Similarity=0.127 Sum_probs=116.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHH---------HHHHHHHHhcCCCCCeeeEEEEEEeC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE---------FKNEVLLIAKLQHRNLVRLLGCCTLR 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~ 418 (517)
..++|...+.||.|+||.||++.. ++..+|+|.+.......... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 57789999997653322222 67899999999999999998886543
Q ss_pred --------CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 419 --------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 419 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
...+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 24569999999999998 99999999999999988
Q ss_pred eEEccccCceecCCC
Q 010146 491 PKISDFGMARAFGVD 505 (517)
Q Consensus 491 ~kl~DFGla~~~~~~ 505 (517)
++|+|||..+....+
T Consensus 173 i~liDfg~~~~~~e~ 187 (232)
T PRK10359 173 LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEEEECCCcccccch
Confidence 999999999877443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-20 Score=184.30 Aligned_cols=159 Identities=27% Similarity=0.322 Sum_probs=137.3
Q ss_pred CCCCccceecccCCeeEEEEEeCCCC-EEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.+++.+..||-|+||.|-++..+... .+|+|.+++. ...+.+.+..|-.+|...+.|.||+++..+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999999877533 4888888764 3445567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|-|-||.|...|.+ .+.++..+..-++..+++|++|||.++ ||.|||||+|.||+.+|-+||.|||+|+.++.+
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999943 455888888899999999999999999 999999999999999999999999999999876
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
. .|-.++||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 4 35557776
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.2e-19 Score=166.14 Aligned_cols=147 Identities=16% Similarity=0.160 Sum_probs=114.1
Q ss_pred CCCCccceecccCCeeEEEEE--eCCCCEEEEEEccCCCcc------------------------CHHHHHHHHHHHhcC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGM--LTEGQEIAVKRLSKSSGQ------------------------GVEEFKNEVLLIAKL 403 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 403 (517)
..|++.+.||+|++|.||+|. ..+|+.||+|.++..... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999998 557999999998753210 012356899999999
Q ss_pred CCC--CeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCC
Q 010146 404 QHR--NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKAS 481 (517)
Q Consensus 404 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~ 481 (517)
.+. .++++++. ...++||||+++.+|...+.. ...+...+...++.|++.+|++||+++ +|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 753 34455543 235899999999888765422 223556667899999999999999876 3999999999
Q ss_pred cEEECCCCCeEEccccCceecCCCC
Q 010146 482 NVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 482 NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
||+++ ++.++|+|||+|...+.+.
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCcc
Confidence 99999 7899999999999876554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-19 Score=167.25 Aligned_cols=162 Identities=25% Similarity=0.345 Sum_probs=136.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 422 (517)
..++|.+.++||+|+|++|..++++. .+.+|+|++++. .....+-.+.|-.++.+. +||.+|.++.++.+...++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34678889999999999999999764 789999998764 344555677787777776 5999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|.||+++|+|--++ ++...++++.+.-+..+|.-||.|||+.+ ||.||||.+|||||..|.+||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996665 44566999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCcccccCceecC
Q 010146 503 GVDQTEANTDRVVGT 517 (517)
Q Consensus 503 ~~~~~~~~~~~~~GT 517 (517)
-.+. ..|..++||
T Consensus 402 l~~g--d~tstfcgt 414 (593)
T KOG0695|consen 402 LGPG--DTTSTFCGT 414 (593)
T ss_pred CCCC--cccccccCC
Confidence 2222 234456776
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-20 Score=187.37 Aligned_cols=151 Identities=27% Similarity=0.468 Sum_probs=137.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|+...++|.|.+|.|||+++. .++..|+|.++-.......-+++|+-+++..+||||+.++|-+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4567888999999999999999965 489999999988777778888999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+.+|+|++.-+ -...+++.++..+.+..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence 999999998763 3456899999999999999999999998 89999999999999999999999999988754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=160.81 Aligned_cols=136 Identities=20% Similarity=0.267 Sum_probs=114.2
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCcc--------CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|++++..+.|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 5778999976543211 123577899999999999988777777777888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999998431 12 78899999999999999998 99999999999999 7789999999998643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=162.53 Aligned_cols=148 Identities=22% Similarity=0.409 Sum_probs=122.4
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEE-EEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGC-CTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 425 (517)
.+.|.+.+.||+|.||.+-+++++. .+.+++|-+.. ......+|.+|..---.| .|.||+.-+++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568888999999999999999875 67899998876 345567888888765555 48999987765 66777888999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC--CCCCeEEccccCceecC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISDFGMARAFG 503 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~ 503 (517)
||++.|+|.+-+. ...+-+.....++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+++..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999988662 234778888899999999999999999 99999999999993 34479999999998765
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 175 ~ 175 (378)
T KOG1345|consen 175 T 175 (378)
T ss_pred c
Confidence 3
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-19 Score=167.43 Aligned_cols=154 Identities=22% Similarity=0.282 Sum_probs=130.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCC--CC----eeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RN----LVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~l~~~~~~~~~ 420 (517)
..++|.+..++|+|.||.|..+.+.. +..||||+++.. ....++.+-|+++|.+|.+ |+ +|.+.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 47889999999999999999998765 789999999763 4566778889999999942 22 7888889999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-------------
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------- 487 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~------------- 487 (517)
.+||+|.+ |-++.++|.+. ....++..++..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999999 77999999543 3456899999999999999999999988 999999999999832
Q ss_pred -------CCCeEEccccCceecCCCCc
Q 010146 488 -------DMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 488 -------~~~~kl~DFGla~~~~~~~~ 507 (517)
+..+||+|||.|+.-.+..+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcc
Confidence 23489999999998766653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=154.42 Aligned_cols=133 Identities=24% Similarity=0.213 Sum_probs=107.1
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc----CHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ----GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+...|++|+||+||.+.. .+..++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 5788888877654321 1225789999999995 5889999886 4579999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCC-CCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+|.+|.+.+. . ....++.|++++|.++|+++ |+|||| ||+|||+++++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 0 11357889999999999998 999999 79999999999999999999996654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=159.38 Aligned_cols=147 Identities=18% Similarity=0.233 Sum_probs=114.6
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc----------------------CHHHHHHHHHHHh
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ----------------------GVEEFKNEVLLIA 401 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~ 401 (517)
++......|.+.+.||+|+||.||++..++|+.||||+++..... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457788999999999999999888999999987643210 1123567888898
Q ss_pred cCCCC--CeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 402 KLQHR--NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 402 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
++.|+ .+++.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 88877 4444443 245689999999999876541 0234578899999999999988 9999999
Q ss_pred CCcEEECCCCCeEEccccCceecCCCC
Q 010146 480 ASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+||++++++.++|+|||++..+..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=161.43 Aligned_cols=138 Identities=33% Similarity=0.479 Sum_probs=124.5
Q ss_pred CCeeEEEEEeCC-CCEEEEEEccCCCccC-HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhc
Q 010146 362 GFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD 439 (517)
Q Consensus 362 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 439 (517)
+||.||++.... ++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999998754444 68899999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 440 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.. .+++..++.++.+++++|.+||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 32 2889999999999999999999988 999999999999999999999999999988654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=180.88 Aligned_cols=148 Identities=18% Similarity=0.294 Sum_probs=117.5
Q ss_pred chhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEE-ccCCCc-------cCHHHHHHHHHHHhcCCCCCeeeEE
Q 010146 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKR-LSKSSG-------QGVEEFKNEVLLIAKLQHRNLVRLL 412 (517)
Q Consensus 341 ~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~ 412 (517)
++.........|...+.||+|+||.||++...... +++|+ +.+... ...+++.+|++++.+++|++++...
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 34443444455667799999999999999876543 33333 222111 1235688999999999999999888
Q ss_pred EEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeE
Q 010146 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK 492 (517)
Q Consensus 413 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 492 (517)
.++......++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence 88877778899999999999999883 35678999999999999988 9999999999999 577899
Q ss_pred EccccCceecCC
Q 010146 493 ISDFGMARAFGV 504 (517)
Q Consensus 493 l~DFGla~~~~~ 504 (517)
|+|||+|+....
T Consensus 468 liDFGla~~~~~ 479 (535)
T PRK09605 468 LIDFGLGKYSDL 479 (535)
T ss_pred EEeCcccccCCc
Confidence 999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=159.38 Aligned_cols=151 Identities=23% Similarity=0.351 Sum_probs=128.0
Q ss_pred cCCCCccceecccCCeeEEEEE-eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 426 (517)
.-+|.+.++||+|+||.++.|+ +-+++.||||.-...+ ..-+++.|.+..+.|. .+.|...+-+...+-+..||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3579999999999999999998 4568999999865432 3356778888888875 6899999988888888999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-----CCeEEccccCcee
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-----MNPKISDFGMARA 501 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DFGla~~ 501 (517)
.+ |.+|++++.-. ++.++.++++.+|.|++.-++|+|++. +|.|||||+|.||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 89999987433 345899999999999999999999999 9999999999999643 3499999999999
Q ss_pred cCCCCc
Q 010146 502 FGVDQT 507 (517)
Q Consensus 502 ~~~~~~ 507 (517)
+.+..+
T Consensus 179 YrDp~T 184 (449)
T KOG1165|consen 179 YRDPKT 184 (449)
T ss_pred hcCccc
Confidence 877654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=168.36 Aligned_cols=145 Identities=28% Similarity=0.373 Sum_probs=123.1
Q ss_pred CCCccceecccCCeeEEEEEeCCC--CEEEEEEccCCCccCHHHHHHHHHHHhcCCC----CCeeeEEEEE-EeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEG--QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----RNLVRLLGCC-TLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 423 (517)
+|.+.++||+|+||.||.+..... ..+|+|............+..|..++..+.. +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788888766433333377888888888873 6888999888 47778899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-----CCeEEccccC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-----MNPKISDFGM 498 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DFGl 498 (517)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+.+ ++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 899999875544 567999999999999999999999998 9999999999999765 4699999999
Q ss_pred ce
Q 010146 499 AR 500 (517)
Q Consensus 499 a~ 500 (517)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=155.65 Aligned_cols=133 Identities=23% Similarity=0.322 Sum_probs=107.4
Q ss_pred eecccCCeeEEEEEeCCCCEEEEEEccCCCc--------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.||+|++|.||++.. ++..+++|....... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 478899998643211 11256778999999999887665555556667789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++|+|||+++....
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 999999987321 10 78999999999999988 99999999999999 78999999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-18 Score=173.04 Aligned_cols=147 Identities=27% Similarity=0.376 Sum_probs=123.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++.|.+...+|.|+|+.|-.+... +++..+||++.+... ...+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888889999999999998865 488999999976522 234566555544 6999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE-CCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~~~~ 504 (517)
|.+.++-|.+.+... .... ..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.+..
T Consensus 396 e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999888877432 2223 777889999999999999998 9999999999999 5889999999999998876
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 5
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-18 Score=167.97 Aligned_cols=157 Identities=21% Similarity=0.266 Sum_probs=136.5
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCC------CCCeeeEEEEEEe
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ------HRNLVRLLGCCTL 417 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~ 417 (517)
.+....+|.+....|+|-|+.|.+|.+.. |+.||||+|..+ +...+.=+.|+++|++|+ .-|.++++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34456789888999999999999999765 889999999874 334455678999999995 3478999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDF 496 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DF 496 (517)
.++++||+|-+ ..+|.+.|.+......|....+..++.|+.-||..|...+ |+|.||||.||||++.. .+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999998 6899999988877777899999999999999999999888 99999999999998764 5899999
Q ss_pred cCceecCCCC
Q 010146 497 GMARAFGVDQ 506 (517)
Q Consensus 497 Gla~~~~~~~ 506 (517)
|.|...++++
T Consensus 582 GSA~~~~ene 591 (752)
T KOG0670|consen 582 GSASFASENE 591 (752)
T ss_pred cccccccccc
Confidence 9998887665
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=163.11 Aligned_cols=134 Identities=28% Similarity=0.377 Sum_probs=114.9
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCC-----C---CCeeeEEEEEEe---
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----H---RNLVRLLGCCTL--- 417 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~--- 417 (517)
.+|.+.++||-|.|++||++.+.. .+.||+|+.+. .....+..+.||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678999999999999999999764 67899999876 4566778899999999884 3 369999999864
Q ss_pred -CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC
Q 010146 418 -RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488 (517)
Q Consensus 418 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 488 (517)
+.+.++|+|++ |.+|..+|.... .+.++...+.+|++||+.||.|||... +|||-||||+||||...
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 46789999999 889999986544 345899999999999999999999976 69999999999999654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-18 Score=161.55 Aligned_cols=160 Identities=23% Similarity=0.367 Sum_probs=135.7
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEE
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 414 (517)
..++.....+++...++-+|.||.||+|.+. +.+.|.+|.++.. ++.+...++.|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455556677888889999999999999654 3456788888754 44566789999999999999999999999
Q ss_pred EEeC-CEEEEEEEeCCCCCHHHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC
Q 010146 415 CTLR-DERMLIYEYLPNKSLEQFIF-----DVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488 (517)
Q Consensus 415 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 488 (517)
+.+. ...++++.++.-|+|..||. +....+.++..+...++.|++.||+|||.++ |||.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 56789999999999999997 3344556788889999999999999999998 9999999999999999
Q ss_pred CCeEEccccCceecCC
Q 010146 489 MNPKISDFGMARAFGV 504 (517)
Q Consensus 489 ~~~kl~DFGla~~~~~ 504 (517)
.+|||+|=.++|.+-+
T Consensus 433 LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFP 448 (563)
T ss_pred eeEEeccchhccccCc
Confidence 9999999999997644
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.3e-18 Score=162.28 Aligned_cols=149 Identities=25% Similarity=0.484 Sum_probs=129.9
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeC
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR 418 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 418 (517)
.+....+.|..+++||+|.|++||++.+. ..+.||+|.+...+ ...++.+|+++|..+. +.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678899999999999999999854 36789999997643 3456899999999996 89999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEcccc
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG 497 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFG 497 (517)
+...+|+||+++....++... ++..++..++..++.||+++|.+| ||||||||+|+|.+.. +.-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999999999998843 678899999999999999999999 9999999999999864 568999999
Q ss_pred CceecC
Q 010146 498 MARAFG 503 (517)
Q Consensus 498 la~~~~ 503 (517)
+|...+
T Consensus 179 LA~~~d 184 (418)
T KOG1167|consen 179 LAQRYD 184 (418)
T ss_pred hHHHHH
Confidence 998543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=146.54 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=100.1
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCcc--CHHH----------------------HHHHHHHHhcCCCC--Ce
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--GVEE----------------------FKNEVLLIAKLQHR--NL 408 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--ni 408 (517)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 13455556555433 24
Q ss_pred eeEEEEEEeCCEEEEEEEeCCCCCHHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEEC
Q 010146 409 VRLLGCCTLRDERMLIYEYLPNKSLEQF-IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 409 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~ 486 (517)
.+.++. ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 246899999998543211 11100 11 5677899999999999999 77 99999999999999
Q ss_pred CCCCeEEccccCceecCCCC
Q 010146 487 NDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 487 ~~~~~kl~DFGla~~~~~~~ 506 (517)
++.++|+|||.|..+..+.
T Consensus 150 -~~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred -CCcEEEEECcccccccCcc
Confidence 8899999999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-17 Score=153.52 Aligned_cols=147 Identities=31% Similarity=0.454 Sum_probs=121.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 419 (517)
..+|.-.+.++.|.- .|..+.+. .+++||+|++... .....++..+|..++..+.|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788888887 55555533 3889999988653 2344567889999999999999999999986443
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
+.|+|||+| ..+|.+.+. ..++-..+..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 469999999 688988884 23677888999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.-+.+
T Consensus 166 r~e~~~ 171 (369)
T KOG0665|consen 166 RTEDTD 171 (369)
T ss_pred cccCcc
Confidence 976554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=138.16 Aligned_cols=137 Identities=21% Similarity=0.202 Sum_probs=115.9
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC--CCeeeEEEEEEeCCEEEEEEEeCCCC
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 431 (517)
+.+.|++|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++.+....+..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999864 7899999866433 5678899999999976 58999999888888899999999887
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.++...
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 66432 556677889999999999998654569999999999999998899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=118.61 Aligned_cols=66 Identities=52% Similarity=1.094 Sum_probs=57.9
Q ss_pred CCCCCceEEeecccCCCCccceeccccChHHHHHHhhcccCccceecccccCCCcceEEeccccccc
Q 010146 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDM 251 (517)
Q Consensus 185 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~~l~~~ 251 (517)
|+.+|+|+++++|++|+++...++.+.++++|++.||+||||+||+|.++. ++.+|++|.++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 555799999999999999887776779999999999999999999997654 557899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=143.39 Aligned_cols=136 Identities=21% Similarity=0.269 Sum_probs=105.9
Q ss_pred ceec-ccCCeeEEEEEeCCCCEEEEEEccCCC-------------ccCHHHHHHHHHHHhcCCCCCe--eeEEEEEEeCC
Q 010146 356 NKLG-EGGFGPVYRGMLTEGQEIAVKRLSKSS-------------GQGVEEFKNEVLLIAKLQHRNL--VRLLGCCTLRD 419 (517)
Q Consensus 356 ~~Ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~ 419 (517)
..|| .|+.|+||++... +..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999999875 7788998775311 1223567889999999998774 67777654332
Q ss_pred ----EEEEEEEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 420 ----ERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 420 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
..++|||++++ .+|.+++.+ ..++.. .+.+++.+|.+||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689988843 224443 3678999999999998 9999999999999998899999
Q ss_pred cccCceecC
Q 010146 495 DFGMARAFG 503 (517)
Q Consensus 495 DFGla~~~~ 503 (517)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-14 Score=144.26 Aligned_cols=150 Identities=36% Similarity=0.518 Sum_probs=128.9
Q ss_pred CCccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc---CHHHHHHHHHHHhcCCCC-CeeeEEEEEEeCCEEEEEEEe
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQHR-NLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 427 (517)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999987 88999998765333 367899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 506 (517)
+.+++|.+++........++......++.|++.++.|+|+.+ ++|||+||+||+++... .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743221125888999999999999999999998 99999999999999988 69999999999775544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=164.49 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=115.9
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~ 422 (517)
+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-.. .-=.+++.+|+ -+.|+.+.......+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 334567888899999999999999988899999999876543221 11112223333 234555555556677889
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-------CCCeEEcc
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------DMNPKISD 495 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~~~~kl~D 495 (517)
||+||.+.|+|.+++. ..+.++|.....++.|+++-++.||..+ |||+||||+|.||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999994 5567999999999999999999999998 999999999999942 33599999
Q ss_pred ccCceec
Q 010146 496 FGMARAF 502 (517)
Q Consensus 496 FGla~~~ 502 (517)
||-|-.+
T Consensus 845 fG~siDm 851 (974)
T KOG1166|consen 845 FGRSIDM 851 (974)
T ss_pred cccceee
Confidence 9998755
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=148.72 Aligned_cols=142 Identities=23% Similarity=0.313 Sum_probs=100.3
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHH----------------------------------------HHHH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE----------------------------------------EFKN 395 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 395 (517)
+.||.|++|.||+|++++|+.||||+.++....... .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 689999999999999999999999998654211100 1334
Q ss_pred HHHHHhcC----CCCCeeeEEEEE-EeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHhHhcC
Q 010146 396 EVLLIAKL----QHRNLVRLLGCC-TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR-GLLYLHQDS 469 (517)
Q Consensus 396 e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~ 469 (517)
|.+.+.++ +|.+-+.+-..+ ......+|||||++|++|.++....... . .+..++.+++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 55444444 222222222222 2234579999999999998876421111 2 23456666666 478889888
Q ss_pred CCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 470 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++|+|+||.||++++++.++|+|||++..+.+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 999999999999999999999999999988654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-13 Score=107.40 Aligned_cols=80 Identities=50% Similarity=0.941 Sum_probs=66.0
Q ss_pred CCCCCCC---CceEEeecccCCCCccceeccccChHHHHHHhhcccCccceecccccCCCcceEEeccccccceeccCCC
Q 010146 182 QLDCEHG---DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGG 258 (517)
Q Consensus 182 ~l~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~~l~~~~~~~~~~ 258 (517)
+++|... +.|++++++++|+..+.. ..+++++|++.||+||+|.||+|.+ ++.+|++|...+.+.......+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4568654 689999999999887653 6789999999999999999999975 2456999999998877655556
Q ss_pred ceeEEEee
Q 010146 259 QDLYIRMA 266 (517)
Q Consensus 259 ~~~ylkv~ 266 (517)
.++||||+
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 89999984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=8e-13 Score=137.92 Aligned_cols=145 Identities=17% Similarity=0.217 Sum_probs=94.9
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccC----------------------------------HHH--
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG----------------------------------VEE-- 392 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~-- 392 (517)
..|+. +.||+|++|.||+|++++ |+.||||++++..... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 799999999999999987 9999999997542100 011
Q ss_pred ----HHHHHHHHhcCC----CCCeeeEEEEEEe-CCEEEEEEEeCCCCCHHHHHhccCCC---CCCCHHHHHHHHHHHHH
Q 010146 393 ----FKNEVLLIAKLQ----HRNLVRLLGCCTL-RDERMLIYEYLPNKSLEQFIFDVTRT---KFLDWSKRCQIIEGIAR 460 (517)
Q Consensus 393 ----~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~~ 460 (517)
+.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++-.-...+ ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 333444444432 3333333333322 45678999999999998753111111 112222233333333
Q ss_pred HHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEccccCceecCCC
Q 010146 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFGMARAFGVD 505 (517)
Q Consensus 461 aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGla~~~~~~ 505 (517)
+..+ ++|+|+||.||+++.++ .++++|||++..+.+.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3456 99999999999999888 8999999999988654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.9e-13 Score=118.35 Aligned_cols=131 Identities=22% Similarity=0.175 Sum_probs=98.0
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeCCCCCHH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSLE 434 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~ 434 (517)
+.|+.|.++.||++... ++.+++|....... ....+..|+.++..+.+.++ .+++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999876 78899998765422 22346788888888865444 4455443 33458999999998775
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 435 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
... . ....++.+++++|+.||+.+ +..++|+|++|.||+++ ++.++|+|||.|..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 420 1 11245678999999999876 23469999999999999 568999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.3e-13 Score=102.79 Aligned_cols=71 Identities=24% Similarity=0.393 Sum_probs=61.6
Q ss_pred CCCCCceEEeecccCCCCccceeccccChHHHHHHhhc---ccCccceecccccCCCcceEEecccc-ccceeccCCCce
Q 010146 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSK---NCSCTAYANADVRGGGSGCLLWFHDL-IDMKVLSEGGQD 260 (517)
Q Consensus 185 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~~~~~l-~~~~~~~~~~~~ 260 (517)
|...+.|+++.+|++|++.. .+.++|+++|++ ||||.||+|.+. +.+|.+|.++| ++++...+.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44567899999999998876 488999999999 999999999752 35899999999 999888778899
Q ss_pred eEEE
Q 010146 261 LYIR 264 (517)
Q Consensus 261 ~ylk 264 (517)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-11 Score=112.63 Aligned_cols=139 Identities=12% Similarity=0.092 Sum_probs=101.6
Q ss_pred ceecccCCeeEEEEEeCC-------CCEEEEEEccCCC------------c----------cCHHHHH----HHHHHHhc
Q 010146 356 NKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSS------------G----------QGVEEFK----NEVLLIAK 402 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~e~~~l~~ 402 (517)
..||.|--+.||.|...+ +..+|||+.+... + .....+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 4799999764321 0 0022333 79999998
Q ss_pred CCC--CCeeeEEEEEEeCCEEEEEEEeCCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCceEecCC
Q 010146 403 LQH--RNLVRLLGCCTLRDERMLIYEYLPNKSLEQ-FIFDVTRTKFLDWSKRCQIIEGIARGLLYL-HQDSRLRIIHRDL 478 (517)
Q Consensus 403 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~Dl 478 (517)
+.. -++++++++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 566777764 56789999997654422 221 12245556778889999999999 7777 999999
Q ss_pred CCCcEEECCCCCeEEccccCceecCCCC
Q 010146 479 KASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 479 kp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+|.|||+++ +.++|+|||.|-....+.
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~hp~ 178 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTHPH 178 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCCCC
Confidence 999999974 579999999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.5e-13 Score=140.86 Aligned_cols=147 Identities=25% Similarity=0.306 Sum_probs=113.0
Q ss_pred CccceecccCCeeEEEEEeCC-CCEEEEEEcc----C-CCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLS----K-SSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~----~-~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.....+|.|++|.|+...... ....+.|... . ... .....+..|+.+-..++|+|++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999877776432 3333443322 1 111 11122666777788899999988887777766666669
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||++. +|..++.. ...+...++-.++.|++.|++|||+.+ |.||||||+|++++.++.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 99999843 345788888999999999999999999 999999999999999999999999999877544
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
-
T Consensus 474 ~ 474 (601)
T KOG0590|consen 474 W 474 (601)
T ss_pred c
Confidence 3
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-12 Score=145.96 Aligned_cols=95 Identities=20% Similarity=0.249 Sum_probs=73.5
Q ss_pred cCCC-CCeeeEEEEE-------EeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCce
Q 010146 402 KLQH-RNLVRLLGCC-------TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473 (517)
Q Consensus 402 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 473 (517)
.++| +||.++++.+ ......++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777777776 2234567788887 67999999532 345899999999999999999999988 9
Q ss_pred EecCCCCCcEEECC-------------------CCCeEEccccCceec
Q 010146 474 IHRDLKASNVLLDN-------------------DMNPKISDFGMARAF 502 (517)
Q Consensus 474 iH~Dlkp~NIll~~-------------------~~~~kl~DFGla~~~ 502 (517)
+||||||+||||+. ++.+||+|||+++..
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 99999999999954 445666677766643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-11 Score=106.76 Aligned_cols=135 Identities=21% Similarity=0.295 Sum_probs=102.4
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEE-ccCC--Cc-----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKR-LSKS--SG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~-~~~~--~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+++|+-+.+|.+.+. |.++++|. +++. .+ -..++-.+|++++.+++--.|....=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999765 44455553 3332 11 1124567899999998765555555556677888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..-...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999999888432 2567888888899999998 99999999999998774 999999999855433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.9e-11 Score=112.83 Aligned_cols=143 Identities=17% Similarity=0.237 Sum_probs=111.2
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCC--CCeeeEEEEEEeCC---EEEEEEEeCC
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRD---ERMLIYEYLP 429 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 429 (517)
+.|+.|..+.||++...+|+.+++|....... .....+..|.++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999999865432 245678899999999875 44677777766532 5689999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS---------------------------------------- 469 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 469 (517)
+.++.+.+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 24677778888888888888888531
Q ss_pred -------------CCceEecCCCCCcEEECC--CCCeEEccccCceec
Q 010146 470 -------------RLRIIHRDLKASNVLLDN--DMNPKISDFGMARAF 502 (517)
Q Consensus 470 -------------~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~ 502 (517)
+..++|+|++|.|||++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 235899999999999998 566899999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=101.64 Aligned_cols=146 Identities=23% Similarity=0.306 Sum_probs=107.2
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEE-ccCC-------CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKR-LSKS-------SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
....|-+|+-+.|+++.+. |+...||. ..+. ..-...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999987 66666663 3222 1123456788999999987555544444566677778999
Q ss_pred EeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEccccCcee
Q 010146 426 EYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARA 501 (517)
Q Consensus 426 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~ 501 (517)
||+++ .++.+++....... ........++.+|-+.+.-||.+. |+|+||..+||+|.+++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888886544333 222333688999999999999998 999999999999976553 58999999875
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
-..
T Consensus 166 s~~ 168 (229)
T KOG3087|consen 166 SRL 168 (229)
T ss_pred ccC
Confidence 433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=110.68 Aligned_cols=149 Identities=25% Similarity=0.332 Sum_probs=99.5
Q ss_pred CCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCC----------CCeeeEEEEEE-
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH----------RNLVRLLGCCT- 416 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 416 (517)
+...+.||.|+++.||.+++.+ ++++|||..... .....+++++|.-.+..+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3455799999999999999876 899999987533 23446677777766665433 12222222211
Q ss_pred --------eCC--------EEEEEEEeCCCCCHHHHHh---ccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEec
Q 010146 417 --------LRD--------ERMLIYEYLPNKSLEQFIF---DVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476 (517)
Q Consensus 417 --------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~ 476 (517)
... ..+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||..+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 236778877 688888753 2222 123445566778899999999999999 9999
Q ss_pred CCCCCcEEECCCCCeEEccccCceecCC
Q 010146 477 DLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 477 Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+|+|++++++|.++|+||+.....+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 9999999999999999999998877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-12 Score=129.31 Aligned_cols=144 Identities=26% Similarity=0.316 Sum_probs=118.9
Q ss_pred eecccCCeeEEEEE----eCCCCEEEEEEccCCCcc--CHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 357 KLGEGGFGPVYRGM----LTEGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.+|+|.||.|+++. .+.+..+|+|.+.+.... .......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999865 234778899988765321 1124566788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+|.|...+ .....+.+.....+...++-|++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-+..
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99998877 33445677777778889999999999988 9999999999999999999999999999774443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=113.01 Aligned_cols=139 Identities=27% Similarity=0.470 Sum_probs=114.6
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
.+..+|.+...|..|+|+++ |..+++|++.-. .....+.|..|.-.|+-+.||||..+++.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34467889999999999997 566777777543 333445788899999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
|+|.+.|++. ..-..+..++.+++.++++|++|||+..++ |.---|....++||++.+++|+
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee
Confidence 9999999653 334578889999999999999999998632 4444688999999999987764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-11 Score=132.21 Aligned_cols=143 Identities=20% Similarity=0.261 Sum_probs=115.2
Q ss_pred CCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC-ccCHHHHHHHHHH--HhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS-GQGVEEFKNEVLL--IAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++...+.||.+.|=+|.+|+.++|. |+||++-+.. ....+.+.++++- +..++|||.+.+.-+-....-.|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677799999999999999998877 8888876543 3344555544443 4556899999887776666667888888
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
. .-+|.+.| ..+..+...+...|+.|++.||.-+|..+ |.|||||.+||||++-.-+.|+||.--|.
T Consensus 103 v-khnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 V-KHNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred H-hhhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 8 46788877 44567888899999999999999999988 99999999999999998999999976553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.6e-10 Score=100.30 Aligned_cols=129 Identities=24% Similarity=0.317 Sum_probs=85.7
Q ss_pred eEEEEEeCCCCEEEEEEccCCC--------------c------------cCHHHHHHHHHHHhcCCCC--CeeeEEEEEE
Q 010146 365 PVYRGMLTEGQEIAVKRLSKSS--------------G------------QGVEEFKNEVLLIAKLQHR--NLVRLLGCCT 416 (517)
Q Consensus 365 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 416 (517)
.||.|...+|..+|||..+... . .......+|.+.|.++... ++++++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999889999999764321 0 0113467899999999865 567777552
Q ss_pred eCCEEEEEEEeCC--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-hHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 417 LRDERMLIYEYLP--NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 417 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
...|||||++ +..+..+... . ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3579999998 5555443311 1 1234556678888886666 46777 9999999999999988 9999
Q ss_pred ccccCceecCCCC
Q 010146 494 SDFGMARAFGVDQ 506 (517)
Q Consensus 494 ~DFGla~~~~~~~ 506 (517)
+|||.|.....+.
T Consensus 148 IDf~qav~~~~p~ 160 (188)
T PF01163_consen 148 IDFGQAVDSSHPN 160 (188)
T ss_dssp --GTTEEETTSTT
T ss_pred EecCcceecCCcc
Confidence 9999998876443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.2e-09 Score=100.60 Aligned_cols=141 Identities=21% Similarity=0.146 Sum_probs=100.3
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCc-----------cCHHHHHHHHHHHhcCCC--CCeeeEEEEEEe-----
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-----------QGVEEFKNEVLLIAKLQH--RNLVRLLGCCTL----- 417 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~----- 417 (517)
+.+-.-....|++... +|+.+.||+...... .....+.+|...+.++.. -..++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444334445777766 478899997643221 111247789988888853 334445555543
Q ss_pred CCEEEEEEEeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-------CC
Q 010146 418 RDERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------DM 489 (517)
Q Consensus 418 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~~ 489 (517)
....+||||++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++|.|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23578999999876 8999884321 233556677889999999999999999 999999999999975 46
Q ss_pred CeEEccccCcee
Q 010146 490 NPKISDFGMARA 501 (517)
Q Consensus 490 ~~kl~DFGla~~ 501 (517)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.1e-10 Score=106.80 Aligned_cols=89 Identities=25% Similarity=0.461 Sum_probs=70.6
Q ss_pred CCCCeeeEEEEEEe---------------------------CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 010146 404 QHRNLVRLLGCCTL---------------------------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456 (517)
Q Consensus 404 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 456 (517)
+|||||++.++|.+ +...|+||..+ ..+|.+++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 59999998887643 23468999888 47899998432 255666777899
Q ss_pred HHHHHHHHhHhcCCCceEecCCCCCcEEE--CCCC--CeEEccccCce
Q 010146 457 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNDM--NPKISDFGMAR 500 (517)
Q Consensus 457 qi~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~--~~kl~DFGla~ 500 (517)
|+++|+.|||.++ |.|||+|.+|||| |++. .+.|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999999 9999999999999 4443 47899999764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.5e-09 Score=109.19 Aligned_cols=100 Identities=31% Similarity=0.485 Sum_probs=90.5
Q ss_pred HhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 400 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.....++++|+.||+|||.-. -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4578999999999999999999999999999999999965 3455899999999999999999999865 22999999
Q ss_pred CCcEEECCCCCeEEccccCceecC
Q 010146 480 ASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+.|.++|..+.+||+|||+.....
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-10 Score=121.20 Aligned_cols=152 Identities=26% Similarity=0.367 Sum_probs=122.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC--CCEEEEEEccCCC--ccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 423 (517)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456777889999999998887543 4456777665442 333445556777777777 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCceEecCCCCCcEEECCCC-CeEEccccCcee
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARA 501 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~ 501 (517)
+.||..++++.+.+.. ......+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999887731 11113566677789999999999999 777 99999999999999999 999999999998
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 876
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.9e-08 Score=104.69 Aligned_cols=162 Identities=17% Similarity=0.280 Sum_probs=102.4
Q ss_pred CCCccchhHHHHh------------cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCH-------------
Q 010146 336 ELPMFDWNTIADA------------TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGV------------- 390 (517)
Q Consensus 336 ~~~~~~~~~i~~~------------~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------- 390 (517)
..|.+++++.... ...|+. +.|+.++-|.||+|++++|+.||||+.++.-....
T Consensus 100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~ 178 (517)
T COG0661 100 RVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL 178 (517)
T ss_pred CCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence 4666666554432 223432 78999999999999999999999999876421110
Q ss_pred -----------------HH----------HHHHHHHHhcCC-----CCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHh
Q 010146 391 -----------------EE----------FKNEVLLIAKLQ-----HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF 438 (517)
Q Consensus 391 -----------------~~----------~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 438 (517)
++ +.+|...+.++. .+++.-..=++.-.....|+|||++|..+.+...
T Consensus 179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~ 258 (517)
T COG0661 179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA 258 (517)
T ss_pred HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence 00 223444343332 2333222222333567899999999999988852
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 439 DVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 439 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
-.. ...+.+.+.....++. +..+-..+ ++|.|.+|.||+++.++++-+.|||+...+++.
T Consensus 259 l~~--~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 259 LKS--AGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHh--cCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 222 2244333333222222 22222234 999999999999999999999999999988654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.3e-08 Score=103.48 Aligned_cols=121 Identities=20% Similarity=0.311 Sum_probs=102.0
Q ss_pred CCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHH
Q 010146 372 TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451 (517)
Q Consensus 372 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~ 451 (517)
.++.+|.|...+.......+...+-++.|+.++||||++++......+..|||+|.+ ..|..++.+ +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence 358888888887655544566788899999999999999999999999999999998 567777743 335566
Q ss_pred HHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 452 ~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
...+.||+.||.|||+.+ .++|++|.-+.|+|++.|..||++|-++...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 678899999999999765 4999999999999999999999999887554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.1e-08 Score=90.56 Aligned_cols=109 Identities=27% Similarity=0.298 Sum_probs=86.1
Q ss_pred CHHHHHHHHHHHhcCC--CCCeeeEEEEEEeCC----EEEEEEEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 010146 389 GVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRD----ERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461 (517)
Q Consensus 389 ~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~a 461 (517)
......+|...+..+. .-.+++.+++..... ..+||+|++++ .+|.+++..... .+......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 3456788888887775 344566666665432 35899999987 479999854222 5667788999999999
Q ss_pred HHHhHhcCCCceEecCCCCCcEEECCCC---CeEEccccCceecC
Q 010146 462 LLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARAFG 503 (517)
Q Consensus 462 L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~~ 503 (517)
++-||+.+ |+|+|++|.|||++.+. .+.|+||+.++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 99999999999999887 79999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.7e-08 Score=90.69 Aligned_cols=148 Identities=19% Similarity=0.228 Sum_probs=103.0
Q ss_pred hHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--------------------C--ccCHHHHHHHHHHH
Q 010146 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--------------------S--GQGVEEFKNEVLLI 400 (517)
Q Consensus 343 ~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~e~~~l 400 (517)
..+.....-..+...||.|--+.||.|..+.|.++|||.=+.. + .......++|.++|
T Consensus 84 ~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 84 HALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 3333333335566899999999999999999999999943211 0 01223467899999
Q ss_pred hcCCCC--CeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCC
Q 010146 401 AKLQHR--NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL 478 (517)
Q Consensus 401 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 478 (517)
.+|... .+++.+++ +...+|||++++-.|...- ++....-.++..|++-+.-+-..| |||+|+
T Consensus 164 ~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDl 228 (304)
T COG0478 164 QRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDL 228 (304)
T ss_pred HHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 999755 67777654 5678999999886664321 122233344444555555444555 999999
Q ss_pred CCCcEEECCCCCeEEccccCceecCCC
Q 010146 479 KASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 479 kp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.+-|||++++|.+.++||=-+...+.+
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVPISHP 255 (304)
T ss_pred chheEEEecCCCEEEEeCcccccCCCC
Confidence 999999999999999999776655444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.3e-07 Score=84.72 Aligned_cols=141 Identities=14% Similarity=0.153 Sum_probs=105.2
Q ss_pred eecccCCeeEEEEEeCCCCEEEEEEccCC------CccCHHHHHHHHHHHhcCCC--CCeeeEEEEEEeC----CEEEEE
Q 010146 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKS------SGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLR----DERMLI 424 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv 424 (517)
--++||-+.|++.... |+.+-+|+.... .+.....|.+|...|.++.. ..++++....... -..+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3466888899998776 457888977522 14567789999999999863 3355555222221 235899
Q ss_pred EEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC--eEEccccCcee
Q 010146 425 YEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~ 501 (517)
+|-+++ .+|.+++.+.. ....+...+..++.++++.++-||+.+ +.|+|+-+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998753 68988884422 224677888899999999999999999 999999999999986667 99999987764
Q ss_pred c
Q 010146 502 F 502 (517)
Q Consensus 502 ~ 502 (517)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.3e-08 Score=96.06 Aligned_cols=141 Identities=20% Similarity=0.278 Sum_probs=114.1
Q ss_pred CeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEEEEEEEeCCC-CCHHHH
Q 010146 363 FGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIYEYLPN-KSLEQF 436 (517)
Q Consensus 363 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 436 (517)
-.+.|++... +|..+++|+++....+.......-++.++++.|+|+|++.+++.. +..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567888854 699999999965444444445566788999999999999998863 3457999999985 567776
Q ss_pred Hhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 437 IFDV------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 437 l~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
-+.. ..+..+++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 12335788999999999999999999998 99999999999999999999999999988876
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 65
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.8e-08 Score=101.75 Aligned_cols=150 Identities=23% Similarity=0.311 Sum_probs=122.0
Q ss_pred CCCccceecc--cCCeeEEEEEe--C-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEE
Q 010146 351 NFSWKNKLGE--GGFGPVYRGML--T-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 351 ~y~~~~~Ig~--G~~g~Vy~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 422 (517)
.+.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.. .+.....=.+|+...++++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556688999 99999999986 3 4788999984332 2333344456777777775 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEcccc
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG 497 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFG 497 (517)
+-+|++ +.+|.++... ....++....+.+..+... ||..+|... ++|-|+||.||++..+ ...++.|||
T Consensus 195 iqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 999998 5888888743 3344778888888888888 999999998 9999999999999999 789999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+...++...
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999997765
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.60 E-value=8e-07 Score=83.67 Aligned_cols=139 Identities=17% Similarity=0.185 Sum_probs=85.7
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC--CeeeEEEEEEeCCEEEEEEEeCCCCC-
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGCCTLRDERMLIYEYLPNKS- 432 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gs- 432 (517)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 25567788876532 345678899999888643 35677888777778889999998863
Q ss_pred HHHHH--------------hc----cCC--CCCCCHHHHH-HHHH----------HHHH-HHHHhHh-cCCCceEecCCC
Q 010146 433 LEQFI--------------FD----VTR--TKFLDWSKRC-QIIE----------GIAR-GLLYLHQ-DSRLRIIHRDLK 479 (517)
Q Consensus 433 L~~~l--------------~~----~~~--~~~l~~~~~~-~i~~----------qi~~-aL~~LH~-~~~~~iiH~Dlk 479 (517)
+...+ .+ ... ....+..... .+.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 000 0001111100 0000 0011 1112211 122357899999
Q ss_pred CCcEEECCCCCeEEccccCce
Q 010146 480 ASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~ 500 (517)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.7e-08 Score=101.86 Aligned_cols=151 Identities=23% Similarity=0.280 Sum_probs=119.8
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC--CCCEEEEEEccCCCccCHHH--HHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
.....+|..+..||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 345667888899999999999998744 47789999886653332222 23455555555 48889988888888888
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEccccCc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMA 499 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla 499 (517)
.++--||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 89999999999987765 22344788889999999999999999887 9999999999999886 78899999998
Q ss_pred eec
Q 010146 500 RAF 502 (517)
Q Consensus 500 ~~~ 502 (517)
..+
T Consensus 415 t~~ 417 (524)
T KOG0601|consen 415 TRL 417 (524)
T ss_pred ccc
Confidence 754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.1e-08 Score=105.28 Aligned_cols=112 Identities=25% Similarity=0.387 Sum_probs=78.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
...+|..++.|..|++|.||..+++. .+.+|+| +++... .+++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-----------------
Confidence 34678888999999999999999875 6788884 433211 0111 22222333333
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|+-...+. ..+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..
T Consensus 136 ----gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 45555552 2223332 2278999999988 999999999999999999999999999864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2e-06 Score=78.82 Aligned_cols=139 Identities=16% Similarity=0.183 Sum_probs=91.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHH---------HHHHHHHHhcCCC---CCeeeEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE---------FKNEVLLIAKLQH---RNLVRLLGCC 415 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~niv~l~~~~ 415 (517)
...+|...+.+-......|.+-..+ |+.+++|..+.......+. ..+++..+.+++. ...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4466777778877777777776665 7889999887643322222 2233333333322 2222222222
Q ss_pred E-----eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 416 T-----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 416 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
. .....+++|||++|..|.++.. +++ .++..+.+++.-||+.| ++|+|++|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 1 2234578999999988866531 222 35567788899999998 9999999999999866 5
Q ss_pred eEEccccCceec
Q 010146 491 PKISDFGMARAF 502 (517)
Q Consensus 491 ~kl~DFGla~~~ 502 (517)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999887754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-06 Score=81.00 Aligned_cols=157 Identities=17% Similarity=0.195 Sum_probs=105.9
Q ss_pred CccchhHHHHhcCCCCccceec---ccCCeeEEEEEeCCCCEEEEEEccCCCccC-------------------HH----
Q 010146 338 PMFDWNTIADATDNFSWKNKLG---EGGFGPVYRGMLTEGQEIAVKRLSKSSGQG-------------------VE---- 391 (517)
Q Consensus 338 ~~~~~~~i~~~~~~y~~~~~Ig---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~---- 391 (517)
-..+++.+.....+..+....| .|.-+.||+|...++..+|||+........ ..
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3456677777777776666555 566678999998889999999886532111 11
Q ss_pred -HHHHHHHHHhcCC--CCCeeeEEEEEEeCCEEEEEEEeCCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh
Q 010146 392 -EFKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ-FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467 (517)
Q Consensus 392 -~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 467 (517)
-...|..-|.++. +-.+++.+.+. ...|||||+....+.. .| ..-.+...+...+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 1234666666663 44555555543 3479999995431110 11 11123333577788889999988887
Q ss_pred -cCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 468 -DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 468 -~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
.+ +||+||..=|||+. ++.+.|+|||-|.....+.
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence 44 99999999999999 7799999999998776443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-06 Score=82.25 Aligned_cols=145 Identities=23% Similarity=0.232 Sum_probs=86.7
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC--CeeeEEEEEEe---CCEEEEEEEeCC
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGCCTL---RDERMLIYEYLP 429 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~ 429 (517)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999886 69999987653 4456778888888887532 35677765433 334689999999
Q ss_pred CCCHHH----------------HHh---cc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhHh
Q 010146 430 NKSLEQ----------------FIF---DV-TRTKFLDWSK---------RCQI------------IEGIAR-GLLYLHQ 467 (517)
Q Consensus 430 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qi~~-aL~~LH~ 467 (517)
+..+.. .+. .. .......... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 0111111100 0000 111222 2333332
Q ss_pred ----cCCCceEecCCCCCcEEEC-CCCCeEEccccCceec
Q 010146 468 ----DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAF 502 (517)
Q Consensus 468 ----~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~ 502 (517)
..+..++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1345699999999999999 5666689999988653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=9.4e-07 Score=91.78 Aligned_cols=141 Identities=15% Similarity=0.212 Sum_probs=90.5
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCH-------------------------------H------HHHHHHH
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGV-------------------------------E------EFKNEVL 398 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~e~~ 398 (517)
+.||..+.|.|++|++++|+.||||+-++.-.... + .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 78999999999999999999999998766421110 0 1223333
Q ss_pred HHhc----CCCCC------eeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc
Q 010146 399 LIAK----LQHRN------LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468 (517)
Q Consensus 399 ~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 468 (517)
-..+ +.|-+ |++++-. -.....|+||||+|..+.+.-.- ....++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc--
Confidence 3222 23444 3333322 23568999999999887765321 1222555544443333332222222
Q ss_pred CCCceEecCCCCCcEEECC----CCCeEEccccCceecCCC
Q 010146 469 SRLRIIHRDLKASNVLLDN----DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 469 ~~~~iiH~Dlkp~NIll~~----~~~~kl~DFGla~~~~~~ 505 (517)
| ++|+|-+|.||++.. +..+.+-|||+.+.+...
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3 999999999999984 667999999999877543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.5e-07 Score=81.77 Aligned_cols=62 Identities=23% Similarity=0.131 Sum_probs=54.0
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+|.+++... ...+++.+++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 6899998542 345999999999999999999999865 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.8e-08 Score=97.30 Aligned_cols=81 Identities=27% Similarity=0.392 Sum_probs=72.9
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..+|.|+++...+|.++|.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666678889999999999999999 55 999999999999999999999999999
Q ss_pred eecCCCC
Q 010146 500 RAFGVDQ 506 (517)
Q Consensus 500 ~~~~~~~ 506 (517)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 9886655
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.41 E-value=6.7e-07 Score=68.86 Aligned_cols=73 Identities=36% Similarity=0.702 Sum_probs=55.3
Q ss_pred CCceEEeecccCCCCccceeccccChHHHHHHhhc-ccCccceecccccCCCcceEEec-cccccceeccCCCceeEEE
Q 010146 188 GDGFLKRESVKLPDTSFSRVDKNISILACKELCSK-NCSCTAYANADVRGGGSGCLLWF-HDLIDMKVLSEGGQDLYIR 264 (517)
Q Consensus 188 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~~~-~~l~~~~~~~~~~~~~ylk 264 (517)
...|..++++.+++..... ....++++|++.|++ +|+|.||.|.. .+.+|.+|. ..+.+.......+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3569999999999665542 356789999999999 99999999964 244699999 6677666445555666654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.8e-06 Score=80.29 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=87.5
Q ss_pred ceecccCC-eeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 356 NKLGEGGF-GPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 356 ~~Ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
+.|..|.. ..||+.... +..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 35556665 788998765 4788888876532 345677888887774 44566788877766678999999998877
Q ss_pred HHHH-------------------hccCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHhHh----
Q 010146 434 EQFI-------------------FDVTR-TKFLDW--SKRCQIIE--------------------GIARGLLYLHQ---- 467 (517)
Q Consensus 434 ~~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qi~~aL~~LH~---- 467 (517)
.... +.... ...+.. ...+.... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11100 000110 00000000 01111222211
Q ss_pred cCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 468 ~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
...+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1234589999999999999987789999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.8e-07 Score=85.95 Aligned_cols=97 Identities=27% Similarity=0.324 Sum_probs=80.9
Q ss_pred HHHHhcCCCCCeeeEEEEEEeC-----CEEEEEEEeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 010146 397 VLLIAKLQHRNLVRLLGCCTLR-----DERMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSR 470 (517)
Q Consensus 397 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~ 470 (517)
..-|-.+.|.|||+++.++.+. .+..++.|||+.|+|.++|++... ...+......+++.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445566799999999988644 346889999999999999976433 345778888899999999999999986
Q ss_pred CceEecCCCCCcEEECCCCCeEEc
Q 010146 471 LRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 471 ~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
++|+|+++..+-|++..++-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 789999999999999988888874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.8e-06 Score=77.39 Aligned_cols=106 Identities=24% Similarity=0.267 Sum_probs=82.8
Q ss_pred HHHHHHHhcCCC-CCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCc
Q 010146 394 KNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472 (517)
Q Consensus 394 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 472 (517)
.+|..++..+++ +++++++|.|- .+++.||...+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999993 4678999987765421000011123689999999999999999999865445
Q ss_pred eEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 473 iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+.-.|++|+|+-+++++++|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=69.91 Aligned_cols=134 Identities=25% Similarity=0.403 Sum_probs=95.4
Q ss_pred CCCccchhHHHHhcCCCCccceecccCC-eeEEEEEeCCCCEEEEEEccC---CCc------------------cCHHHH
Q 010146 336 ELPMFDWNTIADATDNFSWKNKLGEGGF-GPVYRGMLTEGQEIAVKRLSK---SSG------------------QGVEEF 393 (517)
Q Consensus 336 ~~~~~~~~~i~~~~~~y~~~~~Ig~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~ 393 (517)
.+..|+.. ..+++..+.||.|.. |.||++.+. |+.+|+|.... ... .....|
T Consensus 28 KL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 34455552 277888999999999 999999997 78999999221 100 112357
Q ss_pred HHHHHHHhcCC---CCCe--eeEEEEEEeC------------------CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHH
Q 010146 394 KNEVLLIAKLQ---HRNL--VRLLGCCTLR------------------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450 (517)
Q Consensus 394 ~~e~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 450 (517)
..|.+...+|+ +.++ |+.+|+..-. ....||.||.+... .+.
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~--- 166 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ--- 166 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc---
Confidence 78999888885 4456 8999987422 12357888775432 122
Q ss_pred HHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 451 ~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 234567777888999888 999999999986 5689999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.4e-05 Score=87.88 Aligned_cols=78 Identities=18% Similarity=0.342 Sum_probs=57.8
Q ss_pred cceecccCCeeEEEEEeCCC---CEEEEEEccCCC-ccCHHHHHHHHHHHhcCC-CCCe--eeEEEEEEeC---CEEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNL--VRLLGCCTLR---DERMLI 424 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 424 (517)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ ++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999887653 467777765432 223457889999999985 6654 7888887654 457899
Q ss_pred EEeCCCCC
Q 010146 425 YEYLPNKS 432 (517)
Q Consensus 425 ~e~~~~gs 432 (517)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.5e-05 Score=75.69 Aligned_cols=73 Identities=16% Similarity=0.258 Sum_probs=46.4
Q ss_pred ceecccCCe-eEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC---CeeeEEEEEEeC---CEEEEEEEeC
Q 010146 356 NKLGEGGFG-PVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVRLLGCCTLR---DERMLIYEYL 428 (517)
Q Consensus 356 ~~Ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 428 (517)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 58875 24577776543 22345788999998877532 344555443332 2348899999
Q ss_pred CCCCHH
Q 010146 429 PNKSLE 434 (517)
Q Consensus 429 ~~gsL~ 434 (517)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 887663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.1e-05 Score=75.27 Aligned_cols=78 Identities=14% Similarity=0.101 Sum_probs=57.4
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC---CCeeeEEEEEEe---CCEEEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVRLLGCCTL---RDERMLIYE 426 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e 426 (517)
...+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.|.. ..++++++.+.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3447899999999999886655 466676432 1133578899999988853 468888888754 366899999
Q ss_pred eCCCCCH
Q 010146 427 YLPNKSL 433 (517)
Q Consensus 427 ~~~~gsL 433 (517)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.6e-05 Score=69.78 Aligned_cols=135 Identities=17% Similarity=0.269 Sum_probs=92.7
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEccCCC----------------ccCHHHHHHHHHHHhcCC------CCCeeeE
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----------------GQGVEEFKNEVLLIAKLQ------HRNLVRL 411 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l 411 (517)
....||+|+.=.||. +++.....||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999988885 4445667788876544 223456677776655555 7899999
Q ss_pred EEEEEeCCEEEEEEEeCCC------CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 412 LGCCTLRDERMLIYEYLPN------KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 412 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
+|+..++...-+|+|.+.+ .+|.+++.+ ..++. ...+.+.++ ..||-++. |+.+||+|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998642 457777732 23554 333444444 45556655 9999999999999
Q ss_pred CCCC----CeEEcc-ccCcee
Q 010146 486 DNDM----NPKISD-FGMARA 501 (517)
Q Consensus 486 ~~~~----~~kl~D-FGla~~ 501 (517)
.... .+.|+| ||-...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 5432 477777 455444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.5e-05 Score=74.98 Aligned_cols=75 Identities=17% Similarity=0.215 Sum_probs=55.6
Q ss_pred ceecccCCeeEEEEEeCCC-CEEEEEEccCC------C-ccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTEG-QEIAVKRLSKS------S-GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 424 (517)
+.||.|.+..||++...+| +.++||..... . +...++...|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998876 58999985421 1 234567788888887763 3467778877 34567899
Q ss_pred EEeCCCCC
Q 010146 425 YEYLPNKS 432 (517)
Q Consensus 425 ~e~~~~gs 432 (517)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.6e-05 Score=67.01 Aligned_cols=132 Identities=20% Similarity=0.238 Sum_probs=90.1
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCee-eEEEEEEeCCEEEEEEEeCCCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGCCTLRDERMLIYEYLPNK 431 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 431 (517)
...+.|++|++|.||++.+. |..+|+|+-+.+ .....+..|+++|..++-.++. +++.+- ..++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34578999999999999987 568999987654 3456789999999999866654 344432 334569999988
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC-CCcEEECCCCCeEEccccCceecCC
Q 010146 432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 432 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
.|.+.-.. .+.++++. ++++---|-..+ |-|+.|. |..++|..+..+.|+||.-|+.-..
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 98776521 12333333 333433344344 8898885 5555555555899999999985433
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=69.05 Aligned_cols=141 Identities=17% Similarity=0.266 Sum_probs=81.5
Q ss_pred ceecccCCeeEEEEEeCC--CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.++..+.... .+++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 577888888999998764 678889977543221 122346888888775333 344544332 247999998876
Q ss_pred HHHH--------------H---hccCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 010146 433 LEQF--------------I---FDVTRT--------KFLD-WSKRCQIIE----------------------GIARGLLY 464 (517)
Q Consensus 433 L~~~--------------l---~~~~~~--------~~l~-~~~~~~i~~----------------------qi~~aL~~ 464 (517)
+... | ++.... .... +..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1 111111 0111 112111111 11111111
Q ss_pred h----Hhc-CCCceEecCCCCCcEEECC-CCCeEEccccCcee
Q 010146 465 L----HQD-SRLRIIHRDLKASNVLLDN-DMNPKISDFGMARA 501 (517)
Q Consensus 465 L----H~~-~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~ 501 (517)
| ... .+..++|+|+.|.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2345999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.6e-05 Score=71.46 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=78.3
Q ss_pred eecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeCCCCCHHH
Q 010146 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSLEQ 435 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 435 (517)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++.... ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 455677888998874 467888887654322211134678888888764333 34444332 368999998866532
Q ss_pred --------------HH---hccCC-CCCCCHHHH-HHHHHH---------HHHHHHHhHhc-----CCCceEecCCCCCc
Q 010146 436 --------------FI---FDVTR-TKFLDWSKR-CQIIEG---------IARGLLYLHQD-----SRLRIIHRDLKASN 482 (517)
Q Consensus 436 --------------~l---~~~~~-~~~l~~~~~-~~i~~q---------i~~aL~~LH~~-----~~~~iiH~Dlkp~N 482 (517)
.+ +.... ...++.... .....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 11111 111222111 111111 11112222111 12358999999999
Q ss_pred EEECCCCCeEEccccCcee
Q 010146 483 VLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 483 Ill~~~~~~kl~DFGla~~ 501 (517)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.6e-05 Score=73.11 Aligned_cols=142 Identities=21% Similarity=0.225 Sum_probs=84.9
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC--CeeeEEEE------EEeCCEEEEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGC------CTLRDERMLIYE 426 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 426 (517)
.+.|..|....+|+.... +..+++|+... ...+.+..|++++..+.+. .+++++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777887899998765 45788888764 2345667778777777432 24444431 233456789999
Q ss_pred eCCCCCHHH-----------HH---hccCC----C----CCCCHHHHH----------HHHHHHHHHHHHhHh----cCC
Q 010146 427 YLPNKSLEQ-----------FI---FDVTR----T----KFLDWSKRC----------QIIEGIARGLLYLHQ----DSR 470 (517)
Q Consensus 427 ~~~~gsL~~-----------~l---~~~~~----~----~~l~~~~~~----------~i~~qi~~aL~~LH~----~~~ 470 (517)
|++|..+.. .| +.... . ....|.... .....+..++.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866421 11 11100 0 011111110 111223344555543 122
Q ss_pred CceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 471 LRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 471 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00089 Score=66.66 Aligned_cols=141 Identities=21% Similarity=0.251 Sum_probs=76.1
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC--CCeeeEEE------EEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLG------CCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 427 (517)
+.|+.|....+|+....+| .+++|+... ...+.+..|+.++..|.. -.+++.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5566777788999886655 688888752 122334445555554421 12333332 12235667899999
Q ss_pred CCCCCHH-----------HHHh---ccCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHhHhc---
Q 010146 428 LPNKSLE-----------QFIF---DVTRT--------KFLDW-SKRCQ------------IIEG-IARGLLYLHQD--- 468 (517)
Q Consensus 428 ~~~gsL~-----------~~l~---~~~~~--------~~l~~-~~~~~------------i~~q-i~~aL~~LH~~--- 468 (517)
++|..+. ..|. ..... ..+.+ ..... .+.+ +...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886431 1121 11000 01111 11111 1111 11122233211
Q ss_pred -CCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 469 -SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 469 -~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
-+.+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0015 Score=64.65 Aligned_cols=143 Identities=22% Similarity=0.261 Sum_probs=81.8
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC--CeeeEEEE------EEeCCEEEEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGC------CTLRDERMLIYE 426 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 426 (517)
.+.++.|....+|+....++ .+++|+.... ...+.+..|++++..|... .+++++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876544 5778876542 1234555667766666422 23444432 122456789999
Q ss_pred eCCCCCHH-----------HHH---hccCCC------C---CCCHHHHH------------HHHHHHHHHHHHhHh----
Q 010146 427 YLPNKSLE-----------QFI---FDVTRT------K---FLDWSKRC------------QIIEGIARGLLYLHQ---- 467 (517)
Q Consensus 427 ~~~~gsL~-----------~~l---~~~~~~------~---~l~~~~~~------------~i~~qi~~aL~~LH~---- 467 (517)
|++|..+. ..+ +..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99875431 111 111000 0 01111100 111223345555543
Q ss_pred cCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 468 ~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
..+..++|+|+++.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00047 Score=68.09 Aligned_cols=142 Identities=24% Similarity=0.339 Sum_probs=83.8
Q ss_pred ceecccCCeeEEEEEeCC-------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 427 (517)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+.... ..++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 466667777899988654 5789999876533 22334567777777775322 3455555432 358999
Q ss_pred CCCCCHHHH--------------H---hccCCCC------CCC--HHHHHH--------------------------HHH
Q 010146 428 LPNKSLEQF--------------I---FDVTRTK------FLD--WSKRCQ--------------------------IIE 456 (517)
Q Consensus 428 ~~~gsL~~~--------------l---~~~~~~~------~l~--~~~~~~--------------------------i~~ 456 (517)
++|..+... | ++..... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 1 1111110 011 111100 112
Q ss_pred HHHHHHHHhHh------cCCCceEecCCCCCcEEECCC----CCeEEccccCceec
Q 010146 457 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDND----MNPKISDFGMARAF 502 (517)
Q Consensus 457 qi~~aL~~LH~------~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 502 (517)
++...+..|.. ..+..++|+|+.|.|||++++ +.++|+||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233444432 234569999999999999985 78999999988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0012 Score=64.85 Aligned_cols=137 Identities=18% Similarity=0.241 Sum_probs=83.4
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccC--CCccCHHHHHHHHHHHhcCCC--CCeeeEEEEEEeCC--EEEEEEEeC
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRD--ERMLIYEYL 428 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~ 428 (517)
.+.+..|..-.+|..... +++++++ ... ..........+|.++|+.+.- .-+.+.++.|..+. ..+.||+|.
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344444444455555544 7788888 331 123344566778888887753 34556677777666 669999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHH-HHHHHHHHHhH-----------------------------------------
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQII-EGIARGLLYLH----------------------------------------- 466 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~aL~~LH----------------------------------------- 466 (517)
+|..+.+.+... +.. .+++ ..+++.|+-||
T Consensus 108 eGe~~~~~~~~~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPE------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcc------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 874333222100 000 0111 23333333343
Q ss_pred ---------hc-----CCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 467 ---------QD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 467 ---------~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++ ++..++|+|+++.||+++.+.-+-|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 223699999999999999988899999999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0014 Score=63.77 Aligned_cols=31 Identities=26% Similarity=0.528 Sum_probs=26.0
Q ss_pred CceEecCCCCCcEEECCCCC-eEEccccCcee
Q 010146 471 LRIIHRDLKASNVLLDNDMN-PKISDFGMARA 501 (517)
Q Consensus 471 ~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~ 501 (517)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0024 Score=62.19 Aligned_cols=76 Identities=21% Similarity=0.296 Sum_probs=48.3
Q ss_pred CCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .-..+++++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445788989999999987 5688999998763 2335677777777766 3456888999888777889999999
Q ss_pred CCC
Q 010146 429 PNK 431 (517)
Q Consensus 429 ~~g 431 (517)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00032 Score=53.14 Aligned_cols=51 Identities=20% Similarity=0.355 Sum_probs=37.0
Q ss_pred EEeecccCCCCccceeccccChHHHHHHhhcccCccceecccccCCCcceEEecc
Q 010146 192 LKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFH 246 (517)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~ 246 (517)
..++++.++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++..
T Consensus 7 ~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 7 RQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred cccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 3445777777665533 3568899999999999999999964 2334988554
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0024 Score=63.58 Aligned_cols=79 Identities=15% Similarity=0.161 Sum_probs=51.7
Q ss_pred eecccCCeeEEEEEeCCC-CEEEEEEccC-------CCccCHHHHHHHHHHHhcCC--CC-CeeeEEEEEEeCCEEEEEE
Q 010146 357 KLGEGGFGPVYRGMLTEG-QEIAVKRLSK-------SSGQGVEEFKNEVLLIAKLQ--HR-NLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 425 (517)
.||.|....||++..++| +.|+||.-.. .-+...++..-|.+.|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578999999999998754 6899996432 11344556667777776653 23 45666654 455667999
Q ss_pred EeCCCC-CHHHHH
Q 010146 426 EYLPNK-SLEQFI 437 (517)
Q Consensus 426 e~~~~g-sL~~~l 437 (517)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0035 Score=63.05 Aligned_cols=142 Identities=17% Similarity=0.252 Sum_probs=81.2
Q ss_pred ceecccCCeeEEEEEeCC-----CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeCC
Q 010146 356 NKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 429 (517)
+.|-.|-.-.+|+....+ ++.+++|+..........+ .+|..+++.+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455567778899987542 3678899886544333333 668888887764443 3455555322 5799998
Q ss_pred CCCHHHH-----------------HhccCC-C-C-CCCHHHHHHHHHH-----------------HHHHHHHh----Hh-
Q 010146 430 NKSLEQF-----------------IFDVTR-T-K-FLDWSKRCQIIEG-----------------IARGLLYL----HQ- 467 (517)
Q Consensus 430 ~gsL~~~-----------------l~~~~~-~-~-~l~~~~~~~i~~q-----------------i~~aL~~L----H~- 467 (517)
+.+|... +++... . . ...+.++..+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 111110 0 0 1112222222211 11112222 21
Q ss_pred cCCCceEecCCCCCcEEECC-CCCeEEccccCceec
Q 010146 468 DSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAF 502 (517)
Q Consensus 468 ~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 502 (517)
..+..++|+|+++.|||+++ ++.++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22345899999999999986 467999999988743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00011 Score=80.38 Aligned_cols=151 Identities=19% Similarity=0.231 Sum_probs=104.5
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
...+.+.+.+.+-+|.++.++.+.-.. |...+.|..... .....+..+.+-.++-..++|-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345667778889999999999877433 433344333221 1222233333333333345566665555455677889
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|+++|+.+++|...|+... ..+..-....+..+.+++++||... +.|+|++|.|+|+..++..+++|||+....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999885432 3444445556677889999999876 899999999999999999999999966544
Q ss_pred C
Q 010146 503 G 503 (517)
Q Consensus 503 ~ 503 (517)
+
T Consensus 955 g 955 (1205)
T KOG0606|consen 955 G 955 (1205)
T ss_pred c
Confidence 3
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.012 Score=59.70 Aligned_cols=80 Identities=13% Similarity=0.103 Sum_probs=54.4
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCC----C---ccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS----S---GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 424 (517)
.+.||.|....||+.... ++.++||.-... . +...++-..|.+.|+.+. ...+++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478899999999998864 567899976521 1 123444555666666553 357888888876 556888
Q ss_pred EEeCCC--CCHHHHH
Q 010146 425 YEYLPN--KSLEQFI 437 (517)
Q Consensus 425 ~e~~~~--gsL~~~l 437 (517)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3455444
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00059 Score=65.80 Aligned_cols=131 Identities=17% Similarity=0.209 Sum_probs=90.3
Q ss_pred CCCccceecccCCeeEEEEEeCCCCEEEEEEccCC-----------------Cc---c--CHHHHHHHHHHHhcCCC--C
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS-----------------SG---Q--GVEEFKNEVLLIAKLQH--R 406 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~---~--~~~~~~~e~~~l~~l~h--~ 406 (517)
-+.+.+.||-|--+.||.+...+|++.++|.-+.. .. . ..-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999999999998842211 00 0 11234567777777753 2
Q ss_pred CeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 407 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
-+++.+++ +..++|||++.+-.|.+.- ...+..+ +...+..-+.-|..+| +||+|..--||+|+
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34455543 4578999999888775432 1123333 3333444455666667 99999999999999
Q ss_pred CCCCeEEcccc
Q 010146 487 NDMNPKISDFG 497 (517)
Q Consensus 487 ~~~~~kl~DFG 497 (517)
++..++++||=
T Consensus 237 dd~~i~vIDFP 247 (465)
T KOG2268|consen 237 DDDKIVVIDFP 247 (465)
T ss_pred cCCCEEEeech
Confidence 99999999995
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0038 Score=61.35 Aligned_cols=144 Identities=19% Similarity=0.190 Sum_probs=96.1
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEccCCC------c----------------cCHH----HHHHHHHHHhcCCCCC
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS------G----------------QGVE----EFKNEVLLIAKLQHRN 407 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~----------------~~~~----~~~~e~~~l~~l~h~n 407 (517)
+...|..|--+-||.+.-.+|..+|||+.+..- . ...+ -...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 446788899999999999999999999875421 0 0011 1345777777776444
Q ss_pred eeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC
Q 010146 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 487 (517)
Q Consensus 408 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 487 (517)
|.-.--.. -....|||+|+....... ..-+.-.++...+..+-.|++.-|.-|.+.+ ++||.||.--|+|+-+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 32111000 123469999995322111 1112234677788888999999999998877 4999999999999854
Q ss_pred CCCeEEccccCceecCCC
Q 010146 488 DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 488 ~~~~kl~DFGla~~~~~~ 505 (517)
|.+.|+|-+-+-....+
T Consensus 301 -G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred -CEEEEEEccccccCCCh
Confidence 58999999877655443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0039 Score=62.84 Aligned_cols=81 Identities=12% Similarity=0.115 Sum_probs=54.3
Q ss_pred cceecccCCeeEEEEEeCC-CCEEEEEEccC------CCccCHHHHHHHHHHHhcCC--CC-CeeeEEEEEEeCCEEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK------SSGQGVEEFKNEVLLIAKLQ--HR-NLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 424 (517)
.+.||-|.-.-||++...+ ++.|+||.-.. .-+...++..-|.+.|+... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4689999999999999753 57899986432 11345667777888777653 23 46666654 45566889
Q ss_pred EEeCCCC-CHHHHH
Q 010146 425 YEYLPNK-SLEQFI 437 (517)
Q Consensus 425 ~e~~~~g-sL~~~l 437 (517)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998542 344443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.087 Score=52.54 Aligned_cols=93 Identities=14% Similarity=0.102 Sum_probs=53.9
Q ss_pred ccchhHHHHhcCCCCcc---c-eecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC--CCeeeEE
Q 010146 339 MFDWNTIADATDNFSWK---N-KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLL 412 (517)
Q Consensus 339 ~~~~~~i~~~~~~y~~~---~-~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~ 412 (517)
.++.+.+..+...+-+. + ..=.+.-..||+....++..+++|..+.. .....++..|++.+..|.. -.++...
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 44455555554444321 1 11223446799998877888999987542 3355677778877766632 1122211
Q ss_pred ---E--EEEeCCEEEEEEEeCCCCC
Q 010146 413 ---G--CCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 413 ---~--~~~~~~~~~lv~e~~~~gs 432 (517)
| ....++..+.++++++|..
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1233566788999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.029 Score=55.52 Aligned_cols=29 Identities=24% Similarity=0.366 Sum_probs=25.3
Q ss_pred CceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 471 LRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 471 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999988 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.027 Score=55.93 Aligned_cols=140 Identities=26% Similarity=0.349 Sum_probs=82.3
Q ss_pred eecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC------eeeEEEEE--EeC--CEEEEEEE
Q 010146 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVRLLGCC--TLR--DERMLIYE 426 (517)
Q Consensus 357 ~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~--~~~--~~~~lv~e 426 (517)
.|.+ .-..+|+....+|+. ++|+.+.. ....++..|+..+..|.-.. +..+-|-. ... ...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 4444 456789998887776 88888764 45566777777777663211 22222211 112 36788999
Q ss_pred eCCCCCHHH-----H-------H---hc----cC--C---CCCCCHHH-------------HHHHHHHHHHHHHHhHhc-
Q 010146 427 YLPNKSLEQ-----F-------I---FD----VT--R---TKFLDWSK-------------RCQIIEGIARGLLYLHQD- 468 (517)
Q Consensus 427 ~~~~gsL~~-----~-------l---~~----~~--~---~~~l~~~~-------------~~~i~~qi~~aL~~LH~~- 468 (517)
|++|..+.. . + +. .. . .....|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887772 1 1 10 00 0 01122320 011233344444444432
Q ss_pred ---CC---CceEecCCCCCcEEECCCCC-eEEccccCce
Q 010146 469 ---SR---LRIIHRDLKASNVLLDNDMN-PKISDFGMAR 500 (517)
Q Consensus 469 ---~~---~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~ 500 (517)
-+ ..+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 12999999999999999875 9999999775
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.028 Score=56.16 Aligned_cols=142 Identities=16% Similarity=0.273 Sum_probs=78.6
Q ss_pred ceecccCCeeEEEEEeCC----CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.|..|-...+|+....+ +..|++|+......... .-.+|..+++.+...++ +++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456557777889887543 23788888765433222 23567788877765444 35565553 22 48899877
Q ss_pred CCHHH--------------HH---hccC-C-CC-CCCHHHHHHHHHH----------------------HHHHHHHh---
Q 010146 431 KSLEQ--------------FI---FDVT-R-TK-FLDWSKRCQIIEG----------------------IARGLLYL--- 465 (517)
Q Consensus 431 gsL~~--------------~l---~~~~-~-~~-~l~~~~~~~i~~q----------------------i~~aL~~L--- 465 (517)
..|.. .| ++.. . .. ...+..+.++..+ +.+-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 11 1111 0 00 1112222222211 11112211
Q ss_pred H-h-cCCCceEecCCCCCcEEECC-CCCeEEccccCceec
Q 010146 466 H-Q-DSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAF 502 (517)
Q Consensus 466 H-~-~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 502 (517)
. . ..+.-+.|.|+.|.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1 1 11234799999999999975 468999999988643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.021 Score=57.08 Aligned_cols=136 Identities=13% Similarity=0.103 Sum_probs=85.1
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEE------Ee-CCEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCC------TL-RDERMLI 424 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~-~~~~~lv 424 (517)
...+.||+|+.+.+|..-.- ..-+.|+..........+.. ..|.+. .||-+..-+.+- .. +...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34578999999999964321 12244666554333222222 223333 455443311110 11 1225577
Q ss_pred EEeCCCCC-HHHHHh---ccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 425 YEYLPNKS-LEQFIF---DVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 425 ~e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
|..+++.. ...++. +.+.-....|...++.++.++.+.+.||++| .+-+|+.++|+|+++++.|.|.|=
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 77776542 233332 1122345789999999999999999999999 899999999999999988888764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.00057 Score=71.22 Aligned_cols=145 Identities=18% Similarity=0.135 Sum_probs=100.5
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLI 424 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 424 (517)
+..++.+...+.++++++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++...++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3344445555778999999999988554444445555432 45567889999999999 77777777777778899
Q ss_pred EEeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
+++...+ +-...+ ......+..-+...+.+.-+++|++||+.- -+|+| ||+..+ ...|..||+.+..+.
T Consensus 313 ~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999766 221111 011112333445566777788999999854 48998 888776 579999999998876
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
+.
T Consensus 383 ~~ 384 (829)
T KOG0576|consen 383 RT 384 (829)
T ss_pred cc
Confidence 54
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.045 Score=50.62 Aligned_cols=75 Identities=20% Similarity=0.302 Sum_probs=51.8
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.+.-|.--..|.... +..++.||+-.. .....|..|+.-|..| +...+.+++.+-...++.|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4454454444555443 367888987543 3445677777665555 45668888988889999999999998766
Q ss_pred HH
Q 010146 433 LE 434 (517)
Q Consensus 433 L~ 434 (517)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 55
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.012 Score=54.74 Aligned_cols=30 Identities=33% Similarity=0.506 Sum_probs=21.4
Q ss_pred ceEecCCCCCcEEE-CCCCCeEEccccCcee
Q 010146 472 RIIHRDLKASNVLL-DNDMNPKISDFGMARA 501 (517)
Q Consensus 472 ~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~ 501 (517)
.+.|+||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8888999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.052 Score=53.72 Aligned_cols=31 Identities=26% Similarity=0.348 Sum_probs=27.8
Q ss_pred CCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 470 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
+..++|+|+.+.|||++.++.+.|+||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999899999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.031 Score=51.31 Aligned_cols=102 Identities=16% Similarity=0.147 Sum_probs=67.0
Q ss_pred EEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHH
Q 010146 376 EIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454 (517)
Q Consensus 376 ~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i 454 (517)
+..+|+++...-. ...-|.++.+++++++ .|+++..- .....-++.|++-.... .. ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch----hHH
Confidence 4556666554333 4556788899999876 46666632 23334588888832111 11 112
Q ss_pred HHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 455 ~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
+..=+.+|.-.|+.. ...+|+|-.|+|||-|..|.+||.|=+.
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 222256788888553 4599999999999999999999999763
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.029 Score=56.15 Aligned_cols=59 Identities=22% Similarity=0.195 Sum_probs=41.6
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEEC
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~ 486 (517)
..++-+|+++.++..++... ..+++...+++.-.++||.-+-. .+ ++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence 45677788899999988432 24555666666666666654433 34 99999999999994
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.19 Score=57.87 Aligned_cols=141 Identities=21% Similarity=0.292 Sum_probs=76.8
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-------CCCCeeeEE-E----EEEe-CC--E
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-------QHRNLVRLL-G----CCTL-RD--E 420 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~l~-~----~~~~-~~--~ 420 (517)
+.|+ |..-.+|+....+|+.+++|+.+... .......|..++..| .-|.+++-. | .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4453 44577899888788899999997642 223344444455433 223333321 1 1111 22 4
Q ss_pred EEEEEEeCCCCCHHHH--------------H---h----ccCC---CCCCCHH-----------------HHHHHHHHHH
Q 010146 421 RMLIYEYLPNKSLEQF--------------I---F----DVTR---TKFLDWS-----------------KRCQIIEGIA 459 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~--------------l---~----~~~~---~~~l~~~-----------------~~~~i~~qi~ 459 (517)
.+.+++|++|..|.+. + + .... ...+.|. ....++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5778999999877651 1 0 0000 0112221 1112223333
Q ss_pred HHHH-----HhHhcCCCceEecCCCCCcEEECCCC--CeE-EccccCce
Q 010146 460 RGLL-----YLHQDSRLRIIHRDLKASNVLLDNDM--NPK-ISDFGMAR 500 (517)
Q Consensus 460 ~aL~-----~LH~~~~~~iiH~Dlkp~NIll~~~~--~~k-l~DFGla~ 500 (517)
+... .|.+ -+..+||+|+.+.|||++.+. .+. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 1211 234599999999999999875 454 99999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 517 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-28 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-96
Identities = 73/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 327 DRGNRKENMELPMFDWNTIADATDNFS------WKNKLGEGGFGPVYRGMLTEGQEIAVK 380
++ + F + + + T+NF NK+GEGGFG VY+G + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 381 RLSK----SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF 436
+L+ ++ + ++F E+ ++AK QH NLV LLG + D+ L+Y Y+PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 437 IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496
+ + T L W RC+I +G A G+ +LH++ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 497 GMARAFGVDQTEANTDRVVGT 517
G+ARA T R+VGT
Sbjct: 178 GLARASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 8e-92
Identities = 80/180 (44%), Positives = 108/180 (60%), Gaps = 3/180 (1%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE-EFKNEVL 398
F + A+DNFS KN LG GGFG VY+G L +G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEG 457
+I+ HRNL+RL G C ER+L+Y Y+ N S+ + + ++ LDW KR +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
ARGL YLH +IIHRD+KA+N+LLD + + DFG+A+ T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 7e-83
Identities = 73/175 (41%), Positives = 115/175 (65%), Gaps = 6/175 (3%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+ +AT+NF K +G G FG VY+G+L +G ++A+KR + S QG+EEF+ E+ ++ +
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLL 463
H +LV L+G C R+E +LIY+Y+ N +L++ ++ T + W +R +I G ARGL
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGT 517
YLH + IIHRD+K+ N+LLD + PKI+DFG+++ +DQT +T V GT
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 4e-65
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
+ G FG V++ L + +AVK Q + + EV + ++H N
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHEN 79
Query: 408 LVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
+++ +G + + LI + SL F+ + + W++ C I E +ARGL
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLA 135
Query: 464 YLHQD-------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
YLH+D + I HRD+K+ NVLL N++ I+DFG+A F ++ +T VG
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 517 T 517
T
Sbjct: 196 T 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 2e-55
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 30/202 (14%)
Query: 335 MELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK 394
ME + + DN +G G +G VY+G L + + +AVK S ++ Q F
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFI 53
Query: 395 NE--VLLIAKLQHRNLVRLLGCCT-----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
NE + + ++H N+ R + R E +L+ EY PN SL +++ D
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSD 109
Query: 448 WSKRCQIIEGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
W C++ + RGL YLH + + I HRDL + NVL+ ND ISDFG++
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 502 F------GVDQTEANTDRVVGT 517
+ + VGT
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 6/165 (3%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
K K+G G FG V+R G ++AVK L + + V EF EV ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
G T ++ EYL SL + + + LD +R + +A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+HR+LK+ N+L+D K+ DFG++R T ++ GT
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 6/160 (3%)
Query: 355 KNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
LG+G FG + G+ + +K L + + F EV ++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
I EY+ +L I WS+R + IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
IHRDL + N L+ + N ++DFG+AR ++T+ R
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVR 410
+ +G GGFG VYR G E+AVK Q +E + E L A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
L G C L+ E+ L + + K + IARG+ YLH ++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 471 LRIIHRDLKASNVLLDNDMNP--------KISDFGMAR 500
+ IIHRDLK+SN+L+ + KI+DFG+AR
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ +G G FG V + +++A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+L G C + L+ EY SL + + + ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 470 RLRIIHRDLKASNVLLDNDMN-PKISDFGMAR 500
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 7/152 (4%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
KL E G +++G +G +I VK L S + +F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 413 GCCT--LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
G C LI ++P SL + + T +D S+ + +ARG+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEP 132
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
L I L + +V++D DM +IS + +F
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 45/181 (24%), Positives = 93/181 (51%), Gaps = 23/181 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-------VEEFKNEVLLIA 401
+ ++ ++G+GGFG V++G L + +A+K L +G +EF+ EV +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
L H N+V+L G + ++ E++P L + D + + WS + +++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAFGVDQTEANTDRVVG 516
+ Y+ I+HRDL++ N+ L + + K++DFG+++ Q+ + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 517 T 517
Sbjct: 189 N 189
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 24/194 (12%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
LP+ TIA ++G+G +G V+ G G+++AVK + E
Sbjct: 27 LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79
Query: 397 --VLLIAKLQHRNLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
+ ++H N++ + + LI +Y N SL ++ ++ LD
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135
Query: 451 RCQIIEGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNDMNPKISDFGMARAF--G 503
++ GL +LH + I HRDLK+ N+L+ + I+D G+A F
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 504 VDQTEANTDRVVGT 517
++ + + VGT
Sbjct: 196 TNEVDIPPNTRVGT 209
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
++G G FG VY+G ++AVK L+ + + Q ++ FKNEV ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
G T + ++ ++ SL + + K I ARG+ YLH
Sbjct: 87 GYST-APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IIHRDLK++N+ L D KI DFG+A +++ G+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-40
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
+G+G FG VY G E+A++ + + ++ FK EV+ + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
G C +I ++L + D LD +K QI + I +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR---VVGT 517
I+H+DLK+ NV DN I+DFG+ GV Q D+ G
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 24/194 (12%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
LP+ TIA + +G+G FG V+RG G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFRE 84
Query: 397 --VLLIAKLQHRNLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
+ L+H N++ + + L+ +Y + SL ++ +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEG 140
Query: 451 RCQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--G 503
++ A GL +LH + + I HRDLK+ N+L+ + I+D G+A
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 504 VDQTEANTDRVVGT 517
D + + VGT
Sbjct: 201 TDTIDIAPNHRVGT 214
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE--VLLIAKLQHRNLVRLLG 413
+G+G +G V+RG +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 414 CCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+ LI Y SL ++ + LD +I+ IA GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 470 RLR-----IIHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGT 517
I HRDLK+ N+L+ + I+D G+A + +Q + + VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+ + +LG+G FG V G+ +AVK+L S+ + + +F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
H N+V+ G C R LI EYLP SL ++ + K L ++ I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
+G+ YL R IHRDL N+L++N+ KI DFG+ + D+
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+ + +LG+G FG V G+ +AVK+L S+ + + +F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
H N+V+ G C R LI EYLP SL ++ + K L ++ I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
+G+ YL R IHRDL N+L++N+ KI DFG+ + D+
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 52/160 (32%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 408
LGEG FG V G+ +AVK L +G Q +K E+ ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 409 VRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
++ GCC L+ EY+P SL ++ + ++ + I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
IHRDL A NVLLDND KI DFG+A+A
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
+ + ++LG+G FG V G +AVK+L S +F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
+V+ G + L+ EYLP+ L F+ + ++ L +S I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+G+ YL R +HRDL A N+L++++ + KI+DFG+A+ +D+
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKSSGQGV-EEFKNEVLLIAKL 403
F LG G FG VY+G+ E +A+K L +++ +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIA 459
+ ++ RLLG C LI + +P L ++ + + L+W IA
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
+G+ YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E + +
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 21/164 (12%)
Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNL 408
LGEG FG V G+++AVK L +S G + + K E+ ++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 409 VRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGL 462
V+ G CT LI E+LP+ SL++++ + + L ++ I +G+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------QICKGM 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
YL + +HRDL A NVL++++ KI DFG+ +A D+
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRN 407
++ ++G G FG V+ G L + +AVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+VRL+G CT + ++ E + F+ T L Q++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL A N L+ KISDFGM+R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
K +LGEG FG V+ + +AVK L ++S ++F+ E L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQF------------IFDVTRTKFLDWSKRCQIIE 456
VR G CT ++++EY+ + L +F + L + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 355 KNKLGEGGFGPVYRGMLT---EGQEI--AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 408
LG G FG V++G+ E +I +K + SG Q + + +L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLY 464
VRLLG C L+ +YLP SL + + L+W IA+G+ Y
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
L ++HR+L A NVLL + +++DFG+A D +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
K +LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQF-------------IFDVTRTKFLDWSKRCQII 455
V+ G C D ++++EY+ + L +F L S+ I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 14/166 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
++ ++G G FG V+ G ++A+K + + E+F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYL 465
+L G C + L+ E++ + L ++ L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMAYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+IHRDL A N L+ + K+SDFGM R DQ ++T
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 23/166 (13%)
Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRN 407
+LGE FG VY+G L + Q +A+K L + G EEF++E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQF-------------IFDVTRTKFLDWSKRCQI 454
+V LLG T +I+ Y + L +F D T L+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ IA G+ YL S ++H+DL NVL+ + +N KISD G+ R
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAKL 403
F LG G FG VY+G+ E +A+K L +S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIA 459
+ ++ RLLG C LI + +P L ++ + + L+W IA
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
+G+ YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E + +
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 10/158 (6%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
+LG G FG V +G+ ++ +A+K L + + EE E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
L+G C + ML+ E L +F+ V + + + S +++ ++ G+ YL
Sbjct: 75 LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+HRDL A NVLL N KISDFG+++A G D +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ + +LG G FG V G ++AVK + K +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+ G C+ ++ EY+ N L ++ + K L+ S+ ++ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ IHRDL A N L+D D+ K+SDFGM R
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
+ + +LG+G FG VY G+ +A+K +++ +S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------IFDVTRTKFLDWSKRCQII 455
++VRLLG + ++I E + L+ + + + SK Q+
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IA G+ YL + + +HRDL A N ++ D KI DFGM R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 21/238 (8%)
Query: 274 ERTKRRKKKKVVIIIICALLATGVILIGGFMYMRKKKRRDQGNT-VGSSELDYIDRGNRK 332
+RR I++ I + K+ N + +ID
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSK-SSG 387
+ + + + +G G FG VY G L + AVK L++ +
Sbjct: 73 PELVQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131
Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-RMLIYEYLPNKSLEQFI----FDVTR 442
V +F E +++ H N++ LLG C + +++ Y+ + L FI + T
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ + +A+G+ +L + + +HRDL A N +LD K++DFG+AR
Sbjct: 192 KDLIGFGL------QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 357 KLGEGGFGPVYRGML-TEGQEI--AVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+LG G FG V +G + AVK L + +E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
+G C + ML+ E L ++ + + + + +++ ++ G+ YL
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+HRDL A NVLL KISDFG+++A D+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ ++ +LG G FG V G ++A+K + K +EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+L G CT + +I EY+ N L ++ + ++ + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ +HRDL A N L+++ K+SDFG++R
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 6/154 (3%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
KLG G FG V+ + ++AVK + K VE F E ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
T ++ +I E++ SL F+ K IA G+ ++ + IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
RDL+A+N+L+ + KI+DFG+AR ++ A
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 51/163 (31%), Positives = 70/163 (42%), Gaps = 21/163 (12%)
Query: 357 KLGEGGFGPVYRGMLT--EGQEI--AVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLV 409
KLG+G FG V RG G+ + AVK L S + +++F EV + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
RL G ++ E P SL + ++ +A G+ YL
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
R IHRDL A N+LL KI DFG+ RA +
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 6/163 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+ + K+KLG G +G VY G+ +AVK L K VEEF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V+LLG CT +I E++ +L ++ + + + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+ IHRDL A N L+ + K++DFG++R D A+
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 10/158 (6%)
Query: 355 KNKLGEGGFGPVYRGML-TEGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
+LG G FG V +G+ ++I A+K L + EE E ++ +L + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
L+G C + ML+ E L +F+ V + + + S +++ ++ G+ YL
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
+HR+L A NVLL N KISDFG+++A G D +
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ +G G G V G L +A+K L + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
RL G T M++ EY+ N SL+ F+ T + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L +HRDL A NVL+D+++ K+SDFG++R D A T
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLI 400
D + LGEG FG V E +AVK L ++ + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-- 457
+ +H+N++ LLG CT +I EY +L +++ R +++S +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 153
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML--------TEGQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
++ + LG+G F +++G+ E+ +K L K+ E F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEG 457
KL H++LV G C DE +L+ E++ SL+ ++ + L+ +K
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------Q 121
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--------KISDFGMAR 500
+A + +L +IH ++ A N+LL + + K+SD G++
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSK-SSG 387
+++ +P + +G+G FG VY G + + A+K LS+ +
Sbjct: 12 KDVLIP-HERVVTHS-------DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFI----FDVTR 442
Q VE F E LL+ L H N++ L+G + ++ Y+ + L QFI + T
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ + +ARG+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 124 KDLISFGL------QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 28/183 (15%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE---IAVKRL-SKSSGQGVE 391
P+ DWN I +++ +GEG FG V + + + A+KR+ +S
Sbjct: 18 IYPVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70
Query: 392 EFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------------I 437
+F E+ ++ KL H N++ LLG C R L EY P+ +L F
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 438 FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
+ L + +ARG+ YL S+ + IHRDL A N+L+ + KI+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 498 MAR 500
++R
Sbjct: 188 LSR 190
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 410 RLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+LLG ++ EY+ SL ++ R L + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+HRDL A NVL+ D K+SDFG+ +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ +LG G FG V+ G ++AVK L K + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
RL T ++ +I EY+ N SL F+ L +K + IA G+ ++
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
IHRDL+A+N+L+ + ++ KI+DFG+AR
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 408
LGEG FG V G L ++AVK + SS + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 409 VRLLGCCTLRD-----ERMLIYEYLPNKSLEQFI---FDVTRTKFLDWSKRCQIIEGIAR 460
+RLLG C + M+I ++ L ++ T K + + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
G+ YL S +HRDL A N +L +DM ++DFG+++
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 31/179 (17%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
+N + +GEG FG V++ +AVK L ++S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF---------------------IFDVT 441
+ N+V+LLG C + L++EY+ L +F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
L +++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLI 400
D + LGEG FG V E +AVK L ++ + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-- 457
+ +H+N++ LLG CT +I EY +L +++ R +++S +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 199
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR
Sbjct: 200 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 415 CTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
++ EY+ SL ++ R L + + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR 500
+HRDL A NVL+ D K+SDFG+ +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 352 FSWKNK--LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
++ LG+G +G VY G L+ IA+K + + + + E+ L L+H+N+
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLY 464
V+ LG + + E +P SL + R+K+ Q I + GL Y
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQTEANTDRVVGT 517
LH + +I+HRD+K NVL++ KISDFG ++ T GT
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 356 NKLGEGGFGPVYRGMLTEG----QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
+G G FG VY G L + AVK L++ + V +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 411 LLGCCTLRDE-RMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
LLG C + +++ Y+ + L FI + T + + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGMKYL 144
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ + +HRDL A N +LD K++DFG+AR
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
+KLG G +G VY G+ +AVK L K VEEF E ++ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
CT +I E++ +L ++ + + + + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
HR+L A N L+ + K++DFG++R D A+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
N + LG G FG VY G ++ ++AVK L + S Q +F E L+I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGI 458
H+N+VR +G R ++ E + L+ F+ ++ L + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMAR 500
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
KLG+G FG V+ G +A+K L K E F E ++ KL+H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ + ++ EY+ SL F+ K+L + + IA G+ Y+ R+ +H
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
RDL+A+N+L+ ++ K++DFG+AR ++ A
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
KLG+G FG V+ G +A+K L K E F E ++ KL+H LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
+ + ++ EY+ SL F+ K+L + + IA G+ Y+ R+ +H
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
RDL+A+N+L+ ++ K++DFG+AR ++ A
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 31/179 (17%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
N LGEG FG V + +AVK L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------IFDVTRTKFLDWSKRCQII 455
+ H ++++L G C+ +LI EY SL F + S
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 456 EG--------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ I++G+ YL + ++++HRDL A N+L+ KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 18/161 (11%)
Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 408
LG+G FG V L ++AVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 409 VRLLGCCTLRDER------MLIYEYLPNKSLEQFIFD---VTRTKFLDWSKRCQIIEGIA 459
+L+G + M+I ++ + L F+ L + + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
G+ YL S IHRDL A N +L DM ++DFG++R
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
++G G F VY+G+ E+A + K + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 414 CC--TLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
T++ ++ + + E + + +L+ ++ R K + I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 470 RLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IIHRDLK N+ + + KI D G+A + A V+GT
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGT 193
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
N + LG G FG VY G ++ ++AVK L + S Q +F E L+I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGI 458
H+N+VR +G R ++ E + L+ F+ ++ L + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMAR 500
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 355 KNKLGEGGFGPVYRGMLT--EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 409
LGEG FG VY G+ T +G++I AVK K + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
+L+G + +I E P L ++ + + +S I + + YL
Sbjct: 77 KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL 129
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
+ +HRD+ N+L+ + K+ DFG++R
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 404
N S +G G FG V G L + +A+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H N++RL G T M++ EY+ N SL+ F+ + ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
L S + +HRDL A N+L+++++ K+SDFG+ R D A
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 48/167 (28%), Positives = 88/167 (52%), Gaps = 19/167 (11%)
Query: 355 KNKLGEGGFGPVYRGML---TEGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 408
+ +G G FG VY+GML + +E+ A+K L + + +F E ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
+RL G + M+I EY+ N +L++F+ + + + + + GIA G+ Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR------GIAAGMKY 162
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L + + +HRDL A N+L+++++ K+SDFG++R D T
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ E N L ++ + K +D +R + + + +HQ
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+H DLK +N L+ + K+ DFG+A D T D VGT
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
+F LG+G FG V + + + A+K++ + + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 408 LVRLLGC----------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
+VR T ++ ++ EY N +L I + + ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
I L Y+H IIHRDLK N+ +D N KI DFG+A+
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 357 KLGEGGFGPVYRGMLT--EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
+GEG FG V++G+ E + A+K +S E+F E L + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+G T + +I E L F+ + + + ++ ++ L YL
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY------QLSTALAYL-- 132
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
R +HRD+ A NVL+ ++ K+ DFG++R
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 28/185 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+F +G GGFG V++ +G+ +KR+ ++ E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 409 VRLLGC-------------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRC 452
V GC + R + ++ E+ +LEQ+I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
++ E I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ + D +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTR- 180
Query: 513 RVVGT 517
GT
Sbjct: 181 -SKGT 184
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 27/174 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
D LG G FG V + +AVK L ++ +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 403 L-QHRNLVRLLGCCTLRDE-RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--- 457
+ H N+V LLG CT M+I E+ +L ++ R +F+ + + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYKDFL 145
Query: 458 -----------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 28/175 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAK 402
+ S+ LG G FG V +AVK L S E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
L H N+V LLG CT+ ++I EY L F+ R F+ I+E
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR-KRDSFICSKTSPAIMEDDELA 141
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L + IHRDL A N+LL + KI DFG+AR
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQH 405
NF + K+G G F VYR L +G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLY 464
N+++ +E ++ E L + I + + + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+H R++HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ E N L ++ + K +D +R + + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+H DLK +N L+ + K+ DFG+A D T D VGT
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 355 KNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-Q 404
LGEG FG V ++AVK L S ++ + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG------- 457
H+N++ LLG CT +I EY +L +++ R L++S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 458 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 49/170 (28%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
+N + LG G FG V ++AVK L S + E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----------IFDVTRTKFLDWSK 450
L QH N+V LLG CT ++I EY L F
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L + IHRD+ A NVLL N KI DFG+AR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 21/194 (10%)
Query: 333 ENMELPMFDWNTIADATDNFSW---KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQ 388
E + L + + W + ++G G FG V+R G + AVK++
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----- 92
Query: 389 GVEEFK-NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
+E F+ E++ A L +V L G + E L SL Q I + L
Sbjct: 93 -LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP 148
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMAR---AFG 503
+ + GL YLH RI+H D+KA NVLL +D + + DFG A G
Sbjct: 149 EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 504 VDQTEANTDRVVGT 517
+ ++ D + GT
Sbjct: 206 LGKSLLTGDYIPGT 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 9/150 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
KLGEGGF V L +G A+KR+ Q EE + E + H N++RL+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 416 TLRDERM----LIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSR 470
L+ + +L I + FL + ++ GI RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
HRDLK +N+LL ++ P + D G
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 17/176 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRN 407
+F LG GGFG V+ + A+KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 408 LVRLLGC---------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
+VR ++ +Y + ++L+ ++ + + S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
IA + +LH ++HRDLK SN+ D K+ DFG+ A D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
++ E N L ++ + K +D +R + + + +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+H DLK +N L+ + K+ DFG+A D T D VG
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 47/227 (20%)
Query: 307 RKKKRRDQGNTVGSSELDYIDRGNRKENMELPM-----FDWNTIADATDNFSWKNKLGEG 361
R + + GSS+ +Y E F + + LG G
Sbjct: 8 RYESQLQMVQVTGSSDNEYFYVDF----REYEYDLKWEFPRENL-------EFGKVLGSG 56
Query: 362 GFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLG 413
FG V ++AVK L + E +E+ ++ +L H N+V LLG
Sbjct: 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 414 CCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEG---------- 457
CTL LI+EY L + F ++ + + + +
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 458 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L +HRDL A NVL+ + KI DFG+AR
Sbjct: 177 FAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-28
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 304 MYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGF 363
+ +K+ S DY + + ++ +P I + +GEG F
Sbjct: 346 LANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQF 403
Query: 364 GPVYRGMLT--EGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418
G V++G+ E + A+K + +S E+F E L + + H ++V+L+G T
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462
Query: 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL 478
+ +I E L F+ R LD + ++ L YL R +HRD+
Sbjct: 463 NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDI 517
Query: 479 KASNVLLDNDMNPKISDFGMARA 501
A NVL+ ++ K+ DFG++R
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRY 540
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 52/177 (29%), Positives = 93/177 (52%), Gaps = 27/177 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 401
+ + K+GEG +G VY+ ++G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGI 458
+L H N+V L+ L++E++ K L++ + D +T D + Q++ G+
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQLLRGV 132
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
A + HQ RI+HRDLK N+L+++D K++DFG+ARAFG+ + T VV
Sbjct: 133 A----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV 181
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 406
+ + K+GEG FG +G++ +K +S+ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+V+ ++ +Y L + I + + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH 142
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+I+HRD+K+ N+ L D ++ DFG+AR A +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 50/175 (28%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
++ D ++ K+G+G G VY M GQE+A+++++ E NE+L++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
++ N+V L + DE ++ EYL SL DV +D + + + L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH + ++IHRD+K+ N+LL D + K++DFG +Q++ +T +VGT
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
+++ +G G +G + ++G+ + K L + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 407 NLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLL 463
N+VR R L + EY L I T+ + +LD +++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 464 YLHQ--DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H+ D ++HRDLK +NV LD N K+ DFG+AR D + A T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 50/175 (28%), Positives = 90/175 (51%), Gaps = 21/175 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
+NF K+GEG +G VY+ G+ +A+K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
+L H N+V+LL ++ L++E+L + L++F+ D + + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
GL + H R++HRDLK N+L++ + K++DFG+ARAFGV T VV
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV 165
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
D K+GEG G V G+++AVK + Q E NEV+++
Sbjct: 39 DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
QH N+V + + +E ++ E+L +L D+ L+ + + E + + L
Sbjct: 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQAL 154
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH +IHRD+K+ ++LL D K+SDFG D + + +VGT
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 27/177 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 401
+ + K+GEG +G VY+ G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGI 458
+L+H N+V+L + +L++E+L + L++ + DV + + Q++ GI
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQLLNGI 113
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
A Y H R++HRDLK N+L++ + KI+DFG+ARAFG+ T +V
Sbjct: 114 A----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLG 413
LG+GGF + + + A K + KS E+ E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
D ++ E +SL + R + R + I G YLH+ R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 162
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMA 499
IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 43/146 (29%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLG 413
LG+GGF + + + A K + KS E+ E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
D ++ E +SL + R + R + I G YLH R R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMA 499
IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 44/173 (25%), Positives = 85/173 (49%), Gaps = 8/173 (4%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
D + + +LG+G FG VY+ E G A K + S + +E++ E+ ++A
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H +V+LLG + ++ E+ P +++ + + + L + + + L +
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNF 132
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 25/178 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
+ + LGEG F VY+ Q +A+K++ E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEG 457
+L H N++ LL + L+++++ LE I + ++G
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII-KDNSLVLTPSHIKAYMLMTLQG 124
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+ YLHQ I+HRDLK +N+LLD + K++DFG+A++FG A T +VV
Sbjct: 125 LE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV 174
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 2e-26
Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 28/178 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
+ K+GEG +G V++ E + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEG 457
+L+H+N+VRL + L++E+ + L+++ D + Q+++G
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLDPEIVKSFLFQLLKG 113
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+ + H ++HRDLK N+L++ + K+++FG+ARAFG+ + VV
Sbjct: 114 LG----FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV 163
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 9/146 (6%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEE-FKNEVLLIAKLQHRNLVRLLG 413
LG+G F VYR G E+A+K + K + G+ + +NEV + +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
+ L+ E N + +++ R K ++ + I G+LYLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMA 499
+HRDL SN+LL +MN KI+DFG+A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 24/181 (13%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EVLLI 400
++ F KLG G + VY+G+ G +A+K + S +G E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPN---KSLEQFIFDVTRTKFLDWSKRC---QI 454
+L+H N+VRL ++ L++E++ N K ++ T + Q+
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
++G+A + H++ +I+HRDLK N+L++ K+ DFG+ARAFG+ + V
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEV 169
Query: 515 V 515
V
Sbjct: 170 V 170
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLI 400
N AD + F+ K+G+G FG V++G+ + +A+K + + + +E+ + E+ ++
Sbjct: 15 NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
++ + + G + +I EYL S D+ LD ++ I+ I +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILK 130
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GL YLH + + IHRD+KA+NVLL K++DFG+A Q + NT VGT
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKL 403
+ + +KLGEG + VY+G +A+K + +G EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIAR 460
+H N+V L L++EYL +K L+Q++ D + + Q++ G+A
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLA- 114
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
Y H+ +++HRDLK N+L++ K++DFG+ARA + T+ + VV
Sbjct: 115 ---YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV 162
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRN 407
+ + LG+G V+RG G A+K + S + V+ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 408 LVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
+V+L R LI E+ P SL + + + L S+ ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 466 HQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 20/174 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQ 404
+ + +GEG +G V + + G+ +A+K+ +S + K E+ L+ +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARG 461
H NLV LL C + L++E++ + ++ + ++ + QII GI
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIG-- 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+ H IIHRD+K N+L+ K+ DFG AR E D V
Sbjct: 139 --FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA 186
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 45/155 (29%), Positives = 67/155 (43%), Gaps = 10/155 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGC 414
L EGGF VY + G+E A+KRL + + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 415 CTLRDERM-------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
++ E L+ L L +F+ + L +I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ IIHRDLK N+LL N K+ DFG A
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHR 406
+ + LG+G V+RG T G A+K + S + V+ E ++ KL H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 407 NLVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
N+V+L R LI E+ P SL + + + L S+ ++ + G+ +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 465 LHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 16/172 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHR 406
+ + K+GEG +G V++ + GQ +A+K+ +S V + E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLL 463
NLV LL + L++EY + ++ + D + + + Q ++ +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN---- 116
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+ H+ IHRD+K N+L+ K+ DFG AR ++ D V
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA 164
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 10/176 (5%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
+ + F KLGEG +G VY+ + E GQ +A+K++ ++E E+ ++
Sbjct: 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQ 79
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
+ ++V+ G + ++ EY S+ I R K L + I++ +G
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKG 137
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L YLH R IHRD+KA N+LL+ + + K++DFG+A + NT V+GT
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 312 RDQGNTVGSSELDYIDRGNRKENMELP-MFDWNTIADATDNFSWKNKLGEGGFGPVYRGM 370
N +D + G R +++ P + + D FS ++G G FG VY
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 371 -LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426
+ + +A+K++S K S + ++ EV + KL+H N ++ GC L+ E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486
Y S + K L + + G +GL YLH +IHRD+KA N+LL
Sbjct: 135 YCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS 188
Query: 487 NDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
K+ DFG A AN+ VGT
Sbjct: 189 EPGLVKLGDFGSA----SIMAPANS--FVGT 213
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 15/196 (7%)
Query: 330 NRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ 388
+ L D + + D F +G G +G VY+G + GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 389 GVEEFKNEVLLIAKL-QHRNLVRLLGC------CTLRDERMLIYEYLPNKSLEQFIFDVT 441
EE K E+ ++ K HRN+ G + D+ L+ E+ S+ + T
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNT 121
Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
+ L I I RGL +LHQ ++IHRD+K NVLL + K+ DFG++
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 502 FGVDQTEANTDRVVGT 517
NT +GT
Sbjct: 179 LDRTVGRRNT--FIGT 192
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 42/191 (21%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN--------EVLLI 400
+ K+G+G FG V++ + + A+K++ +E K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 401 AKLQHRNLVRLLGCCTLRDERM--------LIYEYLPN--KSLEQFIFDVTRTKFLDWSK 450
L+H N+V L+ C + L++++ + L KF
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEI 126
Query: 451 RC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
+ ++ G+ Y+H++ +I+HRD+KA+NVL+ D K++DFG+ARAF + +
Sbjct: 127 KRVMQMLLNGLY----YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 508 EAN---TDRVV 515
T+RVV
Sbjct: 180 SQPNRYTNRVV 190
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 38/185 (20%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
D + KLGEG +G VY+ + T + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQII 455
+LQHRN++ L LI+EY L++++ + K + Q+I
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY----QLI 142
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVDQTEAN 510
G+ + H R +HRDLK N+LL KI DFG+ARAFG+
Sbjct: 143 NGVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQF 194
Query: 511 TDRVV 515
T ++
Sbjct: 195 THEII 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLS-KSSGQGVEEFKN----EVLLIA 401
AT + ++G G +G VY+ G +A+K + + G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 402 KLQ---HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
+L+ H N+VRL+ C L++E++ ++ L ++ D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
++ RGL +LH + I+HRDLK N+L+ + K++DFG+AR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 514 VV 515
VV
Sbjct: 180 VV 181
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 18/196 (9%)
Query: 331 RKENMELPMFDWNTIADATDNFSW--KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ 388
++E D T S+ K+ LG G G + + + +++AVKR+
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-- 60
Query: 389 GVEEFKNEV-LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
EV LL +H N++R R + + E +L++++ +
Sbjct: 61 -FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHL 116
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAF 502
+ +++ GL +LH L I+HRDLK N+L+ + ISDFG+ +
Sbjct: 117 GLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 503 GVDQTE-ANTDRVVGT 517
V + + V GT
Sbjct: 174 AVGRHSFSRRSGVPGT 189
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 48/194 (24%), Positives = 72/194 (37%), Gaps = 35/194 (18%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKL-Q 404
T F K+G G FG V++ + +G A+KR + + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 405 HRNLVRLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGL 462
H ++VR D+ MLI EY SL I + R + ++ ++ + RGL
Sbjct: 70 HSHVVRYFSAW-AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARAFG 503
Y+H ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 504 VDQTEANTDRVVGT 517
Q E G
Sbjct: 186 SPQVE------EGD 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 36/192 (18%)
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLL 399
D T ++ +G G FG V++ L E E+A+K++ + + FKN E+ +
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85
Query: 400 IAKLQHRNLVRLLGC----CTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
+ ++H N+V L +DE L+ EY+P +++ + ++K Q
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRAS--------RHYAKLKQ 136
Query: 454 IIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFG 503
+ + R L Y+H + I HRD+K N+LLD K+ DFG A+
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL- 192
Query: 504 VDQTEANTDRVV 515
E N +
Sbjct: 193 -IAGEPNVSYIC 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 31/184 (16%)
Query: 350 DNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLL 399
+ ++GEG +G V++ + G+ +A+KR+ V+ + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 400 IAKLQ---HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
+ L+ H N+VRL CT+ L++E++ ++ L ++ D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
++ + RGL +LH R++HRDLK N+L+ + K++DFG+AR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 512 DRVV 515
VV
Sbjct: 178 SVVV 181
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 49/181 (27%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 349 TDNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQH 405
+ K +LG GGFG V R T G+++A+K+ + E + E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDT-GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 406 RNLVRLL------GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
N+V D +L EY L +++ L ++ I+
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
L YLH+ RIIHRDLK N++L + KI D G A+ VG
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVG 185
Query: 517 T 517
T
Sbjct: 186 T 186
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 20/153 (13%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLL 412
LGEG +G V + +E AVK L K G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 413 GCCTLRDERM--LIYEYLPNKSLEQFIFD-VTRTKFLDWSKR---CQIIEGIARGLLYLH 466
+++ ++ EY E + D V +F CQ+I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
I+H+D+K N+LL KIS G+A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRN 407
D++ + +G G V + +++A+KR++ + ++E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE--GIA------ 459
+V ++DE L+ + L S+ D+ + + +++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 460 -RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA-----RAFGVDQTEANTDR 513
GL YLH++ IHRD+KA N+LL D + +I+DFG++ T
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185
Query: 514 VVGT 517
VGT
Sbjct: 186 FVGT 189
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F LG+G FG VY + +A+K L K+ + + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
N++RL G LI EY P ++ + + +KF + I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYC 125
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
H R+IHRD+K N+LL + KI+DFG +
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 37/192 (19%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLL 399
+++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ +
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQI 100
Query: 400 IAKLQHRNLVRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
+ KL H N+VRL E+ L+ +Y+P +++ + +R K Q
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAK--------Q 151
Query: 454 IIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFG 503
+ + R L Y+H I HRD+K N+LLD D K+ DFG A+
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL- 207
Query: 504 VDQTEANTDRVV 515
+ E N +
Sbjct: 208 -VRGEPNVSYIC 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 25/172 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS-----------------SGQGVEE 392
+++ L +G F + + A+K+ KS ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLD 447
FKNE+ +I +++ + G T DE +IYEY+ N S+ F+ D T F+
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
II+ + Y+H + I HRD+K SN+L+D + K+SDFG +
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 38/173 (21%), Positives = 62/173 (35%), Gaps = 15/173 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QH 405
+F ++LG G +G V++ +G+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 406 RNLVRLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
VRL + + E SL+Q L ++ + L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAH 172
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH ++H D+K +N+ L K+ DFG+ G G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGD 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 30/195 (15%), Positives = 64/195 (32%), Gaps = 14/195 (7%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEG--GFGPVYRGM-LTEGQEIAVKR--LSKSSG 387
L ++ + +G+G V G+ + V+R L S
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
+ V + E+ + H N+V +E ++ ++ S + + ++
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN 126
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
I++G+ + L Y+H +HR +KAS++L+ D +S +
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 508 EANT-----DRVVGT 517
V
Sbjct: 184 RQRVVHDFPKYSVKV 198
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 45/188 (23%), Positives = 72/188 (38%), Gaps = 27/188 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNL 408
+ + LG G G V +G+ +AVKR+ + E+ LL H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
+R T + E N +L+ + K ++ IA G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 465 LHQDSRLRIIHRDLKASNVLLDN-------------DMNPKISDFGMARAFGVDQT--EA 509
LH L+IIHRDLK N+L+ ++ ISDFG+ + Q+
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 510 NTDRVVGT 517
N + GT
Sbjct: 188 NLNNPSGT 195
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 11/165 (6%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
KLG GG VY ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
D L+ EY+ +L ++I L I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I+HRD+K N+L+D++ KI DFG+A+A + + T+ V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGT 175
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 36/184 (19%)
Query: 357 KLGEGGFGPVYRGM---LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
K+G G +G VY+ + ++ A+K++ + +G + + E+ L+ +L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 414 CCTLRDER--MLIYEYL-------------PNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
+R L+++Y + + K L + QI++GI
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY----QILDGI 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGV-DQTEANTDR 513
YLH + ++HRDLK +N+L+ + KI+D G AR F + A+ D
Sbjct: 142 H----YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 514 VVGT 517
VV T
Sbjct: 195 VVVT 198
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 22/180 (12%), Positives = 40/180 (22%), Gaps = 38/180 (21%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
L G V+ E ++ A+K + S +E A+L +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 414 CCTL--------------------------RDERMLIYEYLPNKSLEQFI----FDVTRT 443
L +L+ + LE F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFR 188
Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
+ + R L ++H N+ + D + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 23/189 (12%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQGVEEFKN 395
+ + ++ LG+G FG V + QE AVK ++K+ +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR-- 451
EV L+ KL H N+++L ++ E L FD + R +F S+
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDA 123
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTE 508
+II+ + G+ Y+H+ I+HRDLK N+LL + D + KI DFG++ F +
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 509 ANTDRVVGT 517
+GT
Sbjct: 180 --MKDRIGT 186
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 8e-22
Identities = 29/194 (14%), Positives = 55/194 (28%), Gaps = 38/194 (19%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH-------- 405
LG+ G+ V + +++ K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 406 --------RNLVRLLGCCTLRD-----ERMLIYEY-----LPNKSLEQFIF----DVTRT 443
+LV+ + M + +L+ F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
K L R Q+ + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 504 VDQTEANTDRVVGT 517
+ R
Sbjct: 263 -ASAVSPIGRGFAP 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 16/168 (9%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
D + +LG G FG V+R E G+ K ++ KNE+ ++ +
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIAR 460
L H L+ L + E +LI E+L L FD + ++ +
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACE 160
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQ 506
GL ++H+ I+H D+K N++ + KI DFG+A D+
Sbjct: 161 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
D ++ +N +G G +G V + A K++ K + V+ FK E+ ++ L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIAR 460
H N++RL + L+ E L F+ V + F + +I++ +
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVLS 117
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ Y H+ L + HRDLK N L D K+ DFG+A F + VGT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGT 171
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 23/189 (12%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQGVEEFKN 395
MF + ++ + KLG G +G V E A+K + K+ S +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR-- 451
EV ++ L H N+++L + L+ E L FD + R KF ++
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKF---NEVDA 138
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
II+ + G+ YLH+ I+HRDLK N+LL++ D KI DFG++ F +
Sbjct: 139 AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194
Query: 509 ANTDRVVGT 517
+GT
Sbjct: 195 --MKERLGT 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
LG GG V+ L + +++AVK R + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 413 --GCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
G + ++ EY+ +L + + + ++I + L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-VDQTEANTDRVVGT 517
+ IIHRD+K +N+++ K+ DFG+ARA + T V+GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D+F LG+G FG VY + +A+K L KS + + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 406 RNLVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGL 462
N++R+ D + L+ E+ P L + + + D + +E +A L
Sbjct: 74 PNILRMYN--YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADAL 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
Y H ++IHRD+K N+L+ KI+DFG
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 41/202 (20%), Positives = 77/202 (38%), Gaps = 16/202 (7%)
Query: 308 KKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVY 367
++ G+ +Y + P D++ +LG G FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 368 RGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424
R TE G A K + E + E+ ++ L+H LV L +E ++I
Sbjct: 175 RV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232
Query: 425 YEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482
YE++ L F+ + + + + + +GL ++H+ +H DLK N
Sbjct: 233 YEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPEN 285
Query: 483 VLLDNDMNP--KISDFGMARAF 502
++ + K+ DFG+
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHL 307
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
S LG G FG V++ T G ++A K + + EE KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+L +++ +L+ EY+ L FD + + L ++ I G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 468 DSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQT 507
+ I+H DLK N+L N KI DFG+AR + +
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-21
Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 23/169 (13%)
Query: 357 KLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL- 412
+ GG G +Y G+ + +K L S E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 413 -GCCTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
T R + Y EY+ +SL++ L ++ + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ +++ DLK N++L + K+ D G ++ + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY----LYGT 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQG 389
+ + + ++ LG+G FG V + QE AVK ++K+ +
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 390 VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLD 447
EV L+ KL H N+++L ++ E L FD + R +F
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF-- 118
Query: 448 WSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAF 502
S+ +II+ + G+ Y+H+ I+HRDLK N+LL++ D + KI DFG++ F
Sbjct: 119 -SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 503 GVDQTEANTDRVVGT 517
+ +GT
Sbjct: 175 QQNTK---MKDRIGT 186
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 12/178 (6%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKL 403
D F +K KLG G FG V+ G E +K ++K Q +E+ + E+ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
H N++++ ++ E L E+ + R K L ++++ + L
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGT 517
Y H ++H+DLK N+L + KI DFG+A F D+ N GT
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGT 189
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS---SGQGVEEFK 394
MF ++ A +D + + LG+G FG V GQE AVK +SK E
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR- 451
EV L+ +L H N+++L + L+ E L FD ++R +F S+
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVD 127
Query: 452 -CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQT 507
+II + G+ Y+H+ +I+HRDLK N+LL++ D N +I DFG++ F +
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 508 EANTDRVVGT 517
+GT
Sbjct: 185 ---MKDKIGT 191
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 27/188 (14%), Positives = 52/188 (27%), Gaps = 22/188 (11%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
+ + LGEG F VY Q+ +K ++ + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIAR 460
++ ++ +L+ E +L I + T K + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-----------KISDFGMARAFGVDQTEA 509
+ +H IIH D+K N +L N + D G + +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 510 NTDRVVGT 517
T
Sbjct: 241 IFTAKCET 248
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 31/190 (16%), Positives = 60/190 (31%), Gaps = 41/190 (21%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ--------- 404
LG+ E G+ V + +++ K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 405 ----------------HRNLVRLLGCCTLRDERMLIY---EYLPNKSLEQF---IFDVTR 442
+ ++R+ RD +L +L+ F + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 443 T-KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
T K L R Q+ + R L LH ++H L+ +++LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 502 FGVDQTEANT 511
G + +
Sbjct: 256 DGARVVSSVS 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 50/168 (29%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGC 414
LGEG +G V +T + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR---CQIIEGIARGLLYLHQDS 469
+ + L EY L FD + + Q++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ I HRD+K N+LLD N KISDFG+A F + E +++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 48/183 (26%), Positives = 72/183 (39%), Gaps = 23/183 (12%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAK 402
D + +G+G F V R + GQ+ AVK + + S G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDW---SKRCQIIEG 457
L+H ++V LL + +++E++ L V R + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRV 514
I L Y H IIHRD+K VLL +N K+ FG+A G A
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--R 193
Query: 515 VGT 517
VGT
Sbjct: 194 VGT 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 50/168 (29%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGC 414
LGEG +G V +T + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
+ + L EY L FD + + Q++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ I HRD+K N+LLD N KISDFG+A F + E +++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 25/156 (16%)
Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
+G+G F V +LT G+E+A+K + K+ + +++ EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYLH 466
LI EY + ++ R+KF QI+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF------RQIVSAVQ----YCH 131
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ RI+HRDLKA N+LLD DMN KI+DFG + F
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 23/190 (12%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFK 394
F N +DN+ K +LG+G F V R + G E A K ++ S + ++ +
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR- 451
E + KLQH N+VRL L+++ + L F+ V R + S+
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEAD 129
Query: 452 -CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQT 507
I+ I + Y H I+HR+LK N+LL K++DFG+A + +
Sbjct: 130 ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS 184
Query: 508 EANTDRVVGT 517
EA GT
Sbjct: 185 EAWHG-FAGT 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 405
+DN+ K +LG+G F V R + G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
N+VRL L+++ + L F+ V R + S+ I+ I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILES 117
Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ Y H I+HR+LK N+LL K++DFG+A D + GT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG--FAGT 170
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 43/177 (24%), Positives = 71/177 (40%), Gaps = 24/177 (13%)
Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLL 412
++ LGEG V + L QE AVK + K G EV ++ + Q HRN++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARGLLYLHQD 468
D L++E + S+ R F ++ +++ +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129
Query: 469 SRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR-----VVGT 517
I HRDLK N+L + KI DF + ++ + G+
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 25/181 (13%)
Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV--------- 390
++ +N+ K LG G V R + +E AVK + + G
Sbjct: 8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 391 EEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLD 447
E EV ++ K+ H N+++L L+++ + L FD +
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTL-- 121
Query: 448 WSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
S++ +I+ + + LH+ L I+HRDLK N+LLD+DMN K++DFG +
Sbjct: 122 -SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 506 Q 506
+
Sbjct: 178 E 178
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 13/166 (7%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+ + + LG G FG V+R + + + K + G K E+ ++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLL 463
RN++ L +E ++I+E++ + F+ T L+ + + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQT 507
+LH I H D++ N++ + KI +FG AR
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 31/203 (15%)
Query: 331 RKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSG 387
+ E + DW + + K+ +G G V R G E AVK + ++
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC--VHRATGHEFAVKIMEVTAE 132
Query: 388 QG--------VEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF 438
+ E + E ++ ++ H +++ L+ L+++ + L F
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----F 188
Query: 439 D--VTRTKFLDWSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494
D + S++ I+ + + +LH I+HRDLK N+LLD++M ++S
Sbjct: 189 DYLTEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS 242
Query: 495 DFGMARAFGVDQTEANTDRVVGT 517
DFG + + + GT
Sbjct: 243 DFGFSCHLEPGEK-LRE--LCGT 262
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 25/182 (13%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKR-LSKSSGQGVEEFKN----EVLLIAK 402
D F + G+G FG V G G +A+K+ + F+N + +A
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 403 LQHRNLVRLLGCCTLRDER-------MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQI 454
L H N+V+L ER ++ EY+P +L + + R +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDR 513
+ + R + LH S + + HRD+K NVL++ K+ DFG A+ +E N
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAY 191
Query: 514 VV 515
+
Sbjct: 192 IC 193
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 39/170 (22%), Positives = 62/170 (36%), Gaps = 21/170 (12%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRL- 411
+G GG G VY + +A+K +S++ + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 412 -LGCCTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
G + L Y + L + R L + I+ I L H
Sbjct: 101 DFG----EIDGQL-YVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
HRD+K N+L+ D + DFG+A A D+ VGT
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGT 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 29/178 (16%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNE 396
+ D++ +LG G F V + + G+E A K + K G EE + E
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--C 452
V ++ +++H N++ L + + +LI E + L FD + ++
Sbjct: 59 VNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEAT 111
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQ 506
Q ++ I G+ YLH RI H DLK N++L + P K+ DFG+A
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+ F + LG G F V+ G+ A+K + KS +NE+ ++ K++H
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
N+V L L+ + + L FD + R + +++ +I+ +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSA 118
Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF 502
+ YLH+ I+HRDLK N+L + + I+DFG+++
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNE 396
D + +LG G F V + E G E A K + K G EE + E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQII 455
V ++ ++ H N++ L R + +LI E + L FD + + + L + I
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI 121
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANT 511
+ I G+ YLH +I H DLK N++L + P K+ DFG+A +
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK 176
Query: 512 DRVVGT 517
+ + GT
Sbjct: 177 N-IFGT 181
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS------GQGVEEFKNE 396
D + +LG G F V + E G E A K + K G EE + E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQII 455
V ++ ++ H N++ L R + +LI E + L FD + + + L + I
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI 121
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANT 511
+ I G+ YLH +I H DLK N++L + P K+ DFG+A +
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK 176
Query: 512 DRVVGT 517
+ + GT
Sbjct: 177 N-IFGT 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQHR--NL 408
LG GGFG VY G+ +++ +A+K + K E N EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 409 VRLLGCCTLRDERMLIYEY-LPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIAR 460
+RLL D +LI E P + L FI ++ R+ F Q++E +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF------WQVLEAVR- 163
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMA 499
+ H ++HRD+K N+L+D N K+ DFG
Sbjct: 164 ---HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLI 400
T T+ + +LG+G F V R + + GQE A ++ S + ++ + E +
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIE 456
L+H N+VRL + LI++ + L F+ V R + S+ I+
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQ 117
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR 513
I +L+ HQ + ++HR+LK N+LL K++DFG+A +Q
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 514 VVGT 517
GT
Sbjct: 173 FAGT 176
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LG G FG V G LT G ++AVK L++ S V + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYL 465
+ + ++ EY+ L +I R F QI+ + Y
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF------QQILSAVD----YC 127
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
H R ++HRDLK NVLLD MN KI+DFG++
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 26/154 (16%)
Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LG G FG V G LT G ++AVK L++ S V + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYL 465
+ + ++ EY+ L +I +R F QI+ G+ Y
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF------QQILSGVD----YC 132
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
H R ++HRDLK NVLLD MN KI+DFG++
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 13/195 (6%)
Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK 384
+D RK D+F ++LG G G V++ G +A K +
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68
Query: 385 SSGQGV-EEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTR 442
+ + E+ ++ + +V G D + I E++ SL+Q + +
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISICMEHMDGGSLDQVL---KK 124
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ ++ + +GL YL + +I+HRD+K SN+L+++ K+ DFG++
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-- 180
Query: 503 GVDQTEANTDRVVGT 517
+ + AN+ VGT
Sbjct: 181 QLIDSMANS--FVGT 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 26/185 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNEV 397
+ D + +LG G F V + E G + A K + K G E+ + EV
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIE 456
++ ++QH N++ L + + +LI E + L FD + + L + + ++
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLK 121
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTD 512
I G+ YLH L+I H DLK N++L + P KI DFG+A D +
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 513 RVVGT 517
+ GT
Sbjct: 177 -IFGT 180
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 44/235 (18%), Positives = 72/235 (30%), Gaps = 50/235 (21%)
Query: 330 NRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVK-----RLS 383
+ E F ++ + + K +G+G +G V + + A+K ++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
+ + + VE K EV L+ KL H N+ RL L+ E L +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 444 KFLDWSKRC-------------------------------------QIIEGIARGLLYLH 466
+ I+ I L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 467 QDSRLRIIHRDLKASNVLL--DNDMNPKISDFGMARAFGVDQTEANTDR--VVGT 517
I HRD+K N L + K+ DFG+++ F GT
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 19/150 (12%)
Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
LGEG FG V T Q++A+K +S+ + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKT-QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
T + +++ EY E F + V + + + R QII I Y H
Sbjct: 76 DVITTPTDIVMVIEYA---GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH--- 125
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
R +I+HRDLK N+LLD+++N KI+DFG++
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 34/200 (17%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS------------ 385
M+ +++ KLG G +G V E A+K + KS
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 386 -SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTR 442
+ EE NE+ L+ L H N+++L + L+ E+ L F+ + R
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINR 140
Query: 443 TKFLDWSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFG 497
KF + I++ I G+ YLH+ I+HRD+K N+LL+N +N KI DFG
Sbjct: 141 HKF---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 498 MARAFGVDQTEANTDRVVGT 517
++ F D +GT
Sbjct: 195 LSSFFSKDYK---LRDRLGT 211
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 35/163 (21%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EV----LLIAKLQHR 406
LG+GGFG V+ G LT+ ++A+K + ++ G + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF---------DVTRTKFLDWSKRCQIIEG 457
++RLL ++ ML+ E P + + F + +R F Q++
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFF------GQVVAA 151
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMA 499
I + H ++HRD+K N+L+D K+ DFG
Sbjct: 152 IQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 20/157 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS--------SGQGVEEFKNEVLLIAKLQHRNL 408
LG G FG V+ + + +E+ VK + K + + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYL 465
+++L + L+ E + L+ F F + + Q++ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----YL 146
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
IIHRD+K N+++ D K+ DFG A
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 24/178 (13%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
TD + K +G G + R + E AVK + KS EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARGLL 463
++ L ++ E + L D + + F S+R ++ I + +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVE 130
Query: 464 YLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 48/180 (26%)
Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKS--------------------------SGQG 389
+G+G +G V A+K LSK
Sbjct: 21 IGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 390 VEEFKNEVLLIAKLQHRNLVRL---LGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKF 445
+E+ E+ ++ KL H N+V+L L D +++E + + + T
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPL 134
Query: 446 LDWSKRC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ R +I+GI YLH +IIHRD+K SN+L+ D + KI+DFG++ F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EV 397
++ D+ +LG G +G V + GQ +AVKR+ + +E K ++
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIE 456
+ + V G + + E + + SL++F V + + + +I
Sbjct: 59 SM-RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
I + L +LH S+L +IHRD+K SNVL++ K+ DFG++ VD + D G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AG 171
Query: 517 T 517
Sbjct: 172 C 172
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 45/183 (24%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--------SGQGVEEFKNEVLL 399
D + LG G G V + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 400 IAKLQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEG 457
+ KL H ++++ E ++ E + L FD V K L +
Sbjct: 194 LKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 247
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRV 514
+ + YLH+ IIHRDLK NVLL + D KI+DFG ++ G + + T +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--L 301
Query: 515 VGT 517
GT
Sbjct: 302 CGT 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 34/187 (18%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE--------FKNEVLL 399
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 400 IAKLQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFD--VTRTKFL-DWSKRC--Q 453
+ KL H ++++ E ++ E + L FD V + K Q
Sbjct: 69 LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 122
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEAN 510
++ + YLH IIHRDLK NVLL + D KI+DFG ++ G + +
Sbjct: 123 MLLAVQ----YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMR 174
Query: 511 TDRVVGT 517
T + GT
Sbjct: 175 T--LCGT 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 53/179 (29%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQH 405
++F + LGEG F V A+K L K V E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
V+L T +D+ L Y N L + FD T T+F +I+ +
Sbjct: 90 PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY----TAEIVSAL 143
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH IIHRDLK N+LL+ DM+ +I+DFG A+ + +A + VGT
Sbjct: 144 E----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+D F +++LG G VYR + A+K L K+ + + E+ ++ +L H
Sbjct: 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSH 107
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
N+++L E L+ E + L FD V + + S+R ++ I
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY---SERDAADAVKQILEA 160
Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ YLH+ I+HRDLK N+L D KI+DFG+++ V GT
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVL-----LIAKL 403
++ ++G G +G V + + GQ +AVKR+ + E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARG 461
+V+ G + + E + + S ++F V + +I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
L +L L+IIHRD+K SN+LLD N K+ DFG
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 24/184 (13%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
+ D LGEG F + + Q AVK +SK + E+ +
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALK 60
Query: 402 KLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIE 456
+ H N+V+L + L+ E L L F+ + F S+ I+
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMR 113
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR 513
+ + ++H + ++HRDLK N+L ++++ KI DFG AR D T
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168
Query: 514 VVGT 517
T
Sbjct: 169 PCFT 172
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 38/208 (18%), Positives = 74/208 (35%), Gaps = 51/208 (24%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHR 406
+ +S LG G FG V E G+ A+K++ + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 407 NLVRLLGC-----------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-------- 447
N+++L+ D+ + + V ++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 448 ----------WSKRCQIIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLD-N 487
+ + + I + R + ++H L I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 488 DMNPKISDFGMARAFGVDQTEANTDRVV 515
D K+ DFG A+ +E + +
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 45/167 (26%), Positives = 64/167 (38%), Gaps = 27/167 (16%)
Query: 355 KNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR-NL 408
+LG G F V + GQE A K L K E +E+ ++ + +
Sbjct: 34 SKELGRGKFAVVRQC--ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGIARGL 462
+ L E +LI EY + S+ QI+EG+
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQILEGVY--- 145
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQ 506
YLHQ I+H DLK N+LL + + KI DFGM+R G
Sbjct: 146 -YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 26/160 (16%)
Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
+G G FG R LT + +AVK + + + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLT-KELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVI 85
Query: 416 TLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+I EY L + I D R F Q++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ------QLLSGVS----YCH-- 133
Query: 469 SRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGVDQ 506
++I HRDLK N LLD KI DFG +++ +
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 53/181 (29%), Positives = 77/181 (42%), Gaps = 26/181 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D F LG GGFG V+ + ++ A K+L+K +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 406 RNLVRLLGCCTLRDERMLIYEY---------LPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
R +V L + + L+ + N + F R F +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY-------TAQ 297
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
I GL +LHQ II+RDLK NVLLD+D N +ISD G+A QT+ G
Sbjct: 298 -IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAG 351
Query: 517 T 517
T
Sbjct: 352 T 352
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 29/145 (20%), Positives = 54/145 (37%), Gaps = 13/145 (8%)
Query: 383 SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR 442
SS ++ ++ + +N V L + + + + ++L+ ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ + I IA + +LH ++HRDLK SN+ D K+ DFG+ A
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 503 GVDQTEANTD----------RVVGT 517
D+ E VGT
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
D++ KLG G + V+ + +T +++ VK L + + K E+ ++
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKIL 84
Query: 401 AKLQ-HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
L+ N++ L ++D L++E++ N +Q D+ R +
Sbjct: 85 ENLRGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMY 137
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRV 514
E I + L Y H S I+HRD+K NV++D++ ++ D+G+A F E RV
Sbjct: 138 E-ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE-YNVRV 191
Query: 515 V 515
Sbjct: 192 A 192
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 39/222 (17%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 307 RKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFD-WNTIADATDNFSWKNKLGEGGFGP 365
++ +TV S+ + R + ++ D + ++ +G G +G
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 366 VYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRNLVRLLGCC 415
V + +A+K++ + F++ E+ ++ +L H ++V++L
Sbjct: 69 VCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121
Query: 416 TLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ-IIEGIARGLLYLHQDS 469
+D ++ E ++ T + + ++ + G+ Y+H S
Sbjct: 122 IPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTE--LHIKTLLYNLLVGVKYVH--S 174
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
I+HRDLK +N L++ D + K+ DFG+AR + +
Sbjct: 175 A-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 42/192 (21%), Positives = 73/192 (38%), Gaps = 28/192 (14%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE--FKN---- 395
+ ++ + + G +G V G+ +EG +A+KR+ + G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 396 -----EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKF 445
E+ L+ H N++ L +E L+ E + L Q I +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQR 128
Query: 446 LDWSK-RCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
+ S Q + I GL LH+ ++HRDL N+LL ++ + I DF +AR
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--E 183
Query: 504 VDQTEANTDRVV 515
T V
Sbjct: 184 DTADANKTHYVT 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 37/174 (21%), Positives = 69/174 (39%), Gaps = 17/174 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVL-----LIAKL 403
++ ++G G G V++ + G IAVK++ +S +E +L ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSH 81
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
+V+ G + + E + E+ + + + I + L
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALY 138
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YL + +IHRD+K SN+LLD K+ DFG++ VD + G
Sbjct: 139 YLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS-GRLVDDKAKDRS--AGC 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 19/149 (12%), Positives = 52/149 (34%), Gaps = 12/149 (8%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLL 412
G ++ + T +++A+ + ++E + L ++++ + R+L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
R +++ E++ SL+ +V T + ++ +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTS-PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARA 501
+ S V + D + ++
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMPD 178
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 52/179 (29%), Positives = 73/179 (40%), Gaps = 25/179 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
+ F LG+GGFG V + ++ A K+L K +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGI 458
R +V L +D L+ + L Q F R F I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAEI 295
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
GL LH R RI++RDLK N+LLD+ + +ISD G+A QT VGT
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 44/184 (23%), Positives = 83/184 (45%), Gaps = 34/184 (18%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
T + + +G G +G V + G+++A+K+LS+ F++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAK 68
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKF 445
E+LL+ +QH N++ LL T L+ ++ L++ + KF
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKF 123
Query: 446 LDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
+ ++ Q ++ + +GL Y+H ++HRDLK N+ ++ D KI DFG+AR
Sbjct: 124 SE--EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 505 DQTE 508
+ T
Sbjct: 179 EMTG 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 38/160 (23%), Positives = 62/160 (38%), Gaps = 22/160 (13%)
Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVRLL 412
K LG G G V GQ+ A+K L S + + EV ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 413 GCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLH 466
+ + + E + L I + F ++R +I+ I + +LH
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLH 145
Query: 467 QDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG 503
I HRD+K N+L + D K++DFG A+
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 33/190 (17%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN------ 395
+ D ++ + +GEG +G V +A+K++S F++
Sbjct: 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQR 71
Query: 396 ---EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLD 447
E+ ++ + +H N++ + ++ + + L + + +T+ L
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLS 126
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
C + I RGL Y+H S ++HRDLK SN+LL+ + KI DFG+AR D
Sbjct: 127 NDHICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 508 EAN--TDRVV 515
T+ V
Sbjct: 184 HTGFLTEYVA 193
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 41/190 (21%), Positives = 79/190 (41%), Gaps = 45/190 (23%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
T + + +G G +G V + G ++A+K+L + F++
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAK 69
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
E+ L+ ++H N++ LL + P+++L+ F +
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498
+ + + L + ++ + +GL Y+H IIHRDLK N+ ++ D KI DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 499 ARAFGVDQTE 508
AR + T
Sbjct: 175 ARQADSEMTG 184
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VL-LIAK 402
++FS +G GGFG VY + ++ A+K L K QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEG 457
+V + D+ I + + L + +F +F
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAE 300
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
I GL ++H +++RDLK +N+LLD + +ISD G+A F +
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 40/164 (24%), Positives = 65/164 (39%), Gaps = 22/164 (13%)
Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVRLL 412
LG G G V + ++ A+K L + + EV L Q ++VR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121
Query: 413 GCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLH 466
L R + E L L I D F ++R +I++ I + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLH 178
Query: 467 QDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQT 507
+ I HRD+K N+L + K++DFG A+ +
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 22/173 (12%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNE 396
A D LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 397 V-LLIAKLQHRNLVRLLGCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR 451
V L Q ++VR++ L R + E L L I D F ++R
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TER 117
Query: 452 --CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMA 499
+I++ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 118 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 45/190 (23%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
TI + + + + +G G +G V T+ G +AVK+LS+ F++
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAK 73
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
E+ L+ ++H N++ LL + P +SLE+F +
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLN 121
Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498
+ + + L +I I RGL Y+H IIHRDLK SN+ ++ D KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 499 ARAFGVDQTE 508
AR + T
Sbjct: 179 ARHTADEMTG 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 50/198 (25%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
++ + +G G G V + +A+K+LS+ F+N
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAK 69
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
E++L+ + H+N++ LL + P KSLE+F + +
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLC 117
Query: 440 -VTRTKFLDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
V + + +R ++ + G+ +LH IIHRDLK SN+++ +D KI DFG
Sbjct: 118 QVIQMELDH--ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 498 MARAFGVDQTEANTDRVV 515
+AR + T VV
Sbjct: 173 LAR--TAGTSFMMTPYVV 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 31/191 (16%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-- 395
F DN+ K+ +G G +G VY + +A+K++++ F++
Sbjct: 15 YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLI 67
Query: 396 -------EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRT 443
E+ ++ +L+ ++RL D ++ E L++ T
Sbjct: 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPI 124
Query: 444 KFLDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ + + I+ + G ++H IIHRDLK +N LL+ D + K+ DFG+AR
Sbjct: 125 FLTE--EHIKTILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 503 GVDQTEANTDR 513
++ +
Sbjct: 180 NSEKDTNIVND 190
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 40/193 (20%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
++ + +G G G V + +A+K+LS+ F+N
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAK 106
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERM------LIYEYLP---NKSLEQFIFDVTR 442
E++L+ + H+N++ LL T + L+ E + + ++ +
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
+ L Q++ G+ +LH IIHRDLK SN+++ +D KI DFG+AR
Sbjct: 167 SYLL-----YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212
Query: 503 GVDQTEANTDRVV 515
+ T VV
Sbjct: 213 TAGTSFMMTPYVV 225
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 2e-13
Identities = 37/200 (18%), Positives = 65/200 (32%), Gaps = 46/200 (23%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRL--------SKSSGQGVEEFKNEVLL 399
T+ K+GEG FG V++ + +A+K + + S + EE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 400 IAKLQ---------HRNLVRLLG--CCTLRDERMLIYEY------------LPNKSLEQF 436
+L + L C +L+ + P+ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 437 IFDVT------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484
+F V RTK + I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 485 LDNDMNPKISDFGMARAFGV 504
L K+ ++ +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D+F +G G F V + + ++ A+K ++K V F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL------EQFIFDVTRTKFLDWSKRCQIIEG 457
R + +L +DE L + EY L +F + E
Sbjct: 121 RWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-------LAE- 170
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
I + +H+ L +HRD+K N+LLD + +++DFG D T + VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 39/200 (19%), Positives = 75/200 (37%), Gaps = 42/200 (21%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
D + LG GG G V+ + + + +A+K++ +
Sbjct: 3 NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVK 53
Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
E+ +I +L H N+V++ + SL + + +
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQ----LTDDVGSLTELNSVYIVQEYMETDLA 109
Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFG 497
V L + + RGL Y+H + ++HRDLK +N+ ++ D+ KI DFG
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 498 MARAFGVDQTEAN--TDRVV 515
+AR + ++ +V
Sbjct: 167 LARIMDPHYSHKGHLSEGLV 186
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 38/180 (21%), Positives = 70/180 (38%), Gaps = 26/180 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F +G G FG V L ++ A+K L+K F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL------EQFIFDVTRTKFLDWSKRCQIIEG 457
+ + L +D+ L + +Y L + +F + E
Sbjct: 134 KWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-------LAE- 183
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ + +HQ L +HRD+K N+L+D + + +++DFG D T + VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 42/178 (23%), Positives = 70/178 (39%), Gaps = 24/178 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
+++ +G G FG V +++ A+K LSK F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPN----KSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
+V+L +D+R L + EY+P + + +F E +
Sbjct: 129 PWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-------TAE-VV 178
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L +H + IHRD+K N+LLD + K++DFG + D VGT
Sbjct: 179 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGT 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 43/161 (26%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D F LG G FG V E A+K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
LV+L +D L + EY+ + F +F QI+
Sbjct: 101 PFLVKLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY----AAQIVLTF 154
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
YLH L +I+RDLK N+L+D +++DFG A
Sbjct: 155 E----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 31/179 (17%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVL 398
+ +F K+ LGEG +G V G+ +A+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 399 LIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
++ +H N++ + +I E + L + I T+ L
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
I R + LH + +IHRDLK SN+L++++ + K+ DFG+AR + +
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 22/160 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS----GQGVEEFKNEVLLIAKLQ 404
+F LG G FG V+ A+K L K Q VE +E L+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIA 459
H ++R+ G + +I +Y+ L + F KF E +
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-------AAE-VC 116
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
L YLH II+RDLK N+LLD + + KI+DFG A
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 44/171 (25%), Positives = 65/171 (38%), Gaps = 19/171 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
+ F + LG+G FG V A+K L K + V E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
L L D + EY L + +F R +F I
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVS 259
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L YLH S +++RDLK N++LD D + KI+DFG+ + D T
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 34/181 (18%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVL 398
+ KLG+G +G V++ + G+ +AVK++ + F+N E++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 399 LIAKLQ-HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
++ +L H N+V LL LR + L+++Y+ L I R L+ Q
Sbjct: 61 ILTELSGHENIVNLLNV--LRADNDRDVYLVFDYME-TDLHAVI----RANILE-PVHKQ 112
Query: 454 -IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
++ + + + YLH S ++HRD+K SN+LL+ + + K++DFG++R+F + N
Sbjct: 113 YVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 513 R 513
Sbjct: 170 P 170
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 19/160 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
D LG G FG V + +AVK L + + +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 403 L-QHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
+ H N+V LLG CT M+I E+ +L ++ SKR + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
G + + I DLK + + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+A+G+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 23/177 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D+F +G+G FG V + +++ A+K ++K V E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
LV L ++ ++ + L L + F K I E +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-------ICE-LVM 126
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L YL RIIHRD+K N+LLD + I+DF +A +T+ T + GT
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGT 177
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 43/171 (25%), Positives = 66/171 (38%), Gaps = 20/171 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F + LG+G FG V A+K L K + V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
L L D + EY L + +F R +F E I
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-------GAE-IVS 116
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L YLH +++RD+K N++LD D + KI+DFG+ + D T
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
DNF + LG+G FG V + E ++ AVK L K VE E +L +A+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 81
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
H L +L C D + E++ L + FD R +F E I
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-------AAE-I 133
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L++LH II+RDLK NVLLD++ + K++DFGM + + T
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 51/173 (29%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
+F++ LG+G FG V E+ AVK L K VE E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
+ L +L C D + EY+ L + F F E I
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------AAE-I 451
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
A GL +L II+RDLK NV+LD++ + KI+DFGM + D T
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 51/173 (29%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
+F++ LG+G FG V E+ AVK L K VE E VL +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
+ L +L C D + EY+ L + F F E I
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------AAE-I 130
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
A GL +L II+RDLK NV+LD++ + KI+DFGM + D T
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 43/173 (24%), Positives = 68/173 (39%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
+F +G G + V L + I A++ + K + ++ + E V A
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-S 110
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
H LV L C + EY+ L Q +F E I
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-------SAE-I 162
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+ L YLH+ II+RDLK NVLLD++ + K++D+GM + +T
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 44/173 (25%), Positives = 68/173 (39%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
+F +G G + V L + I A+K + K + ++ + E V A
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-S 67
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
H LV L C + EY+ L Q +F E I
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-------SAE-I 119
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+ L YLH+ II+RDLK NVLLD++ + K++D+GM + +T
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 49/161 (30%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
++F LG+G FG V+ + + A+K L K VE E VL +A
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-W 75
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
+H L + ++ + EYL L FD++R F E I
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY-------AAE-I 127
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
GL +LH I++RDLK N+LLD D + KI+DFGM
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 350 DNFSWKNKLGEGGFGPVY---RGMLTEGQEI-AVKRLSKSS----GQGVEEFKNEVLLIA 401
+ F LG+GG+G V+ + +I A+K L K+ + K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIE 456
+++H +V L+ + LI EYL L + IF F + E
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAE 129
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
I+ L +LHQ II+RDLK N++L++ + K++DFG+ + D T +T
Sbjct: 130 -ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
+F + +G+G FG V + AVK L K + + +E VLL +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-V 96
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
+H LV L D+ + +Y+ L + F R +F E I
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-------AAE-I 148
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
A L YLH L I++RDLK N+LLD+ + ++DFG+ + + +T
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY----RGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL 403
F LG+G FG V+ Q A+K L K++ + K E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
H +V+L + LI ++L L ++ +F KF + E +
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-------LAE-L 135
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
A L +LH L II+RDLK N+LLD + + K++DFG+++ + +A +
Sbjct: 136 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 37/180 (20%), Positives = 71/180 (39%), Gaps = 43/180 (23%)
Query: 354 WK--NKLGEGGFGPVYRGMLTEGQEI------AVKRLSKSSGQGVEEFK-----NEVLLI 400
WK +G+GGFG +Y + + + VK +G E K + I
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 401 AKLQHRNLVRLLGCCTLR----------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
K ++ LG R +I + L++ I++ +F S+
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SR 151
Query: 451 RC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI--SDFGMARAF 502
+ +I++ + Y+H+ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 152 KTVLQLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 35/231 (15%)
Query: 304 MYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADAT-------DNFSWKN 356
M ++G + G + D G+ E + + T +NF
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 357 KLGEGGFGPVY---RGMLTEGQEI-AVKRLSKSS----GQGVEEFKNE--VLLIAKLQHR 406
LG G +G V+ + + ++ A+K L K++ + E + E VL + Q
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSP 119
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARG 461
LV L + LI +Y+ L ++ F + + E I
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-------VGE-IVLA 171
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANT 511
L +LH+ L II+RD+K N+LLD++ + ++DFG+++ F D+TE A
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 36/158 (22%), Positives = 65/158 (41%), Gaps = 17/158 (10%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGC 414
K+G G FG +Y G + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLHQDSRLR 472
D +L+ + L SLE +F+ K S + + + + + ++H S
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVEFVHSKS--- 123
Query: 473 IIHRDLKASNVLLDNDMNPK---ISDFGMARAFGVDQT 507
+HRD+K N L+ I DFG+A+ + T
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 43/180 (23%)
Query: 354 WK--NKLGEGGFGPVYRGM---------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
WK + G +Y + Q+ ++K L G+ E
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKP 102
Query: 403 LQHRNLVRLLGCCTL------------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
LQ +L L R L+ L +SL+ + + S+
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL---SE 158
Query: 451 RC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI--SDFGMARAF 502
R ++++ + +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 159 RSVLQVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 13/156 (8%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGC 414
K+G G FG +Y G + G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
D +++ E L SLE +F+ KF + + + + Y+H + I
Sbjct: 74 GAEGDYNVMVMELL-GPSLED-LFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 475 HRDLKASNVLLDNDMNPK---ISDFGMARAFGVDQT 507
HRD+K N L+ I DFG+A+ + +T
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 25/158 (15%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
K+G G FG + G L + +A+K S + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDS 469
++ E L SLE +FD+ F S + Q+I + Y+H +
Sbjct: 75 PCGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRME----YVHSKN 125
Query: 470 RLRIIHRDLKASNVLLDNDMNPK-----ISDFGMARAF 502
+I+RD+K N L+ N I DF +A+ +
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 40/208 (19%), Positives = 76/208 (36%), Gaps = 43/208 (20%)
Query: 330 NRKENMELPM-FDWNTIADATDNFSWK--NKLGEGGFGPVYRGM-LTEGQEIA---VKRL 382
+ M F + D + W K+G GGFG +Y + ++ A VK
Sbjct: 14 GTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE 73
Query: 383 SKSSGQGVEEFK-----NEVLLIAKLQHRNLVRLLGCCTLR----------DERMLIYEY 427
+ +G E K + I K R + LG R ++ E
Sbjct: 74 YQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER 133
Query: 428 LPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDSRLRIIHRDLKAS 481
L L++ I F K ++++ + Y+H++ +H D+KA+
Sbjct: 134 L-GIDLQK-ISGQNG-TF---KKSTVLQLGIRMLDVLE----YIHENE---YVHGDIKAA 180
Query: 482 NVLLDNDMNPKI--SDFGMARAFGVDQT 507
N+LL ++ +D+G++ + +
Sbjct: 181 NLLLGYKNPDQVYLADYGLSYRYCPNGN 208
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/158 (20%), Positives = 64/158 (40%), Gaps = 25/158 (15%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
++GEG FG ++ G L Q++A+K + S + + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFG 75
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDS 469
+L+ + L SLE + D+ KF S + Q++ + +H+ S
Sbjct: 76 QEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAKQMLARVQ----SIHEKS 126
Query: 470 RLRIIHRDLKASNVLLDNDMNPK-----ISDFGMARAF 502
+++RD+K N L+ + + DFGM + +
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 83/573 (14%), Positives = 154/573 (26%), Gaps = 207/573 (36%)
Query: 15 MSSWKSAD-DPA--QDNYIYEVDP-RGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPN 70
MS K+ P+ YI + D Q VF K + + R P+ L +L+P
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ-VFAKYN-VS-RLQPYLKLR-QALLELRPA 150
Query: 71 P---VY----------TFEYVSNE-------NEVFY-RFNLIKS--SVLTMM-----VIN 102
+ + + ++F+ S +VL M+ I+
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 103 P---------QGEPQRLTWMEQ----TQKWAPFVPFSGLILDQCDNYALCGAYAICNMNS 149
P R+ ++ K P+ L+L + + N
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLL--N---------VQNA-- 256
Query: 150 NSARCECLEGFVPKSPSEWDLLDTSDGCI-------RRTQLDCEH-GDGFLKRESVKLPD 201
+ F LL T + T + +H E
Sbjct: 257 -----KAWNAFNLSCKI---LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV----- 303
Query: 202 TSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDL 261
K L K + +D + QDL
Sbjct: 304 ---------------KSLLLK---------------------Y----LDCRP-----QDL 318
Query: 262 YIRMATSELDNFERTKRRKKKKV---VIIIICALLATGVILIGGFMYMRKKKRRDQGNTV 318
R+ + II + G+ + ++ K +
Sbjct: 319 ----------------PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK---LTTII 359
Query: 319 GSSELDYIDRGNRKEN-MELPMFDWNT-IADATDNFSWKNKLGEGGFGPVYRGMLTEGQE 376
SS L+ ++ ++ L +F + I + W + ++
Sbjct: 360 ESS-LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD-------------VIKSDVM 405
Query: 377 IAVKRLSKSS---GQGVE----------EFKNEVLLIAKLQHRNLV---RLLGC-----C 415
+ V +L K S Q E E K ++ L HR++V +
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDL 464
Query: 416 TLRDERMLIYEYLPN--KSLEQF-IFDVTRTKFLD--WSKRCQIIEGIAR----GLLYLH 466
Y ++ + K++E + R FLD + ++ + A +L
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 467 QDSRL---RIIHRDLKASNVLLDNDMNPKISDF 496
Q + I D K ++ I DF
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNA------ILDF 551
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 41/172 (23%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ----------- 404
KLG G F V+ + +A+K + + E ++E+ L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 405 HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQ 453
++++LL + +++E L ++L I + K Q
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--------Q 135
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP------KISDFGMA 499
I + + GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 23/158 (14%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK---RLSKSSGQGVEEFKNEVLLIAKLQHR----- 406
+ +G+G FG V + E + +A+K Q + EV L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLL 463
+V L R+ L++E L + +L + T F S + + + LL
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL---RNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMA 499
+L L IIH DLK N+LL N KI DFG +
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 19/153 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR------NLVR 410
+G+G FG V + Q +A+K + ++ + + E+ ++ L+ + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF--LDWSKRCQIIEGIARGLLYLHQD 468
+L T R+ + +E L + +L + I + KF + I + L LH
Sbjct: 164 MLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFSLPLVRKFAHSILQCLDALH-- 217
Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMA 499
+ RIIH DLK N+LL K+ DFG +
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.94 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.93 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.92 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.92 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.92 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.92 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.91 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.91 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.91 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.91 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.9 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.9 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.9 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.9 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.89 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.89 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.89 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.89 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.89 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.13 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.69 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.04 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 97.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.57 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 96.52 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 96.41 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 96.4 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 96.35 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 95.91 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 95.85 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.74 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 94.94 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 94.66 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 94.17 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.59 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 92.23 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 91.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.79 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 87.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.4 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 83.78 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 82.22 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=291.25 Aligned_cols=162 Identities=30% Similarity=0.437 Sum_probs=146.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999976 4999999999753 3455678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|.++|.+. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999543 45999999999999999999999998 999999999999999999999999999999766
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 655555667887
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=293.03 Aligned_cols=165 Identities=30% Similarity=0.498 Sum_probs=141.7
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|.+.+.||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|++.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45778899999999999999864 367899999987666667889999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 424 IYEYLPNKSLEQFIFDVT----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
||||+++|+|.++|.+.. ....+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2356999999999999999999999988 999999999999999999999
Q ss_pred ccccCceecCCCCcccccCceecC
Q 010146 494 SDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 494 ~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
+|||+|+.+........+....||
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred CCcccceecCCCCceeecCceecC
Confidence 999999987655443333344554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.75 Aligned_cols=165 Identities=28% Similarity=0.477 Sum_probs=133.6
Q ss_pred CCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 378899999987766677889999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 424 IYEYLPNKSLEQFIFDVTR------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
||||+++|+|.++|.+... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975432 245899999999999999999999988 9999999999999999999
Q ss_pred EEccccCceecCCCCcccccCceecC
Q 010146 492 KISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 492 kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
||+|||+|+.+........+....||
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EECCCC----------------CCCC
T ss_pred EEcccccceeccCCCcceecCccccc
Confidence 99999999988655443333334454
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=288.55 Aligned_cols=159 Identities=27% Similarity=0.431 Sum_probs=142.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999976 49999999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCcc
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 508 (517)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..+...
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999854 34899999999999999999999998 999999999999999999999999999998655432
Q ss_pred cccCceecC
Q 010146 509 ANTDRVVGT 517 (517)
Q Consensus 509 ~~~~~~~GT 517 (517)
+..++||
T Consensus 227 --~~~~~GT 233 (346)
T 4fih_A 227 --RKSLVGT 233 (346)
T ss_dssp --BCCCCSC
T ss_pred --ccccccC
Confidence 2335676
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=287.75 Aligned_cols=164 Identities=32% Similarity=0.498 Sum_probs=138.6
Q ss_pred CCCccceecccCCeeEEEEEeC------CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++++.++||+|+||.||+|.+. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556789999999999999863 3678999999754 33456789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 424 IYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
||||+++|+|.++|..... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 235899999999999999999999998 999999999999999999
Q ss_pred eEEccccCceecCCCCcccccCceecC
Q 010146 491 PKISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 491 ~kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
+||+|||+|+.+........+....||
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred EEECCcccceeccCCCceeEecccccC
Confidence 999999999987655433333344554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=291.07 Aligned_cols=153 Identities=25% Similarity=0.406 Sum_probs=132.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 4999999999754 2334568999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|.++|... +...+++.+++.++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999643 3445799999999999999999999998 999999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=283.51 Aligned_cols=161 Identities=27% Similarity=0.481 Sum_probs=132.0
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.+++.+.++||+|+||+||+|+++ ..||||+++.. .....++|.+|+.++++++|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467888899999999999999875 36999998753 33446789999999999999999999998864 56899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++|+|.++|... ...+++.+++.|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999643 345999999999999999999999988 9999999999999999999999999999876544
Q ss_pred cccccCceecC
Q 010146 507 TEANTDRVVGT 517 (517)
Q Consensus 507 ~~~~~~~~~GT 517 (517)
....+...+||
T Consensus 187 ~~~~~~~~~GT 197 (307)
T 3omv_A 187 GSQQVEQPTGS 197 (307)
T ss_dssp -------CCCC
T ss_pred cceeecccccC
Confidence 43334445665
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=291.28 Aligned_cols=160 Identities=27% Similarity=0.428 Sum_probs=143.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.+.|++.++||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999976 4999999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999853 24899999999999999999999998 99999999999999999999999999999865543
Q ss_pred ccccCceecC
Q 010146 508 EANTDRVVGT 517 (517)
Q Consensus 508 ~~~~~~~~GT 517 (517)
. ...++||
T Consensus 303 ~--~~~~~GT 310 (423)
T 4fie_A 303 R--RKSLVGT 310 (423)
T ss_dssp C--BCCCEEC
T ss_pred c--ccccccC
Confidence 3 2346776
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=277.62 Aligned_cols=154 Identities=27% Similarity=0.410 Sum_probs=127.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--------
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-------- 419 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 419 (517)
++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999976 58999999997543 334567899999999999999999999987654
Q ss_pred ----EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 420 ----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 420 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
..++||||+++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965444444667788999999999999999998 99999999999999999999999
Q ss_pred ccCceecCCCC
Q 010146 496 FGMARAFGVDQ 506 (517)
Q Consensus 496 FGla~~~~~~~ 506 (517)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.67 Aligned_cols=149 Identities=29% Similarity=0.510 Sum_probs=126.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|... +++.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 5999999999754 2344568999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+ +|+|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999854 345999999999999999999999998 999999999999999999999999999987544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.02 Aligned_cols=158 Identities=29% Similarity=0.351 Sum_probs=132.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.+.|++.++||+|+||.||+|+.+ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356778889999999999999976 499999999976422 24699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 506 (517)
+++|+|.++|.+. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999643 45999999999999999999999998 99999999999999987 69999999999986553
Q ss_pred cc---cccCceecC
Q 010146 507 TE---ANTDRVVGT 517 (517)
Q Consensus 507 ~~---~~~~~~~GT 517 (517)
.. .....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 22 122335676
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.77 Aligned_cols=157 Identities=29% Similarity=0.462 Sum_probs=132.2
Q ss_pred CccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIY 425 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 425 (517)
.+.++||+|+||.||+|.... ++.||+|++... .....+.|.+|++++++++|||||++++++.. .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 556789999999999999764 889999998653 23345679999999999999999999999865 34579999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 504 (517)
||+++|+|.++|.+. ..+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999643 45899999999999999999999875 46999999999999984 78999999999986543
Q ss_pred CCcccccCceecC
Q 010146 505 DQTEANTDRVVGT 517 (517)
Q Consensus 505 ~~~~~~~~~~~GT 517 (517)
.. +..++||
T Consensus 185 ~~----~~~~~GT 193 (290)
T 3fpq_A 185 SF----AKAVIGT 193 (290)
T ss_dssp TS----BEESCSS
T ss_pred Cc----cCCcccC
Confidence 32 2235665
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=279.82 Aligned_cols=160 Identities=26% Similarity=0.302 Sum_probs=130.9
Q ss_pred CCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|+.. .++.||||+++... ......+.+|++++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999853 37899999997542 2234468899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++|+|.++|.+. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999643 45999999999999999999999998 9999999999999999999999999999775
Q ss_pred CCCcccccCceecC
Q 010146 504 VDQTEANTDRVVGT 517 (517)
Q Consensus 504 ~~~~~~~~~~~~GT 517 (517)
..... ...++||
T Consensus 178 ~~~~~--~~~~~GT 189 (304)
T 3ubd_A 178 DHEKK--AYSFCGT 189 (304)
T ss_dssp ---CC--CCSCCCC
T ss_pred CCCcc--ccccccC
Confidence 54332 2235666
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=279.55 Aligned_cols=175 Identities=27% Similarity=0.380 Sum_probs=146.1
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCC-CCeeeE
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQH-RNLVRL 411 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l 411 (517)
++.++.+...++|++.+.||+|+||.||+|.... ++.||||++.... ....++|.+|+++|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4445555667889999999999999999998642 3689999997643 3345679999999999965 899999
Q ss_pred EEEEEeC-CEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecC
Q 010146 412 LGCCTLR-DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477 (517)
Q Consensus 412 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~D 477 (517)
+|+|.+. +..+||||||++|+|.++|++... ...+++.+++.++.||++||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999965321 345899999999999999999999998 99999
Q ss_pred CCCCcEEECCCCCeEEccccCceecCCCCcccccCceecC
Q 010146 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 478 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
|||+||||++++.+||+|||+|+.+..+.....+....||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999999999988766554444555665
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=271.54 Aligned_cols=162 Identities=25% Similarity=0.386 Sum_probs=129.8
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----EEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 425 (517)
++|.+.++||+|+||.||+|+++ |+.||||+++... .....+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35777899999999999999985 8999999996532 11223345666677899999999999998654 579999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-----CCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
||+++|+|.++|.+ ..+++..+++++.|+++||+|||++ ..++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 2489999999999999999999987 12359999999999999999999999999999
Q ss_pred ecCCCCcc--cccCceecC
Q 010146 501 AFGVDQTE--ANTDRVVGT 517 (517)
Q Consensus 501 ~~~~~~~~--~~~~~~~GT 517 (517)
.+...... ..+...+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 88655432 222335565
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=268.86 Aligned_cols=162 Identities=25% Similarity=0.436 Sum_probs=135.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe------CC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------RD 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 419 (517)
.++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999976 59999999997542 2334678899999999999999999998764 35
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..||||||++ |+|.+++.+ ...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999995 789999943 456999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCc--ccccCceecC
Q 010146 500 RAFGVDQT--EANTDRVVGT 517 (517)
Q Consensus 500 ~~~~~~~~--~~~~~~~~GT 517 (517)
+.+..... ......++||
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp BCC-------CCCCCSSCCC
T ss_pred eecccCccccccccccceeC
Confidence 98754322 2223345666
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=260.76 Aligned_cols=151 Identities=23% Similarity=0.377 Sum_probs=134.0
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR 418 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 418 (517)
.+....++|++.++||+|+||.||+|+.+ .++.||+|++... ....++.+|+++|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33445688999999999999999999853 3678999998653 3456788999999998 699999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEcccc
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG 497 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFG 497 (517)
+..++||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999982 3899999999999999999999998 9999999999999876 789999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+|+.+...
T Consensus 164 la~~~~~~ 171 (361)
T 4f9c_A 164 LAQGTHDT 171 (361)
T ss_dssp TCEECTTC
T ss_pred CCcccCCc
Confidence 99977543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=275.44 Aligned_cols=159 Identities=26% Similarity=0.339 Sum_probs=136.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHH---HHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFK---NEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|+.+. |+.||||++.+. .......+. .++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4679999999999999999999764 999999999653 122333333 446777888999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
||||||++||+|.++|.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999643 45999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCcccccCceecC
Q 010146 502 FGVDQTEANTDRVVGT 517 (517)
Q Consensus 502 ~~~~~~~~~~~~~~GT 517 (517)
+..... ..++||
T Consensus 342 ~~~~~~----~t~~GT 353 (689)
T 3v5w_A 342 FSKKKP----HASVGT 353 (689)
T ss_dssp CSSCCC----CSCCSC
T ss_pred cCCCCC----CCccCC
Confidence 865542 335676
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=271.70 Aligned_cols=153 Identities=24% Similarity=0.431 Sum_probs=138.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999976 4999999999876555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC--CCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DFGla~~~~~~ 505 (517)
+++|+|.++|.+ ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999843 2345899999999999999999999998 9999999999999854 78999999999998655
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 311 ~ 311 (573)
T 3uto_A 311 Q 311 (573)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=244.51 Aligned_cols=163 Identities=40% Similarity=0.731 Sum_probs=146.0
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 419 (517)
+.+.++...+++|++.+.||+|+||.||+|..++++.||||++........+.+.+|+.++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44555667889999999999999999999998889999999998766666788999999999999999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999854322 235899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
++.....
T Consensus 186 ~~~~~~~ 192 (321)
T 2qkw_B 186 SKKGTEL 192 (321)
T ss_dssp CEECSSS
T ss_pred ccccccc
Confidence 9986543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=240.76 Aligned_cols=171 Identities=43% Similarity=0.738 Sum_probs=149.7
Q ss_pred CCCccchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEE
Q 010146 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGC 414 (517)
Q Consensus 336 ~~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~ 414 (517)
.+..+++.++....++|++.+.||+|+||.||+|...+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456789999999999999999999999999999998889999999997643 2233478999999999999999999999
Q ss_pred EEeCCEEEEEEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 415 CTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 415 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
+...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999997543 2345899999999999999999999982223999999999999999999999
Q ss_pred ccccCceecCCCC
Q 010146 494 SDFGMARAFGVDQ 506 (517)
Q Consensus 494 ~DFGla~~~~~~~ 506 (517)
+|||+|+.+....
T Consensus 176 ~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 176 GDFGLAKLMDYKD 188 (326)
T ss_dssp CCCSSCEECCSSS
T ss_pred ccCccccccCccc
Confidence 9999999886543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=234.91 Aligned_cols=168 Identities=40% Similarity=0.695 Sum_probs=149.8
Q ss_pred CCCCccchhHHHHhcCCCCcc------ceecccCCeeEEEEEeCCCCEEEEEEccCCC----ccCHHHHHHHHHHHhcCC
Q 010146 335 MELPMFDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQ 404 (517)
Q Consensus 335 ~~~~~~~~~~i~~~~~~y~~~------~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~ 404 (517)
...+.|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 356789999999999998877 8999999999999987 48899999986532 234567999999999999
Q ss_pred CCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEE
Q 010146 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484 (517)
Q Consensus 405 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 484 (517)
||||+++++++...+..++||||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999976555566999999999999999999999998 999999999999
Q ss_pred ECCCCCeEEccccCceecCCCC
Q 010146 485 LDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++++.+||+|||+++......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCS
T ss_pred EcCCCcEEEeeccccccccccc
Confidence 9999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=235.91 Aligned_cols=163 Identities=27% Similarity=0.394 Sum_probs=144.9
Q ss_pred CCccchhHHHHhcCC----------CCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC
Q 010146 337 LPMFDWNTIADATDN----------FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405 (517)
Q Consensus 337 ~~~~~~~~i~~~~~~----------y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h 405 (517)
.+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888777654 666789999999999999987 599999999987666777889999999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 406 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
|||+++++++...+..++||||+++++|.+++.+ ..+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999842 35899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCCCC
Q 010146 486 DNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~~ 506 (517)
+.++.+||+|||+++.+....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcEEEeeeeeeeecccCc
Confidence 999999999999999886543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=232.70 Aligned_cols=153 Identities=28% Similarity=0.501 Sum_probs=139.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3468999999999999999999964 589999999977666667889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++++|.+++.+. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999542 4899999999999999999999998 9999999999999999999999999999886554
Q ss_pred c
Q 010146 507 T 507 (517)
Q Consensus 507 ~ 507 (517)
.
T Consensus 171 ~ 171 (297)
T 3fxz_A 171 S 171 (297)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=251.16 Aligned_cols=162 Identities=20% Similarity=0.249 Sum_probs=142.3
Q ss_pred chhHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 010146 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416 (517)
Q Consensus 341 ~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 416 (517)
.+.++....++|++.++||+|+||.||+++.+. ++.||+|++.+. .....+.+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455566677899999999999999999999875 789999998652 1223345889999999999999999999999
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
+.+..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999542 345899999999999999999999998 999999999999999999999999
Q ss_pred cCceecCCCCc
Q 010146 497 GMARAFGVDQT 507 (517)
Q Consensus 497 Gla~~~~~~~~ 507 (517)
|+|+.+..+..
T Consensus 220 Gla~~~~~~~~ 230 (437)
T 4aw2_A 220 GSCLKLMEDGT 230 (437)
T ss_dssp TTCEECCTTSC
T ss_pred hhhhhcccCCC
Confidence 99998765543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=235.32 Aligned_cols=152 Identities=28% Similarity=0.493 Sum_probs=137.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
++|.+.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888899999999999999976 48999999987766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999653 345899999999999999999999998 9999999999999999999999999999875543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.92 Aligned_cols=154 Identities=25% Similarity=0.383 Sum_probs=135.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------- 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 419 (517)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888999999999999999986 69999999997543 334578999999999999999999999986654
Q ss_pred --------------------------------------------------EEEEEEEeCCCCCHHHHHhccCCCCCCCHH
Q 010146 420 --------------------------------------------------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449 (517)
Q Consensus 420 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 449 (517)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999765555556777
Q ss_pred HHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 450 ~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
.++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999998 999999999999999999999999999988765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=246.05 Aligned_cols=161 Identities=21% Similarity=0.263 Sum_probs=141.7
Q ss_pred chhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 010146 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416 (517)
Q Consensus 341 ~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 416 (517)
.+.++....++|++.+.||+|+||.||+++.+ +++.||||++++.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555566788999999999999999999986 59999999996531 223445889999999999999999999999
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
+.+..++||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999998 999999999999999999999999
Q ss_pred cCceecCCCC
Q 010146 497 GMARAFGVDQ 506 (517)
Q Consensus 497 Gla~~~~~~~ 506 (517)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999886554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=239.24 Aligned_cols=152 Identities=30% Similarity=0.489 Sum_probs=137.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4568999999999999999999974 6999999998654 233456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999543 34899999999999999999999998 99999999999999999999999999987755
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 167 ~ 167 (328)
T 3fe3_A 167 G 167 (328)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=245.61 Aligned_cols=158 Identities=22% Similarity=0.244 Sum_probs=139.5
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 417 (517)
..++....++|++.+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34455567889999999999999999999764 889999998652 22334568899999999999999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
.+..++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999854 24899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+|+.+....
T Consensus 214 ~a~~~~~~~ 222 (410)
T 3v8s_A 214 TCMKMNKEG 222 (410)
T ss_dssp TCEECCTTS
T ss_pred eeEeeccCC
Confidence 999886543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=237.92 Aligned_cols=150 Identities=25% Similarity=0.325 Sum_probs=135.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++..+ +++.||+|++++. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999976 4899999999753 334567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999998543 35899999999999999999999998 99999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=240.95 Aligned_cols=155 Identities=30% Similarity=0.501 Sum_probs=136.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR 418 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 418 (517)
.++|.+.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 35579999997643 33456799999999999 899999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975432 235899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCCCC
Q 010146 486 DNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~~ 506 (517)
+.++.+||+|||+|+.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNID 257 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCC
T ss_pred CCCCCEEEccccCCcccCccc
Confidence 999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=237.43 Aligned_cols=152 Identities=29% Similarity=0.423 Sum_probs=133.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 58999999986542 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++++|.+++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 3445899999999999999999999998 9999999999999999999999999999875443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-27 Score=234.61 Aligned_cols=152 Identities=28% Similarity=0.406 Sum_probs=136.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
..+.|++.+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4467999999999999999999976 489999999976422 245789999999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEccc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDF 496 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DF 496 (517)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999943 456899999999999999999999998 99999999999998877 7999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999988654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=238.94 Aligned_cols=151 Identities=32% Similarity=0.454 Sum_probs=134.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 422 (517)
..++|++.+.||+|+||.||+|+.+. ++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999999764 899999999753 234567788999999988 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999543 45899999999999999999999998 999999999999999999999999999865
Q ss_pred CC
Q 010146 503 GV 504 (517)
Q Consensus 503 ~~ 504 (517)
..
T Consensus 175 ~~ 176 (353)
T 3txo_A 175 IC 176 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=239.01 Aligned_cols=151 Identities=25% Similarity=0.356 Sum_probs=136.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3578899999999999999999765 889999998653 234567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999953 345899999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=233.79 Aligned_cols=160 Identities=31% Similarity=0.542 Sum_probs=135.5
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----EEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 424 (517)
.++|++.+.||+|+||.||+|... ++.||||++... .........|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467899999999999999999986 799999999653 233445667999999999999999999998754 46999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc----------CCCceEecCCCCCcEEECCCCCeEEc
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999954 2389999999999999999999988 6 9999999999999999999999
Q ss_pred cccCceecCCCCcccccCceecC
Q 010146 495 DFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 495 DFGla~~~~~~~~~~~~~~~~GT 517 (517)
|||+|+.+.............||
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCC
T ss_pred cCCcccccccccCccccccCccC
Confidence 99999988665443333333443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=232.73 Aligned_cols=150 Identities=28% Similarity=0.394 Sum_probs=135.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 356888999999999999999976 5899999999753 234567788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999954 345899999999999999999999998 99999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=230.93 Aligned_cols=151 Identities=28% Similarity=0.448 Sum_probs=134.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 48999999986532 23346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999543 35899999999999999999999998 99999999999999999999999999987754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=235.50 Aligned_cols=152 Identities=30% Similarity=0.428 Sum_probs=134.9
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 421 (517)
...++|.+.+.||+|+||.||+|+.+. ++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 356789999999999999999999864 899999999754 234567788899999876 899999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999543 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCC
Q 010146 502 FGV 504 (517)
Q Consensus 502 ~~~ 504 (517)
...
T Consensus 168 ~~~ 170 (345)
T 1xjd_A 168 NML 170 (345)
T ss_dssp CCC
T ss_pred ccc
Confidence 543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=240.28 Aligned_cols=148 Identities=25% Similarity=0.361 Sum_probs=131.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+++.+. ++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4578899999999999999999765 7899999997642 23345688899999876 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||||+++|+|..++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999543 45899999999999999999999998 999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=234.48 Aligned_cols=151 Identities=25% Similarity=0.312 Sum_probs=136.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357889999999999999999976 5899999998653 234567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999653 34899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 194 ~ 194 (350)
T 1rdq_E 194 R 194 (350)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=232.26 Aligned_cols=153 Identities=29% Similarity=0.501 Sum_probs=134.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456888899999999999999975 3456999999764 33445679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999543 345899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 203 ~~~ 205 (325)
T 3kul_A 203 DDP 205 (325)
T ss_dssp ---
T ss_pred cCc
Confidence 543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=239.03 Aligned_cols=166 Identities=28% Similarity=0.419 Sum_probs=141.5
Q ss_pred CccchhHHHHhcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCee
Q 010146 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLV 409 (517)
Q Consensus 338 ~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv 409 (517)
..++........++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455666677788999999999999999999983 236799999997643 23446799999999999 799999
Q ss_pred eEEEEEEeCCE-EEEEEEeCCCCCHHHHHhccCC----------------------------------------------
Q 010146 410 RLLGCCTLRDE-RMLIYEYLPNKSLEQFIFDVTR---------------------------------------------- 442 (517)
Q Consensus 410 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 442 (517)
++++++...+. .++||||+++++|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999987654 8999999999999999965432
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 443 -----------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 443 -----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999998 999999999999999999999999999987554
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 247 ~ 247 (359)
T 3vhe_A 247 P 247 (359)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=229.56 Aligned_cols=153 Identities=22% Similarity=0.349 Sum_probs=136.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||++.... ++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 35789999999999999999999764 889999998753 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC--CCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999943 2335899999999999999999999998 999999999999987 78999999999998865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 157 ~~ 158 (321)
T 1tki_A 157 GD 158 (321)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=225.38 Aligned_cols=150 Identities=27% Similarity=0.483 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999976 48999999997543 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++..
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 666665432 345899999999999999999999998 999999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=238.16 Aligned_cols=152 Identities=19% Similarity=0.234 Sum_probs=133.0
Q ss_pred HHhcCCCCccceecccCCeeEEEEE------eCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC---CCCeeeEEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCT 416 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 416 (517)
....++|.+.+.||+|+||.||+|. ..+++.||||++... ...++..|+.++++++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 345889999999653 4567788888888887 999999999999
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-------
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVT--RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------- 487 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~------- 487 (517)
..+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996432 3456999999999999999999999988 999999999999998
Q ss_pred ----CCCeEEccccCceecC
Q 010146 488 ----DMNPKISDFGMARAFG 503 (517)
Q Consensus 488 ----~~~~kl~DFGla~~~~ 503 (517)
++.+||+|||+|+.+.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ----CTTEEECCCTTCEEGG
T ss_pred cccccCCEEEeeCchhhhhh
Confidence 8999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=229.04 Aligned_cols=155 Identities=26% Similarity=0.410 Sum_probs=137.4
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--EEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 424 (517)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3568899999999999999999775 8999999997543 345678899999999999999999999998765 77999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE----CCCCCeEEccccCce
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR 500 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 500 (517)
|||+++++|.+++........+++.+++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 778889999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 886554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=233.84 Aligned_cols=159 Identities=31% Similarity=0.529 Sum_probs=132.6
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
+....++|++.+.||+|+||.||+|... ++.||||++.... ....+++.+|+.++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3344567889999999999999999874 8899999987643 233467899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999965433334899999999999999999999875 35999999999999999999999999999866
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 190 ~~~ 192 (309)
T 3p86_A 190 AST 192 (309)
T ss_dssp ---
T ss_pred ccc
Confidence 443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=224.92 Aligned_cols=150 Identities=27% Similarity=0.503 Sum_probs=136.4
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||++...+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 568888999999999999999988899999999764 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999542 345899999999999999999999998 999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=229.01 Aligned_cols=153 Identities=30% Similarity=0.490 Sum_probs=134.4
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
...++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999889999999997542 22346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++.
T Consensus 98 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99997 5888888542 345899999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 172 ~ 172 (311)
T 3niz_A 172 P 172 (311)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=234.43 Aligned_cols=148 Identities=26% Similarity=0.355 Sum_probs=132.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+++.+. ++.||+|++.... ....+.+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 568889999999999999999764 8899999997642 23345688999999987 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999543 35899999999999999999999998 9999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=228.63 Aligned_cols=151 Identities=27% Similarity=0.418 Sum_probs=135.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999976 489999999875422 2467899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEcccc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG 497 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 497 (517)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999943 456899999999999999999999998 99999999999999887 79999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+|+.+...
T Consensus 164 ~a~~~~~~ 171 (326)
T 2y0a_A 164 LAHKIDFG 171 (326)
T ss_dssp TCEECCTT
T ss_pred CCeECCCC
Confidence 99988644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=231.21 Aligned_cols=156 Identities=28% Similarity=0.481 Sum_probs=137.0
Q ss_pred hcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788999999999999999986 235789999997643 3445678999999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR---------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
.++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975432 234899999999999999999999998 9999999
Q ss_pred CCcEEECCCCCeEEccccCceecCCCC
Q 010146 480 ASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+|||+++++.+||+|||+++.+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred hheEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=238.77 Aligned_cols=153 Identities=29% Similarity=0.467 Sum_probs=135.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457888899999999999999986 58999999997542 223456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999643 235899999999999999999999998 999999999999999999999999999976543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=237.13 Aligned_cols=153 Identities=31% Similarity=0.540 Sum_probs=128.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999865 4778999999764 33445679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++.+. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999543 345899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 199 ~~~ 201 (373)
T 2qol_A 199 DDP 201 (373)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=233.89 Aligned_cols=150 Identities=31% Similarity=0.378 Sum_probs=134.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 422 (517)
..++|++.+.||+|+||.||++..+. ++.||+|++... .....+.+..|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34679999999999999999999875 889999999754 234567788999999988 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999543 34899999999999999999999998 999999999999999999999999999875
Q ss_pred C
Q 010146 503 G 503 (517)
Q Consensus 503 ~ 503 (517)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=222.70 Aligned_cols=152 Identities=32% Similarity=0.498 Sum_probs=137.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|+||.||++..+++..||+|++... ....+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4678889999999999999999988889999999764 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999653 235899999999999999999999998 9999999999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=234.57 Aligned_cols=158 Identities=28% Similarity=0.543 Sum_probs=138.6
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 417 (517)
+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999975 24789999997643 3345679999999999999999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEec
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTR---------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~ 476 (517)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999975321 146899999999999999999999998 9999
Q ss_pred CCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 477 DLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 477 Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||||+|||+++++.+||+|||+++.+...
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 227 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSA 227 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccC
Confidence 99999999999999999999999877543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=230.76 Aligned_cols=154 Identities=27% Similarity=0.408 Sum_probs=135.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-----CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999976 4899999998642 22356789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEccccCc
Q 010146 424 IYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMA 499 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla 499 (517)
||||+++++|.+++.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998875432 3345899999999999999999999998 999999999999987654 999999999
Q ss_pred eecCCCC
Q 010146 500 RAFGVDQ 506 (517)
Q Consensus 500 ~~~~~~~ 506 (517)
+.+....
T Consensus 181 ~~~~~~~ 187 (351)
T 3c0i_A 181 IQLGESG 187 (351)
T ss_dssp EECCTTS
T ss_pred eEecCCC
Confidence 9886543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=231.49 Aligned_cols=150 Identities=27% Similarity=0.393 Sum_probs=125.5
Q ss_pred cCCCCccceecccCCeeEEEEEe----CCCCEEEEEEccCCC----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999997 468999999997642 2344568899999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999543 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 7543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.13 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=128.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--------------------------cCHHHHHHHHHHHh
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------------------------QGVEEFKNEVLLIA 401 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 401 (517)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 488999999865421 12356889999999
Q ss_pred cCCCCCeeeEEEEEEe--CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 402 KLQHRNLVRLLGCCTL--RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 402 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
+++||||+++++++.. .+..++||||+++++|.+++ ....+++.+++.++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56889999999999997754 2346899999999999999999999998 9999999
Q ss_pred CCcEEECCCCCeEEccccCceecCCC
Q 010146 480 ASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=235.77 Aligned_cols=156 Identities=30% Similarity=0.476 Sum_probs=136.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL 417 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 417 (517)
..++|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467889999999999999999852 23579999997642 33456789999999999 89999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEE
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 484 (517)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975432 245899999999999999999999998 999999999999
Q ss_pred ECCCCCeEEccccCceecCCCC
Q 010146 485 LDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~~~ 506 (517)
|++++.+||+|||+|+.+....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~ 245 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHID 245 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCC
T ss_pred EcCCCcEEEcccCccccccccc
Confidence 9999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=232.06 Aligned_cols=152 Identities=28% Similarity=0.465 Sum_probs=134.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 48999999997542 23456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---CeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~ 501 (517)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999843 346899999999999999999999998 99999999999998654 599999999998
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-26 Score=231.83 Aligned_cols=153 Identities=26% Similarity=0.389 Sum_probs=136.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++......++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999976 4899999999775555566899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC--CCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999843 2335899999999999999999999998 999999999999974 467999999999988654
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=230.85 Aligned_cols=156 Identities=28% Similarity=0.477 Sum_probs=123.2
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-C---CEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
...++|++.+.||+|+||.||+|.... + ..||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999999764 3 27999999764 33456789999999999999999999999987766
Q ss_pred E------EEEEEeCCCCCHHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 421 R------MLIYEYLPNKSLEQFIFDVTR---TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 421 ~------~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
. ++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 999999999999999864322 225899999999999999999999998 9999999999999999999
Q ss_pred EEccccCceecCCC
Q 010146 492 KISDFGMARAFGVD 505 (517)
Q Consensus 492 kl~DFGla~~~~~~ 505 (517)
||+|||+|+.+...
T Consensus 177 kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 177 CVADFGLSRKIYSG 190 (323)
T ss_dssp EECCCCC-------
T ss_pred EEeecccccccccc
Confidence 99999999887544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=225.46 Aligned_cols=149 Identities=28% Similarity=0.507 Sum_probs=133.6
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999986542 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.++.
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LD-QDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CS-EEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 97 4999988543 345899999999999999999999998 99999999999999999999999999987754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=223.71 Aligned_cols=151 Identities=26% Similarity=0.490 Sum_probs=134.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++|++.+.||+|+||.||++...++..||+|++... ....+++.+|++++.+++||||+++++++...+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45678889999999999999999988889999999764 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999643 234899999999999999999999998 99999999999999999999999999987644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=241.85 Aligned_cols=154 Identities=29% Similarity=0.394 Sum_probs=137.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999976 5999999998653 234566789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999996533 334899999999999999999999998 99999999999999999999999999998865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 339 ~~ 340 (576)
T 2acx_A 339 GQ 340 (576)
T ss_dssp TC
T ss_pred Cc
Confidence 43
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=224.94 Aligned_cols=153 Identities=29% Similarity=0.532 Sum_probs=121.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999975 48999999987543 3345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999986432 2245899999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 160 ~~ 161 (317)
T 2pmi_A 160 IP 161 (317)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=230.96 Aligned_cols=156 Identities=31% Similarity=0.509 Sum_probs=134.2
Q ss_pred hcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
..++|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457889999999999999999996 23568999999754 334557899999999999 8999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRT--------------------KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34799999999999999999999998 9999999
Q ss_pred CCcEEECCCCCeEEccccCceecCCCC
Q 010146 480 ASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 480 p~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+||||+.++.+||+|||+++.+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCc
Confidence 999999999999999999999876544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=229.13 Aligned_cols=152 Identities=33% Similarity=0.580 Sum_probs=132.0
Q ss_pred cCCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
.++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788999999999999999984 24889999999876666667899999999999999999999998643 458
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999653 234899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.95 Aligned_cols=153 Identities=30% Similarity=0.522 Sum_probs=138.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.... +..||||.+... ....+++.+|+.++++++||||+++++++...+..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568888999999999999999875 889999999764 3457889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999996533 345899999999999999999999998 999999999999999999999999999987544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-26 Score=237.51 Aligned_cols=151 Identities=29% Similarity=0.507 Sum_probs=136.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999976 5999999999653 223457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999943 446899999999999999999999998 99999999999999999999999999998865
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 169 ~ 169 (476)
T 2y94_A 169 G 169 (476)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=221.51 Aligned_cols=153 Identities=25% Similarity=0.415 Sum_probs=138.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34578899999999999999999765 77999999987666678899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~ 503 (517)
|+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999998543 34899999999999999999999998 9999999999999 788899999999999876
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 161 ~~~ 163 (277)
T 3f3z_A 161 PGK 163 (277)
T ss_dssp TTS
T ss_pred Ccc
Confidence 543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=230.17 Aligned_cols=150 Identities=27% Similarity=0.459 Sum_probs=134.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999974 5899999998643 223456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78999988543 35899999999999999999999998 99999999999999999999999999987755
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=239.81 Aligned_cols=155 Identities=32% Similarity=0.428 Sum_probs=138.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|.+.+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999986 4999999999653 234567889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999965432 346899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=241.41 Aligned_cols=153 Identities=30% Similarity=0.483 Sum_probs=136.5
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+...++|.+.+.||+|+||.||+|..+++..||||+++.. ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3455678889999999999999999988899999999764 356788999999999999999999999986 66789999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999996432 234788999999999999999999998 99999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=233.93 Aligned_cols=149 Identities=25% Similarity=0.323 Sum_probs=124.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHH-HhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLL-IAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+++.+. ++.||+|++.+.. ....+.+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4578999999999999999999765 8899999997642 2334456677776 577899999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999543 35889999999999999999999998 9999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=227.49 Aligned_cols=156 Identities=29% Similarity=0.503 Sum_probs=135.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC--------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL 417 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 417 (517)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3468899999999999999999863 46789999997643 33456789999999999 89999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEE
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 484 (517)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965432 234899999999999999999999998 999999999999
Q ss_pred ECCCCCeEEccccCceecCCCC
Q 010146 485 LDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~~~ 506 (517)
++.++.+||+|||+++.+....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNID 211 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTS
T ss_pred EcCCCCEEEccccccccccccc
Confidence 9999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=235.94 Aligned_cols=152 Identities=34% Similarity=0.519 Sum_probs=132.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999953 3678999999754 334455788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---CeEEc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKIS 494 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 494 (517)
++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975432 245899999999999999999999998 99999999999999554 59999
Q ss_pred cccCceecC
Q 010146 495 DFGMARAFG 503 (517)
Q Consensus 495 DFGla~~~~ 503 (517)
|||+|+.+.
T Consensus 227 DFG~a~~~~ 235 (367)
T 3l9p_A 227 DFGMARDIY 235 (367)
T ss_dssp CCHHHHHHH
T ss_pred CCccccccc
Confidence 999998663
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=230.83 Aligned_cols=161 Identities=28% Similarity=0.470 Sum_probs=138.9
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEE
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGC 414 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~ 414 (517)
.++.....++|++.+.||+|+||.||+|... .++.||+|.+.... ......+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3444556678999999999999999999864 36789999997543 2344578999999999999999999999
Q ss_pred EEeCCEEEEEEEeCCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC
Q 010146 415 CTLRDERMLIYEYLPNKSLEQFIFDVT-------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 487 (517)
Q Consensus 415 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 487 (517)
+...+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 999999999999999999999986432 1245789999999999999999999998 999999999999999
Q ss_pred CCCeEEccccCceecCCC
Q 010146 488 DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 488 ~~~~kl~DFGla~~~~~~ 505 (517)
++.+||+|||+++.+...
T Consensus 174 ~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp TCCEEECCTTCCCGGGGG
T ss_pred CCeEEECcCccccccccc
Confidence 999999999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=241.66 Aligned_cols=150 Identities=26% Similarity=0.319 Sum_probs=125.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 457889999999999999999975 4899999999753 334456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998543 358999999999999999999998 77 9999999999999999999999999998754
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 301 ~ 301 (446)
T 4ejn_A 301 K 301 (446)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=230.66 Aligned_cols=152 Identities=24% Similarity=0.377 Sum_probs=129.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE---
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE--- 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 420 (517)
..++|++.+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999974 589999999976432 234578899999999999999999999876543
Q ss_pred -EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 421 -RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 421 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999543 35899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.+...
T Consensus 164 ~~~~~~ 169 (311)
T 3ork_A 164 RAIADS 169 (311)
T ss_dssp ------
T ss_pred cccccc
Confidence 987554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=230.64 Aligned_cols=149 Identities=26% Similarity=0.355 Sum_probs=131.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999976 5899999999764 3344678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC--eEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~~~ 503 (517)
|+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+|+...
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999998543 34899999999999999999999998 999999999999987765 9999999998543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=236.87 Aligned_cols=153 Identities=26% Similarity=0.411 Sum_probs=133.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999975 58999999987542 23456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC---CCCCeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~ 501 (517)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998543 45899999999999999999999998 99999999999998 457899999999988
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 76543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=239.74 Aligned_cols=150 Identities=23% Similarity=0.467 Sum_probs=123.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999976 5899999998653 233456789999999999999999999998543 56
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 5899999843 345999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 205 ~~~~~ 209 (458)
T 3rp9_A 205 TVDYP 209 (458)
T ss_dssp CTTSC
T ss_pred hccCc
Confidence 87643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=229.98 Aligned_cols=159 Identities=31% Similarity=0.457 Sum_probs=137.3
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT 416 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 416 (517)
.....++|++.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999653 2479999997643 23456789999999999 8999999999999
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVT-----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
..+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999986432 1235799999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCCCC
Q 010146 486 DNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~~ 506 (517)
++++.+||+|||+++.+....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCT
T ss_pred CCCCeEEECcccccccccccc
Confidence 999999999999999775543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=230.18 Aligned_cols=152 Identities=18% Similarity=0.269 Sum_probs=136.2
Q ss_pred hcCCCCccceeccc--CCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
..++|++.+.||+| +||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44679999999999 99999999987 59999999997542 334567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999996532 345899999999999999999999998 999999999999999999999999998765
Q ss_pred C
Q 010146 503 G 503 (517)
Q Consensus 503 ~ 503 (517)
.
T Consensus 179 ~ 179 (389)
T 3gni_B 179 I 179 (389)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=227.87 Aligned_cols=152 Identities=30% Similarity=0.548 Sum_probs=128.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|.... ++ .||+|.+... .....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568888999999999999999643 44 4688888643 3456678999999999999999999999998654 789
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999653 345899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCCc
Q 010146 504 VDQT 507 (517)
Q Consensus 504 ~~~~ 507 (517)
....
T Consensus 169 ~~~~ 172 (327)
T 3poz_A 169 AEEK 172 (327)
T ss_dssp TTCC
T ss_pred CCcc
Confidence 5543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=234.27 Aligned_cols=150 Identities=27% Similarity=0.468 Sum_probs=133.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-EEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888899999999999999986 7899999997643 5678999999999999999999999987765 7899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999996542 334799999999999999999999998 99999999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=235.55 Aligned_cols=151 Identities=26% Similarity=0.474 Sum_probs=132.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----C
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----D 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 419 (517)
..++|++.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 34789999999999999999999764 889999999754 233456789999999999999999999998766 5
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999985 699999943 345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.+...
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=220.30 Aligned_cols=151 Identities=29% Similarity=0.425 Sum_probs=135.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457889999999999999999976 58999999986543 3345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++++|.+++. ....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999883 3446899999999999999999999998 999999999999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=226.08 Aligned_cols=157 Identities=32% Similarity=0.490 Sum_probs=137.4
Q ss_pred hcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCCc-cCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 419 (517)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788999999999999999985 2467999999976432 3456799999999999 8999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEE
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTR---------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 484 (517)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999965432 124899999999999999999999998 999999999999
Q ss_pred ECCCCCeEEccccCceecCCCCc
Q 010146 485 LDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~~~~ 507 (517)
++.++.+||+|||+++.+.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~ 200 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN 200 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT
T ss_pred EcCCCCEEEcccccccccccccc
Confidence 99999999999999998866543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=225.77 Aligned_cols=150 Identities=25% Similarity=0.279 Sum_probs=128.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.++||+|+||.||+|... +++.||||++.... .....++..|+..+.++ +||||+++++++..++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 59999999986542 22333455566555554 8999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 77999988654 345999999999999999999999998 999999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-26 Score=225.16 Aligned_cols=150 Identities=21% Similarity=0.275 Sum_probs=132.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467899999999999999999964 58999999987542 234688999999999 89999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-----eEEccccCcee
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISDFGMARA 501 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~~ 501 (517)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346999999999999999999999998 999999999999998887 99999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 76543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=227.50 Aligned_cols=167 Identities=28% Similarity=0.310 Sum_probs=144.5
Q ss_pred cCCCCCccchhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-----CC
Q 010146 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----HR 406 (517)
Q Consensus 333 ~~~~~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ 406 (517)
++.+...+++.+.....++|.+.++||+|+||.||+|... +++.||||++... ....+.+..|+.++++++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3445667778887888899999999999999999999975 5899999999752 344566788999999986 99
Q ss_pred CeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 407 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 999999996543 335899999999999999999999998 99999999999997
Q ss_pred C-------------------------CCCeEEccccCceecCCC
Q 010146 487 N-------------------------DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 487 ~-------------------------~~~~kl~DFGla~~~~~~ 505 (517)
+ ++.+||+|||+|+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~ 215 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY 215 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC
Confidence 5 788999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=229.50 Aligned_cols=147 Identities=31% Similarity=0.450 Sum_probs=127.0
Q ss_pred cceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999975 5899999999876555667899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE--CCCCCeEEccccCceecCCCC
Q 010146 434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 434 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~DFGla~~~~~~~ 506 (517)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9988542 345899999999999999999999998 9999999999999 567789999999999886543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=222.43 Aligned_cols=151 Identities=25% Similarity=0.375 Sum_probs=133.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|+||.||+|.... ++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3678999999999999999999864 89999998865422 23467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999998743 345899999999999999999999998 999999999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=232.16 Aligned_cols=155 Identities=26% Similarity=0.410 Sum_probs=136.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--EEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 424 (517)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578899999999999999999765 8999999997543 345678889999999999999999999998765 67999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE----CCCCCeEEccccCce
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR 500 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 500 (517)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965544445999999999999999999999998 9999999999999 777789999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=216.71 Aligned_cols=152 Identities=28% Similarity=0.404 Sum_probs=134.3
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
++|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555679999999999999975 48899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++........+++..+..++.||+.||+|||+++ |+|+||||+|||++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999976544455788999999999999999999998 999999999999987 88999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=229.79 Aligned_cols=152 Identities=26% Similarity=0.381 Sum_probs=131.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCC--CCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34678999999999999999999888999999998754 23345678999999999986 999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+|+.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 458999999964 345899999999999999999999998 99999999999997 5689999999999886
Q ss_pred CCCc
Q 010146 504 VDQT 507 (517)
Q Consensus 504 ~~~~ 507 (517)
....
T Consensus 159 ~~~~ 162 (343)
T 3dbq_A 159 PDTT 162 (343)
T ss_dssp ----
T ss_pred cccc
Confidence 5543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=229.01 Aligned_cols=158 Identities=26% Similarity=0.370 Sum_probs=134.9
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-----CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 417 (517)
++....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999975 4889999998643 23456789999999999999999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVT-------------------------------------RTKFLDWSKRCQIIEGIAR 460 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~ 460 (517)
.+..++||||+++++|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999984210 0112467788899999999
Q ss_pred HHHHhHhcCCCceEecCCCCCcEEECCCC--CeEEccccCceecCC
Q 010146 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDM--NPKISDFGMARAFGV 504 (517)
Q Consensus 461 aL~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~ 504 (517)
||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 999999998 99999999999998776 899999999998744
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=219.46 Aligned_cols=157 Identities=28% Similarity=0.419 Sum_probs=135.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+..+.++ +||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467889999999999999999986 5999999998764 233456788999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC--------------
Q 010146 424 IYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-------------- 488 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-------------- 488 (517)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965322 245899999999999999999999998 9999999999999844
Q ss_pred -----CCeEEccccCceecCCCCc
Q 010146 489 -----MNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 489 -----~~~kl~DFGla~~~~~~~~ 507 (517)
..+||+|||+++.+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~ 189 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV 189 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC
T ss_pred ccCCceEEEEcccccccccCCccc
Confidence 4799999999998865443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=227.83 Aligned_cols=152 Identities=30% Similarity=0.491 Sum_probs=130.8
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
++|++.+.||+|+||.||+|.... ++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 568888999999999999999653 44 38888875432 344456788999999999999999999986 566899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999543 345899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCCc
Q 010146 504 VDQT 507 (517)
Q Consensus 504 ~~~~ 507 (517)
....
T Consensus 167 ~~~~ 170 (325)
T 3kex_A 167 PDDK 170 (325)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=222.23 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=131.9
Q ss_pred cCCCCcc-ceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~-~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.+.|++. +.||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999965 5899999999876666778899999999985 7999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~ 502 (517)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999653 35899999999999999999999998 999999999999998776 999999999876
Q ss_pred CC
Q 010146 503 GV 504 (517)
Q Consensus 503 ~~ 504 (517)
..
T Consensus 165 ~~ 166 (316)
T 2ac3_A 165 KL 166 (316)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=220.77 Aligned_cols=152 Identities=32% Similarity=0.559 Sum_probs=132.2
Q ss_pred CCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER 421 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 421 (517)
+.|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999983 35889999999754 344567899999999999999999999999876 668
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999995432 34899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 86543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=222.52 Aligned_cols=151 Identities=28% Similarity=0.414 Sum_probs=135.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||++... +++.||+|.+..... ...+++.+|+.++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999976 489999999875422 2467899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEcccc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG 497 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 497 (517)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999953 345899999999999999999999998 99999999999999888 79999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=223.21 Aligned_cols=154 Identities=31% Similarity=0.523 Sum_probs=138.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.... ++.||+|.+... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999875 889999999753 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999653 3345899999999999999999999998 9999999999999999999999999998876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=227.45 Aligned_cols=153 Identities=25% Similarity=0.379 Sum_probs=135.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 418 (517)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567999999999999999999965 488999999876421 1334678899999999999999999999999
Q ss_pred CEEEEEEEeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 419 DERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 419 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
+..++||||+..| +|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 99999853 345899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+++.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999886543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=222.04 Aligned_cols=151 Identities=25% Similarity=0.481 Sum_probs=135.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-C-------CEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-G-------QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
.++|.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999998653 3 4799999987666777889999999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC--------eE
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--------PK 492 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~k 492 (517)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999643 234899999999999999999999998 999999999999998887 99
Q ss_pred EccccCceecCC
Q 010146 493 ISDFGMARAFGV 504 (517)
Q Consensus 493 l~DFGla~~~~~ 504 (517)
|+|||+++....
T Consensus 162 l~Dfg~~~~~~~ 173 (289)
T 4fvq_A 162 LSDPGISITVLP 173 (289)
T ss_dssp ECCCCSCTTTSC
T ss_pred eccCcccccccC
Confidence 999999976643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=219.18 Aligned_cols=148 Identities=28% Similarity=0.433 Sum_probs=127.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhc--CCCCCeeeEEEEEEeC----CEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLR----DER 421 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 421 (517)
..++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346799999999999999999998 5899999998653 34556666666665 7999999999987543 457
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
++||||+++++|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 99999999999999993 235899999999999999999999 766 999999999999999999999
Q ss_pred ccccCceecCCCC
Q 010146 494 SDFGMARAFGVDQ 506 (517)
Q Consensus 494 ~DFGla~~~~~~~ 506 (517)
+|||+|+.+....
T Consensus 155 ~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 155 ADLGLAVMHSQST 167 (301)
T ss_dssp CCCTTCEEEETTT
T ss_pred eeCCCeeeccccc
Confidence 9999998875543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=236.74 Aligned_cols=148 Identities=21% Similarity=0.299 Sum_probs=125.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--------ccCHHHHHHHHHHHhcCC---------CCCeeeE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---------HRNLVRL 411 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l 411 (517)
.++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 58999999997542 234478899999988885 8888888
Q ss_pred EEEEE------------------------------eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 010146 412 LGCCT------------------------------LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461 (517)
Q Consensus 412 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~a 461 (517)
.+.+. ..+..+|||||+++|++.+.+.+ ..+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77653 26789999999999976665522 458999999999999999
Q ss_pred HHHhH-hcCCCceEecCCCCCcEEECCCC--------------------CeEEccccCceecCC
Q 010146 462 LLYLH-QDSRLRIIHRDLKASNVLLDNDM--------------------NPKISDFGMARAFGV 504 (517)
Q Consensus 462 L~~LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DFGla~~~~~ 504 (517)
|+||| +++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 888 99999999999999887 899999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=226.50 Aligned_cols=150 Identities=27% Similarity=0.427 Sum_probs=122.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.... ++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45679999999999999999999874 8899999997542 34678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~ 503 (517)
|+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+.
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999943 445899999999999999999999998 999999999999975 8899999999999775
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 203 ~~ 204 (349)
T 2w4o_A 203 HQ 204 (349)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=238.36 Aligned_cols=152 Identities=29% Similarity=0.532 Sum_probs=132.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++|++.+.||+|+||.||+|...++..||||+++... ...+++.+|+.++++++||||+++++++.. +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788889999999999999999888889999997643 456789999999999999999999999875 678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999532 2235899999999999999999999998 999999999999999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=217.26 Aligned_cols=153 Identities=31% Similarity=0.517 Sum_probs=135.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467889999999999999999974 5899999998653 22345789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999542 345899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 164 ~~ 165 (278)
T 3cok_A 164 MP 165 (278)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=219.64 Aligned_cols=154 Identities=27% Similarity=0.443 Sum_probs=133.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357888999999999999999975 48899999987643 3456889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceec
Q 010146 427 YLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF 502 (517)
Q Consensus 427 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 502 (517)
|+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998543 22356899999999999999999999998 9999999999999 45678999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=231.30 Aligned_cols=150 Identities=27% Similarity=0.370 Sum_probs=133.8
Q ss_pred CCCCccceecccCCeeEEEEEe----CCCCEEEEEEccCCC----ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
++|++.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788999999999999999997 358999999987532 23456678899999999 69999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999643 35899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 208 ~~~~~ 212 (355)
T 1vzo_A 208 EFVAD 212 (355)
T ss_dssp ECCGG
T ss_pred ecccC
Confidence 87544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=217.01 Aligned_cols=150 Identities=27% Similarity=0.478 Sum_probs=136.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|+||.||++...+++.||+|++... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3568888999999999999999988889999999764 335578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999643 345899999999999999999999998 99999999999999999999999999987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.62 Aligned_cols=152 Identities=32% Similarity=0.548 Sum_probs=134.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++|++.+.||+|+||.||+|...+++.||+|.+... ....+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 34678889999999999999999988889999999764 345678999999999999999999999986 4568999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999984321 125899999999999999999999998 999999999999999999999999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=223.53 Aligned_cols=152 Identities=30% Similarity=0.512 Sum_probs=135.5
Q ss_pred CCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEE--eCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT--LRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 422 (517)
++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 358899999998766666678999999999999999999999987 456689
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999996432 34899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=224.82 Aligned_cols=164 Identities=29% Similarity=0.435 Sum_probs=139.4
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEe------CCCCEEEEEEccCCCc-cCHHHHHHHHHHHhcC-CCCCeeeE
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRL 411 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l 411 (517)
+.........++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45555566678899999999999999999984 2468999999976432 3446789999999999 79999999
Q ss_pred EEEEEeCC-EEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecC
Q 010146 412 LGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477 (517)
Q Consensus 412 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~D 477 (517)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987755 48999999999999999965432 123789999999999999999999998 99999
Q ss_pred CCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 478 LKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 478 lkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|||+|||++.++.+||+|||+++.+....
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred CccceEEECCCCCEEECCCccccccccCc
Confidence 99999999999999999999999876544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=218.59 Aligned_cols=151 Identities=28% Similarity=0.390 Sum_probs=135.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|.+.+.||+|+||.||++.... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678889999999999999999875 8899999986542 23456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 35899999999999999999999998 99999999999999999999999999998754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 168 ~ 168 (294)
T 2rku_A 168 D 168 (294)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=223.26 Aligned_cols=152 Identities=28% Similarity=0.390 Sum_probs=136.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|.+.+.||+|+||.||++...+ ++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678899999999999999999765 8899999986542 2345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999998543 35899999999999999999999998 9999999999999999999999999999875
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 193 ~~ 194 (335)
T 2owb_A 193 YD 194 (335)
T ss_dssp ST
T ss_pred cC
Confidence 43
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=230.97 Aligned_cols=150 Identities=26% Similarity=0.383 Sum_probs=129.6
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC--CCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999998654 2344578999999999996 599999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
| +.+++|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+|+.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 5689999999643 35889999999999999999999998 99999999999996 578999999999988655
Q ss_pred Cc
Q 010146 506 QT 507 (517)
Q Consensus 506 ~~ 507 (517)
..
T Consensus 208 ~~ 209 (390)
T 2zmd_A 208 TT 209 (390)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=244.13 Aligned_cols=152 Identities=31% Similarity=0.378 Sum_probs=135.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 422 (517)
..++|++.+.||+|+||.||+|.... ++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45679999999999999999999764 889999998753 234567788999999988 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999653 35899999999999999999999998 999999999999999999999999999975
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
..+
T Consensus 493 ~~~ 495 (674)
T 3pfq_A 493 IWD 495 (674)
T ss_dssp CCT
T ss_pred ccC
Confidence 433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=215.79 Aligned_cols=152 Identities=34% Similarity=0.550 Sum_probs=125.6
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467888999999999999999986 8899999987542 23457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC--------CCCeEEccc
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------DMNPKISDF 496 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~DF 496 (517)
|||+++++|.+++. ...+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 345899999999999999999999987556899999999999986 678999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999877544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=227.83 Aligned_cols=150 Identities=26% Similarity=0.556 Sum_probs=124.4
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCC--E
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD--E 420 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 420 (517)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 4899999998653 2344567889999999997 999999999997654 6
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999996 689998854 35899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
.+..
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 8754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-25 Score=217.38 Aligned_cols=152 Identities=27% Similarity=0.415 Sum_probs=130.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC----ccCHHHHHHHHHHHhcCCCCCeeeEEEEEE--eCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCT--LRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 420 (517)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999975 48899999997532 234578999999999999999999999984 4457
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||++++ |.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999866 777775433 456899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
.+..
T Consensus 158 ~~~~ 161 (305)
T 2wtk_C 158 ALHP 161 (305)
T ss_dssp ECCT
T ss_pred ccCc
Confidence 8754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=218.88 Aligned_cols=151 Identities=30% Similarity=0.429 Sum_probs=133.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34678899999999999999999765 779999998643 22345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999999543 34899999999999999999999988 9999999999999999999999999987654
Q ss_pred C
Q 010146 504 V 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 161 ~ 161 (279)
T 3fdn_A 161 S 161 (279)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=220.85 Aligned_cols=142 Identities=27% Similarity=0.375 Sum_probs=126.1
Q ss_pred cceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
.+.||+|+||.||++... +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999976 489999999964 34567889999999997 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---CeEEccccCceecCCC
Q 010146 433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARAFGVD 505 (517)
Q Consensus 433 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~~~~ 505 (517)
|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999954 345899999999999999999999998 99999999999997765 7999999999977554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=216.53 Aligned_cols=153 Identities=29% Similarity=0.469 Sum_probs=135.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999764 899999998654 233456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~ 501 (517)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999988543 45899999999999999999999998 999999999999987655 99999999988
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
.....
T Consensus 158 ~~~~~ 162 (284)
T 3kk8_A 158 VNDSE 162 (284)
T ss_dssp CCSSC
T ss_pred cccCc
Confidence 76543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.1e-25 Score=215.05 Aligned_cols=151 Identities=28% Similarity=0.480 Sum_probs=136.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999975 58999999997543 4456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999842 45899999999999999999999998 9999999999999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=223.82 Aligned_cols=154 Identities=31% Similarity=0.471 Sum_probs=127.5
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc-----cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 419 (517)
....++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999976 489999999975321 11346889999999999999999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999975 89888843 2345889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.+...
T Consensus 160 ~~~~~~ 165 (346)
T 1ua2_A 160 KSFGSP 165 (346)
T ss_dssp STTTSC
T ss_pred eeccCC
Confidence 987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=224.01 Aligned_cols=160 Identities=23% Similarity=0.439 Sum_probs=140.1
Q ss_pred chhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--------cCHHHHHHHHHHHhcC-CCCCeee
Q 010146 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKL-QHRNLVR 410 (517)
Q Consensus 341 ~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~ 410 (517)
.+.......++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34445556678999999999999999999986 599999999875431 1145678999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 411 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
+++++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 999999999999999999999999999542 35899999999999999999999998 999999999999999999
Q ss_pred eEEccccCceecCCCC
Q 010146 491 PKISDFGMARAFGVDQ 506 (517)
Q Consensus 491 ~kl~DFGla~~~~~~~ 506 (517)
+||+|||+++.+....
T Consensus 239 ikl~DfG~~~~~~~~~ 254 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE 254 (365)
T ss_dssp EEECCCTTCEECCTTC
T ss_pred EEEEecCcccccCCCc
Confidence 9999999999886543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=222.06 Aligned_cols=160 Identities=29% Similarity=0.506 Sum_probs=127.8
Q ss_pred hHHHHhcCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 010146 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416 (517)
Q Consensus 343 ~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 416 (517)
.++....++|.+.+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344456788999999999999999998642 458999999754 2334567899999999999999999999998
Q ss_pred eCCE-----EEEEEEeCCCCCHHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC
Q 010146 417 LRDE-----RMLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488 (517)
Q Consensus 417 ~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 488 (517)
..+. .++||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 6653 49999999999999998532 23356899999999999999999999998 9999999999999999
Q ss_pred CCeEEccccCceecCCC
Q 010146 489 MNPKISDFGMARAFGVD 505 (517)
Q Consensus 489 ~~~kl~DFGla~~~~~~ 505 (517)
+.+||+|||+++.+...
T Consensus 184 ~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSG 200 (313)
T ss_dssp SCEEECSCSCC------
T ss_pred CcEEEeecCcceecccc
Confidence 99999999999887543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=219.03 Aligned_cols=149 Identities=32% Similarity=0.535 Sum_probs=123.9
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..++|++.+.||+|+||.||+|... ..||+|++.... ....+.+.+|+.++++++||||++++++. .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3567999999999999999999865 469999987542 33456799999999999999999999965 456789999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999432 345899999999999999999999998 99999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=223.46 Aligned_cols=150 Identities=31% Similarity=0.461 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
+.|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999964 589999999875422 23457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+. |+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 7888887543 245899999999999999999999998 999999999999999999999999999887543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=222.45 Aligned_cols=163 Identities=31% Similarity=0.495 Sum_probs=137.6
Q ss_pred CCccchhHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEE
Q 010146 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGC 414 (517)
Q Consensus 337 ~~~~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 414 (517)
.+.+++.++....++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++++ +||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344556666677889999999999999999999975 5899999998753 34557889999999998 79999999999
Q ss_pred EEe------CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC
Q 010146 415 CTL------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488 (517)
Q Consensus 415 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 488 (517)
+.. .+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+|+||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN 165 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTT
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCC
Confidence 987 467899999999999999996532 345899999999999999999999998 9999999999999999
Q ss_pred CCeEEccccCceecCC
Q 010146 489 MNPKISDFGMARAFGV 504 (517)
Q Consensus 489 ~~~kl~DFGla~~~~~ 504 (517)
+.+||+|||+++.+..
T Consensus 166 ~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDR 181 (326)
T ss_dssp CCEEECCCTTTC----
T ss_pred CCEEEeeCcCceecCc
Confidence 9999999999987754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=218.17 Aligned_cols=152 Identities=26% Similarity=0.420 Sum_probs=124.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
..++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678899999999999999999753 457999998764 2334567899999999999999999999984 56789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999643 335899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-26 Score=240.23 Aligned_cols=151 Identities=29% Similarity=0.531 Sum_probs=134.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++|+||+++++++.. +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788889999999999999999888889999997643 456789999999999999999999999865 678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.++|... ....+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999542 1234899999999999999999999998 99999999999999999999999999987754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=231.33 Aligned_cols=152 Identities=24% Similarity=0.396 Sum_probs=128.6
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--------ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 417 (517)
...++|.+.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 345789999999999999999999764 8999999986531 112235789999999999999999999975
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---CeEEc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKIS 494 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 494 (517)
.+..++||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 566899999999999998883 3456899999999999999999999998 99999999999997544 59999
Q ss_pred cccCceecCCC
Q 010146 495 DFGMARAFGVD 505 (517)
Q Consensus 495 DFGla~~~~~~ 505 (517)
|||+|+.++..
T Consensus 285 DFG~a~~~~~~ 295 (419)
T 3i6u_A 285 DFGHSKILGET 295 (419)
T ss_dssp CSSTTTSCC--
T ss_pred ecccceecCCC
Confidence 99999987644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=218.84 Aligned_cols=152 Identities=21% Similarity=0.281 Sum_probs=130.9
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999976 588999999976432 234678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999643 35899999999999999999999998 9999999999999999999999999998775
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=215.04 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=133.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC------ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999987 58999999986542 124678999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEccccC
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFGM 498 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGl 498 (517)
+||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999542 35899999999999999999999998 99999999999998877 799999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
++.+...
T Consensus 159 ~~~~~~~ 165 (283)
T 3bhy_A 159 AHKIEAG 165 (283)
T ss_dssp CEECC--
T ss_pred ceeccCC
Confidence 9987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=221.07 Aligned_cols=153 Identities=33% Similarity=0.580 Sum_probs=134.9
Q ss_pred cCCCCccceecccCCeeEEEEEe-----CCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--EE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 421 (517)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 358899999998766666778999999999999999999999987554 67
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999653 235899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 195 ~~~~~ 199 (326)
T 2w1i_A 195 LPQDK 199 (326)
T ss_dssp CCSSC
T ss_pred ccccc
Confidence 86543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=219.73 Aligned_cols=153 Identities=29% Similarity=0.422 Sum_probs=133.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 422 (517)
..++|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3467999999999999999999974 589999999876555667789999999999999999999999873 34679
Q ss_pred EEEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 423 LIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+||||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999986532 3456899999999999999999999998 99999999999999999999999999887
Q ss_pred cC
Q 010146 502 FG 503 (517)
Q Consensus 502 ~~ 503 (517)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 54
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=232.11 Aligned_cols=154 Identities=31% Similarity=0.466 Sum_probs=134.1
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc-------------cCHHHHHHHHHHHhcCCCCCeeeEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-------------QGVEEFKNEVLLIAKLQHRNLVRLL 412 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~ 412 (517)
...++|.+.++||+|+||.||+|.... ++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 355789999999999999999999764 88999999875321 3457899999999999999999999
Q ss_pred EEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC---
Q 010146 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM--- 489 (517)
Q Consensus 413 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~--- 489 (517)
+++......++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999998543 34899999999999999999999998 99999999999998776
Q ss_pred CeEEccccCceecCCCC
Q 010146 490 NPKISDFGMARAFGVDQ 506 (517)
Q Consensus 490 ~~kl~DFGla~~~~~~~ 506 (517)
.+||+|||+|+.+....
T Consensus 187 ~~kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY 203 (504)
T ss_dssp SEEECCCTTCEECCTTS
T ss_pred cEEEEECCCCEEcCCCC
Confidence 69999999999886543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=217.31 Aligned_cols=148 Identities=34% Similarity=0.541 Sum_probs=131.2
Q ss_pred CCccceecccCCeeEEEEEeC-----CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEE
Q 010146 352 FSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML 423 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 423 (517)
|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 388899999999999998643 47899999997643 33456789999999999999999999999874 67899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999432 3899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 186 ~~~ 188 (318)
T 3lxp_A 186 EGH 188 (318)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=232.05 Aligned_cols=149 Identities=29% Similarity=0.450 Sum_probs=125.9
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
..++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999976 4899999999754 234456788999999999999999999999654
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 457999999965 5767662 23899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 211 a~~~~~~ 217 (464)
T 3ttj_A 211 ARTAGTS 217 (464)
T ss_dssp C-----C
T ss_pred eeecCCC
Confidence 9987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=218.22 Aligned_cols=149 Identities=27% Similarity=0.495 Sum_probs=132.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 44679999999999999999999864 89999999987666778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999998543 234899999999999999999999998 99999999999999999999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=221.41 Aligned_cols=152 Identities=30% Similarity=0.547 Sum_probs=126.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
.++|++.+.||+|+||.||+|.... ++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3678999999999999999999653 44 3578877543 4456788999999999999999999999998654 78
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 5543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=221.40 Aligned_cols=151 Identities=27% Similarity=0.481 Sum_probs=130.2
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|+||.||++.... ++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3578899999999999999999765 89999999865432 23456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999888643 345899999999999999999999998 999999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=216.02 Aligned_cols=153 Identities=29% Similarity=0.505 Sum_probs=128.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-----ccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLR 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 418 (517)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999964 58999999986432 222356677887777664 99999999999876
Q ss_pred C-----EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEE
Q 010146 419 D-----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI 493 (517)
Q Consensus 419 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 493 (517)
. ..++||||+. ++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999996 69999996533 334899999999999999999999998 999999999999999999999
Q ss_pred ccccCceecCCC
Q 010146 494 SDFGMARAFGVD 505 (517)
Q Consensus 494 ~DFGla~~~~~~ 505 (517)
+|||+|+.+...
T Consensus 162 ~Dfg~a~~~~~~ 173 (308)
T 3g33_A 162 ADFGLARIYSYQ 173 (308)
T ss_dssp CSCSCTTTSTTC
T ss_pred eeCccccccCCC
Confidence 999999877543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=223.37 Aligned_cols=160 Identities=24% Similarity=0.360 Sum_probs=134.2
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCcc-----------CHHHHHHHHHHHhcCCCCCe
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNL 408 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni 408 (517)
....++....++|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456788889999999999999999999999888999999998653211 13778999999999999999
Q ss_pred eeEEEEEEeC-----CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcE
Q 010146 409 VRLLGCCTLR-----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV 483 (517)
Q Consensus 409 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 483 (517)
+++++++... ...++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998543 36799999997 788888853 3346899999999999999999999998 99999999999
Q ss_pred EECCCCCeEEccccCceecCCC
Q 010146 484 LLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 484 ll~~~~~~kl~DFGla~~~~~~ 505 (517)
|++.++.+||+|||+++.....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~ 187 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD 187 (362)
T ss_dssp EECTTCCEEECCTTC-------
T ss_pred EEcCCCCEEEEecCcccccccc
Confidence 9999999999999999865443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=214.77 Aligned_cols=152 Identities=28% Similarity=0.468 Sum_probs=136.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3467999999999999999999986 5899999998653 23456789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999643 34899999999999999999999998 9999999999999999999999999998875
Q ss_pred CC
Q 010146 504 VD 505 (517)
Q Consensus 504 ~~ 505 (517)
..
T Consensus 163 ~~ 164 (276)
T 2h6d_A 163 DG 164 (276)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=220.67 Aligned_cols=149 Identities=26% Similarity=0.427 Sum_probs=129.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..++|++.+.||+|+||.||++..+ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467899999999999999999976 4889999999764332 34677888777 7999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-C---CeEEccccCcee
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-M---NPKISDFGMARA 501 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~---~~kl~DFGla~~ 501 (517)
||+++++|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ + .+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999854 345899999999999999999999998 9999999999998543 2 499999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 170 ~~~~~ 174 (342)
T 2qr7_A 170 LRAEN 174 (342)
T ss_dssp CBCTT
T ss_pred CcCCC
Confidence 76543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=232.77 Aligned_cols=152 Identities=28% Similarity=0.415 Sum_probs=130.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456899999999999999999976 48899999987642 344678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC---CCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~ 502 (517)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.. +.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988543 34899999999999999999999998 9999999999999764 45999999999988
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 190 ~~~~ 193 (494)
T 3lij_A 190 ENQK 193 (494)
T ss_dssp BTTB
T ss_pred CCCc
Confidence 6543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=223.17 Aligned_cols=153 Identities=31% Similarity=0.498 Sum_probs=128.2
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345578999999999999999999965 58999999997543 223456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-----CCCCeEEcccc
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NDMNPKISDFG 497 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~DFG 497 (517)
+||||++ ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 5999998543 34899999999999999999999998 99999999999994 45569999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+|+.+...
T Consensus 183 ~a~~~~~~ 190 (329)
T 3gbz_A 183 LARAFGIP 190 (329)
T ss_dssp HHHHHC--
T ss_pred CccccCCc
Confidence 99877543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=213.99 Aligned_cols=151 Identities=19% Similarity=0.292 Sum_probs=133.1
Q ss_pred hcCCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999996 458999999986532 334678899999999 7999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-----eEEccccCce
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISDFGMAR 500 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~ 500 (517)
||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+|+
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999643 335899999999999999999999988 999999999999987776 9999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 160 ~~~~~~ 165 (298)
T 1csn_A 160 FYRDPV 165 (298)
T ss_dssp ESBCTT
T ss_pred cccccc
Confidence 886543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=214.33 Aligned_cols=151 Identities=32% Similarity=0.596 Sum_probs=131.9
Q ss_pred CCCCccc-eecccCCeeEEEEEeC---CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~-~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|.+.+ .||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 9999999999999854 47789999997643 34567799999999999999999999999 56678999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999953 2345899999999999999999999998 99999999999999999999999999998865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 163 ~~ 164 (287)
T 1u59_A 163 DD 164 (287)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=214.66 Aligned_cols=149 Identities=28% Similarity=0.425 Sum_probs=134.2
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 578889999999999999999764 789999998643 2334578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999653 34899999999999999999999988 99999999999999999999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=215.50 Aligned_cols=153 Identities=27% Similarity=0.381 Sum_probs=135.6
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---------ccCHHHHHHHHHHHhcCC-CCCeeeEEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---------GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCC 415 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 415 (517)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45578999999999999999999986 48999999986542 122456789999999996 99999999999
Q ss_pred EeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 416 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
...+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999543 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCceecCCC
Q 010146 496 FGMARAFGVD 505 (517)
Q Consensus 496 FGla~~~~~~ 505 (517)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-25 Score=219.26 Aligned_cols=150 Identities=29% Similarity=0.543 Sum_probs=130.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-------- 417 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 417 (517)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999975 58999999986542 3345678899999999999999999999987
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
.+..++||||++ ++|.+.+... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccC-CCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 446899999997 5787777443 345899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCC
Q 010146 498 MARAFGV 504 (517)
Q Consensus 498 la~~~~~ 504 (517)
+|+.+..
T Consensus 170 ~a~~~~~ 176 (351)
T 3mi9_A 170 LARAFSL 176 (351)
T ss_dssp TCEECCC
T ss_pred hcccccc
Confidence 9998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=220.62 Aligned_cols=152 Identities=30% Similarity=0.549 Sum_probs=128.6
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998653 2369999997642 334557899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999643 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 198 ~~~ 200 (333)
T 1mqb_A 198 EDD 200 (333)
T ss_dssp ---
T ss_pred ccc
Confidence 654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=217.43 Aligned_cols=153 Identities=25% Similarity=0.394 Sum_probs=128.1
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC--CCCCeeeEEEEEEeC----C
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--QHRNLVRLLGCCTLR----D 419 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~ 419 (517)
....++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345578999999999999999999986 899999998643 234455566665554 899999999999887 7
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCceEecCCCCCcEEECCCCCeEEc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
..++||||+++++|.+++.. ..+++..++.++.|++.||+|||++. +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999954 24899999999999999999999880 1129999999999999999999999
Q ss_pred cccCceecCCCC
Q 010146 495 DFGMARAFGVDQ 506 (517)
Q Consensus 495 DFGla~~~~~~~ 506 (517)
|||+|+.+....
T Consensus 185 Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 185 DLGLAVKFISDT 196 (337)
T ss_dssp CCTTCEECC---
T ss_pred eCCCceeecccc
Confidence 999998875543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=212.75 Aligned_cols=151 Identities=28% Similarity=0.577 Sum_probs=130.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc-------CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
.++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467889999999999999999975 5899999998654322 1267899999999999999999999986554
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-----eEEcc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISD 495 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~D 495 (517)
++||||+++++|.+++.+. ...+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999988543 346899999999999999999999875 35999999999999988776 99999
Q ss_pred ccCceecCC
Q 010146 496 FGMARAFGV 504 (517)
Q Consensus 496 FGla~~~~~ 504 (517)
||+|+....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=221.40 Aligned_cols=149 Identities=30% Similarity=0.519 Sum_probs=128.5
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc-CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999976 5899999998754321 122456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 96 6999988643 345899999999999999999999998 99999999999999999999999999987653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=216.99 Aligned_cols=152 Identities=29% Similarity=0.496 Sum_probs=130.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEE-eCCEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCT-LRDERM 422 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 422 (517)
..+|++.+.||+|+||.||+|...+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998643 2368999987643 334567899999999999999999999865 456789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 2345899999999999999999999998 999999999999999999999999999977
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 179 ~~~ 181 (298)
T 3f66_A 179 YDK 181 (298)
T ss_dssp SCG
T ss_pred ccc
Confidence 543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=214.33 Aligned_cols=151 Identities=31% Similarity=0.504 Sum_probs=132.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe---------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--------- 417 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 417 (517)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999999999999986 58999999997543 356789999999999999999998864
Q ss_pred -------CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC
Q 010146 418 -------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490 (517)
Q Consensus 418 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 490 (517)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345799999999999999996532 345899999999999999999999998 999999999999999999
Q ss_pred eEEccccCceecCCCC
Q 010146 491 PKISDFGMARAFGVDQ 506 (517)
Q Consensus 491 ~kl~DFGla~~~~~~~ 506 (517)
+||+|||+++.+....
T Consensus 161 ~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG 176 (284)
T ss_dssp EEECCCTTCEESSCCS
T ss_pred EEECcchhheeccccc
Confidence 9999999999886543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=218.56 Aligned_cols=155 Identities=26% Similarity=0.466 Sum_probs=121.4
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
...++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999965 58999999987542 34456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 425 YEYLPNKSLEQFIFDV-----TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
|||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCC
Q 010146 500 RAFGV 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=223.26 Aligned_cols=152 Identities=23% Similarity=0.326 Sum_probs=127.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC------CCEEEEEEccCCCcc-----------CHHHHHHHHHHHhcCCCCCeee
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNLVR 410 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~ 410 (517)
..++|++.+.||+|+||.||+|.+.. ++.||||++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 478999998754321 1123445666778889999999
Q ss_pred EEEEEEeC----CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC
Q 010146 411 LLGCCTLR----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486 (517)
Q Consensus 411 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 486 (517)
+++++... ...++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998764 4579999999 99999999653 345999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEccccCceecCCC
Q 010146 487 --NDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 487 --~~~~~kl~DFGla~~~~~~ 505 (517)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=222.88 Aligned_cols=150 Identities=26% Similarity=0.449 Sum_probs=126.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----- 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 419 (517)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999975 5999999999653 2233567889999999999999999999997653
Q ss_pred -EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 420 -ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 420 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8999999854 34899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 175 a~~~~~~ 181 (367)
T 1cm8_A 175 ARQADSE 181 (367)
T ss_dssp CEECCSS
T ss_pred ccccccc
Confidence 9987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=213.97 Aligned_cols=152 Identities=29% Similarity=0.490 Sum_probs=131.0
Q ss_pred HhcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
...++|++.+.||+|+||.||+|.... ++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345679999999999999999999764 899999999753 34578899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 345899999999999999999999998 999999999999999999999999999887654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=217.91 Aligned_cols=151 Identities=26% Similarity=0.407 Sum_probs=128.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCC--------ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 418 (517)
..++|.+.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34578999999999999999999764 8899999986532 12234588999999999999999999998765
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEcc
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISD 495 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~D 495 (517)
+ .++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999984 3456899999999999999999999998 999999999999987664 99999
Q ss_pred ccCceecCCC
Q 010146 496 FGMARAFGVD 505 (517)
Q Consensus 496 FGla~~~~~~ 505 (517)
||+++.+...
T Consensus 161 fg~~~~~~~~ 170 (322)
T 2ycf_A 161 FGHSKILGET 170 (322)
T ss_dssp CTTCEECCCC
T ss_pred Cccceecccc
Confidence 9999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=237.16 Aligned_cols=148 Identities=31% Similarity=0.584 Sum_probs=128.9
Q ss_pred CCccc-eecccCCeeEEEEEeC---CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 352 FSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 352 y~~~~-~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
+.+.+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|+.++++++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999864 36679999998653 3467889999999999999999999999975 56899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+
T Consensus 416 ~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 416 MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp CCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999953 2445899999999999999999999998 999999999999999999999999999987544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=231.15 Aligned_cols=152 Identities=32% Similarity=0.480 Sum_probs=136.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457889999999999999999976 5899999998654 234577899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~ 501 (517)
|||+.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999854 345899999999999999999999998 9999999999999 5678899999999988
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 179 ~~~~~ 183 (484)
T 3nyv_A 179 FEASK 183 (484)
T ss_dssp BCCCC
T ss_pred ccccc
Confidence 76543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.50 Aligned_cols=151 Identities=30% Similarity=0.536 Sum_probs=131.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57889999999999999999976 58999999987542 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.++..
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 156 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence 997 69999986533 245899999999999999999999998 999999999999999999999999999877543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=218.27 Aligned_cols=150 Identities=33% Similarity=0.604 Sum_probs=129.9
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCE--EEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQE--IAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|.... +.. +|+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 468889999999999999999653 554 499988753 334456789999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999998 9999999999999999999
Q ss_pred EEccccCceec
Q 010146 492 KISDFGMARAF 502 (517)
Q Consensus 492 kl~DFGla~~~ 502 (517)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=223.78 Aligned_cols=149 Identities=23% Similarity=0.325 Sum_probs=134.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357889999999999999999976 5899999999764 23345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||||+.++.+||+|||+++.+.
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999543 3489999999999999999999985 7 9999999999999999999999999997653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=216.16 Aligned_cols=151 Identities=28% Similarity=0.510 Sum_probs=130.8
Q ss_pred cCCCCccc-eecccCCeeEEEEEeC---CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 349 TDNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 349 ~~~y~~~~-~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
.++|.+.+ .||+|+||.||+|... .++.||||++.... ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999642 36889999997643 23356899999999999999999999999 567789
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999964 235899999999999999999999998 999999999999999999999999999988
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 168 ~~~~ 171 (291)
T 1xbb_A 168 RADE 171 (291)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=215.71 Aligned_cols=150 Identities=28% Similarity=0.473 Sum_probs=132.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL---------- 417 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 417 (517)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999975 589999999965 33445778999999999999999999998865
Q ss_pred ---CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 418 ---RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 418 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35679999999999999999642 345788999999999999999999998 9999999999999999999999
Q ss_pred cccCceecCC
Q 010146 495 DFGMARAFGV 504 (517)
Q Consensus 495 DFGla~~~~~ 504 (517)
|||+++.+..
T Consensus 159 dfg~~~~~~~ 168 (303)
T 1zy4_A 159 DFGLAKNVHR 168 (303)
T ss_dssp CCCCCSCTTC
T ss_pred eCcchhhccc
Confidence 9999987753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-25 Score=223.54 Aligned_cols=148 Identities=26% Similarity=0.349 Sum_probs=124.5
Q ss_pred cCCCCcc-ceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHH-hcCCCCCeeeEEEEEEe----CCEE
Q 010146 349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVRLLGCCTL----RDER 421 (517)
Q Consensus 349 ~~~y~~~-~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 421 (517)
.++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 68999999999999976 4899999998642 4577888887 44589999999999875 5678
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccC
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM 498 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGl 498 (517)
+|||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999999653 2345899999999999999999999998 999999999999997 78899999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 211 a~~~~~~ 217 (400)
T 1nxk_A 211 AKETTSH 217 (400)
T ss_dssp CEECC--
T ss_pred ccccCCC
Confidence 9987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=217.53 Aligned_cols=150 Identities=25% Similarity=0.414 Sum_probs=131.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999976 5899999999865545556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~~ 504 (517)
+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999998543 35899999999999999999999998 9999999999999 7788999999999986543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=220.46 Aligned_cols=153 Identities=33% Similarity=0.516 Sum_probs=130.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467999999999999999999842 4778999999754 334456789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKIS 494 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~ 494 (517)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 245899999999999999999999998 999999999999984 4469999
Q ss_pred cccCceecCC
Q 010146 495 DFGMARAFGV 504 (517)
Q Consensus 495 DFGla~~~~~ 504 (517)
|||+++.+..
T Consensus 186 Dfg~~~~~~~ 195 (327)
T 2yfx_A 186 DFGMARDIYR 195 (327)
T ss_dssp CCHHHHHHHC
T ss_pred cccccccccc
Confidence 9999986643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=222.44 Aligned_cols=152 Identities=28% Similarity=0.434 Sum_probs=135.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccC-----------------HHHHHHHHHHHhcCCCCCeeeE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG-----------------VEEFKNEVLLIAKLQHRNLVRL 411 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 411 (517)
.++|.+.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 79999999986532111 1789999999999999999999
Q ss_pred EEEEEeCCEEEEEEEeCCCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEE
Q 010146 412 LGCCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVL 484 (517)
Q Consensus 412 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIl 484 (517)
++++...+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ ++ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 124569999999999999999999999 87 999999999999
Q ss_pred ECCCCCeEEccccCceecCCC
Q 010146 485 LDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 485 l~~~~~~kl~DFGla~~~~~~ 505 (517)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.8e-25 Score=215.18 Aligned_cols=155 Identities=22% Similarity=0.405 Sum_probs=128.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999974 58999999987532 3345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 424 IYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986432 2455899999999999999999999998 999999999999999999999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 187 ~~~ 189 (310)
T 2wqm_A 187 SSK 189 (310)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=215.36 Aligned_cols=149 Identities=32% Similarity=0.460 Sum_probs=129.0
Q ss_pred CCCccceecccCCeeEEEEEeCC-C---CEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE-EEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER-MLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 424 (517)
.|...+.||+|+||.||+|...+ + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999998532 2 379999987543 33457889999999999999999999999876655 999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+.+++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 2345899999999999999999999998 99999999999999999999999999987644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=211.51 Aligned_cols=143 Identities=11% Similarity=0.098 Sum_probs=127.5
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999865 89999999976532 2346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
|||+++++|.+++.+ . ....++..++.||+.||+|||+++ |+||||||+||||++++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999932 1 355678899999999999999998 999999999999999999999988765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=224.32 Aligned_cols=150 Identities=29% Similarity=0.494 Sum_probs=122.4
Q ss_pred CCCccceecccCCeeEEEEEeCC----CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe-CCEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDERMLI 424 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 424 (517)
.|.+.+.||+|+||.||+|...+ +..||+|.++.. .....+++.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46667899999999999998642 236899998754 33446789999999999999999999998754 4578999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999999542 345789999999999999999999998 99999999999999999999999999997754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 245 ~ 245 (373)
T 3c1x_A 245 K 245 (373)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=217.86 Aligned_cols=165 Identities=26% Similarity=0.398 Sum_probs=140.2
Q ss_pred CCccchhHHHHhcCCCCcc-ceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC-CCCeeeE
Q 010146 337 LPMFDWNTIADATDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVRL 411 (517)
Q Consensus 337 ~~~~~~~~i~~~~~~y~~~-~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l 411 (517)
.+...+.......+.|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.++.++. ||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445555666677788877 88999999999999976 4899999998754 3345678999999999995 6999999
Q ss_pred EEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---C
Q 010146 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---D 488 (517)
Q Consensus 412 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~ 488 (517)
++++...+..++||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTB
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCC
Confidence 99999999999999999999999988432 2356899999999999999999999998 999999999999988 7
Q ss_pred CCeEEccccCceecCCC
Q 010146 489 MNPKISDFGMARAFGVD 505 (517)
Q Consensus 489 ~~~kl~DFGla~~~~~~ 505 (517)
+.+||+|||+++.+...
T Consensus 171 ~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp CCEEECCGGGCEEC---
T ss_pred CcEEEeeCccccccCCc
Confidence 89999999999987644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=231.64 Aligned_cols=152 Identities=30% Similarity=0.463 Sum_probs=135.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999976 5899999998643 234567899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC---CCCCeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~ 501 (517)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988543 35899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=217.84 Aligned_cols=150 Identities=26% Similarity=0.443 Sum_probs=125.5
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||++... ++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46788899999999999999986 789999999643 34578999999999999999999999876 45799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC-eEEccccCceecCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-PKISDFGMARAFGV 504 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~~~~ 504 (517)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999976544445789999999999999999999932233999999999999998886 79999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-26 Score=228.98 Aligned_cols=153 Identities=17% Similarity=0.219 Sum_probs=125.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHH---HHHhcCCCCCeeeEE-------E
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEV---LLIAKLQHRNLVRLL-------G 413 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 413 (517)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467888999999999999999964 5999999999743 334457889999 556666899999998 6
Q ss_pred EEEeCCE-----------------EEEEEEeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCc
Q 010146 414 CCTLRDE-----------------RMLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472 (517)
Q Consensus 414 ~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 472 (517)
++...+. .++||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6665532 78999999 6899999964321 123446888899999999999999998
Q ss_pred eEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 473 iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+||||||+||||+.++.+||+|||+|+..+.
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 258 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence 99999999999999999999999999997543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=219.81 Aligned_cols=157 Identities=29% Similarity=0.383 Sum_probs=135.8
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEE--------
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCT-------- 416 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~-------- 416 (517)
....+|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457899999999999999999975 58999999987665556678899999999996 999999999984
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
.....++||||+. |+|.+++........+++.+++.++.||+.||+|||+++ .+|+||||||+||||+.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3345799999995 899999876545566999999999999999999999875 35999999999999999999999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.+...
T Consensus 183 g~~~~~~~~ 191 (337)
T 3ll6_A 183 GSATTISHY 191 (337)
T ss_dssp TTCBCCSSC
T ss_pred ccceecccc
Confidence 999987653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=220.94 Aligned_cols=153 Identities=24% Similarity=0.395 Sum_probs=126.7
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
....++|++.+.||+|+||.||+|... +++.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999975 5899999998654322 24799999999999999999998543
Q ss_pred --------------------------------CEEEEEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 010146 419 --------------------------------DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYL 465 (517)
Q Consensus 419 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~L 465 (517)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999997 6888877542 2345699999999999999999999
Q ss_pred HhcCCCceEecCCCCCcEEEC-CCCCeEEccccCceecCCCC
Q 010146 466 HQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 466 H~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++ |+||||||+|||++ +++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9988 99999999999997 68899999999999875543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=215.06 Aligned_cols=146 Identities=24% Similarity=0.408 Sum_probs=130.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEe--CCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTL--RDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 424 (517)
.++|++.+.||+|+||.||+|... +++.||||++.. ...+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367899999999999999999864 589999999964 34578999999999997 9999999999987 6678999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFG 503 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 503 (517)
|||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 2889999999999999999999998 99999999999999776 89999999999876
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 183 ~~~ 185 (330)
T 3nsz_A 183 PGQ 185 (330)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=210.66 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=133.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC--CEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 424 (517)
.++|++.+.||+|+||.||+|..+ ++.||||++.... ....+.+.+|+.++++++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999986 8899999997642 33456799999999999999999999999877 778999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++... ....+++.+++.++.||+.||+|||+++ .+|+||||||+|||+++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999653 2335899999999999999999999865 4599999999999999999999999998766433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-24 Score=215.38 Aligned_cols=150 Identities=25% Similarity=0.408 Sum_probs=132.5
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhc--CCCCCeeeEEEEEEeCC----
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLRD---- 419 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~---- 419 (517)
....++|.+.+.||+|+||.||+|... ++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 445678999999999999999999985 899999999643 34677888888877 78999999999998776
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCceEecCCCCCcEEECCCCCe
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
..++||||+++++|.+++.+ ..+++.+++.++.|++.||+||| +.+ |+||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999954 24899999999999999999999 666 9999999999999999999
Q ss_pred EEccccCceecCCCC
Q 010146 492 KISDFGMARAFGVDQ 506 (517)
Q Consensus 492 kl~DFGla~~~~~~~ 506 (517)
||+|||+++.+....
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-25 Score=215.85 Aligned_cols=148 Identities=26% Similarity=0.459 Sum_probs=125.4
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEE-----------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT----------- 416 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 416 (517)
.++|.+.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999875 8999999998766666778999999999999999999999873
Q ss_pred ---eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCCeE
Q 010146 417 ---LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPK 492 (517)
Q Consensus 417 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k 492 (517)
.....++||||++ ++|.+++.+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999997 699999832 45899999999999999999999998 99999999999997 567899
Q ss_pred EccccCceecCC
Q 010146 493 ISDFGMARAFGV 504 (517)
Q Consensus 493 l~DFGla~~~~~ 504 (517)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=212.01 Aligned_cols=152 Identities=28% Similarity=0.442 Sum_probs=130.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 422 (517)
..|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 447778899999999999999764 889999998653 23445678999999999999999999999875 35689
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCCeEEccccCcee
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARA 501 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~ 501 (517)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999543 45899999999999999999999875 3599999999999998 788999999999976
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 5443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=219.87 Aligned_cols=150 Identities=21% Similarity=0.327 Sum_probs=124.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCCCcc-----------CHHHHHHHHHHHhcCCCCCeeeEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNLVRLLG 413 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 413 (517)
.++|.+.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 4788999998764321 2234667888999999999999999
Q ss_pred EEEe----CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC
Q 010146 414 CCTL----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489 (517)
Q Consensus 414 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 489 (517)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77899999999 99999998543 26899999999999999999999998 99999999999998887
Q ss_pred --CeEEccccCceecCCC
Q 010146 490 --NPKISDFGMARAFGVD 505 (517)
Q Consensus 490 --~~kl~DFGla~~~~~~ 505 (517)
.+||+|||+|+.+...
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=215.64 Aligned_cols=146 Identities=36% Similarity=0.625 Sum_probs=122.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHH--HhcCCCCCeeeEEEEEEe-----CCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLL--IAKLQHRNLVRLLGCCTL-----RDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~ 421 (517)
.++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46789999999999999999987 4899999999643 23344444444 556899999999986542 2356
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc---------CCCceEecCCCCCcEEECCCCCeE
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNDMNPK 492 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~iiH~Dlkp~NIll~~~~~~k 492 (517)
++||||+++++|.+++... ..++..++.++.||+.||+|||+. + |+||||||+||||+.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999999542 258899999999999999999998 6 99999999999999999999
Q ss_pred EccccCceecCCC
Q 010146 493 ISDFGMARAFGVD 505 (517)
Q Consensus 493 l~DFGla~~~~~~ 505 (517)
|+|||+|+.+...
T Consensus 161 L~DFG~a~~~~~~ 173 (336)
T 3g2f_A 161 ISDFGLSMRLTGN 173 (336)
T ss_dssp ECCCTTCEECSSS
T ss_pred Eeeccceeecccc
Confidence 9999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=219.35 Aligned_cols=150 Identities=25% Similarity=0.452 Sum_probs=131.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999976 48899999997533 33346789999999999999999999998755 36
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||++ ++|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999996 699998853 24899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.....
T Consensus 177 ~~~~~ 181 (364)
T 3qyz_A 177 VADPD 181 (364)
T ss_dssp ECCGG
T ss_pred ecCCC
Confidence 87654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=212.68 Aligned_cols=157 Identities=27% Similarity=0.407 Sum_probs=132.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 423 (517)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999976 58999999997542 3345678999999999999999999998854 568899
Q ss_pred EEEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 424 IYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996532 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 165 ~~~~~ 169 (279)
T 2w5a_A 165 ILNHD 169 (279)
T ss_dssp HC---
T ss_pred eeccc
Confidence 77544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=209.69 Aligned_cols=148 Identities=26% Similarity=0.348 Sum_probs=128.4
Q ss_pred cCCCCcc-ceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHH-hcCCCCCeeeEEEEEEe----CCEE
Q 010146 349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVRLLGCCTL----RDER 421 (517)
Q Consensus 349 ~~~y~~~-~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 421 (517)
.++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567666 78999999999999975 589999999864 24577888887 66689999999999887 6678
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccC
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM 498 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGl 498 (517)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999996532 345899999999999999999999998 999999999999998 78899999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.+...
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9987643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.8e-25 Score=213.16 Aligned_cols=154 Identities=25% Similarity=0.333 Sum_probs=122.4
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
..++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467899999999999999999975 589999999976422 2223445555668889999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
|||++ ++|.+++... .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 5888887542 2345699999999999999999999998 8 999999999999999999999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-25 Score=236.16 Aligned_cols=144 Identities=29% Similarity=0.534 Sum_probs=126.3
Q ss_pred ceecccCCeeEEEEEeC---CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 36789999997642 334678999999999999999999999986 4568899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 999999954 345899999999999999999999998 9999999999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=211.69 Aligned_cols=152 Identities=27% Similarity=0.446 Sum_probs=130.2
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
..++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998643 346999999765 23445789999999999999999999999764 4578
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999653 234899999999999999999999998 999999999999999999999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=235.14 Aligned_cols=142 Identities=20% Similarity=0.233 Sum_probs=111.2
Q ss_pred ceecccCCeeEEEEEe-CCCCEEEEEEccCCC----------ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEE
Q 010146 356 NKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS----------GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 423 (517)
..++.|++|.+..++. --|+.+++|.+.... +...++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3456666666665542 238899999986541 23346799999999999 69999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||++|++|.++|.+ ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999954 3346654 58999999999999999 9999999999999999999999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
.+.
T Consensus 391 ~~~ 393 (569)
T 4azs_A 391 QDC 393 (569)
T ss_dssp ---
T ss_pred CCC
Confidence 554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-25 Score=212.56 Aligned_cols=150 Identities=27% Similarity=0.465 Sum_probs=125.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-CEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||++... ++.||||.+... ...+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999876 889999999753 3567899999999999999999999997654 468999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999995432 223789999999999999999999998 999999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=220.56 Aligned_cols=151 Identities=25% Similarity=0.362 Sum_probs=125.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE------EE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE------RM 422 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 422 (517)
..+|.+.+.||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3568899999999999999999887777999988653222 2369999999999999999999865443 78
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCCeEEccccCcee
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARA 501 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~ 501 (517)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999976544443322233456899999999999999999999998 99999999999999 789999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=215.86 Aligned_cols=150 Identities=26% Similarity=0.432 Sum_probs=131.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999976 48999999997532 23455788999999999999999999988654 67
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||+. ++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999996 699998854 35899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 161 ~~~~~ 165 (353)
T 2b9h_A 161 IIDES 165 (353)
T ss_dssp ECC--
T ss_pred ccccc
Confidence 87643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-25 Score=217.74 Aligned_cols=159 Identities=23% Similarity=0.359 Sum_probs=134.0
Q ss_pred cchhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 010146 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ--HRNLVRLLGCC 415 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 415 (517)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4444455566789999999999999999999888999999998653 2334578899999999997 59999999999
Q ss_pred EeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcc
Q 010146 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495 (517)
Q Consensus 416 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 495 (517)
...+..++||| +.+++|.+++... ..+++..++.++.||++||.|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 5689999999643 45899999999999999999999998 999999999999965 7899999
Q ss_pred ccCceecCCCC
Q 010146 496 FGMARAFGVDQ 506 (517)
Q Consensus 496 FGla~~~~~~~ 506 (517)
||+++.+....
T Consensus 170 fg~~~~~~~~~ 180 (313)
T 3cek_A 170 FGIANQMQPDT 180 (313)
T ss_dssp CSSSCC-----
T ss_pred ccccccccCcc
Confidence 99999876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=209.24 Aligned_cols=153 Identities=29% Similarity=0.451 Sum_probs=135.6
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
...++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999976 5899999998654 23456789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC---CCeEEccccCce
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMAR 500 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~ 500 (517)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999988543 35899999999999999999999998 9999999999999764 469999999998
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=221.02 Aligned_cols=149 Identities=31% Similarity=0.461 Sum_probs=116.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------ 418 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 418 (517)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999965 5899999999753 223456788999999999999999999998754
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
...++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 7899988843 45899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCC
Q 010146 499 ARAFGV 504 (517)
Q Consensus 499 a~~~~~ 504 (517)
|+....
T Consensus 179 a~~~~~ 184 (367)
T 2fst_X 179 ARHTAD 184 (367)
T ss_dssp ------
T ss_pred cccccc
Confidence 987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=218.16 Aligned_cols=149 Identities=28% Similarity=0.443 Sum_probs=125.8
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-----
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----- 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 419 (517)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999976 4889999998753 2334567889999999999999999999997665
Q ss_pred -EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 420 -ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 420 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
..++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 57888883 23889999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 174 a~~~~~~ 180 (371)
T 2xrw_A 174 ARTAGTS 180 (371)
T ss_dssp -------
T ss_pred ccccccc
Confidence 9877543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=235.82 Aligned_cols=148 Identities=22% Similarity=0.355 Sum_probs=128.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC--CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-----
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----- 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 420 (517)
.++|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 58999999986542 3345678899999999999999999999987665
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+||||+++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987732 5899999999999999999999998 9999999999999986 89999999999
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 88654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=210.57 Aligned_cols=152 Identities=32% Similarity=0.474 Sum_probs=124.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC--CCC--EEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT--EGQ--EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|... +++ .||+|+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999853 233 6899998754 2334578899999999999999999999997655 8
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999653 245899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 171 ~~~~~ 175 (291)
T 1u46_A 171 LPQND 175 (291)
T ss_dssp CCC-C
T ss_pred ccccc
Confidence 86543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=215.61 Aligned_cols=159 Identities=25% Similarity=0.328 Sum_probs=121.9
Q ss_pred hHHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-
Q 010146 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE- 420 (517)
Q Consensus 343 ~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 420 (517)
.......++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999976 4899999998653 3334466788888999999999999999876443
Q ss_pred ------EEEEEEeCCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHhH--hcCCCceEecCCCCCcEEECC-CCC
Q 010146 421 ------RMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-DMN 490 (517)
Q Consensus 421 ------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~iiH~Dlkp~NIll~~-~~~ 490 (517)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 55554432 234556899999999999999999999 777 999999999999997 889
Q ss_pred eEEccccCceecCCCC
Q 010146 491 PKISDFGMARAFGVDQ 506 (517)
Q Consensus 491 ~kl~DFGla~~~~~~~ 506 (517)
+||+|||+|+.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEECCCTTCBCCCTTS
T ss_pred EEEeeCCCceecCCCC
Confidence 9999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-25 Score=219.64 Aligned_cols=147 Identities=18% Similarity=0.252 Sum_probs=128.3
Q ss_pred cCCCCccceecccCCeeEEEEEeCC---------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeee---------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR--------- 410 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 410 (517)
.++|.+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999764 789999998753 45789999999999999887
Q ss_pred ------EEEEEEe-CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcE
Q 010146 411 ------LLGCCTL-RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV 483 (517)
Q Consensus 411 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 483 (517)
+++++.. +...++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77889999999 999999996532 345999999999999999999999998 99999999999
Q ss_pred EECCCC--CeEEccccCceecCCC
Q 010146 484 LLDNDM--NPKISDFGMARAFGVD 505 (517)
Q Consensus 484 ll~~~~--~~kl~DFGla~~~~~~ 505 (517)
|++.++ .+||+|||+|+.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 8999999999887643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=217.42 Aligned_cols=152 Identities=23% Similarity=0.317 Sum_probs=131.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcC------CCCCeeeEEEEEEeCCE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL------QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 420 (517)
...+|++.+.||+|+||.||+|.... ++.||||++... ....+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 44679999999999999999998764 889999999753 33345677788887776 57799999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC--eEEccccC
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGM 498 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGl 498 (517)
.++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 79999986533 334899999999999999999999998 999999999999999887 99999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 249 a~~~~~~ 255 (429)
T 3kvw_A 249 SCYEHQR 255 (429)
T ss_dssp CEETTCC
T ss_pred ceecCCc
Confidence 9876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=212.34 Aligned_cols=153 Identities=27% Similarity=0.488 Sum_probs=128.6
Q ss_pred HhcCCCCccceecccCCeeEEEEEeC--CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcC---CCCCeeeEEEEEE---
Q 010146 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCT--- 416 (517)
Q Consensus 347 ~~~~~y~~~~~Ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 416 (517)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999973 58899999986432 22233566677766655 8999999999987
Q ss_pred --eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 417 --LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 417 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
.....++||||++ ++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 69999996543 334899999999999999999999998 9999999999999999999999
Q ss_pred cccCceecCC
Q 010146 495 DFGMARAFGV 504 (517)
Q Consensus 495 DFGla~~~~~ 504 (517)
|||+++.+..
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=220.01 Aligned_cols=149 Identities=28% Similarity=0.413 Sum_probs=122.9
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC----C--EEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR----D--ERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~--~~~ 422 (517)
.+|++.+.||+|+||.||+|... +++.||||++..... ...+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 45888899999999999999986 489999999865322 234699999999999999999998542 2 257
Q ss_pred EEEEeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-CCeEEccccCce
Q 010146 423 LIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMAR 500 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~ 500 (517)
+||||+++ +|.+.+... .....+++..++.++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 676665432 23456899999999999999999999988 9999999999999965 568999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 206 ~~~~~~ 211 (420)
T 1j1b_A 206 QLVRGE 211 (420)
T ss_dssp ECCTTC
T ss_pred hcccCC
Confidence 875443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=205.36 Aligned_cols=151 Identities=23% Similarity=0.386 Sum_probs=125.6
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEE-EeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC-TLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 425 (517)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999964 58899999875532 223578899999999988766666554 6778889999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 502 (517)
||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999999643 335899999999999999999999998 9999999999999 78899999999999988
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=216.45 Aligned_cols=149 Identities=26% Similarity=0.467 Sum_probs=127.3
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE---
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER--- 421 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 421 (517)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999976 48999999997642 23356788999999999999999999999877654
Q ss_pred ---EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccC
Q 010146 422 ---MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498 (517)
Q Consensus 422 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 498 (517)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 78888872 33899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
|+.....
T Consensus 191 a~~~~~~ 197 (371)
T 4exu_A 191 ARHADAE 197 (371)
T ss_dssp C------
T ss_pred ccccccC
Confidence 9877544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=218.66 Aligned_cols=149 Identities=26% Similarity=0.424 Sum_probs=116.7
Q ss_pred CCCc-cceecccCCeeEEEEEeC---CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEEE
Q 010146 351 NFSW-KNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLI 424 (517)
Q Consensus 351 ~y~~-~~~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 424 (517)
.|++ .++||+|+||.||+|... +++.||||++... .....+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999965 4789999999753 234578899999999999999999999965 6789999
Q ss_pred EEeCCCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE----CCCCCeEEc
Q 010146 425 YEYLPNKSLEQFIFDVT------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKIS 494 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~ 494 (517)
|||++ ++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 68888875321 2234899999999999999999999998 9999999999999 677899999
Q ss_pred cccCceecCCC
Q 010146 495 DFGMARAFGVD 505 (517)
Q Consensus 495 DFGla~~~~~~ 505 (517)
|||+|+.+...
T Consensus 175 Dfg~a~~~~~~ 185 (405)
T 3rgf_A 175 DMGFARLFNSP 185 (405)
T ss_dssp CTTCCC-----
T ss_pred ECCCceecCCC
Confidence 99999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=213.72 Aligned_cols=156 Identities=24% Similarity=0.379 Sum_probs=125.1
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc------CHHHHHHHHHHHhcC----CCCCeeeEE
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ------GVEEFKNEVLLIAKL----QHRNLVRLL 412 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~ 412 (517)
+.....++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456688999999999999999999865 5889999999754321 223456788888888 899999999
Q ss_pred EEEEeCCEEEEEEEe-CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCC
Q 010146 413 GCCTLRDERMLIYEY-LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMN 490 (517)
Q Consensus 413 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~ 490 (517)
+++...+..++|||+ +.+++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 7899999999653 34899999999999999999999998 99999999999999 7889
Q ss_pred eEEccccCceecCCC
Q 010146 491 PKISDFGMARAFGVD 505 (517)
Q Consensus 491 ~kl~DFGla~~~~~~ 505 (517)
+||+|||+++.+...
T Consensus 179 ~kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE 193 (312)
T ss_dssp EEECCCSSCEECCSS
T ss_pred EEEEEcchhhhcccC
Confidence 999999999987654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=216.56 Aligned_cols=150 Identities=11% Similarity=0.130 Sum_probs=113.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHH---HHHhcCCCCCeeeEE-------EE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEV---LLIAKLQHRNLVRLL-------GC 414 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 414 (517)
...|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+ .+|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345888899999999999999976 589999999987532 3345677784 45555 799988755 45
Q ss_pred EEeC-----------------CEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHhHhcCCC
Q 010146 415 CTLR-----------------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGIARGLLYLHQDSRL 471 (517)
Q Consensus 415 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~ 471 (517)
+... ...++||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 4433 33799999998 89999996532 23455566 788899999999999998
Q ss_pred ceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 472 ~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+||||||+||||+.++.+||+|||+|+..+..
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~ 247 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence 999999999999999999999999999987644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=217.20 Aligned_cols=150 Identities=23% Similarity=0.358 Sum_probs=129.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC-CCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.++||+|+||.||+|... +++.||||++..... ..++..|+++++.++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999964 589999998865432 2457889999999986 566677777788889999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceecC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG 503 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~ 503 (517)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999643 345899999999999999999999998 9999999999999 588899999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-24 Score=230.27 Aligned_cols=155 Identities=25% Similarity=0.400 Sum_probs=133.5
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 419 (517)
.....++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 33445678889999999999999999743 4579999987543 334567999999999999999999999985 56
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999999643 335899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCC
Q 010146 500 RAFGVD 505 (517)
Q Consensus 500 ~~~~~~ 505 (517)
+.+...
T Consensus 539 ~~~~~~ 544 (656)
T 2j0j_A 539 RYMEDS 544 (656)
T ss_dssp CSCCC-
T ss_pred eecCCC
Confidence 987554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=203.34 Aligned_cols=151 Identities=23% Similarity=0.389 Sum_probs=129.3
Q ss_pred hcCCCCccceecccCCeeEEEEEe-CCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEE-EeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC-TLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 425 (517)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 458999999986543 234688999999999988766555554 6677889999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE---CCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 502 (517)
||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999999543 345899999999999999999999998 9999999999999 47889999999999988
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 159 ~~~~ 162 (296)
T 3uzp_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=208.61 Aligned_cols=152 Identities=23% Similarity=0.353 Sum_probs=131.6
Q ss_pred hcCCCCccceecccCCeeEEEEEe-C-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC------CeeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGML-T-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR------NLVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~ 419 (517)
..++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.+++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999987 3 5889999999753 34456788999999888655 4999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC------------
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------ 487 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~------------ 487 (517)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 899999996532 345899999999999999999999998 999999999999987
Q ss_pred -------CCCeEEccccCceecCCC
Q 010146 488 -------DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 488 -------~~~~kl~DFGla~~~~~~ 505 (517)
++.+||+|||+++.....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC
T ss_pred cccccccCCCceEeeCcccccCccc
Confidence 668999999999986544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=215.17 Aligned_cols=135 Identities=25% Similarity=0.351 Sum_probs=115.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC--------CCCeeeEEEEEE---
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--------HRNLVRLLGCCT--- 416 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 416 (517)
.++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++ |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999965 4889999999753 344567889999999885 788999999987
Q ss_pred -eCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCC
Q 010146 417 -LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDM 489 (517)
Q Consensus 417 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~ 489 (517)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 456789999999 66777766543 234589999999999999999999998 7 99999999999999775
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=213.49 Aligned_cols=153 Identities=29% Similarity=0.497 Sum_probs=129.6
Q ss_pred hHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE
Q 010146 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 343 ~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 420 (517)
.+.....++|++.+.||+|+||.||+|.... .+|+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3334456789999999999999999999763 5999998754 23344567889999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999999542 345899999999999999999999998 99999999999998 6799999999988
Q ss_pred ecC
Q 010146 501 AFG 503 (517)
Q Consensus 501 ~~~ 503 (517)
...
T Consensus 178 ~~~ 180 (319)
T 2y4i_B 178 ISG 180 (319)
T ss_dssp ---
T ss_pred ccc
Confidence 664
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=214.10 Aligned_cols=147 Identities=27% Similarity=0.467 Sum_probs=127.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCE-----
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----- 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 420 (517)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467899999999999999999976 48999999997542 2335678899999999999999999999987654
Q ss_pred -EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 421 -RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 421 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
.++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 68877662 24899999999999999999999998 999999999999999999999999999
Q ss_pred eecCC
Q 010146 500 RAFGV 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=208.09 Aligned_cols=153 Identities=23% Similarity=0.358 Sum_probs=127.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHH-HHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999986 58999999997642 233345556665 778889999999999999999999999
Q ss_pred EeCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
||++ ++|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 5888877531 2245689999999999999999999998 8 999999999999999999999999999877
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 177 ~~~ 179 (327)
T 3aln_A 177 VDS 179 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.5e-24 Score=210.97 Aligned_cols=155 Identities=26% Similarity=0.366 Sum_probs=133.4
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQ--HRNLVRLLGCC 415 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 415 (517)
.....++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3445678999999999999999999965 588999999875422 12345778999999996 59999999999
Q ss_pred EeCCEEEEEEEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCCeEE
Q 010146 416 TLRDERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKI 493 (517)
Q Consensus 416 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl 493 (517)
...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+ +++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999976 8999999542 45899999999999999999999998 99999999999999 7789999
Q ss_pred ccccCceecCCC
Q 010146 494 SDFGMARAFGVD 505 (517)
Q Consensus 494 ~DFGla~~~~~~ 505 (517)
+|||+++.+...
T Consensus 192 ~Dfg~~~~~~~~ 203 (320)
T 3a99_A 192 IDFGSGALLKDT 203 (320)
T ss_dssp CCCTTCEECCSS
T ss_pred eeCccccccccc
Confidence 999999988654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=205.06 Aligned_cols=150 Identities=24% Similarity=0.315 Sum_probs=121.8
Q ss_pred hcCCCCccc-eecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEE
Q 010146 348 ATDNFSWKN-KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDER 421 (517)
Q Consensus 348 ~~~~y~~~~-~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 421 (517)
..++|.+.+ .||+|+||.||+|... +++.||||++... .....+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999987 5899999998653 1222233344667799999999999876 4458
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccC
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM 498 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGl 498 (517)
++||||+++++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999996532 346899999999999999999999998 999999999999986 44599999999
Q ss_pred ceecCCC
Q 010146 499 ARAFGVD 505 (517)
Q Consensus 499 a~~~~~~ 505 (517)
++.....
T Consensus 178 ~~~~~~~ 184 (336)
T 3fhr_A 178 AKETTQN 184 (336)
T ss_dssp CEEC---
T ss_pred ceecccc
Confidence 9977543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=216.36 Aligned_cols=149 Identities=26% Similarity=0.310 Sum_probs=120.7
Q ss_pred CCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++...+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998777677999999998643 345678999999876 89999999999999999999999995
Q ss_pred CCCHHHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC-------------CCeE
Q 010146 430 NKSLEQFIFDVTRTK----FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-------------MNPK 492 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~~~k 492 (517)
++|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996532211 1234456789999999999999998 9999999999999754 4799
Q ss_pred EccccCceecCCCC
Q 010146 493 ISDFGMARAFGVDQ 506 (517)
Q Consensus 493 l~DFGla~~~~~~~ 506 (517)
|+|||+|+.+..+.
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-24 Score=227.21 Aligned_cols=155 Identities=29% Similarity=0.452 Sum_probs=133.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe------CCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------RDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 420 (517)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999975 4899999998764 33445678999999999999999999998755 667
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCC---eEEcccc
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFG 497 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFG 497 (517)
.++||||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999998 999999999999997765 9999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+++.+....
T Consensus 170 ~a~~~~~~~ 178 (676)
T 3qa8_A 170 YAKELDQGE 178 (676)
T ss_dssp CCCBTTSCC
T ss_pred ccccccccc
Confidence 999876543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-23 Score=209.28 Aligned_cols=157 Identities=25% Similarity=0.367 Sum_probs=131.0
Q ss_pred HHHhcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CC-----CeeeEEEEEEe
Q 010146 345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HR-----NLVRLLGCCTL 417 (517)
Q Consensus 345 i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~ 417 (517)
.....++|++.+.||+|+||.||+|... +++.||||++... ....+++..|+.+++.++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445688999999999999999999976 4889999999753 334567778888888875 44 49999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC--CCCCeEEcc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISD 495 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~D 495 (517)
.+..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999995 69999996543 245899999999999999999999531 2499999999999995 477899999
Q ss_pred ccCceecCCC
Q 010146 496 FGMARAFGVD 505 (517)
Q Consensus 496 FGla~~~~~~ 505 (517)
||+|+.++..
T Consensus 205 FG~a~~~~~~ 214 (382)
T 2vx3_A 205 FGSSCQLGQR 214 (382)
T ss_dssp CTTCEETTCC
T ss_pred ccCceecccc
Confidence 9999988644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=214.25 Aligned_cols=148 Identities=25% Similarity=0.360 Sum_probs=121.5
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
..+|...+.||+|+||.|+.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 345888899999999997665566799999999965432 2356899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-----CCCeEEccccCceec
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAF 502 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~~ 502 (517)
+. ++|.+++.... ..+.+..++.++.||+.||+|||+++ |+||||||+||||+. ...+||+|||+|+.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 69999996432 23455567789999999999999998 999999999999953 235889999999987
Q ss_pred CCC
Q 010146 503 GVD 505 (517)
Q Consensus 503 ~~~ 505 (517)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-23 Score=204.86 Aligned_cols=152 Identities=21% Similarity=0.364 Sum_probs=129.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-C-CEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC------eeeEEEEEEeCC
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-G-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVRLLGCCTLRD 419 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 419 (517)
..++|++.+.||+|+||.||+|.... + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34789999999999999999999753 4 68999999753 344567888999999887655 999999999999
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE--------------
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 485 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-------------- 485 (517)
..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 677777775432 245899999999999999999999988 9999999999999
Q ss_pred -----CCCCCeEEccccCceecCCC
Q 010146 486 -----DNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 486 -----~~~~~~kl~DFGla~~~~~~ 505 (517)
+.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~ 195 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH 195 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC
T ss_pred ccccccCCCcEEEeecCcccccccc
Confidence 56788999999999976543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=203.36 Aligned_cols=151 Identities=22% Similarity=0.368 Sum_probs=117.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc--cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999986 589999999976432 12233445556788889999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
||+ ++.+..++... ...+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 56666655332 34589999999999999999999985 7 99999999999999999999999999987754
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 178 ~ 178 (318)
T 2dyl_A 178 D 178 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=208.85 Aligned_cols=151 Identities=25% Similarity=0.371 Sum_probs=129.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-----------CCCeeeEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVRLLGCCT 416 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 416 (517)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367999999999999999999975 5899999999753 334567889999998886 899999999987
Q ss_pred eCC----EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEEC-----
Q 010146 417 LRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 486 (517)
Q Consensus 417 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~----- 486 (517)
..+ ..++|||++ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899999996533 34489999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEccccCceecCCC
Q 010146 487 -NDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 487 -~~~~~kl~DFGla~~~~~~ 505 (517)
..+.+||+|||+|+.+...
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC
T ss_pred cCcceEEEcccccccccCCC
Confidence 4447999999999987654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=198.20 Aligned_cols=146 Identities=18% Similarity=0.224 Sum_probs=117.6
Q ss_pred hhHHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCc------------------cCHHHHHHHHHHHhcC
Q 010146 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKL 403 (517)
Q Consensus 342 ~~~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l 403 (517)
...+......|.+.+.||+|+||.||+|...+|+.||+|.++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3445555666778899999999999999997799999999964321 1245689999999999
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcE
Q 010146 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV 483 (517)
Q Consensus 404 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 483 (517)
+| +++.+++.. +..++||||+++++|.+ +. . .....++.|++.||.|||+++ |+||||||+||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 94 555554433 45699999999999987 41 1 234579999999999999998 99999999999
Q ss_pred EECCCCCeEEccccCceecCCC
Q 010146 484 LLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 484 ll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+ ++.+||+|||+|+.....
T Consensus 225 Ll~-~~~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EEE-TTEEEECCCTTCEETTST
T ss_pred EEE-CCcEEEEECCCCeECCCC
Confidence 999 999999999999987654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=211.76 Aligned_cols=137 Identities=20% Similarity=0.257 Sum_probs=109.1
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCc--------cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
...+.||+|+||.||++... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44579999999999999544 78899987644221 1134589999999999999999766666678888999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++++|.+++.+ ++.++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+|+.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5589999999999999998 999999999999999 999999999999865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 482 ~~ 483 (540)
T 3en9_A 482 DE 483 (540)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=199.31 Aligned_cols=152 Identities=18% Similarity=0.210 Sum_probs=115.8
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCCC-CCe---------ee-----
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQH-RNL---------VR----- 410 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni---------v~----- 410 (517)
..|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 44667789999999999999965 59999999987432 2346789999999999987 221 11
Q ss_pred -------EEEEEEe-----CCEEEEEEEeCCCCCHHHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceE
Q 010146 411 -------LLGCCTL-----RDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474 (517)
Q Consensus 411 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 474 (517)
+..+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356777765 7999998842 122445788899999999999999999998 99
Q ss_pred ecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 475 H~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||||||+||||+.++.+||+|||+|+..+..
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~ 264 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc
Confidence 9999999999999999999999999876543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=180.91 Aligned_cols=141 Identities=14% Similarity=0.155 Sum_probs=110.0
Q ss_pred CCCccceecccCCeeEEEEEe-CCCCE--EEEEEccCCCcc------------------------CHHHHHHHHHHHhcC
Q 010146 351 NFSWKNKLGEGGFGPVYRGML-TEGQE--IAVKRLSKSSGQ------------------------GVEEFKNEVLLIAKL 403 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 403 (517)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 67888 999987543111 013678999999999
Q ss_pred CCCCe--eeEEEEEEeCCEEEEEEEeCCC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCceEe
Q 010146 404 QHRNL--VRLLGCCTLRDERMLIYEYLPN-K----SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH-QDSRLRIIH 475 (517)
Q Consensus 404 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiH 475 (517)
+|+++ +.++.. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88753 444432 356899999942 3 77776532 234567789999999999999 888 999
Q ss_pred cCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 476 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|||||+|||+++ .++|+|||+|.....+.
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~~ 223 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHPM 223 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTSTT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCcc
Confidence 999999999998 99999999999875543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-18 Score=170.34 Aligned_cols=145 Identities=14% Similarity=0.193 Sum_probs=104.3
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCc--------------cCHHH--------HHHHHHHHh
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------------QGVEE--------FKNEVLLIA 401 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~ 401 (517)
.+.....-|++.+.||+|++|.||+|...+|+.||||+++.... ..... ...|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34443444889999999999999999998899999998754210 01111 234666666
Q ss_pred cCCCCCe--eeEEEEEEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCC
Q 010146 402 KLQHRNL--VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479 (517)
Q Consensus 402 ~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 479 (517)
++.+.++ ...++. . ..+|||||+++.+|..+. .......++.||+.+|.+||+.+ |||||||
T Consensus 169 rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 6654443 222322 1 237999999988875533 11234568899999999999998 9999999
Q ss_pred CCcEEECCCCC----------eEEccccCceecCC
Q 010146 480 ASNVLLDNDMN----------PKISDFGMARAFGV 504 (517)
Q Consensus 480 p~NIll~~~~~----------~kl~DFGla~~~~~ 504 (517)
|.||||++++. +.|+||+-+-....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 99999988763 89999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2e-13 Score=130.77 Aligned_cols=147 Identities=14% Similarity=0.088 Sum_probs=116.2
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEE
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 424 (517)
......|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+++++++....+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 445567888888888889999999855 6899999987532233346888999998885 67788999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc------------------------------------
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD------------------------------------ 468 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------ 468 (517)
|||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999987641 1223347889999999999981
Q ss_pred --------------------CCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 469 --------------------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 469 --------------------~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113499999999999998765677999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=3.4e-12 Score=121.65 Aligned_cols=141 Identities=17% Similarity=0.182 Sum_probs=103.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC--eeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ 425 (517)
....+.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 33445543333456669999998777888999997653 2345778888888886444 567888888778899999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------------
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS------------------------------------ 469 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 469 (517)
||++|.+|. .. . .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 21 1 11 2356778888888888643
Q ss_pred -------------------CCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 470 -------------------RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 470 -------------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=9e-11 Score=117.59 Aligned_cols=142 Identities=15% Similarity=0.244 Sum_probs=107.3
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEcc--CCC-ccCHHHHHHHHHHHhcCC--CCCeeeEEEEEEeC---CEEEEEE
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLS--KSS-GQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLR---DERMLIY 425 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 425 (517)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999876 4678888876 321 123456788999998887 45688899988766 3479999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------------
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS------------------------------------ 469 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 469 (517)
||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988774311 123678888999999999999999831
Q ss_pred -------------------CCceEecCCCCCcEEECCCCC--eEEccccCcee
Q 010146 470 -------------------RLRIIHRDLKASNVLLDNDMN--PKISDFGMARA 501 (517)
Q Consensus 470 -------------------~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~ 501 (517)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=8.4e-11 Score=112.43 Aligned_cols=110 Identities=11% Similarity=0.012 Sum_probs=77.1
Q ss_pred CcccccccCCCceEEEEeCCCCCCCCcceEEEEccCCCcEEEEEeC-CeEEEEecCCCCCceeeccCCCCCCceeeEeee
Q 010146 1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG-SKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVS 79 (517)
Q Consensus 1 mklg~~~~tg~~~~L~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~ 79 (517)
||||+|+.+|+. | ++.+||++|.|+++|+++|. +++|++ +.+||++|+|++..... .+.... .+.+..
T Consensus 143 ~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l--~l~~dG--nLvl~d 211 (276)
T 3m7h_A 143 AIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA--VFQGDG--NLVVYG 211 (276)
T ss_dssp CTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE--EECTTS--CEEEEC
T ss_pred cccccccccCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE--EEcCCC--eEEEEe
Confidence 899999999855 6 67899999999999999986 455664 68999999997643211 122222 122233
Q ss_pred cC-CeEEEEEEeccCceeeeEEEccCCCeEEEEEeCCCcceeeeeccccc
Q 010146 80 NE-NEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGL 128 (517)
Q Consensus 80 ~~-~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~~~~~ 128 (517)
++ ..+++++.. .....|++|+.||+|++|.| ...|..+ +..|
T Consensus 212 ~~~~~vWsS~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf--~~~P 254 (276)
T 3m7h_A 212 AGNAVLWHSHTG--GHASAVLRLQANGSIAILDE---KPVWARF--GFQP 254 (276)
T ss_dssp TTSCEEEECSCT--TCTTCEEEECTTSCEEEEEE---EEEEESS--SCCT
T ss_pred CCCcEEEEecCC--CCCCEEEEEcCCccEEEEcC---CCeEEcc--CccC
Confidence 32 234443322 23358999999999999999 3578888 7777
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-09 Score=102.44 Aligned_cols=100 Identities=11% Similarity=0.042 Sum_probs=72.6
Q ss_pred cccc-cCCC-----ceEEEEeCCCCCCCCcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEe
Q 010146 4 GVNL-VTGL-----KRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEY 77 (517)
Q Consensus 4 g~~~-~tg~-----~~~L~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~ 77 (517)
|.|. .+|+ +++|+| .+||++|.|+|+|+++| ++++++++.+||++|+|++. ++..+.+..... ...+
T Consensus 124 g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly 196 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVL 196 (236)
T ss_dssp CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEE
T ss_pred cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCc-EEEE
Confidence 5566 6776 678874 78999999999999998 67788888899999999754 666677754442 1223
Q ss_pred eecCCeEEEEEEeccCceeeeEEEccCCCeEEEE
Q 010146 78 VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLT 111 (517)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 111 (517)
..++.+++.+|....+ ...|++||+||++++|.
T Consensus 197 ~~~~~~vw~s~~~~~~-~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 197 TNQNIAVWTSGNSRSA-GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp ETTTEEEEECCCCCSS-SCCEEEECSSSCEEEEC
T ss_pred eCCCcEEEEeCCCCCC-CCEEEEEcCCCcEEEeC
Confidence 3344455665554333 46899999999999994
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-08 Score=98.27 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=100.8
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCC--eeeEEEEEEeCC---EEEEEEEeC
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN--LVRLLGCCTLRD---ERMLIYEYL 428 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 428 (517)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3679999999999863 56888886532 34567889999998873 332 455555443333 348899999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS--------------------------------------- 469 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 469 (517)
+|.+|..... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988875432 23677788888899999999888621
Q ss_pred ----------------CCceEecCCCCCcEEECC--CCCeEEccccCceec
Q 010146 470 ----------------RLRIIHRDLKASNVLLDN--DMNPKISDFGMARAF 502 (517)
Q Consensus 470 ----------------~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~ 502 (517)
+..++|+|++|.|||+++ ...+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 235899999999999998 456899999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.4e-07 Score=90.15 Aligned_cols=137 Identities=19% Similarity=0.173 Sum_probs=101.8
Q ss_pred ceecccCCe-eEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGFG-PVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.+..|..+ .||+..... +..+++|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 456666665 589887654 668899986532 3456788999888774 4457889999999999999999999998
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCC------------------------------------------
Q 010146 433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR------------------------------------------ 470 (517)
Q Consensus 433 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~------------------------------------------ 470 (517)
+.+.... .......+..++++.|.-||....
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8876532 122334567777777777775310
Q ss_pred -------------CceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 471 -------------LRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 471 -------------~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
..++|+|+.|.|||+++++.+-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 13799999999999998877789999998743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.7e-07 Score=91.36 Aligned_cols=137 Identities=20% Similarity=0.157 Sum_probs=97.1
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC---CeeeEEEEEE-eCCEEEEEEEeCCC
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVRLLGCCT-LRDERMLIYEYLPN 430 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 430 (517)
.+.++.|....||+. +..+++|+... ......+..|.++|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 367888888899987 56788888532 23456789999999998742 3667777664 34557899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc------------------------------------------
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD------------------------------------------ 468 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------------ 468 (517)
.+|...... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 134555555666666666666643
Q ss_pred ---------------CCCceEecCCCCCcEEECC---CCC-eEEccccCceec
Q 010146 469 ---------------SRLRIIHRDLKASNVLLDN---DMN-PKISDFGMARAF 502 (517)
Q Consensus 469 ---------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~DFGla~~~ 502 (517)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999987 455 589999988754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2e-07 Score=92.88 Aligned_cols=79 Identities=8% Similarity=-0.010 Sum_probs=55.0
Q ss_pred cee-cccCCeeEEEEEeC-------CCCEEEEEEccCCC---ccCHHHHHHHHHHHhcCC-C--CCeeeEEEEEEeC---
Q 010146 356 NKL-GEGGFGPVYRGMLT-------EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ-H--RNLVRLLGCCTLR--- 418 (517)
Q Consensus 356 ~~I-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 418 (517)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88888999998764 26678898875432 111245677888887774 2 3577888877654
Q ss_pred CEEEEEEEeCCCCCHH
Q 010146 419 DERMLIYEYLPNKSLE 434 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~ 434 (517)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=3.7e-06 Score=82.89 Aligned_cols=141 Identities=16% Similarity=0.215 Sum_probs=80.4
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC--CCCeeeEEE------EEEeCCEEEEEEEe
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--HRNLVRLLG------CCTLRDERMLIYEY 427 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~ 427 (517)
+.|+.|..+.||+....++ .+++|+.... ...+..|..+++.|. .-.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987654 5889988652 233444555554442 112333332 12346778999999
Q ss_pred CCCCCHH-----------HH---HhccCC----C-------CCCCHHHH-------------------------------
Q 010146 428 LPNKSLE-----------QF---IFDVTR----T-------KFLDWSKR------------------------------- 451 (517)
Q Consensus 428 ~~~gsL~-----------~~---l~~~~~----~-------~~l~~~~~------------------------------- 451 (517)
++|..+. .. ++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 11 111110 0 01122211
Q ss_pred HHHHHHHHHHHHHhHh----------cCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 452 CQIIEGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 452 ~~i~~qi~~aL~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
..+..++..++.+|++ ..+..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234456667763 1235699999999999998888899999998863
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.1e-06 Score=84.67 Aligned_cols=75 Identities=11% Similarity=0.144 Sum_probs=50.3
Q ss_pred cceecccCCeeEEEEEeC-CCCEEEEEEccCCCc-------cCHHHHHHHHHHHhcCCC--C-CeeeEEEEEEeCCEEEE
Q 010146 355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQH--R-NLVRLLGCCTLRDERML 423 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 423 (517)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 468899997653211 234566788888877642 2 34566654 3455689
Q ss_pred EEEeCCCC
Q 010146 424 IYEYLPNK 431 (517)
Q Consensus 424 v~e~~~~g 431 (517)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.2e-05 Score=75.55 Aligned_cols=77 Identities=21% Similarity=0.245 Sum_probs=57.5
Q ss_pred CCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC---CCeeeEEEEEEeCCEEEEEEEeC
Q 010146 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 352 y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
....+.+|.|..+.||+.+..+|+.+++|+...........+..|.+.|+.|.. ..++++++.. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 444578999999999999999999999998765544445678889988887742 2355555542 247899999
Q ss_pred CCCC
Q 010146 429 PNKS 432 (517)
Q Consensus 429 ~~gs 432 (517)
+++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.1e-05 Score=77.95 Aligned_cols=74 Identities=16% Similarity=0.207 Sum_probs=46.2
Q ss_pred ccceecccCCeeEEEEEeCCCCEEEEEEccCC------C-c--cCHHHHHHHHHHHh-cCCCCCeeeEEEEEEeCCEEEE
Q 010146 354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS------S-G--QGVEEFKNEVLLIA-KLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 354 ~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~l 423 (517)
..+.||.|....||++.. +++.++||..... . . .....+..|+..+. ......+++++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 347899999999999965 4678999943211 0 1 12233444443322 22234567777665 566799
Q ss_pred EEEeC-CC
Q 010146 424 IYEYL-PN 430 (517)
Q Consensus 424 v~e~~-~~ 430 (517)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.88 E-value=7.1e-05 Score=72.74 Aligned_cols=140 Identities=20% Similarity=0.189 Sum_probs=93.1
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
...+.|+.|....+|+.... ++.+++|+.... ....+..|.+.|+.|. ...+++++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34468999999999998864 678889987542 3567888988888774 3668889998888888999999999
Q ss_pred CCCHH--------HH---HhccCC-CC------------------CCCHHHHH---HHH----------------HHHHH
Q 010146 430 NKSLE--------QF---IFDVTR-TK------------------FLDWSKRC---QII----------------EGIAR 460 (517)
Q Consensus 430 ~gsL~--------~~---l~~~~~-~~------------------~l~~~~~~---~i~----------------~qi~~ 460 (517)
+..+. .. |+.... .. .-+|.... ++. .+++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87541 11 222211 00 01343221 111 11222
Q ss_pred HH-HHhHh-cCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 461 GL-LYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 461 aL-~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
.+ ..|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 23322 2346799999999999999887 9999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00028 Score=69.20 Aligned_cols=142 Identities=17% Similarity=0.134 Sum_probs=73.0
Q ss_pred ceecccCCee-EEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC--CCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGFGP-VYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+. .-.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565444 6677654467787876544321 22344555555543 234566776643333 78999998777
Q ss_pred HHHHHhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHhH---
Q 010146 433 LEQFIFDV---------------------TRT--KFLDWSKRC-------Q-------------IIEGIARGLLYLH--- 466 (517)
Q Consensus 433 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~qi~~aL~~LH--- 466 (517)
+.+++... ... ..++..... . ....+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65543211 000 011111100 0 0011122222221
Q ss_pred hcCCCceEecCCCCCcEEECCC----CCeEEccccCceec
Q 010146 467 QDSRLRIIHRDLKASNVLLDND----MNPKISDFGMARAF 502 (517)
Q Consensus 467 ~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 502 (517)
...+..++|+|+.|.|||++.+ ..+.|+||+.+..=
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123469999999999999874 67999999988743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00037 Score=67.89 Aligned_cols=159 Identities=16% Similarity=0.163 Sum_probs=87.2
Q ss_pred cchhHHHHhcCCCCc-----cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCC--CeeeEE
Q 010146 340 FDWNTIADATDNFSW-----KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLL 412 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~-----~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~ 412 (517)
++.+++......|.+ .+.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+... .+.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555654 24566788889999987655 6788888652 1223455676666655321 133333
Q ss_pred EE------EEeCCEEEEEEEeCCCCCHH-----------HH---HhccCC----CC--CC---CHHHHHH----------
Q 010146 413 GC------CTLRDERMLIYEYLPNKSLE-----------QF---IFDVTR----TK--FL---DWSKRCQ---------- 453 (517)
Q Consensus 413 ~~------~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~----~~--~l---~~~~~~~---------- 453 (517)
.. ....+..+++|+|++|..+. .. ++.... .. .. .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 12346678999999876431 11 111110 00 01 1221100
Q ss_pred --HHHHHHHHHHHhHhc----CCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 454 --IIEGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 454 --i~~qi~~aL~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+...+...++.+++. .+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455555532 234699999999999998876568999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00081 Score=65.60 Aligned_cols=142 Identities=13% Similarity=0.166 Sum_probs=82.0
Q ss_pred ceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC--CCeeeEEEE-----EEeCCEEEEEEEeC
Q 010146 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLGC-----CTLRDERMLIYEYL 428 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e~~ 428 (517)
..++ |....||+....+|+.+++|..... ....+.+..|..++..+.. -.+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7788999988777778999998642 2245567778877776642 223444432 22355678899999
Q ss_pred CCCCHH-----H------H---HhccC------CCCCCCHHHH----HHH---------------HHHHHHHHHHhHhc-
Q 010146 429 PNKSLE-----Q------F---IFDVT------RTKFLDWSKR----CQI---------------IEGIARGLLYLHQD- 468 (517)
Q Consensus 429 ~~gsL~-----~------~---l~~~~------~~~~l~~~~~----~~i---------------~~qi~~aL~~LH~~- 468 (517)
+|..+. . . ++... .....++... ..+ ...+...++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875421 1 1 11110 0111222111 000 11111222333221
Q ss_pred ---CCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 469 ---SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 469 ---~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
.+..++|+|++|.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00018 Score=73.40 Aligned_cols=71 Identities=15% Similarity=0.281 Sum_probs=48.8
Q ss_pred ceecccCCeeEEEEEeCC--------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 426 (517)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..+++.+...+ .+++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 678888889999998753 478999987431 22255668888888775333 356776553 2 28999
Q ss_pred eCCCCC
Q 010146 427 YLPNKS 432 (517)
Q Consensus 427 ~~~~gs 432 (517)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.001 Score=68.12 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=46.9
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeCCCCCH
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSL 433 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 433 (517)
+.|+.|-...+|+....+ +..+++|+......... .-.+|..++..|...++ +++++.+. + .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 678888889999998775 47888888754322211 12578888887764444 56777662 3 259999987443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00042 Score=66.93 Aligned_cols=138 Identities=13% Similarity=0.099 Sum_probs=74.1
Q ss_pred cceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe-eeEEEEEEeCCEEEEEEEeC-CCCC
Q 010146 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYL-PNKS 432 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 432 (517)
.+.|+.|....+|+. +.+++|+........ ....+|..+++.+....+ .++++. ..+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 568888776432211 112457666666542222 455554 344457899999 6544
Q ss_pred HHHH---------------H---hccCCC--CCCCH-HHHHHHHH--------------HHHHHHH----HhHh-cCCCc
Q 010146 433 LEQF---------------I---FDVTRT--KFLDW-SKRCQIIE--------------GIARGLL----YLHQ-DSRLR 472 (517)
Q Consensus 433 L~~~---------------l---~~~~~~--~~l~~-~~~~~i~~--------------qi~~aL~----~LH~-~~~~~ 472 (517)
|... | +..... ...+. .....+.. .+.+.+. .|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 1 111100 00111 11111100 0111111 1111 22345
Q ss_pred eEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 473 IIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 473 iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++|+|+.|.||| .+++.+.|+||..|..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566789999998874
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00023 Score=57.83 Aligned_cols=41 Identities=15% Similarity=0.237 Sum_probs=35.7
Q ss_pred EEeCCCCCCCCcceEEEEccCCCcEEEEEe-CCeEEEEecCCCC
Q 010146 16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRK-GSKIKFRAGPWNG 58 (517)
Q Consensus 16 ~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~yw~sg~w~~ 58 (517)
+-|.|.+||++|.|++.++++|. +++|+ ++.+||+|++|+|
T Consensus 70 ~~W~S~~~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 70 AIWASNTNRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp EEEECCCCCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred EEEECCccCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 56999999999999999999998 55666 4679999999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.001 Score=66.30 Aligned_cols=141 Identities=20% Similarity=0.259 Sum_probs=82.9
Q ss_pred ceecccCCeeEEEEEeC--------CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 426 (517)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.|. +.-..++++.+.. . +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence 57777888899999864 2478999986332 234566778998888774 2223566766543 2 8999
Q ss_pred eCCCCCHH--------------HHH---hccCC--CCCCC--HHHHHHHHHHHHH-------------------HHHHhH
Q 010146 427 YLPNKSLE--------------QFI---FDVTR--TKFLD--WSKRCQIIEGIAR-------------------GLLYLH 466 (517)
Q Consensus 427 ~~~~gsL~--------------~~l---~~~~~--~~~l~--~~~~~~i~~qi~~-------------------aL~~LH 466 (517)
|++|..|. +.| +.... .+... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875542 111 11111 11112 3444444443321 233332
Q ss_pred ----hc-CCCceEecCCCCCcEEECCC----CCeEEccccCcee
Q 010146 467 ----QD-SRLRIIHRDLKASNVLLDND----MNPKISDFGMARA 501 (517)
Q Consensus 467 ----~~-~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~ 501 (517)
.. .+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23468999999999999876 6899999998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00074 Score=67.23 Aligned_cols=72 Identities=14% Similarity=0.096 Sum_probs=42.9
Q ss_pred ceecccCCeeEEEEEeCC---------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 425 (517)
+.|+.|....+|+....+ ++.+++|+........ .....|..+++.+...+ .+++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 577888888999998654 2688888875432211 12356777777664223 44666543 2 36899
Q ss_pred EeCCCCC
Q 010146 426 EYLPNKS 432 (517)
Q Consensus 426 e~~~~gs 432 (517)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0053 Score=48.93 Aligned_cols=81 Identities=9% Similarity=0.068 Sum_probs=46.4
Q ss_pred cceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCCC
Q 010146 27 DNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGE 106 (517)
Q Consensus 27 G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~ 106 (517)
|.|+|.|+.+|++. +|++..++|.++..+.......-.+...... ...+..+....+........-.+++|..||+
T Consensus 19 g~y~l~~q~DgNLv--ly~~~~~vW~ant~~~~~~~~~L~l~~dGnL--vL~d~~~~~vWss~t~~~~~~~~l~L~ddGN 94 (105)
T 4h3o_A 19 EPYHFIMQDDCNLV--LYDHSTSTWASNTEIGGKSGCSAVLQSDGNF--VVYDSSGRSLWASHSTRGSGNYILILQDDGN 94 (105)
T ss_dssp TTEEEEECTTSCEE--EEETTEEEEECCCCCTTCCSCEEEECTTSCE--EEECTTCCEEEECCCCCCSSCEEEEECTTSC
T ss_pred CCEEEEECCCCeEE--EEECCEEEEEecCCCCCCccEEEEEeCCccE--EEECCCcEEEEEecCCCCCCCEEEEEeCCCe
Confidence 89999999999854 5678899999876543211111122222211 1112222222222222233346799999999
Q ss_pred eEEEE
Q 010146 107 PQRLT 111 (517)
Q Consensus 107 l~~~~ 111 (517)
|.+|.
T Consensus 95 lVly~ 99 (105)
T 4h3o_A 95 VIIYG 99 (105)
T ss_dssp EEEEE
T ss_pred EEEEC
Confidence 99983
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0036 Score=61.46 Aligned_cols=33 Identities=27% Similarity=0.371 Sum_probs=28.7
Q ss_pred CCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 470 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+..++|+|+.|.|||+++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 346999999999999998888999999887754
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.014 Score=46.88 Aligned_cols=81 Identities=9% Similarity=-0.048 Sum_probs=46.0
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|... +++...+||.++..... ....-.+.....+ .+.+..+.....-.........+++|+.||
T Consensus 18 ~g~~~L~~q~dGnLv--ly~~~~~vW~snt~~~~-~~~~l~l~~dGNL--vl~~~~~~~~W~S~t~~~~~~~~~~L~ddG 92 (109)
T 3dzw_A 18 NGRYVFIMQEDCNLV--LYDVDKPIWATNTGGLD-RRCHLSMQSDGNL--VVYSPRNNPIWASNTGGENGNYVCVLQKDR 92 (109)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCTTSS-SSCEEEECTTSCE--EEECTTSCEEEECCCCCSSSCEEEEECTTS
T ss_pred CCCEEEEEcCCCcEE--EEeCCEEEEECCcccCC-CCEEEEEeCCCCE--EEECCCCCEEEECCCCCCCCCEEEEEeCCC
Confidence 599999999999854 46778899998765321 1111112222211 111222222222111222345789999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
+|++|.
T Consensus 93 Nlvly~ 98 (109)
T 3dzw_A 93 NVVIYG 98 (109)
T ss_dssp CEEEEE
T ss_pred EEEEEC
Confidence 999996
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0031 Score=50.84 Aligned_cols=37 Identities=14% Similarity=0.342 Sum_probs=28.3
Q ss_pred EEeCCCCCCCCcceEEEEccCCCcEEEEEeCCeEEEEecCC
Q 010146 16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPW 56 (517)
Q Consensus 16 ~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w 56 (517)
+-|.|.++|++|.|+++++++|. +++|++ +||+|+++
T Consensus 72 ~~W~S~t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 72 VIWQTKTNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred EEEecCCCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 45888888888888888888887 445664 78888765
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0032 Score=51.48 Aligned_cols=36 Identities=14% Similarity=0.301 Sum_probs=28.5
Q ss_pred EEeCCCCCCCCcceEEEEccCCCcEEEEEeCCeEEEEecC
Q 010146 16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGP 55 (517)
Q Consensus 16 ~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~ 55 (517)
+-|.|.+||++|.|+++++++|. +++++ .+||++|+
T Consensus 82 ~lW~S~~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 82 TVWQSPVAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp EEEECSCCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred EEEcCCCCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45888889988999999988888 45555 38898886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0032 Score=51.19 Aligned_cols=39 Identities=21% Similarity=0.256 Sum_probs=32.9
Q ss_pred EEeCCCCCCCCcceEEEEccCCCcEEEEEeCCeEEEEecCCCC
Q 010146 16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNG 58 (517)
Q Consensus 16 ~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~ 58 (517)
+-|.|.+.|++|.|++.++++|+ +++|+. +||+|++|..
T Consensus 72 ~vW~S~~~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~ 110 (115)
T 2dpf_A 72 DVWGSACWGDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGC 110 (115)
T ss_dssp EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEECSSTTCB
T ss_pred EEEEcCCCCCCCCEEEEEeCCCe--EEEECC--CEEECCCCCC
Confidence 45999999999999999999998 555664 8999999974
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=95.91 E-value=0.022 Score=45.96 Aligned_cols=79 Identities=10% Similarity=0.050 Sum_probs=44.3
Q ss_pred CcceEEEEccCCCcEEEEEeC--CeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEecc--CceeeeEEE
Q 010146 26 QDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIK--SSVLTMMVI 101 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~--~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 101 (517)
.|.|.|.|+.+|.+.+ ++. ..+||.+++.... ....-.+.....+ .+.+..+.. ...... ...-.+++|
T Consensus 23 ~g~~~L~~q~dGNLvL--~~~~~~~~vWssnt~~~~-~~~~l~l~~dGNL--Vl~d~~~~~--iW~S~t~~~~~~~~~~L 95 (113)
T 3mez_B 23 TRDYSLVMRDDCNLVL--TKGSKTNIVWESGTSGRG-QHCFMRLGHSGEL--DITDDRLNT--VFVSNTVGQEGDYVLIL 95 (113)
T ss_dssp ETTEEEEECTTSCEEE--EETTTTEEEEECCCTTSC-SSCEEEECTTSCE--EEECTTSCE--EEECSCCCSSSCCEEEE
T ss_pred cCCEEEEEcCCCEEEE--EECCCCEEEEECCcccCC-cCEEEEEeCCCcE--EEECCCCCE--EEECCCcCCCCCEEEEE
Confidence 4899999999998555 554 5799998875311 1111112222211 111222222 222211 222378999
Q ss_pred ccCCCeEEEE
Q 010146 102 NPQGEPQRLT 111 (517)
Q Consensus 102 ~~~G~l~~~~ 111 (517)
+.||+|++|.
T Consensus 96 ~~dGnlvly~ 105 (113)
T 3mez_B 96 QINGQAVVYG 105 (113)
T ss_dssp CTTSCEEEEC
T ss_pred cCCceEEEec
Confidence 9999999994
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.021 Score=45.82 Aligned_cols=80 Identities=6% Similarity=-0.061 Sum_probs=43.2
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
+|.|.|.|+.+|...+ +++ .+||.++..+.. ....-.+...+.+ .+.+..+.....-.......-.+++|+.||
T Consensus 23 sg~~~L~~q~dGnLvl--~~~-~~vW~snt~~~~-~~~~l~l~~dGNL--vl~d~~~~~iW~S~t~~~~~~~~~~L~~dG 96 (110)
T 3r0e_B 23 AKNHQLVMQGDCNLVL--YGG-KYGWQSNTHGNG-EHCFLRLNHKGEL--IIKDDDFKTIWSSRSSSKQGEYVLILQDDG 96 (110)
T ss_dssp CSSCEEEECTTSCEEE--ECS-SSCEECCCTTSS-SSCEEEECTTSCE--EEECTTCCEEEECCCCCSSSCCEEEECTTS
T ss_pred eCCEEEEEcCCCeEEE--ECC-eEEEECCCcCCC-cCEEEEEeCCCcE--EEEeCCCCEEEEcCCcCCCCCEEEEEcCCc
Confidence 3789999999998544 565 589998765311 1111112222211 111222222221111112223789999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
+|++|.
T Consensus 97 Nlvly~ 102 (110)
T 3r0e_B 97 FGVIYG 102 (110)
T ss_dssp CEEEEC
T ss_pred cEEEec
Confidence 999995
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.023 Score=45.48 Aligned_cols=79 Identities=8% Similarity=0.027 Sum_probs=43.2
Q ss_pred CCcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccC
Q 010146 25 AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQ 104 (517)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 104 (517)
+.|.|.|.|+.+|+..+ +++ ||.+++.... ....-.+.....+ .+.+..+...............+++|+.|
T Consensus 19 ~~g~~~L~~q~dGNLvl--~~~---~Wssnt~~~~-~~~~l~l~~dGnL--vl~d~~~~~vWss~t~~~~~~~~~~L~~d 90 (109)
T 3r0e_A 19 KNGDFDLVMQDDCNLVL--YNG---NWQSNTANNG-RDCKLTLTDYGEL--VIKNGDGSTVWKSGAQSVKGNYAAVVHPD 90 (109)
T ss_dssp EETTEEEEECTTSCEEE--ETT---TEECCCTTSC-SSCEEEECTTSCE--EEECTTSCEEEECCCCCSSSCCEEEEETT
T ss_pred ECCCEEEEEecCCeEEE--EeC---eEEcCCCCCC-CcEEEEEcCCCeE--EEEeCCCCEEEcCCCcCCCcCEEEEEcCC
Confidence 46999999999998655 443 8998775321 1111112222111 11122222222211122234578999999
Q ss_pred CCeEEEE
Q 010146 105 GEPQRLT 111 (517)
Q Consensus 105 G~l~~~~ 111 (517)
|+|++|.
T Consensus 91 GNlvly~ 97 (109)
T 3r0e_A 91 GRLVVFG 97 (109)
T ss_dssp TEEEEEC
T ss_pred CeEEEEe
Confidence 9999995
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.054 Score=54.65 Aligned_cols=73 Identities=14% Similarity=0.103 Sum_probs=46.6
Q ss_pred ceecccCCeeEEEEEeCC--------CCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 426 (517)
+.|..|-...+|+....+ ++.+++|+........ -...+|..+++.+. +.-..++++.+ . .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567778888999998763 5789998875432221 12346777776664 22245566533 2 278999
Q ss_pred eCCCCCH
Q 010146 427 YLPNKSL 433 (517)
Q Consensus 427 ~~~~gsL 433 (517)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=94.94 E-value=0.039 Score=44.33 Aligned_cols=81 Identities=10% Similarity=-0.005 Sum_probs=44.7
Q ss_pred CCcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecC-Ce-EEEEEEec-cCceeeeEEE
Q 010146 25 AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNE-NE-VFYRFNLI-KSSVLTMMVI 101 (517)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~-~~~~~~~~~l 101 (517)
+.|.|.|.|+.+|.+.+ ++... ||.+++.... ....-.+.....+ .+.... .. +..+.... ......+++|
T Consensus 18 ~~g~~~L~~q~dGnLvl--~~~~~-vW~snt~~~~-~~~~l~l~~dGNL--Vl~~~~~~~~vW~S~t~~~~~~~~~~l~L 91 (111)
T 3mez_A 18 SYESAAFVMQGDCNLVL--YNEAG-GFQSNTHGRG-VDCTLRLNNRGQL--EIHSANSNTPVWVYPRSVNTVRGNYAATL 91 (111)
T ss_dssp EETTEEEEECTTSCEEE--ECSSC-CEECCCTTSC-SSCEEEECTTSCE--EEECSSCSSCSEEESSSCCCCSSCCEEEE
T ss_pred ecCCEEEEEccCCeEEE--ECCCC-EEECCcccCC-cCEEEEEcCCCcE--EEEeCCCCEEEEEeccccCCCCcCEEEEE
Confidence 46999999999998654 56555 9998765321 1011112222211 111221 22 33222111 2234578999
Q ss_pred ccCCCeEEEE
Q 010146 102 NPQGEPQRLT 111 (517)
Q Consensus 102 ~~~G~l~~~~ 111 (517)
+.||+|++|.
T Consensus 92 q~dGNlvly~ 101 (111)
T 3mez_A 92 GPDQHVTIYG 101 (111)
T ss_dssp CTTSCEEEEC
T ss_pred CCCCeEEEec
Confidence 9999999995
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=94.66 E-value=0.16 Score=40.98 Aligned_cols=80 Identities=10% Similarity=0.029 Sum_probs=44.4
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|...+ ++...++|.++..+.. .+..-.+.....+.+ +..+...+.-++.. ......+++|+.||
T Consensus 19 ~g~~~L~~~~dgnlvl--y~~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl-~d~~~~~vW~S~~~-~~~g~~~l~l~~dG 93 (115)
T 2dpf_A 19 AGAYTLTIQNKCNLVK--YQNGRQIWASNTDRRG-SGCRLTLLSDGNLVI-YDHNNNDVWGSACW-GDNGKYALVLQKDG 93 (115)
T ss_dssp ETTEEEEECTTSCEEE--EETTEEEEECSCTTSC-SSCEEEECTTSCEEE-ECTTCCEEEECCCC-CSSSCCEEEECTTS
T ss_pred CCCEEEEEcCCCcEEE--EeCCEEEEeCCCCCCC-CceEEEECCCCcEEE-ECCCceEEEEcCCC-CCCCCEEEEEeCCC
Confidence 5899999998887554 5677899998865421 111111222221111 11112222222221 11234679999999
Q ss_pred CeEEE
Q 010146 106 EPQRL 110 (517)
Q Consensus 106 ~l~~~ 110 (517)
++.+|
T Consensus 94 nlvl~ 98 (115)
T 2dpf_A 94 RFVIY 98 (115)
T ss_dssp CEEEE
T ss_pred eEEEE
Confidence 99998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=94.17 E-value=0.3 Score=39.06 Aligned_cols=80 Identities=5% Similarity=0.041 Sum_probs=45.2
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|.+. +++...++|.++.... .......+.....+.. .++...+.-++... .....+++|+.||
T Consensus 18 ~~~~~L~~~~dgnlv--l~~~~~~vW~sn~~~~-~~~~~l~l~~~GNLvl--~d~~~~~W~S~~~~-~~g~~~l~l~~dG 91 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLV--LYDNNRAVWASGTNGK-ASGCVLKMQNDGNLVI--YSGSRAIWASNTNR-QNGNYYLILQRDR 91 (112)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCTTS-CSSEEEEECTTSCEEE--EETTEEEEECCCCC-SCCCCEEEECTTS
T ss_pred CCCEEEEEcCCCcEE--EEECCEEEEeCCCcCC-CCCEEEEEeCCCCEEE--EcCCEEEEECCccC-CCCCEEEEEeCCC
Confidence 588999999998855 4566789999887531 1111222322221111 12222222222211 1234689999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
++.+|.
T Consensus 92 nlvl~~ 97 (112)
T 1xd5_A 92 NVVIYD 97 (112)
T ss_dssp CEEEEC
T ss_pred cEEEEC
Confidence 999974
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.59 E-value=0.17 Score=50.71 Aligned_cols=30 Identities=23% Similarity=0.363 Sum_probs=25.3
Q ss_pred ceEecCCCCCcEEE------CCCCCeEEccccCcee
Q 010146 472 RIIHRDLKASNVLL------DNDMNPKISDFGMARA 501 (517)
Q Consensus 472 ~iiH~Dlkp~NIll------~~~~~~kl~DFGla~~ 501 (517)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566799999998874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=92.23 E-value=1.2 Score=36.01 Aligned_cols=81 Identities=12% Similarity=0.050 Sum_probs=45.1
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|.. ++++...++|.++.... .....-.+...+.+.. +..+...+.-++.... ....+++|+.||
T Consensus 29 ~g~~~L~~~~dgnl--vly~~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl-~d~~~~~lW~S~~~~~-~g~~~l~l~~~G 103 (119)
T 1b2p_A 29 THVYRFIMQTDCNL--VLYDNNNPIWATNTGGL-GNGCRAVLQPDGVLVV-ITNENVTVWQSPVAGK-AGHYVLVLQPDR 103 (119)
T ss_dssp TEEEEEEECTTSCE--EEEETTEEEEECCCTTS-CSSCEEEECTTSCEEE-ECTTCCEEEECSCCCC-SSCEEEEECTTS
T ss_pred CCCEEEEEecCCCE--EEEECCEEEEeCCCccC-CCceEEEEccCCEEEE-EeCCCcEEEcCCCCCC-CCCEEEEEECCC
Confidence 58999999998874 45677889999876432 1111112222221111 1112223333332211 224579999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
++.+|.
T Consensus 104 nlvl~~ 109 (119)
T 1b2p_A 104 NVVIYG 109 (119)
T ss_dssp CEEEEE
T ss_pred cEEEEC
Confidence 998874
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=91.78 E-value=0.95 Score=35.92 Aligned_cols=80 Identities=10% Similarity=-0.041 Sum_probs=44.5
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|.+ ++++...++|.++..... ....-.+.....+.. +..+...+.-++.... ....++.|+.||
T Consensus 19 ~~~~~l~~~~dGnl--vl~~~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl-~~~~~~~~W~S~t~~~-~g~~~l~l~~dG 93 (110)
T 3a0c_A 19 GPSYRLIMQGDCNF--VLYDSGKPVWASNTGGLG-SGCRLTLHNNGNLVI-YDQSNRVIWQTKTNGK-EDHYVLVLQQDR 93 (110)
T ss_dssp TTTEEEEECTTSCE--EEEETTEEEEECCCTTSC-SSCEEEECTTSCEEE-ECTTCCEEEECCCCCS-SSCCEEEECTTS
T ss_pred CCCEEEEEcCCCcE--EEEECCEEEEECCCCCCC-CcEEEEEeCCCCEEE-ECCCCcEEEecCCCCC-CCCEEEEEeCCc
Confidence 57899999999885 446777899998764321 111112222221111 1112233333332221 224578999999
Q ss_pred CeEEE
Q 010146 106 EPQRL 110 (517)
Q Consensus 106 ~l~~~ 110 (517)
++.+|
T Consensus 94 nlvl~ 98 (110)
T 3a0c_A 94 NVVIY 98 (110)
T ss_dssp CEEEE
T ss_pred cEEEE
Confidence 99886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.79 E-value=1.1 Score=40.25 Aligned_cols=89 Identities=9% Similarity=0.071 Sum_probs=64.7
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEEeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HhHhcCCCceEecCCCCC
Q 010146 404 QHRNLVRLLGCCTLRDERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL-YLHQDSRLRIIHRDLKAS 481 (517)
Q Consensus 404 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~iiH~Dlkp~ 481 (517)
.||++ -...-.+.+...+.++.-+++ ++. .+ ..++...+++++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 333346667777777765333 343 33 23788899999999888776 5554 578889999
Q ss_pred cEEECCCCCeEEccccCceecCCCC
Q 010146 482 NVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 482 NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
||+++.++.++|.-.|+-..+.+.+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~e 138 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPDE 138 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSCS
T ss_pred eEEEeCCCcEEEEEcCCcccCCCCC
Confidence 9999999999999999877665543
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=87.16 E-value=0.19 Score=31.56 Aligned_cols=32 Identities=34% Similarity=0.529 Sum_probs=23.8
Q ss_pred CCCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 130 ~~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
.|+|. ...|...|.|........|.|++||.-
T Consensus 3 ~d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G 34 (39)
T 1edm_B 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCCEeEcCCCceEeECCCCCcC
Confidence 36786 467988899964324567999999964
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.40 E-value=1.2 Score=39.97 Aligned_cols=90 Identities=12% Similarity=0.086 Sum_probs=64.9
Q ss_pred CCCCCeeeEEEEEEeCCEEEEEEEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCC
Q 010146 403 LQHRNLVRLLGCCTLRDERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKAS 481 (517)
Q Consensus 403 l~h~niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~ 481 (517)
..||+++.. .+-.+.+...+.++.-+. .++.. -+.++...+++++..|+....+++. =+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 357888766 455556666665554432 22222 2347889999999999988866654 478899999
Q ss_pred cEEECCCCCeEEccccCceecCCC
Q 010146 482 NVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 482 NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++.++.++|.-.|+-..+.+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC
T ss_pred eEEEcCCCCEEEEEccCccCCCCC
Confidence 999999999999999987666544
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=83.78 E-value=0.74 Score=34.25 Aligned_cols=35 Identities=17% Similarity=0.358 Sum_probs=27.5
Q ss_pred cccChHHHHHHhhcccCccceecccccCCCcceEEecc
Q 010146 209 KNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFH 246 (517)
Q Consensus 209 ~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~~~~ 246 (517)
..+++++|+..|+.+=.|.+|.|.. ....|++..+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 4568999999999999999999963 2334988543
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=82.22 E-value=0.71 Score=31.21 Aligned_cols=32 Identities=22% Similarity=0.576 Sum_probs=23.1
Q ss_pred CCCCCC--CCCCCCcccc--CCCCCCcccccCCCcc
Q 010146 131 DQCDNY--ALCGAYAICN--MNSNSARCECLEGFVP 162 (517)
Q Consensus 131 ~~C~~~--~~CG~~~~C~--~~~~~~~C~C~~gf~~ 162 (517)
|+|... ..|-..|.|. .......|.|++||.-
T Consensus 4 ~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G 39 (53)
T 1egf_A 4 PGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp CCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred ccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcC
Confidence 567653 4788889997 3324568999999964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 517 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-48
Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 6/168 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ ++G G FG VY+G + + ++ + Q ++ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+G T + ++ ++ SL + + K I A+G+ YLH S
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IIHRDLK++N+ L D+ KI DFG+A +++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-46
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 6/166 (3%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
+ D + +LG+G FG VY+ E A K + S + +E++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
N+V+LL + ++ E+ +++ + + + L S+ + + L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
H +IIHRDLKA N+L D + K++DFG++ ++
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 37/172 (21%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQH 405
D+F ++LG G G V++ G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
+V G E + E++ SL+Q + + + ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ +I+HRD+K SN+L+++ K+ DFG++ ++ + VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-45
Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 7/168 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ +LG G FG V+ G ++AVK L + S + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
RL T ++ +I EY+ N SL F+ + K L +K + IA G+ ++ + +
Sbjct: 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
IHRDL+A+N+L+ + ++ KI+DFG+AR ++ A
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-43
Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAK 402
D FS ++G G FG VY + +A+K++S S Q ++ EV + K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L+H N ++ GC L+ EY + + K L + + G +GL
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YLH +IHRD+KA N+LL K+ DFG A A + VGT
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRN 407
+++ LGEG +G V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+V+ G + + L EY L I + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ I HRD+K N+LLD N KISDFG+A F + E +++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 6e-43
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 340 FDWNTIADATDNFSWK---------NKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS- 385
F + +A F+ + +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 386 SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF 445
+ + +F +E ++ + H N++ L G T M+I E++ N SL+ F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 446 LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
+ ++ GIA G+ YL + +HRDL A N+L+++++ K+SDFG++R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 506 QTEANTDRVVG 516
++ +G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 9e-43
Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+ + K+KLG G +G VY G+ + +AVK L + + + VEEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V+LLG CT +I E++ +L ++ + R + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
+ IHRDL A N L+ + K++DFG++R D A+
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 1e-42
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHR 406
+++ +G G +G + G+ + K L S + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 407 NLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLL 463
N+VR R L + EY L I T+ + +LD +++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 464 YLHQ--DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
H+ D ++HRDLK +NV LD N K+ DFG+AR D + A
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 42/168 (25%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+ ++ +LG G FG V G ++A+K + + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+L G CT + +I EY+ N L ++ + + ++ + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ +HRDL A N L+++ K+SDFG++R + +D ++
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFP 164
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-42
Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 348 ATDNFSWKN-KLGEGGFGPVYRGML---TEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
DN + +LG G FG V +G+ + ++A+K L + + + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L + +VRL+G C + ML+ E L +F+ + + + S +++ ++ G+
Sbjct: 66 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGT 517
YL + +HRDL A NVLL N KISDFG+++A G D +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-42
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
++ ++G G FG V+ G ++A+K + + + E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+L G C + L++E++ + L ++ + + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+IHRDL A N L+ + K+SDFGM R DQ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 6/166 (3%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
++ + KLG+G FG V+ G +A+K L + E F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
+L + + ++ EY+ SL F+ K+L + + IA G+ Y+ +
Sbjct: 76 QLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
+ +HRDL+A+N+L+ ++ K++DFG+AR ++ A
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
+ +G+G FG V+RG G+E+AVK S + + E+ L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 415 CTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-- 468
+ + L+ +Y + SL ++ + ++ A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 469 ---SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGT 517
+ I HRDLK+ N+L+ + I+D G+A D + + VGT
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-41
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
++ D ++ K+G+G G VY M GQE+A+++++ E NE+L++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
++ N+V L + DE ++ EYL SL + + +D + + + L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+LH ++IHRD+K+ N+LL D + K++DFG +Q++ +T +VGT
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-41
Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 8/159 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 410 RLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+LLG + ++ EY+ SL ++ R L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
+HRDL A NVL+ D K+SDFG+ + Q
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 3e-40
Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 31/196 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
+N + +GEG FG V++ +AVK L + +S +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----------------- 445
+ N+V+LLG C + L++EY+ L +F+ ++
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 446 ----LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
L +++ I +A G+ YL + + +HRDL N L+ +M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 502 FGVDQTEANTDRVVGT 517
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-40
Identities = 50/191 (26%), Positives = 71/191 (37%), Gaps = 26/191 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
+ S+ LG G FG V +AVK L S+ E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD---------------VTRTKFL 446
L H N+V LLG CT+ ++I EY L F+ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
D +A+G+ +L IHRDL A N+LL + KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 507 TEANTDRVVGT 517
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 48/196 (24%), Positives = 72/196 (36%), Gaps = 31/196 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
+N + LG G FG V ++AVK L + + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--------------------VT 441
L H N+V LLG CTL LI+EY L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
L + +A+G+ +L +HRDL A NVL+ + KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 502 FGVDQTEANTDRVVGT 517
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-39
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F LG+G FG VY + +A+K L K+ + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
N++RL G LI EY P ++ + + +++ D + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H R+IHRD+K N+LL + KI+DFG + + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-39
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEFKNEVLLIAKL-Q 404
++ +++ +GEG FG V + + + + A+KR+ + +S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-------------FDVTRTKFLDWSKR 451
H N++ LLG C R L EY P+ +L F+ + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
+ARG+ YL Q + IHRDL A N+L+ + KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 512 DRVVGT 517
Sbjct: 184 TMGRLP 189
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 13/168 (7%)
Query: 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVR 410
+LG G FG V +G + +AVK L + +E E ++ +L + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
++G C + ML+ E L +++ + + + +++ ++ G+ YL +
Sbjct: 73 MIGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES-- 126
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT-DRVVGT 517
+HRDL A NVLL KISDFG+++A D+
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 5/170 (2%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIA 401
+ D ++ + +GEG +G V +A+K++S Q + E+ ++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
+ +H N++ + + YL + ++ + +T+ L C + I RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
L Y+H ++HRDLK SN+LL+ + KI DFG+AR D
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRL 411
++G G F VY+G+ TE E+A L + + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 412 LGCC----TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+ +L+ E + + +L+ ++ R K + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 468 DSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ IIHRDLK N+ + + KI D G+A + V+GT
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGT 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 3e-37
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 8/161 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
D++ +LG G FG V+R G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
V L +E ++IYE++ L + + D + + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQT 507
+H DLK N++ + K+ DFG+ Q+
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-37
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 10/171 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F + LGEG F V L +E A+K L K V E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
V+L ++ Y N L ++I + D + I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
H IIHRDLK N+LL+ DM+ +I+DFG A+ + +A + VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKS-SGQGVEEFKNEVL 398
I T+ F LG G FG VY+G+ E +A+K L ++ S + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
++A + + ++ RLLG C LI + +P L ++ + + I
Sbjct: 64 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
A+G+ YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-37
Identities = 50/175 (28%), Positives = 69/175 (39%), Gaps = 13/175 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAK 402
+ KLG+G FG V RG + +AVK L S + +++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
L HRNL+RL G ++ E P SL + + +A G+
Sbjct: 68 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
YL R IHRDL A N+LL KI DFG+ RA +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 1e-36
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 8/161 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
D + +LG G FG V+R + G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+ L + E +LI E+L L I + ++ + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQT 507
I+H D+K N++ + KI DFG+A D+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAK 402
+ + +LG+G FG VY G+ +A+K ++++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQII 455
++VRLLG + ++I E + L+ ++ + SK Q+
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
IA G+ YL+ + + +HRDL A N ++ D KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 516 GT 517
Sbjct: 197 LP 198
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (342), Expect = 3e-36
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ- 404
++FS +G GGFG VY + G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 405 --HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
+V + D+ I + + L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
++H +++RDLK +N+LLD + +ISD G+A F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQ 404
+ +GEG FG V++G+ +A+K + V E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H ++V+L+G T + +I E L F+ R LD + ++ L Y
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
L R +HRD+ A NVL+ ++ K+ DFG++R D T +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 11/165 (6%)
Query: 355 KNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 409
+G G FG VY G L + AVK L++ + G V +F E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 410 RLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
LLG C + +++ Y+ + L FI + T +A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
+ + +HRDL A N +LD K++DFG+AR + ++ ++
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKSSGQG-VEEFKNEVLLIAKL 403
+ + +G G FG VY+GML +A+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
H N++RL G + M+I EY+ N +L++F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
YL + +HRDL A N+L+++++ K+SDFG++R D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-33
Identities = 48/190 (25%), Positives = 69/190 (36%), Gaps = 25/190 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEV-LLIA 401
D LG G FG V + +AVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 402 KLQHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFIF-------------DVTRTKFLD 447
H N+V LLG CT M+I E+ +L ++ + FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
+A+G+ +L + IHRDL A N+LL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 508 EANTDRVVGT 517
Sbjct: 190 YVRKGDARLP 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 9/161 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+ + LG G FG V+R + T + K + K G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+ L +E ++I+E++ + + I T L+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQT 507
I H D++ N++ + KI +FG AR
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 3e-33
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 8/178 (4%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE-FKNEVLL 399
W D D + +++ LG G F V + +A+K ++K + +G E +NE+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
+ K++H N+V L LI + + L I F ++I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ YLH + + LD D ISDFG+++ GT
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 4e-33
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 20/179 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---------QGVEEFKNEVLL 399
+N+ K LG G V R + +E AVK + + G + E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 400 IAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
+ K+ H N+++L L+++ + L ++ T L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ LH +L I+HRDLK N+LLD+DMN K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (316), Expect = 5e-33
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 10/162 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
+F LG G FG V+ G+ A+K L K + VE +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
++R+ G + +I +Y+ L + R + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
II+RDLK N+LLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (311), Expect = 9e-33
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRN 407
+ + K+GEG +G VY+ G+ A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
+V+L + +L++E+L + L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
R++HRDLK N+L++ + KI+DFG+ARAFG+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-32
Identities = 50/173 (28%), Positives = 72/173 (41%), Gaps = 13/173 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEV-LLIAKLQ 404
++F LG+G FG V+ + Q A+K L K VE E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
H L + ++ + EYL L I D S+ I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
LH I++RDLK N+LLD D + KI+DFGM + + + NT GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+++ +G G FG VY+ L + G+ +A+K++ + E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 409 VRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
VRL E+ L+ +Y+P + L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANT 511
Y+H I HRD+K N+LLD D K+ DFG A+ + +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-31
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 26/191 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
D LGEG FG V ++AVK L ++ + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFL 446
+ +H+N++ LLG CT +I EY +L +++ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
+ARG+ YL + IHRDL A NVL+ D KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 507 TEANTDRVVGT 517
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (295), Expect = 1e-30
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 15/178 (8%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQ 404
+D + LG GG V+ +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 405 HRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
H +V + ++ EY+ +L + + + ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANTDRVVGT 517
L + H + IIHRD+K +N+++ K+ DFG+ARA T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-30
Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
+NF K+GEG +G VY+ G+ +A+K++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+V+LL ++ L++E+L + D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
R++HRDLK N+L++ + K++DFG+ARAFGV
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 9e-30
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE-----FKNEVLLIAKLQHRNLV 409
+ LGEG F VY+ Q +A+K++ ++ E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
LL + L+++++ + L S + +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
I+HRDLK +N+LLD + K++DFG+A++FG
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-29
Identities = 44/184 (23%), Positives = 90/184 (48%), Gaps = 19/184 (10%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG--VEEFKNEVLLIAKL 403
D + K+G+G FG V++ + GQ++A+K++ + + E+ ++ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 404 QHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
+H N+V L+ C + L++++ + + + S+ +++
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVM 123
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-- 513
+ + GL Y+H++ +I+HRD+KA+NVL+ D K++DFG+ARAF + +
Sbjct: 124 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 514 VVGT 517
V T
Sbjct: 181 RVVT 184
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 42/172 (24%), Positives = 67/172 (38%), Gaps = 12/172 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
++F + LG+G FG V G+ A+K L K + V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
L L D + EY L + +R + + I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
H +++RD+K N++LD D + KI+DFG+ + D GT
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 168
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKL 403
A + ++GEG +G V++ + G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ---FIFDVTRTKFLDWSKRCQIIEG 457
+H N+VRL CT+ L + ++Q D + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
+ RGL +LH R++HRDLK N+L+ + K++DFG+AR + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-27
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 7/169 (4%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLL 399
T + + +G G +G V + G ++A+K+L + S + E+ L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYE-YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
+ ++H N++ LL T + + YL + + + + + L + ++ +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
+GL Y+H IIHRDLK N+ ++ D KI DFG+AR + T
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 6e-27
Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
+ K+GEG +G V++ E + +A+KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
N+VRL + L++E+ + F LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
++HRDLK N+L++ + K+++FG+ARAFG+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 18/159 (11%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCC 415
LG G G V + ++ A+K L + + EV L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 416 ----TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
R +++ E L L I D + + +I++ I + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 472 RIIHRDLKASNVLLDNDMNP---KISDFGMARAFGVDQT 507
I HRD+K N+L + K++DFG A+ +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 9e-27
Identities = 40/155 (25%), Positives = 60/155 (38%), Gaps = 10/155 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
D F LG G FG V E G A+K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
LV+L ++ EY+ + + R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
H L +I+RDLK N+L+D +++DFG A+
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 5e-26
Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 19/171 (11%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEE------FKNEVLLIAKLQ--HRN 407
LG GGFG VY G+ +++ +A+K + K E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
++RLL D +LI E +T L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 468 DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
++HRD+K N+L+D N K+ DFG + GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-26
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS------GQGVEEFKNEVLLIAK 402
D + +LG G F V + G + A K + K G E+ + EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
+QH N++ L + + +LI E + L F+ + L + + ++ I G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGT 517
YLH L+I H DLK N++L + P KI DFG+A + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (259), Expect = 2e-25
Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 11/166 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
+ + K+G G FG +Y G G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+ + C + ++ L SLE ++ + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 469 SRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEANT 511
IHRD+K N L I DFG+A+ + +T +
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 8e-25
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS----GQGVEEFKNEVLLIA 401
+NF LG G +G V+ G+ A+K L K++ + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 402 KLQHR-NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
++ LV L + LI +Y+ L + R + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
L +LH +L II+RD+K N+LLD++ + ++DFG+++ F D+TE
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 8e-25
Identities = 37/163 (22%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN 407
D++ KLG G + V+ + +T +++ VK L ++ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 408 LVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
++ L R L++E++ N +Q + L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 466 HQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQT 507
H + I+HRD+K NV++D++ ++ D+G+A + Q
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (252), Expect = 1e-24
Identities = 30/179 (16%), Positives = 66/179 (36%), Gaps = 18/179 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
++ ++GEG FG ++ G L Q++A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
+ + ++ L SLE + + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVDQTEANTDR-----VVGT 517
+++RD+K N L+ + + DFGM + + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-24
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 7/176 (3%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLL 399
TI + + + + +G G +G V T+ G +AVK+LS+ S + E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLI-YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
+ ++H N++ LL T YL + + ++ + + L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
RGL Y+H IIHRDLK SN+ ++ D KI DFG+AR + T R
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.8 bits (240), Expect = 7e-24
Identities = 30/155 (19%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGV--------EEFKNEVLLIAKLQH 405
+GEG V+ + E VK ++ +S + V F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
R L +L G + Y + N L + I + + ++++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
+ I+H DL NVL+ + I DF +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 2e-22
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 21/177 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
+ +G G G V + +A+K+LS+ + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 407 NLVRLLGCCTLRD------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
N++ LL T + + L+ E + + LD + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 130
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
G+ +LH IIHRDLK SN+++ +D KI DFG+AR G V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.8 bits (203), Expect = 9e-18
Identities = 35/175 (20%), Positives = 66/175 (37%), Gaps = 18/175 (10%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
KLG G F V+ + +A+K + E ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 416 TLRDERMLIY--EYLPNKSLEQFIFDVTRTKFLDWSKR-----------CQIIEGIARGL 462
++L + PN +F+V L K+ QI + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 463 LYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
Y+H+ R IIH D+K NVL++ D + +A + + +
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.98 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.21 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.06 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 96.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.79 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 96.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.28 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 93.53 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 93.42 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 93.08 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.08 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.07 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.99 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 90.7 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 90.67 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.46 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.37 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 87.09 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.71 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 83.96 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 83.03 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 82.39 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 81.87 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 81.68 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.03 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 80.35 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 80.13 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-35 Score=278.39 Aligned_cols=163 Identities=29% Similarity=0.424 Sum_probs=140.5
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999976 58999999987543 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999983 3456999999999999999999999998 9999999999999999999999999999886554
Q ss_pred cccccCceecC
Q 010146 507 TEANTDRVVGT 517 (517)
Q Consensus 507 ~~~~~~~~~GT 517 (517)
........+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 43334446666
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-34 Score=277.48 Aligned_cols=155 Identities=30% Similarity=0.516 Sum_probs=139.7
Q ss_pred hcCCCCccceecccCCeeEEEEEeCC-CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||.||+|.+.. ++.||||+++.. ....+++.+|+.++++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34678888999999999999999864 889999999764 4567789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++|+|.+++.+. ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+.
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999653 3456899999999999999999999998 9999999999999999999999999999886554
Q ss_pred c
Q 010146 507 T 507 (517)
Q Consensus 507 ~ 507 (517)
.
T Consensus 170 ~ 170 (287)
T d1opja_ 170 Y 170 (287)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-33 Score=271.30 Aligned_cols=151 Identities=28% Similarity=0.504 Sum_probs=138.7
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999965 5999999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998853 34899999999999999999999998 9999999999999999999999999999986554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=268.44 Aligned_cols=151 Identities=28% Similarity=0.506 Sum_probs=131.5
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||+|.+.+++.||||+++. .....++|.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 56888899999999999999998888999999976 34556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999998543 345899999999999999999999998 9999999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=269.79 Aligned_cols=153 Identities=32% Similarity=0.543 Sum_probs=135.7
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
.++|++.+.||+|+||.||+|.+++++.||||+++.. ....++|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence 3578888999999999999999988889999999763 455678999999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
++|+|.+++.... ...+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999874322 234899999999999999999999998 99999999999999999999999999999865543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=271.06 Aligned_cols=150 Identities=27% Similarity=0.457 Sum_probs=137.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+.|++.+.||+|+||.||+|... +++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999976 48999999998766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
++|+|.+++.+. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999998543 345999999999999999999999998 99999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=270.86 Aligned_cols=162 Identities=30% Similarity=0.437 Sum_probs=138.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46899999999999999999975 5899999998653 2445678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999998765
Q ss_pred CcccccCceecC
Q 010146 506 QTEANTDRVVGT 517 (517)
Q Consensus 506 ~~~~~~~~~~GT 517 (517)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 544444445665
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-33 Score=267.98 Aligned_cols=161 Identities=30% Similarity=0.515 Sum_probs=131.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|+.+ ..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467899999999999999999865 46999999754 3445678999999999999999999999875 456899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+++|+|.+++... ...+++.+++.++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999543 345899999999999999999999988 9999999999999999999999999999886554
Q ss_pred cccccCceecC
Q 010146 507 TEANTDRVVGT 517 (517)
Q Consensus 507 ~~~~~~~~~GT 517 (517)
.......+.||
T Consensus 159 ~~~~~~~~~gt 169 (276)
T d1uwha_ 159 GSHQFEQLSGS 169 (276)
T ss_dssp -------CCCC
T ss_pred CcccccccccC
Confidence 43333344554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=5.7e-33 Score=270.11 Aligned_cols=153 Identities=29% Similarity=0.509 Sum_probs=126.2
Q ss_pred CCCCccceecccCCeeEEEEEeCC-C---CEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||.||+|.++. + ..||||.+... .....++|.+|+.+|++++|||||++++++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999999753 3 26899998754 334556899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988542 345899999999999999999999988 99999999999999999999999999998865
Q ss_pred CCc
Q 010146 505 DQT 507 (517)
Q Consensus 505 ~~~ 507 (517)
...
T Consensus 181 ~~~ 183 (299)
T d1jpaa_ 181 DTS 183 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=262.68 Aligned_cols=150 Identities=29% Similarity=0.428 Sum_probs=136.1
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999986 4899999998643 2345678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999543 35899999999999999999999998 999999999999999999999999999877554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-32 Score=258.77 Aligned_cols=152 Identities=27% Similarity=0.498 Sum_probs=138.6
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.++||+|+||.||+|+.++++.||||+++.. ....++|.+|+.++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 678999999999999999999988889999999864 4456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
+|+|.+++... ...+++..+++++.|+++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999997543 345889999999999999999999988 99999999999999999999999999998765543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-33 Score=275.28 Aligned_cols=150 Identities=23% Similarity=0.313 Sum_probs=135.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 58999999997643 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||+. + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999643 3589999999999999999999974 7 99999999999999999999999999998744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.4e-33 Score=264.26 Aligned_cols=157 Identities=27% Similarity=0.408 Sum_probs=127.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--CCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 424 (517)
++|++.+.||+|+||.||+|+.+ +|+.||||.+.... +...+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999975 58999999987642 3345678999999999999999999999864 4557999
Q ss_pred EEeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCC--CceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 425 YEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSR--LRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~--~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
|||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+. .+|+||||||+||||++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986432 34569999999999999999999998642 3599999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 86543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=7.5e-32 Score=267.45 Aligned_cols=153 Identities=24% Similarity=0.431 Sum_probs=138.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999975 5899999999876656667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC--CCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~ 505 (517)
+++|+|.+++.+ ....+++..+..++.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999843 2345999999999999999999999998 999999999999964 578999999999998665
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=8.3e-32 Score=267.34 Aligned_cols=153 Identities=26% Similarity=0.390 Sum_probs=137.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
.++|++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 5999999999876555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC--CCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~~ 505 (517)
+++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988743 2345999999999999999999999998 99999999999998 5789999999999998765
Q ss_pred C
Q 010146 506 Q 506 (517)
Q Consensus 506 ~ 506 (517)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-32 Score=267.00 Aligned_cols=161 Identities=25% Similarity=0.333 Sum_probs=141.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
.++|++.+.||+|+||.||+|+.+ +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357899999999999999999975 5999999999753 344567899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCcccccCceecC
Q 010146 505 DQTEANTDRVVGT 517 (517)
Q Consensus 505 ~~~~~~~~~~~GT 517 (517)
.... ....+||
T Consensus 158 ~~~~--~~~~~GT 168 (337)
T d1o6la_ 158 DGAT--MKTFCGT 168 (337)
T ss_dssp TTCC--BCCCEEC
T ss_pred CCcc--cccceeC
Confidence 4332 2335665
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.4e-32 Score=266.38 Aligned_cols=153 Identities=25% Similarity=0.383 Sum_probs=124.1
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
..+.|++.+.||+|+||.||+|..+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4467999999999999999999976 48999999997543 233456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC---CCCCeEEccccCceec
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAF 502 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~ 502 (517)
||+++|+|.++|.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999953 346999999999999999999999998 99999999999995 5788999999999987
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 161 ~~~~ 164 (307)
T d1a06a_ 161 DPGS 164 (307)
T ss_dssp ----
T ss_pred cCCC
Confidence 6543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.1e-32 Score=261.75 Aligned_cols=151 Identities=30% Similarity=0.546 Sum_probs=131.8
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP 429 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 429 (517)
++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 578999999999999999999988889999999753 455688999999999999999999999985 456899999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
+|+|..++.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999985432 235899999999999999999999998 9999999999999999999999999999876544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=258.46 Aligned_cols=151 Identities=32% Similarity=0.598 Sum_probs=130.7
Q ss_pred CCCCccc-eecccCCeeEEEEEeC---CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~-~Ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|.+.+ +||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||++++++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999864 25579999997643 3446789999999999999999999999864 568999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999843 2345899999999999999999999998 99999999999999999999999999999876
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-32 Score=257.31 Aligned_cols=149 Identities=28% Similarity=0.446 Sum_probs=128.4
Q ss_pred CccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe----CCEEEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIY 425 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 425 (517)
++.++||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999976 4889999998654 23345678999999999999999999999865 34579999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEEC-CCCCeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~ 504 (517)
||+++|+|.+++.+. ..+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999543 45899999999999999999999875 4599999999999996 578999999999987544
Q ss_pred C
Q 010146 505 D 505 (517)
Q Consensus 505 ~ 505 (517)
.
T Consensus 168 ~ 168 (270)
T d1t4ha_ 168 S 168 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.1e-32 Score=265.25 Aligned_cols=166 Identities=30% Similarity=0.455 Sum_probs=136.8
Q ss_pred cCCCCccceecccCCeeEEEEEeCC-C-----CEEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE-G-----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
.++|++.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998643 2 36999998654 344556899999999998 89999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCC
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTR--------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 480 (517)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965322 235899999999999999999999998 99999999
Q ss_pred CcEEECCCCCeEEccccCceecCCCCcccccCceecC
Q 010146 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 481 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
+|||++.++.+||+|||+|+...............||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 9999999999999999999988665543333334444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.5e-31 Score=261.87 Aligned_cols=150 Identities=28% Similarity=0.391 Sum_probs=136.0
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999975 5999999999653 3445678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998854 345788999999999999999999998 999999999999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=7.3e-32 Score=263.08 Aligned_cols=149 Identities=30% Similarity=0.470 Sum_probs=133.0
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
.|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999965 588999999876432 334578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
|+++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999877643 345899999999999999999999998 999999999999999999999999999977543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=2e-31 Score=255.96 Aligned_cols=152 Identities=28% Similarity=0.403 Sum_probs=136.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc---------CHHHHHHHHHHHhcCC-CCCeeeEEEEEEe
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ---------GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTL 417 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 417 (517)
.++|++.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367999999999999999999975 5899999998754211 2246889999999997 9999999999999
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
++..+|||||+++|+|.++|... ..+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999543 35899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+|+.+....
T Consensus 156 ~a~~~~~~~ 164 (277)
T d1phka_ 156 FSCQLDPGE 164 (277)
T ss_dssp TCEECCTTC
T ss_pred heeEccCCC
Confidence 999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=257.01 Aligned_cols=145 Identities=29% Similarity=0.529 Sum_probs=126.1
Q ss_pred ceecccCCeeEEEEEeCC---CCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeCCC
Q 010146 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 430 (517)
++||+|+||.||+|.+++ ++.||||+++.. .....+++.+|++++++++|||||++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 568999999654 23335689999999999999999999999864 567899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 431 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|+|.+++.+ ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999954 345899999999999999999999998 99999999999999999999999999998865543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-31 Score=257.04 Aligned_cols=152 Identities=30% Similarity=0.558 Sum_probs=128.2
Q ss_pred CCCCccceecccCCeeEEEEEeCCC-----CEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
+.|++.++||+|+||.||+|.++.. ..||||+++.. ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999997642 37999999754 33345578999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+.+++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999988543 345899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.4e-31 Score=255.11 Aligned_cols=152 Identities=28% Similarity=0.430 Sum_probs=136.1
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC------ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|..+ +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 58999999986431 23467899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC----CeEEcccc
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG 497 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 497 (517)
+|||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999543 35999999999999999999999998 99999999999998776 49999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+|+.+....
T Consensus 163 ~a~~~~~~~ 171 (293)
T d1jksa_ 163 LAHKIDFGN 171 (293)
T ss_dssp TCEECTTSC
T ss_pred hhhhcCCCc
Confidence 999886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.2e-31 Score=261.40 Aligned_cols=161 Identities=28% Similarity=0.534 Sum_probs=139.5
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCCc-cCHHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 416 (517)
+++...++|++.+.||+|+||.||+|+.+ +++.||||+++.... ...++|.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999864 357899999976433 34567999999999999999999999999
Q ss_pred eCCEEEEEEEeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEe
Q 010146 417 LRDERMLIYEYLPNKSLEQFIFDVTR---------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475 (517)
Q Consensus 417 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH 475 (517)
..+..+++|||+++|+|.+++..... ...+++..++.|+.||+.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999964221 234889999999999999999999998 999
Q ss_pred cCCCCCcEEECCCCCeEEccccCceecCCCCc
Q 010146 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507 (517)
Q Consensus 476 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 507 (517)
|||||+||||+.++.+||+|||+|+.+.....
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~ 195 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY 195 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc
Confidence 99999999999999999999999998765543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-30 Score=256.17 Aligned_cols=153 Identities=22% Similarity=0.332 Sum_probs=135.5
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
..++|++.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999976 48899999997643 334568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCC--CCeEEccccCceecCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGV 504 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DFGla~~~~~ 504 (517)
|+++++|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999999432 335899999999999999999999998 9999999999999854 4799999999998865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 157 ~~ 158 (321)
T d1tkia_ 157 GD 158 (321)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=7.1e-31 Score=260.53 Aligned_cols=150 Identities=25% Similarity=0.317 Sum_probs=136.6
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 425 (517)
++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.+|+.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 5999999998643 2345678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
||+.+|+|..++.+. ..+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999999543 35899999999999999999999998 999999999999999999999999999988643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.3e-30 Score=259.99 Aligned_cols=152 Identities=26% Similarity=0.324 Sum_probs=132.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHH---HHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFK---NEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+. +|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999976 4999999998643 122333344 447778888999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
++||||+++|+|.++|.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999543 45889999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
+....
T Consensus 157 ~~~~~ 161 (364)
T d1omwa3 157 FSKKK 161 (364)
T ss_dssp CSSSC
T ss_pred cCCCc
Confidence 86553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=255.56 Aligned_cols=162 Identities=29% Similarity=0.507 Sum_probs=132.1
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC----EEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.+|++.+.||+|+||.||+|.... |+ .||+|+++.. .....+++.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 458899999999999999999653 44 6899988654 445678899999999999999999999999864 5678
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
++||+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 88999999999988543 446899999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCcccccCceecC
Q 010146 504 VDQTEANTDRVVGT 517 (517)
Q Consensus 504 ~~~~~~~~~~~~GT 517 (517)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 66554434334444
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-30 Score=251.99 Aligned_cols=152 Identities=30% Similarity=0.531 Sum_probs=131.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999975 58999999996542 3346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
|+.+ ++.+++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....+.
T Consensus 82 ~~~~-~~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9964 55555533 23455999999999999999999999998 9999999999999999999999999999876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=253.50 Aligned_cols=169 Identities=27% Similarity=0.389 Sum_probs=130.1
Q ss_pred HHhcCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEe
Q 010146 346 ADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL 417 (517)
Q Consensus 346 ~~~~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 417 (517)
+...++|++.++||+|+||.||+|... +++.||||+++... ....+++.+|...+.++ +|+||+.+++++..
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 334467999999999999999999853 24689999997542 33456778888888776 68999999999876
Q ss_pred C-CEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcE
Q 010146 418 R-DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV 483 (517)
Q Consensus 418 ~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 483 (517)
. ...++||||+++|+|.++|..... ...+++.+++.++.||++||+|||+++ |+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence 5 468999999999999999964321 235899999999999999999999998 99999999999
Q ss_pred EECCCCCeEEccccCceecCCCCcccccCceecC
Q 010146 484 LLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 484 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
||++++.+||+|||+|+.+........+....||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999999988666554444445554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-30 Score=252.39 Aligned_cols=151 Identities=30% Similarity=0.446 Sum_probs=133.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC---CccCHHHHHHHHHHHh-cCCCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIA-KLQHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999976 4899999999753 2345566777777765 68999999999999999999999
Q ss_pred EEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCC
Q 010146 425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 504 (517)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999543 34899999999999999999999998 99999999999999999999999999997754
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=2.9e-30 Score=249.74 Aligned_cols=150 Identities=27% Similarity=0.474 Sum_probs=134.9
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.++||+|+||+||+|+.++++.||||+++.. .....+.+.+|+.++++++||||+++++.+...+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 678999999999999999999999999999999654 334467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
+.++.+..+. .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877666665 33456999999999999999999999988 999999999999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-30 Score=252.95 Aligned_cols=157 Identities=28% Similarity=0.486 Sum_probs=136.3
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER 421 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 421 (517)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ......+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999864 25789999997542 33445789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 422 MLIYEYLPNKSLEQFIFDV-------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
++||||+++|+|.+++... .....+++..+..++.|+++||.|||+++ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998532 12234789999999999999999999988 9999999999999999999999
Q ss_pred cccCceecCCCCcc
Q 010146 495 DFGMARAFGVDQTE 508 (517)
Q Consensus 495 DFGla~~~~~~~~~ 508 (517)
|||+|+.+......
T Consensus 176 DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 176 DFGMTRDIYETDYY 189 (308)
T ss_dssp CTTCCCGGGGGGCE
T ss_pred ecccceeccCCcce
Confidence 99999988665443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.7e-30 Score=250.63 Aligned_cols=146 Identities=29% Similarity=0.445 Sum_probs=125.9
Q ss_pred cceecccCCeeEEEEEeC-CCCEEEEEEccCCCcc-----CHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEEeC
Q 010146 355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-----GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL 428 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 428 (517)
+++||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 4899999999754221 2346889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
.++++..++ .....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 887776655 33456899999999999999999999998 9999999999999999999999999999876544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-30 Score=248.07 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=124.1
Q ss_pred cCCCCccceecccCCeeEEEEEeCC----CCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML 423 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 423 (517)
.++|++.+.||+|+||.||+|.+.. +..||||.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578899999999999999998653 3578999987543 334567999999999999999999999985 567899
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecC
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 503 (517)
||||+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987543 345899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC
Q 010146 504 VDQ 506 (517)
Q Consensus 504 ~~~ 506 (517)
...
T Consensus 160 ~~~ 162 (273)
T d1mp8a_ 160 DST 162 (273)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=5.4e-30 Score=246.59 Aligned_cols=151 Identities=25% Similarity=0.365 Sum_probs=132.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc---cCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----E
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----E 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 420 (517)
.++|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 599999999976432 33457899999999999999999999987654 3
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+|||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988543 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCC
Q 010146 501 AFGVD 505 (517)
Q Consensus 501 ~~~~~ 505 (517)
.+...
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 77544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-30 Score=247.22 Aligned_cols=152 Identities=32% Similarity=0.468 Sum_probs=124.7
Q ss_pred CCCCccceecccCCeeEEEEEeCC--C--CEEEEEEccCC---CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE--G--QEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 422 (517)
++|++.+.||+|+||.||+|+... + ..||||++... .....++|.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998542 3 37899998754 23345689999999999999999999999965 5678
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceec
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 502 (517)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999988543 345999999999999999999999998 999999999999999999999999999998
Q ss_pred CCCCc
Q 010146 503 GVDQT 507 (517)
Q Consensus 503 ~~~~~ 507 (517)
.....
T Consensus 162 ~~~~~ 166 (273)
T d1u46a_ 162 PQNDD 166 (273)
T ss_dssp CC-CC
T ss_pred ccCCC
Confidence 66544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.4e-30 Score=251.27 Aligned_cols=166 Identities=30% Similarity=0.432 Sum_probs=141.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC------CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 420 (517)
.++|++.++||+|+||.||+|++. +++.||||+++... .....++.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999852 36789999997643 33455789999999999 69999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 421 RMLIYEYLPNKSLEQFIFDVT---------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
.++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999996532 1235899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCCCCcccccCceecC
Q 010146 486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 517 (517)
+.++.+||+|||+++.+.............||
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccCcccccccchheeccCCCcceEeeecccC
Confidence 99999999999999988766554444445554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-30 Score=248.56 Aligned_cols=152 Identities=33% Similarity=0.610 Sum_probs=131.4
Q ss_pred CCCCccceecccCCeeEEEEEeCC-CC--EEEEEEccCC-CccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeCCEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 424 (517)
++|++.++||+|+||.||+|++++ +. .||||+++.. .....+.+.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999764 43 5788887643 344566899999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCe
Q 010146 425 YEYLPNKSLEQFIFDV-------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491 (517)
Q Consensus 425 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 491 (517)
|||+++|+|.++|+.. .....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456999999999999999999999998 9999999999999999999
Q ss_pred EEccccCceecCC
Q 010146 492 KISDFGMARAFGV 504 (517)
Q Consensus 492 kl~DFGla~~~~~ 504 (517)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-30 Score=244.22 Aligned_cols=149 Identities=28% Similarity=0.470 Sum_probs=125.9
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-CEEEEEEEeC
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEYL 428 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 428 (517)
++|++.+.||+|+||.||+|.++ |..||||+++.. ...+++.+|++++++++||||+++++++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46778899999999999999986 789999999753 4557899999999999999999999998654 5679999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 505 (517)
++|+|.++|.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999996432 234899999999999999999999988 999999999999999999999999999987544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=247.12 Aligned_cols=165 Identities=29% Similarity=0.424 Sum_probs=134.9
Q ss_pred cCCCCccceecccCCeeEEEEEeCC--------CCEEEEEEccCCC-ccCHHHHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR 418 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 418 (517)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578888999999999999998532 2479999997653 34457788999999888 799999999999999
Q ss_pred CEEEEEEEeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEE
Q 010146 419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL 485 (517)
Q Consensus 419 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 485 (517)
+..++||||+++|+|.++|..... ...+++.+++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965432 245899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEccccCceecCCCCcccccCceec
Q 010146 486 DNDMNPKISDFGMARAFGVDQTEANTDRVVG 516 (517)
Q Consensus 486 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 516 (517)
+.++.+||+|||+++.+........+....|
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCC
Confidence 9999999999999998876554443333333
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-29 Score=244.52 Aligned_cols=151 Identities=25% Similarity=0.385 Sum_probs=125.5
Q ss_pred CCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----EEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 425 (517)
.+|.+.+.||+|+||.||+|+++ |+.||||+++... ........|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 35667789999999999999975 8999999996532 21222334555666789999999999998654 579999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
||+++|+|.++|.+. .+++.+++.++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999642 4899999999999999999999741 2359999999999999999999999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 157 ~~~~~~ 162 (303)
T d1vjya_ 157 RHDSAT 162 (303)
T ss_dssp EEETTT
T ss_pred cccCCC
Confidence 886554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.2e-29 Score=242.62 Aligned_cols=147 Identities=29% Similarity=0.514 Sum_probs=128.3
Q ss_pred cceecccCCeeEEEEEeCCC----CEEEEEEccCC-CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-CEEEEEEEeC
Q 010146 355 KNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEYL 428 (517)
Q Consensus 355 ~~~Ig~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 428 (517)
.++||+|+||+||+|.+.+. ..||||+++.. .....++|.+|++++++++||||++++|++... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 26899999753 444567899999999999999999999998764 5889999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999854 3345788899999999999999999998 9999999999999999999999999999886554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-29 Score=245.89 Aligned_cols=149 Identities=26% Similarity=0.349 Sum_probs=127.5
Q ss_pred cCCCCccc-eecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhc-CCCCCeeeEEEEEEe----CCEE
Q 010146 349 TDNFSWKN-KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTL----RDER 421 (517)
Q Consensus 349 ~~~y~~~~-~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 421 (517)
.++|.+.. .||+|+||.||+|... +++.||||+++. ...+.+|+.++.+ ++|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 6999999999999974 589999999864 2567889988665 589999999999875 3568
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccC
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM 498 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGl 498 (517)
++||||+++|+|.++|.+. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999643 2346999999999999999999999998 999999999999986 45699999999
Q ss_pred ceecCCCC
Q 010146 499 ARAFGVDQ 506 (517)
Q Consensus 499 a~~~~~~~ 506 (517)
|+.+....
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99886554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-28 Score=238.55 Aligned_cols=151 Identities=26% Similarity=0.441 Sum_probs=135.7
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCEEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 426 (517)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 58999999986542 3346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCceecCCCC
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 506 (517)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||.|+.+....
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345889999999999999999999998 9999999999999999999999999999886544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.8e-29 Score=240.80 Aligned_cols=151 Identities=26% Similarity=0.373 Sum_probs=129.9
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCc------cCHHHHHHHHHHHhcCC--CCCeeeEEEEEEeCC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRD 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 419 (517)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999975 589999999865321 12234678999999986 899999999999999
Q ss_pred EEEEEEEeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-CCCeEEcccc
Q 010146 420 ERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFG 497 (517)
Q Consensus 420 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFG 497 (517)
..++||||+.+ +++.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999975 678888754 345899999999999999999999998 999999999999985 4789999999
Q ss_pred CceecCCC
Q 010146 498 MARAFGVD 505 (517)
Q Consensus 498 la~~~~~~ 505 (517)
+|+.....
T Consensus 157 ~a~~~~~~ 164 (273)
T d1xwsa_ 157 SGALLKDT 164 (273)
T ss_dssp TCEECCSS
T ss_pred cceecccc
Confidence 99987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.3e-29 Score=245.44 Aligned_cols=152 Identities=25% Similarity=0.434 Sum_probs=128.0
Q ss_pred hcCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC-ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC----EE
Q 010146 348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ER 421 (517)
Q Consensus 348 ~~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 421 (517)
..++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+++|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3467999999999999999999965 69999999997543 334567899999999999999999999987543 23
Q ss_pred EEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 422 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
+++++++.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555666779999999953 24899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCC
Q 010146 502 FGVDQ 506 (517)
Q Consensus 502 ~~~~~ 506 (517)
.....
T Consensus 159 ~~~~~ 163 (345)
T d1pmea_ 159 ADPDH 163 (345)
T ss_dssp CCGGG
T ss_pred ccCCC
Confidence 76543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=243.25 Aligned_cols=149 Identities=28% Similarity=0.388 Sum_probs=124.3
Q ss_pred CCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC------CEEEE
Q 010146 351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------DERML 423 (517)
Q Consensus 351 ~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 423 (517)
+|+..++||+|+||+||+|+.. +++.||||++...... ..+|+++|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777899999999999999976 4999999999764322 34799999999999999999998643 24789
Q ss_pred EEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceec
Q 010146 424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAF 502 (517)
Q Consensus 424 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~ 502 (517)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976644444332334556999999999999999999999988 99999999999999775 8999999999988
Q ss_pred CCCC
Q 010146 503 GVDQ 506 (517)
Q Consensus 503 ~~~~ 506 (517)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=3.9e-28 Score=239.37 Aligned_cols=145 Identities=24% Similarity=0.419 Sum_probs=127.8
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeC--CEEEEEE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR--DERMLIY 425 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 425 (517)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 5899999999653 4577899999999995 99999999998744 4689999
Q ss_pred EeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCC-CeEEccccCceecCC
Q 010146 426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGV 504 (517)
Q Consensus 426 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~ 504 (517)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 34899999999999999999999998 99999999999998655 599999999998865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.5e-28 Score=236.28 Aligned_cols=152 Identities=27% Similarity=0.499 Sum_probs=128.0
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe--------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-------- 417 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 417 (517)
.++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.+|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999975 5999999998654 33456788999999999999999999998855
Q ss_pred CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEcccc
Q 010146 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497 (517)
Q Consensus 418 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 497 (517)
.+..++||||++++.+..+. .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999877665544 33456899999999999999999999998 9999999999999999999999999
Q ss_pred CceecCCCC
Q 010146 498 MARAFGVDQ 506 (517)
Q Consensus 498 la~~~~~~~ 506 (517)
+|+.+....
T Consensus 163 ~~~~~~~~~ 171 (318)
T d3blha1 163 LARAFSLAK 171 (318)
T ss_dssp TCEECCC--
T ss_pred eeeeccccc
Confidence 999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.9e-28 Score=240.42 Aligned_cols=150 Identities=26% Similarity=0.446 Sum_probs=125.8
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCC--CccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC------
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 419 (517)
.++|++.++||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 4999999999754 2234567889999999999999999999997654
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||+ +.+|..++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 6778877743 34999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCC
Q 010146 500 RAFGVDQ 506 (517)
Q Consensus 500 ~~~~~~~ 506 (517)
+......
T Consensus 169 ~~~~~~~ 175 (346)
T d1cm8a_ 169 RQADSEM 175 (346)
T ss_dssp EECCSSC
T ss_pred eccCCcc
Confidence 9886543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-28 Score=239.98 Aligned_cols=151 Identities=26% Similarity=0.367 Sum_probs=133.6
Q ss_pred CCCCccceecccCCeeEEEEEeC----CCCEEEEEEccCC----CccCHHHHHHHHHHHhcCCC-CCeeeEEEEEEeCCE
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDE 420 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 420 (517)
++|++.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 3789999998653 22345678899999999976 899999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.+++|||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999543 34788899999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCC
Q 010146 501 AFGVDQ 506 (517)
Q Consensus 501 ~~~~~~ 506 (517)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 886544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=3.8e-27 Score=228.24 Aligned_cols=149 Identities=19% Similarity=0.294 Sum_probs=129.6
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC-CCeeeEEEEEEeCCEEEEEEE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 426 (517)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999976 58999999886532 23457788899999975 899999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC-----CCCeEEccccCcee
Q 010146 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARA 501 (517)
Q Consensus 427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~ 501 (517)
|+ +++|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 79999988543 345899999999999999999999998 999999999999974 56799999999998
Q ss_pred cCCC
Q 010146 502 FGVD 505 (517)
Q Consensus 502 ~~~~ 505 (517)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 8654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-27 Score=233.07 Aligned_cols=152 Identities=26% Similarity=0.447 Sum_probs=124.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-C-CCEEEEEEccCC--CccCHHHHHHHHHHHhcC---CCCCeeeEEEEEEe----
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-E-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTL---- 417 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 417 (517)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 567999998643 222233456677766555 89999999999853
Q ss_pred -CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccc
Q 010146 418 -RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496 (517)
Q Consensus 418 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 496 (517)
....+++|||++++.+..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 246799999998877655442 33456899999999999999999999998 999999999999999999999999
Q ss_pred cCceecCCC
Q 010146 497 GMARAFGVD 505 (517)
Q Consensus 497 Gla~~~~~~ 505 (517)
|+++.....
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.9e-27 Score=235.10 Aligned_cols=149 Identities=30% Similarity=0.421 Sum_probs=126.2
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CE
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE 420 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 420 (517)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999965 59999999997642 23345788999999999999999999998643 33
Q ss_pred EEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 421 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
.++++||+.+++|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677788889999999832 35999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCC
Q 010146 501 AFGV 504 (517)
Q Consensus 501 ~~~~ 504 (517)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=2.7e-26 Score=223.09 Aligned_cols=149 Identities=23% Similarity=0.375 Sum_probs=124.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYEY 427 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 427 (517)
++|++.+.||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+| |+.+..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 589999998875432 345788999999998766 45555666788889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECC---CCCeEEccccCceecCC
Q 010146 428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGV 504 (517)
Q Consensus 428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 504 (517)
+ +++|...+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5677776643 2345899999999999999999999998 999999999999864 45799999999999865
Q ss_pred CC
Q 010146 505 DQ 506 (517)
Q Consensus 505 ~~ 506 (517)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2e-26 Score=229.43 Aligned_cols=149 Identities=29% Similarity=0.425 Sum_probs=121.4
Q ss_pred cCCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCC--ccCHHHHHHHHHHHhcCCCCCeeeEEEEEEe------CC
Q 010146 349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------RD 419 (517)
Q Consensus 349 ~~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 419 (517)
.++|++.++||+|+||+||+|.+. +|+.||||++.... .....++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999976 59999999997542 3344578899999999999999999999864 36
Q ss_pred EEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEccccCc
Q 010146 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499 (517)
Q Consensus 420 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 499 (517)
..++||||+.++ +.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999655 545542 34899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCC
Q 010146 500 RAFGVDQ 506 (517)
Q Consensus 500 ~~~~~~~ 506 (517)
+......
T Consensus 167 ~~~~~~~ 173 (355)
T d2b1pa1 167 RTAGTSF 173 (355)
T ss_dssp -------
T ss_pred hcccccc
Confidence 8775543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3e-23 Score=187.51 Aligned_cols=136 Identities=20% Similarity=0.237 Sum_probs=108.3
Q ss_pred CccceecccCCeeEEEEEeCCCCEEEEEEccCCCc------------------cCHHHHHHHHHHHhcCCCCCeeeEEEE
Q 010146 353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKLQHRNLVRLLGC 414 (517)
Q Consensus 353 ~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 414 (517)
.+.++||+|+||.||+|...+|+.||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999998899999998753210 001234568889999999999988865
Q ss_pred EEeCCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCceEecCCCCCcEEECCCCCeEEc
Q 010146 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494 (517)
Q Consensus 415 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 494 (517)
.. .+++|||+++..+.+ ++......++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 32 379999998765422 444556789999999999999998 9999999999999976 59999
Q ss_pred cccCceecCCCC
Q 010146 495 DFGMARAFGVDQ 506 (517)
Q Consensus 495 DFGla~~~~~~~ 506 (517)
|||+|+....+.
T Consensus 145 DFG~a~~~~~~~ 156 (191)
T d1zara2 145 DFPQSVEVGEEG 156 (191)
T ss_dssp CCTTCEETTSTT
T ss_pred ECCCcccCCCCC
Confidence 999999886544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.86 E-value=3.2e-22 Score=199.38 Aligned_cols=152 Identities=21% Similarity=0.257 Sum_probs=122.2
Q ss_pred CCCCccceecccCCeeEEEEEeC-CCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-----------CCCeeeEEEEEEe
Q 010146 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVRLLGCCTL 417 (517)
Q Consensus 350 ~~y~~~~~Ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 417 (517)
.+|++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999975 5999999999764 233467788998888775 5789999988764
Q ss_pred --CCEEEEEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCceEecCCCCCcEEECCCCC----
Q 010146 418 --RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMN---- 490 (517)
Q Consensus 418 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~---- 490 (517)
....+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35667777776655544443344555678999999999999999999998 66 999999999999986653
Q ss_pred --eEEccccCceecCCC
Q 010146 491 --PKISDFGMARAFGVD 505 (517)
Q Consensus 491 --~kl~DFGla~~~~~~ 505 (517)
+||+|||.|+.....
T Consensus 169 ~~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEEECCCTTCEETTBC
T ss_pred ceeeEeecccccccccc
Confidence 999999999977544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.83 E-value=9.5e-09 Score=95.53 Aligned_cols=149 Identities=15% Similarity=0.095 Sum_probs=105.4
Q ss_pred HHHHhcCCCCccceecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCEEE
Q 010146 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERM 422 (517)
Q Consensus 344 ~i~~~~~~y~~~~~Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 422 (517)
++......|+..+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555566776655544445578998864 46678888886654444556777888877664 445678888888889999
Q ss_pred EEEEeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhcCC--------------------------------
Q 010146 423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR-------------------------------- 470 (517)
Q Consensus 423 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-------------------------------- 470 (517)
+||+++++.++.+... +......++.++++.|+.||+...
T Consensus 87 lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999988876541 111233456667777777775321
Q ss_pred ------------------------CceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 471 ------------------------LRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 471 ------------------------~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876677999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=1.5e-06 Score=79.67 Aligned_cols=132 Identities=18% Similarity=0.149 Sum_probs=87.4
Q ss_pred ceecccCC-eeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCC--CCCeeeEEEEEEeCCEEEEEEEeCCCCC
Q 010146 356 NKLGEGGF-GPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLIYEYLPNKS 432 (517)
Q Consensus 356 ~~Ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs 432 (517)
+.+..|.. +.||+...+++..+++|....... ..+..|...++.+. ...+.+++.+..+++..++|||++++.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 34555553 678999988788889998755332 34566777666553 3446778888888888999999998766
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhHhc--------------------------------------------
Q 010146 433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-------------------------------------------- 468 (517)
Q Consensus 433 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------------------------------------------- 468 (517)
+.+.. ... ..++.++++.|+-||+.
T Consensus 93 ~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 93 LLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 53210 111 11223333334444421
Q ss_pred -----------CCCceEecCCCCCcEEECCCCCeEEccccCcee
Q 010146 469 -----------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 469 -----------~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
.+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112389999999999999876678999998875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.90 E-value=3.5e-05 Score=61.27 Aligned_cols=93 Identities=13% Similarity=0.100 Sum_probs=56.5
Q ss_pred EEEEeCCCCCC--------------CCcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeee
Q 010146 14 FMSSWKSADDP--------------AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVS 79 (517)
Q Consensus 14 ~L~Sw~s~~dp--------------s~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~ 79 (517)
.|.||.+.++| +.|.|+|.|+.+|++. ++++..+||.++..... ......+...... ...+
T Consensus 3 ~~~s~~~~~~~~~~l~~~q~l~~~~~~~~y~l~mQ~DGNLV--Ly~~~~~vWssnt~~~~-~~~~l~l~~dGnL--vL~d 77 (119)
T d1b2pa_ 3 IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLV--LYDNNNPIWATNTGGLG-NGCRAVLQPDGVL--VVIT 77 (119)
T ss_dssp EEECSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSCEE--EEETTEEEEECCCTTSC-SSCEEEECTTSCE--EEEC
T ss_pred EEEeeecCCCCCCEEeCCCeEEEecCCceEEEEECCCCcEE--EEECCeEEEEecCCCCC-cceEEEEEeCCCE--EEEC
Confidence 46677776666 5799999999999954 46888999998765321 1111222222211 1222
Q ss_pred cCCeEEEEEEeccCceeeeEEEccCCCeEEEE
Q 010146 80 NENEVFYRFNLIKSSVLTMMVINPQGEPQRLT 111 (517)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~ 111 (517)
..+...............+++|+.||+|++|.
T Consensus 78 ~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE
T ss_pred CCCcEEEECCCcCCCCceEEEEcCCCCEEEEC
Confidence 23333332222233345689999999999994
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=2.7e-05 Score=76.06 Aligned_cols=75 Identities=12% Similarity=0.150 Sum_probs=49.2
Q ss_pred ceecccCCeeEEEEEeCC-CCEEEEEEccCC-------CccCHHHHHHHHHHHhcCC---CCCeeeEEEEEEeCCEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLI 424 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 424 (517)
+.||.|....||+....+ ++.++||..... -+...++...|.+.|+.+. ...+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998655 678999965321 1223345566777776552 2346666655 45566899
Q ss_pred EEeCCCCC
Q 010146 425 YEYLPNKS 432 (517)
Q Consensus 425 ~e~~~~gs 432 (517)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.30 E-value=0.00023 Score=56.51 Aligned_cols=81 Identities=14% Similarity=0.102 Sum_probs=47.7
Q ss_pred CCcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccC
Q 010146 25 AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQ 104 (517)
Q Consensus 25 s~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 104 (517)
+.|.|+|.|+.+|.+ +++++..+||.++.-. ........+.....+ ...+.+++..+...........+++|++|
T Consensus 33 ~~g~y~L~~q~DGNL--vL~~~~~~vW~s~t~~-~~~~~~~~l~~~GnL--vl~d~~~~~lW~S~t~~~~~~~~l~Lq~D 107 (120)
T d1dlpa2 33 QLSPYRLSMETDCNL--VLFDRDDRVWSTNTAG-KGTGCRAVLQPNGRM--DVLTNQNIAVWTSGNSRSAGRYVFVLQPD 107 (120)
T ss_dssp BCSSCEEEEETTTEE--EEEBTTBCCSCCCCCS-SCSSCEEEEETTTEE--EEEETTTEEEEECCCCCSSSCCEEEECSS
T ss_pred EcCCEEEEEcCCCcE--EEecCCcEEEEEcccc-CCCcEEEEEeCCeeE--EEEcCCCCEEEEeCCCCCCCcEEEEECCC
Confidence 579999999999986 4567788999876532 111112223322211 11223333333222222334468999999
Q ss_pred CCeEEE
Q 010146 105 GEPQRL 110 (517)
Q Consensus 105 G~l~~~ 110 (517)
|+|++|
T Consensus 108 GnlvlY 113 (120)
T d1dlpa2 108 RNLAIY 113 (120)
T ss_dssp SCEEEE
T ss_pred CcEEEe
Confidence 999999
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00046 Score=65.11 Aligned_cols=135 Identities=13% Similarity=0.174 Sum_probs=78.6
Q ss_pred eeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCCe--eeEE-----EEEEeCCEEEEEEEeCCCCCH---
Q 010146 364 GPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL--VRLL-----GCCTLRDERMLIYEYLPNKSL--- 433 (517)
Q Consensus 364 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL--- 433 (517)
-.||++...+|+.+++|+.+.. ....+++..|...+..|....+ +..+ ......+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999999999998653 3456778888888877642221 1111 123456678899999876332
Q ss_pred --HHH------H---hcc------CCCCCCC-------------------HHHHHHHHHHHHHHHHHhHh----cCCCce
Q 010146 434 --EQF------I---FDV------TRTKFLD-------------------WSKRCQIIEGIARGLLYLHQ----DSRLRI 473 (517)
Q Consensus 434 --~~~------l---~~~------~~~~~l~-------------------~~~~~~i~~qi~~aL~~LH~----~~~~~i 473 (517)
..+ + +.. .....++ ...+..+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 1 110 0011111 11111222222233333322 223468
Q ss_pred EecCCCCCcEEECCCCCeEEccccCcee
Q 010146 474 IHRDLKASNVLLDNDMNPKISDFGMARA 501 (517)
Q Consensus 474 iH~Dlkp~NIll~~~~~~kl~DFGla~~ 501 (517)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899998864
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.21 E-value=0.0015 Score=50.88 Aligned_cols=80 Identities=5% Similarity=0.062 Sum_probs=47.3
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|.|.|+.+|++. +|.+..++|.++..+...-. .-.+.....+. . .+.....+...........+++|+.||
T Consensus 18 ~g~~~l~~q~DGNLv--ly~~~~~vW~s~~~~~~~~~-~l~l~~dGnLv--l-~~~~~~~w~s~t~~~~~~~~l~L~ddG 91 (112)
T d1xd5a_ 18 EGGYLFIIQNDCNLV--LYDNNRAVWASGTNGKASGC-VLKMQNDGNLV--I-YSGSRAIWASNTNRQNGNYYLILQRDR 91 (112)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCTTSCSSE-EEEECTTSCEE--E-EETTEEEEECCCCCSCCCCEEEECTTS
T ss_pred ECCEEEEEcCCCCEE--EEcCCcEEEEccCccCCCCc-EEEEeccccEE--E-EecCCeEEEEeeccCCCceEEEEcCCC
Confidence 399999999999854 56788899998765421111 11122222111 1 122333322222333445789999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
+|++|.
T Consensus 92 Nlvly~ 97 (112)
T d1xd5a_ 92 NVVIYD 97 (112)
T ss_dssp CEEEEC
T ss_pred CEEEEC
Confidence 999994
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.06 E-value=0.0013 Score=50.95 Aligned_cols=81 Identities=6% Similarity=-0.018 Sum_probs=47.7
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|+|.|+.+|++ ++|++..++|.++..+... .....+.... .+......+....+..........+++|..||
T Consensus 18 ng~~~l~~q~DGNL--vly~~~~~vW~s~~~~~~~-~~~l~l~~~G--nlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddG 92 (108)
T d1jpca_ 18 YGSFVFIMQEDCNL--VLYDVDKPIWATNTGGLSR-SCFLSMQTDG--NLVVYNPSNKPIWASNTGGQNGNYVCILQKDR 92 (108)
T ss_dssp ETTEEEEECTTSCE--EEEETTEEEEECCCTTSCS-SCEEEECTTS--CEEEECTTCCEEEECCCCCSCSCEEEEECTTS
T ss_pred cCCEEEEECCCCeE--EEEeCCceeeEeCCCCCCC-ccEEEEeccc--eEEEECCCccceEEccccCCCCcEEEEEcCCC
Confidence 49999999999995 4578899999987643211 1111122222 11112223333333222233345678999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
+|++|.
T Consensus 93 NlVly~ 98 (108)
T d1jpca_ 93 NVVIYG 98 (108)
T ss_dssp CEEEEE
T ss_pred CEEEeC
Confidence 999994
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=96.84 E-value=0.0032 Score=48.65 Aligned_cols=82 Identities=10% Similarity=0.031 Sum_probs=45.8
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|+|.|+.+|.+. +|.+..++|.++.-....-...-.+..... +.....++.....-.......-.+++|..||
T Consensus 18 ~g~~~l~~q~dgnLv--l~~~~~~vW~ant~~~~~~~~~l~l~~dGn--Lvl~~~~g~~vW~s~t~~~~~~~~l~L~ddG 93 (109)
T d1kj1a_ 18 VEPYHFIMQEDCNLV--LYDHSTSVWASNTGILGKKGCKAVLQSDGN--FVVYDAEGRSLWASHSVRGNGNYVLVLQEDG 93 (109)
T ss_dssp ETTEEEEECTTSCEE--EEETTEEEEECCCCCTTCCCCEEEECTTSC--EEEECSSSCEEEECCCCCCSSCCEEEECTTS
T ss_pred eCCEEEEecCCCeEE--EEeCCEEEEEeCCCCCCceeEEEEEcCCce--EEEEeCCCcEEEEEeeECCCCCEEEEEeCCC
Confidence 599999999999854 567888999986532111001111222221 1112222222222222223344689999999
Q ss_pred CeEEEE
Q 010146 106 EPQRLT 111 (517)
Q Consensus 106 ~l~~~~ 111 (517)
+|++|.
T Consensus 94 Nlvly~ 99 (109)
T d1kj1a_ 94 NVVIYG 99 (109)
T ss_dssp CEEEEC
T ss_pred cEEEEC
Confidence 999994
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.79 E-value=0.0015 Score=63.35 Aligned_cols=72 Identities=17% Similarity=0.265 Sum_probs=48.2
Q ss_pred ceecccCCeeEEEEEeCC--------CCEEEEEEccCCCccCHHHHHHHHHHHhcCCCCC-eeeEEEEEEeCCEEEEEEE
Q 010146 356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYE 426 (517)
Q Consensus 356 ~~Ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 426 (517)
+.|+.|-.-.+|++..++ .+.|.+++.-. ........+|..+++.+.-.+ .+++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 678888889999998654 34566666542 223345567888888775333 4577777642 68899
Q ss_pred eCCCCCH
Q 010146 427 YLPNKSL 433 (517)
Q Consensus 427 ~~~~gsL 433 (517)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986543
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=96.78 E-value=0.0012 Score=51.73 Aligned_cols=79 Identities=8% Similarity=0.059 Sum_probs=45.1
Q ss_pred CcceEEEEccCCCcEEEEEeCCeEEEEecCCCCCceeeccCCCCCCceeeEeeecCCeEEEEEEeccCceeeeEEEccCC
Q 010146 26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG 105 (517)
Q Consensus 26 ~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G 105 (517)
.|.|+|.|+.+|.+. +|++..+||.+++-+.. .....+.....+. +....+...............+++|+.||
T Consensus 25 ~g~~~l~~q~DGNLv--L~~~~~~vW~s~t~~~~--~~~l~l~~dGNLv--l~d~~~~~vWsS~t~~~~g~y~l~Lq~DG 98 (115)
T d1dlpa1 25 LSSFRFTMQSDCNLV--LFDSDVRVWASNTAGAT--GCRAVLQSDGLLV--ILTAQNTIRWSSGTKGSIGNYVLVLQPDR 98 (115)
T ss_dssp STTEEEEECTTSCEE--EEESSSEEECCCCCSCS--CCBCCBCSSSCBC--CBCTTTCCSCCCCCCCCSSCCEEEECSSS
T ss_pred cCCEEEEECCCCeEE--EEcCCeeEEEcccCCCC--ceEEEEeccCCEE--EEccCCCEEEEcCCCCCCCCEEEEECCCC
Confidence 689999999999964 46788899998753221 1122222222111 11222222111111222334579999999
Q ss_pred CeEEE
Q 010146 106 EPQRL 110 (517)
Q Consensus 106 ~l~~~ 110 (517)
++++|
T Consensus 99 NlvlY 103 (115)
T d1dlpa1 99 TVTIY 103 (115)
T ss_dssp CEEEE
T ss_pred cEEEe
Confidence 99998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.0051 Score=57.20 Aligned_cols=158 Identities=13% Similarity=0.028 Sum_probs=82.5
Q ss_pred cchhHHHHhcCCCCccce-----ecccCCeeEEEEEeCCCCEEEEEEccCCCccCHHHHHHHHHHHhcCCC-----CCee
Q 010146 340 FDWNTIADATDNFSWKNK-----LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-----RNLV 409 (517)
Q Consensus 340 ~~~~~i~~~~~~y~~~~~-----Ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv 409 (517)
.+.++++....+|.+.+. |..|---+.|+....+|+ +++|+..... ..+++..|++++..|.+ |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 355677777888877544 345656778998877654 8889876532 22344556666655532 2111
Q ss_pred eEE---EEEEeCCEEEEEEEeCCCCCHHH-----------H---HhccCC----C--CC------------------CCH
Q 010146 410 RLL---GCCTLRDERMLIYEYLPNKSLEQ-----------F---IFDVTR----T--KF------------------LDW 448 (517)
Q Consensus 410 ~l~---~~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~----~--~~------------------l~~ 448 (517)
... .+.........++.++.+..... . ++.... . .. ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 01223455666777765532210 0 000000 0 00 001
Q ss_pred HHHHHHHHHHHHHHHHhHhc-CCCceEecCCCCCcEEECCCCCeEEccccCce
Q 010146 449 SKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500 (517)
Q Consensus 449 ~~~~~i~~qi~~aL~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 500 (517)
......+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222333333333321 23469999999999999988777899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.28 E-value=0.0034 Score=36.29 Aligned_cols=33 Identities=33% Similarity=0.754 Sum_probs=26.0
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccCC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPKS 164 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~~ 164 (517)
|.|.+-..||. |.|+.-.....|.|-.||+|..
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 67999999995 7897432445799999999863
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=93.53 E-value=0.033 Score=43.09 Aligned_cols=37 Identities=16% Similarity=0.286 Sum_probs=30.5
Q ss_pred EEeCCCCCCCCcceEEEEccCCCcEEEEEeCCeEEEEecCC
Q 010146 16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPW 56 (517)
Q Consensus 16 ~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~yw~sg~w 56 (517)
+-|.+.++.++|.|.+.|+++|...+ | +.+||.+|+-
T Consensus 77 ~vWsS~t~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt~ 113 (115)
T d1dlpa1 77 IRWSSGTKGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGTS 113 (115)
T ss_dssp CSCCCCCCCCSSCCEEEECSSSCEEE--E--CSEEEECSCC
T ss_pred EEEEcCCCCCCCCEEEEECCCCcEEE--e--CCCeecCCCC
Confidence 45999999999999999999999654 4 3589998863
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.42 E-value=0.013 Score=36.28 Aligned_cols=33 Identities=27% Similarity=0.653 Sum_probs=25.9
Q ss_pred CCCCCC-CCCCCCCccccCCCCCCcccccCCCcc
Q 010146 130 LDQCDN-YALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 130 ~~~C~~-~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
.|+|.. ...|..+|.|........|.|++||+-
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 367875 578999999975445678999999963
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.08 E-value=0.025 Score=34.25 Aligned_cols=32 Identities=38% Similarity=0.781 Sum_probs=24.0
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
|.|. ...|...|.|........|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4779999999765356789999999743
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.08 E-value=0.11 Score=32.13 Aligned_cols=32 Identities=28% Similarity=0.607 Sum_probs=24.5
Q ss_pred CCCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 130 ~~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
.|+|.... |+.++.|.....+-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 48898655 557899975445678999999986
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.07 E-value=0.047 Score=33.93 Aligned_cols=35 Identities=26% Similarity=0.588 Sum_probs=24.8
Q ss_pred CCCCCC-CCCCCCCccccCCCCCCcccccCCCccCCc
Q 010146 130 LDQCDN-YALCGAYAICNMNSNSARCECLEGFVPKSP 165 (517)
Q Consensus 130 ~~~C~~-~~~CG~~~~C~~~~~~~~C~C~~gf~~~~~ 165 (517)
.|+|.. ...| .++.|.....+..|.|++||+...+
T Consensus 3 idEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 3 IDECRISPDLC-GRGQCVNTPGDFECKCDEGYESGFM 38 (44)
T ss_dssp CCTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECTT
T ss_pred ccccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCCC
Confidence 377876 4456 4789974435678999999986533
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.99 E-value=0.038 Score=33.39 Aligned_cols=32 Identities=22% Similarity=0.527 Sum_probs=23.9
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
|+|. ...|...|.|....+...|.|++||+-.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 5564 3679999999754356789999999743
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.70 E-value=0.036 Score=33.56 Aligned_cols=32 Identities=34% Similarity=0.529 Sum_probs=25.1
Q ss_pred CCCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 130 ~~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
.|+|. ...|-..|.|....+..+|.|++||+-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence 47787 577999999975435678999999964
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.67 E-value=0.11 Score=31.64 Aligned_cols=31 Identities=29% Similarity=0.752 Sum_probs=23.6
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
|+|...+.| ..+|.....+..|.|++||+..
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678877777 4588754456789999999875
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.46 E-value=0.045 Score=33.94 Aligned_cols=33 Identities=21% Similarity=0.513 Sum_probs=24.9
Q ss_pred CCCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 010146 130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 130 ~~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
.|+|.....| -.+.|.....+..|.|++||+..
T Consensus 3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 4778877666 47899754355789999999875
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.37 E-value=0.079 Score=31.08 Aligned_cols=30 Identities=30% Similarity=0.630 Sum_probs=22.0
Q ss_pred CCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 132 QCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 132 ~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
+|. ...|...|.|....+..+|.|++||+-
T Consensus 2 ~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 2 ECA-SSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp TTT-TCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCC-CCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 453 466888899975435678999999964
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.09 E-value=0.047 Score=32.56 Aligned_cols=31 Identities=32% Similarity=0.573 Sum_probs=23.2
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
|+|. ...|-..|.|........|.|++||+-
T Consensus 3 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 33 (37)
T d2c4fl1 3 DQCA-SSPCQNGGSCKDQLQSYICFCLPAFEG 33 (37)
T ss_dssp CGGG-GCCCCTTCEEEEETTEEEEECCTTEES
T ss_pred ccCC-CCCCCCCCEEECCCCCeEEECCCCCcC
Confidence 5564 567888899975435578999999974
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.71 E-value=0.056 Score=33.26 Aligned_cols=32 Identities=34% Similarity=0.748 Sum_probs=22.8
Q ss_pred CCCCC-CCCCCCCccccCCCCCCcccccCCCccC
Q 010146 131 DQCDN-YALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 131 ~~C~~-~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
|+|.. ++.|. +++|.....+..|.|++||++.
T Consensus 3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 44533 56674 7899754356789999999875
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.96 E-value=0.066 Score=32.30 Aligned_cols=31 Identities=26% Similarity=0.574 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 010146 132 QCDNYALCGAYAICNMNSNSARCECLEGFVPK 163 (517)
Q Consensus 132 ~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~ 163 (517)
.|. +..|...|.|....+...|.|++||.-.
T Consensus 3 ~C~-~~pC~ngg~C~~~~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 3 ACT-NTSCSGHGECVETINNYTCKCDPGFSGL 33 (39)
T ss_dssp CCC-TTGGGGSEEEEEETTEEEEEECTTEEST
T ss_pred ccc-CCcCCCCcEEECCCCCEEEeCCCCCcCc
Confidence 454 4678889999754355789999999643
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.03 E-value=0.069 Score=32.33 Aligned_cols=32 Identities=22% Similarity=0.592 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCCccccCCCCCCcccccCCCccCC
Q 010146 131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPKS 164 (517)
Q Consensus 131 ~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~~~ 164 (517)
|+|...+.|. .+|.....+..|.|+|||....
T Consensus 3 dEC~~~~~C~--~~C~N~~Gsy~C~C~~Gy~l~g 34 (40)
T d1dx5i3 3 DECENGGFCS--GVCHNLPGTFECICGPDSALAG 34 (40)
T ss_dssp CHHHHCSSCS--SEEEECSSSEEEEECSSSSCEE
T ss_pred cccCCCcCcc--CEeeCCCCCeEeECCCCCeeCC
Confidence 5666666674 5786544567899999998753
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.39 E-value=0.35 Score=30.38 Aligned_cols=31 Identities=26% Similarity=0.618 Sum_probs=24.0
Q ss_pred CCCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 010146 130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 130 ~~~C~~~~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
.++|+- ..|. +|.|....+...|.|++||.-
T Consensus 8 ~~~C~~-~PC~-nG~C~~~~~~y~C~C~~G~~G 38 (48)
T d1autl1 8 EHPCAS-LCCG-HGTCIDGIGSFSCDCRSGWEG 38 (48)
T ss_dssp CCSSSS-TTTT-SEEECCCSSCCCEEECTTEES
T ss_pred CCcccC-CCCC-CCEEECCCCCCeEeCCCCCcC
Confidence 578885 7797 599975545678999999964
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.87 E-value=0.4 Score=30.86 Aligned_cols=30 Identities=13% Similarity=0.298 Sum_probs=20.3
Q ss_pred CCCCCCCCccccCCCCCCcccccCCCccCC
Q 010146 135 NYALCGAYAICNMNSNSARCECLEGFVPKS 164 (517)
Q Consensus 135 ~~~~CG~~~~C~~~~~~~~C~C~~gf~~~~ 164 (517)
....|+...+|.....+..|+|++||+...
T Consensus 16 ~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~~ 45 (53)
T d1apqa_ 16 EDPQPQCQHLCHNYVGGYFCSCRPGYELQE 45 (53)
T ss_dssp CSSSCTTSSEEEEETTEEEEECSTTCEECT
T ss_pred cCCCCCccCEeEcCCCCeEeECCCCCeECC
Confidence 334455556786444567899999998753
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.68 E-value=0.33 Score=30.06 Aligned_cols=34 Identities=21% Similarity=0.437 Sum_probs=23.4
Q ss_pred CCCCCCC--CCCCCccccCCCCCCcccccCCCccCC
Q 010146 131 DQCDNYA--LCGAYAICNMNSNSARCECLEGFVPKS 164 (517)
Q Consensus 131 ~~C~~~~--~CG~~~~C~~~~~~~~C~C~~gf~~~~ 164 (517)
|+|.... .+|-..+|.....+..|.|++||+...
T Consensus 2 dEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (45)
T d1szba2 2 DECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHR 37 (45)
T ss_dssp CTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECT
T ss_pred cCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeECC
Confidence 6676642 234566886443567899999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.03 E-value=0.17 Score=30.57 Aligned_cols=26 Identities=19% Similarity=0.528 Sum_probs=19.9
Q ss_pred CCCCCCccccCCCCCCcccccCCCcc
Q 010146 137 ALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 137 ~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
..|.++..|.....+..|.|.+||.-
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~G 32 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTG 32 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcC
Confidence 35888899975435578999999974
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=80.35 E-value=0.42 Score=30.77 Aligned_cols=30 Identities=20% Similarity=0.496 Sum_probs=22.6
Q ss_pred CCCCCCCCCccccC--CCCCCcccccCCCccC
Q 010146 134 DNYALCGAYAICNM--NSNSARCECLEGFVPK 163 (517)
Q Consensus 134 ~~~~~CG~~~~C~~--~~~~~~C~C~~gf~~~ 163 (517)
...+.|-..|.|.. .....+|.|++||.-.
T Consensus 9 c~~~~C~NgG~C~~~~~~~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 9 SYDGYCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp TSSCCSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred CCCCCCCCCcEeeccCCCCCeEeECCCCCcCC
Confidence 34688999999963 2245789999999643
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.13 E-value=0.14 Score=30.96 Aligned_cols=26 Identities=23% Similarity=0.545 Sum_probs=19.8
Q ss_pred CCCCCCccccCCCCCCcccccCCCcc
Q 010146 137 ALCGAYAICNMNSNSARCECLEGFVP 162 (517)
Q Consensus 137 ~~CG~~~~C~~~~~~~~C~C~~gf~~ 162 (517)
..|-..|.|....+...|.|++||.-
T Consensus 7 ~pC~ngg~C~~~~~~y~C~C~~g~~G 32 (40)
T d1g1sa2 7 MSCSKQGECLETIGNYTCSCYPGFYG 32 (40)
T ss_dssp TGGGGSEEEEECSSSEEEEECTTEES
T ss_pred CcCCCCcEEECCCCCeEEeCCCCccC
Confidence 46777888875545678999999964
|